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ABSTRACT 
Phosphoinositides are lipid signals that control cellular processes and are particularly 
closely associated with the control of membrane trafficking. PtdIns(3,5)P2 is the most 
recently identified phosphoinositide and was previously recognised as controlling 
events in the late endocytic system, between the late endosome and the 
vacuole/lysosome. Primarily associated with retrograde trafficking from the 
vacuole/lysosome to the late endosome/MVB, PtdIns(3,5)P2 is generated by the 
kinase Fab1p (PIKfyve in animals). 
In mammalian cells, PtdIns(3,5)P2 has also been implicated in control of ill-defined 
trafficking pathways close to the Golgi; for example, the recycling of mannose-6-
phosphate receptor (M6R) back to the Golgi and also the trafficking of some types of 
ion and nutrient channels from the Golgi to the cell surface.   
This thesis describes attempts to study putative PtdIns(3,5)P2 dependent trafficking in 
the early endocytic system of S cerevisiae using two model proteins; the recycling of 
Vps10p from late endosome to Golgi and of Chs3p from recycling endosome to 
Golgi. 
Vps10p is a membrane ‘receptor’ for the vacuolar carboxypeptidase Y (CPY) protein 
that directs this soluble hydrolyase out of the secretory pathway, so that it is correctly 
sorted into the vacuole. Once it has performed this job, Vps10p recycles back to the 
Golgi, in a retromer dependent fashion, to bind more CPY cargo for successive 
rounds of sorting.  This study examined recycling of Vps10-GFP, expressed at native 
levels in wild-type cells and in cells that cannot synthesize PtdIns(3,5)P2 (∆fab1) by 
co-localisation with red fluorescent protein tagged markers for the yeast TGN and 
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early endosome. By fluorescent microscopy it was shown that neither Fab1p or 
PtdIns(3,5)P2 have an affect on recycling of Vps10p, However the process was 
demonstrated to be dependent upon Vac14p; a protein involved in production of 
PtdIns(3,5)P2 but which this thesis shows has independent functions. The trafficking 
of other cargoes was also examined, including Mrl1p: a protein that shares homology 
with M6Rs. PtdIns(3,5)P2 appears to be involved in localisation of this protein, 
suggesting that PtdIns(3,5)P2 is important for the recycling of some cargoes and that 
Mrl1p trafficking could be used as screen to isolate mutants involved in PtdIns(3,5)P2 
dependent late endosome to Golgi recycling. 
Chs3p is a protein involved in chitin biosynthesis that traffics from internal stores to 
the plasma membrane. Deletion of Chs6p traps Chs3p inside the cell because the 
protein becomes enmeshed in an ‘intracellular treadmill’ of futile recycling between 
the recycling endosome and Golgi. Part of this recycling is dependent on 
PtdIns(3,5)P2 as disruption of PtdIns(3,5)P2 synthesis frees Chs3p from this futile 
cycling and allows it to access the cell surface again. When Chs3p is present at the 
cell surface, the structure of the cell wall changes and can be detected using FACS 
analysis. FACS analysis was used to isolate mutants that act in the same trafficking 
pathway as PtdIns(3,5)P2. Vps13p was found to be a novel component of Fab1p 
dependent trafficking at the early endosome and to link to Chs3p trafficking. 
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Chapter 1 
Introduction. 
1.1 Membrane trafficking   
All living organisms are composed of cells, ‘the building blocks of complex life’. 
This fact has been known since Hook and Anton van Leeuwenhoek used the first 
microscopes to examine living things. We can recognise a cell from its boundary, the 
plasma membrane that divides and separates it from the environment. Somewhere in 
evolution this boundary membrane underwent hypertrophy, giving rise to internal 
structures and compartments that were each surrounded by their own membrane. At 
first these structures would have been simple, like the involutions of the plasma 
membrane that are the still the site of energy metabolism in bacteria today. Cells 
possessing this enhanced internal organisation could be termed ‘proto-eukaryotes’ 
because at this time the nucleus was not yet the fully formed structure we know today. 
As time went on however, these internal organelles became more and more elaborate 
until the point was reached where each compartment had a unique complement of 
proteins and lipids, both in the membranes and also in the organelle lumen. In this 
way the ER, the Golgi, the nucleus and the endosomal organelles are thought to have 
evolved (Warren and Wickner, 1996). Concurrently, the peroxisomes, mitochondria 
and other plastids became part of these already larger and more complex ‘proto-
eukaryotic’ cells through the process of endosymbiosis. The fact that two disparate 
processes formed the organelles present in modern eukaryotes is reflected in the fact 
that the ER, Golgi, plasma membrane and endosomes continuously ‘communicate’ 
with each other by means of transport vesicles; constantly exchanging membrane and 
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luminal contents (Schekman, 1994, Farquhar and Palade, 1998). In contrast, the 
mitochondria and other organelles of endosymbiotic origin do not participate in 
vesicle trafficking and lie largely outside of the ‘endomembrane system’(Haucke and 
Schatz, 1997). 
One of the central problems in cell biology is to understand how each organelle in the 
endomembrane system can maintain its unique complement of membranes, proteins 
and lipids in the face of this constant exchange of material with other compartments 
(Bowers and Stevens, 2005). To begin to answer this question, it is necessary to 
understand how all membrane trafficking occurs. Much of what we know about the 
endomembrane system derives from research carried out in the 1950s by Porter, 
Palade, Novikoff, deDuve and Claude (De Duve, 1971, Palade, 1975). Porter used 
newly developed stains to examine thin sections of cells using the electron 
microscope, visualising organelles in unparalleled detail. Claude introduced the idea 
of cell fractionation, allowing isolated organelles to be studied; this lead deDuve to 
study lysosomes and to develop ideas about endosymbiosis (De Duve, 1971).  
Of them all, perhaps Palade’s work is the most seminal, as he proposed, after studies 
on the Golgi, that the organelles of the endomembrane system exchanged material via 
‘transport intermediates’ and went on to show that these were small vesicles (Palade, 
1975). What emerged from this all this work was a unified view of membrane 
trafficking that essentially reduces all protein sorting to a series of regulated 
membrane fission and fusion events that are all fundamentally similar (Mellman and 
Warren, 2000).  
In this theory, all compartments are reduced to ‘donor’ or ‘acceptor’ organelles, 
though in reality all organelles are both donors and acceptors. The ‘donor’ 
 3 
compartment contains two types of proteins; those that reside in the donor organelle 
and those that are destined for another compartment; these latter proteins are 
designated as ‘cargo’ although they may have more than passive roles in the process 
of trafficking themselves (Palade, 1975, Rothman and Wieland, 1996). One important 
idea to emerge from Palade’s work was that the sorting information necessary for a 
cargo protein to end up in the right compartment is often encoded in the protein itself. 
This sorting information, a kind of ‘molecular postcode’ can be a short linear 
sequence of amino-acids, such as the YXXΘ sequence necessary for AP-1 based 
sorting, or can also be more complex three dimensional structures, like the 
amphipathic helix required for protein sorting into mitochondria (Palade, 1975, Marks 
et al., 1997).  
The first step in regulated transmembrane protein sorting at donor compartments is 
the association of cargo with an ‘intermediary’ protein that links it to so-called ‘coat-
proteins’(Schekman and Orci, 1996). This association is driven by the sorting 
information contained in the cargo protein. Hence at least one intermediary protein 
needs to exist for each acceptor compartment in the cell, since they are the specific 
component in the system that recognises the sorting information in cargo proteins 
(Schekman and Orci, 1996). The first intermediary proteins discovered were the 
adaptins, such as AP-1, but the general properties of most intermediary proteins are 
the same; they are soluble proteins that transiently associate with membranes, 
specifically bind cargos and cluster them into defined membrane microdomains, 
before recruiting a protein coat. Likewise, all protein coats seem to work in a 
fundamentally similar way; they are soluble, self associating proteins that 
spontaneously form spherical, cage-like structures. These coat proteins are recruited 
by the intermediary proteins to the membrane microdomain that is enriched in cargo. 
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This deforms the membrane, since the lattice structure of all known coat proteins has 
intrinsic curvature. Thus coat protein binding forms an invagination that contains the 
cargo linked through the intermediary protein, to the protein coat. More cargo can 
now be recruited as the invagination deepens and more coat and intermediary proteins 
are recruited to the forming vesicle (Schekman and Orci, 1996). Eventually, vesicle 
formation is terminated by membrane scission; the process whereby the vesicle is 
separated from the donor membrane. Sometimes the energy of coat protein 
polymerisation itself is sufficient for this function (e.g. for COPII vesicles) but 
sometimes an accessory protein is required (e.g. dynamin for clathrin) (Kirchhausen, 
1999, Rothman and Wieland, 1996, Schmid, 1997).  
Once the vesicle, a ‘ball of membrane’, sheathed in the basket-like lattice of the coat 
protein, has budded off from the donor compartment, it ‘uncoats’ to prepare it for 
fusion with the acceptor compartment. Uncoating requires energy; indeed this is 
usually the major step during which energy is supplied to this system, so it is carried 
out by ATPase enzymes that break the coat protein lattice down into monomers 
(Schekman and Orci, 1996). 
Once uncoating has occurred, the vesicle trafficks along cytoskeletal elements, 
powered by motor proteins such as dynein and myosin, to the acceptor compartment. 
It is at this point that docking and fusion can occur. Docking allows a complex 
recognition system to determine if the vesicle is compatible with the acceptor 
organelle. This recognition step is principally mediated by SNARE proteins on both 
the vesicle and the acceptor compartment (Pelham, 1999). For successful recognition, 
the SNAREs on the vesicle must ‘match’ those on the acceptor compartment to form a 
stable four-helix bundle. Specific SNAREs are associated with each trafficking step in 
the cell; though some seem to be able to mediate more than one step. The correct 
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SNAREs are loaded onto a vesicle as if it were passive cargo, at the stage of vesicle 
formation, whereas SNAREs specific for each acceptor compartment are part of the 
unique protein complement of that compartment and contain specific sorting 
information that allows them to reside there (Pelham, 1999). Formation of the four-
helix SNARE bundle is spontaneous for compatible SNAREs and drives membrane 
fusion, allowing the vesicle to deliver its cargo. Note that the machinery, such as 
vesicular SNAREs, and other transmembrane proteins that directed the vesicle the 
acceptor compartment are now ‘cargo’ and must be recycled back to their correct 
compartment; so called retrograde trafficking (Pelham, 1999, Munier-Lehmann et al., 
1996).  Intermediary and coat proteins are both soluble and hence do not need to be 
recycled. This is likely to have evolved because the specificity in membrane 
trafficking comes, not from any one protein, but from the formation of specific 
complexes of proteins. Hence it is important that these complexes never form 
inappropriately.  
The above picture is merely an outline of trafficking as many more proteins are 
involved, some of which are essential, but whose function is obscure. It is also true 
that for many trafficking steps, the coat and intermediary proteins have not yet been 
isolated. Indeed the above model raises more questions than it answers.  
Note also that the above discussion of sorting relates to transmembrane protein cargo; 
the specific sorting of soluble, lumenal cargo is similar, save that each soluble protein 
first associates with a transmembrane ‘receptor’ that then links the soluble cargo to an 
intermediary protein or sometimes directly to a coat protein. The first such 
transmembrane receptor for soluble cargo to be discovered was the Mannose-6-
phosphate receptor (M6R), which links enzymes destined for the lysosome to the AP-
1 adaptins and thence to clathrin (Munier-Lehmann et al., 1996, Schmid, 1997). 
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The caveat to the idea of regulated protein sorting is that of ‘default trafficking’; i.e. 
what happens to proteins that contain no recognisable sorting information? From 
studies in the yeast S. cerevisiae, we now know that the default destination for soluble 
proteins that contain no sorting information, yet reside in the lumen of an organelle, is 
to be secreted to the outside of the cell (Schekman, 1994). In contrast, transmembrane 
proteins that contain no recognisable sorting information are sent to the vacuole 
(lysosome in higher eukaryotes) to be degraded (Bowers and Stevens, 2005). This 
latter sorting bias is probably an evolutionary protection mechanism to prevent 
protein aggregation; since one of the commonest types of cargo without sorting 
information are proteins that have become unfolded where the sorting information is 
no longer recognisable or accessible. These membrane proteins pose a risk to the cell 
since they are thermodynamically driven to associate with other unfolded proteins and 
this can result in precipitation of the membrane, which often triggers apoptosis. Hence 
the cell has evolved to degrade them as rapidly as possible. 
Much of our knowledge of membrane trafficking comes from studies of the yeast S. 
cerevisiae.  This model eukaryotic organism is so useful because laboratory strains 
are haploid, grow rapidly in defined liquid or solid culture, possess a small and 
compact genome that encodes very few introns and boast a DNA repair system that is 
heavily biased towards homologous recombination; rendering the targeted deletion of 
any gene relatively trivial.  
 
1.2 Compartment identity.  
One thing that has made S. cerevisiae problematic for studies of membrane trafficking 
is the issue of compartment identity; yeast endosomal compartments have often been 
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defined on genetic rather than morphological criteria, making it hard to generalise 
observations made in yeast to higher eukaryotes because of uncertainties about which 
yeast compartment is homologous to the mammalian late endosome, for example. 
One reason this may be so problematic is the suspicion that the yeast endosomal 
system has become truncated throughout the course of evolution, when compared 
with slower growing, ‘higher’ eukaryotes. Indeed yeast seem to have lost many genes 
and pathways that they must once have possessed, not just in trafficking but across a 
wide spectrum of their cell physiology, based on evolutionary data.  It has been 
proposed that by using SNARE and Rab proteins as markers for compartments, the 
issue may be made less ambiguous (Pelham, 2002, Dove et al., 2009) and this is the 
approach adopted in this work; the compartments are defined as follows: 
The Snc1p (SNARE) positive compartment underlies the yeast plasma membrane, 
where FM4-64, an endocytosed lipophillic dye, appears at early time points.This 
indicates the compartment is either an early or recycling endosome (Dove et al., 
2009). However from this compartment there is no direct trafficking pathway, to the 
cell surface and any cargo to be transported to the plasma membrane appears to first 
pass though the Golgi. So this compartment is sometimes named the ‘post-Golgi 
endosome’ or PGE to avoid confusion with true early or recycling endosomes in 
mammals (Dove et al., 2009).  
The Pep12p (SNARE)-positive compartment has trafficking pathways to and from the 
plasma membrane, and is also the site of multi-vesicular body (MVB) formation and 
maturation in yeast (Ali et al., 2004), a function normally associated with mammalian 
‘late endosomes’ (Dove et al., 2009). However entry into the yeast Pep12p-positive 
compartment is controlled by Vps21p; a Rab GTPase, most closely resembling 
mammalian Rab5, which resides on early endosomes (Schimmoller and Riezman, 
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1993). Therefore it has been proposed that the Pep12p positive compartment is an 
early endosome that can mature or acquire late endosomal characteristics. Indeed a 
recent immuno-EM study of Pep12p distribution suggests that this compartment loses 
Pep12p staining just around the time it starts to develop the intra-lumenal vesicles 
characteristic of MVBs (Prescianotto-Baschong and Riezman, 2002). To avoid 
confusion the Pep12p-positive compartment will be known as the ‘pre-vacuolar 
endosome’ or PVE (Dove et al., 2009).  
  
It is often assumed that the yeast vacuole is homologous to the lysosome, due to its 
large size and acidity, with a pH of around 6.0. They appear to have a similar 
functions since both are home to many proteolytic enzymes (Rusten et al., 2007b) but 
the lysosome is even more acidic with a pH of 4-5 (Dove et al., 2009). Indeed a pH of 
6.0 is characteristic of the mammalian late endosome. In addition, Ypt7p, which is 
homologous to mammalian Rab7, resides in the vacuole. In animal cells, Rab7 
controls entry to late endosomes leading to the suggestion that the yeast vacuole may 
be more like a modified version of the mammalian late endosome, or an endosome-
lysosome hybrid (Dove et al., 2009). 
 
1.3 Yeast in trafficking research. 
Much of the machinery for membrane trafficking was first isolated from studies of 
yeast SEC and VPS mutants; all of which possess defects in the sorting of soluble 
proteins. The SEC mutants have defects in the secretion of soluble proteins to the 
outside of the cell. The VPS mutants all missort a vacuolar hydrolyase, known as 
carboxypeptidase Y (CPY), and end up secreting it (Bowers and Stevens, 2005). Both 
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sets of mutants were identified by chemical mutagenesis of wild-type yeast and then 
the resulting pools of mutants were screened for either internal retention of normally 
secreted proteins or for secretion of the normally vacuolar enzyme, CPY respectively. 
The VPS mutants were then classified based on the morphology of their vacuoles, into 
a series of groupings (see table below) (Bowers and Stevens, 2005, Raymond et al., 
1992, Banta et al., 1988). It later emerged, after the defective genes in these strains 
were isolated, that each class of VPS mutant represent disparate defects that are all 
blocked at the same step. For example, all class E VPS mutants have a defect in MVB 
formation and hence class E VPS genes encode components of the ESCRT sorting 
machinery required for MVB formation (Bowers and Stevens, 2005). 
 
Table 1.1 Classification of VPS mutants (Bowers and Stevens, 2005). 
Class Vacuolar morphology 
A 
 
Wild-type with 3-10 spherical vacuoles that cluster in one area of the 
cytoplasm.  
B Fragmented vacuoles: more than 20 small, vacuole like compartments. 
C No identifiable vacuoles. 
D Single large vacuole that fails to extend into daughter cell buds. 
E Larger than wild-type, with a very large aberrant pre-vacuolar endosome. 
F One large vacuole surrounded by fragmented vacuolar structures.   
 
Subsequently, the END screen, the ALP screen and the ATG screens revealed the 
genes involved in endocytosis, the AP-3 pathway and autophagy respectively in a 
similar way to the original SEC and VPS screens. Hence yeast have proved pivotal in 
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the isolation of components of nearly all the fundamental membrane trafficking 
pathways present in eukaryotes. 
 
Figure 1.2  Diagram of the endocytic system in S. cerevisiae. 
 
Diagram shows many of the common trafficking events, which take place inside the cell. There are 
multiple vesicular transport pathways that deliver proteins to and from the vacuole. 
 
 
 
1.4 Routes to the Vacuole/Lysosome. 
The major route into the vacuole is known as the ‘biosynthetic pathway’ and is 
primarily defined as the route followed by CPY, as elucidated by the VPS screen. 
Newly synthesized soluble proteins travel non-specifically to the TGN where they 
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bind to a number of cargo receptors, such as Vps10p (Marcusson et al., 1994). The 
soluble proteins are then specifically sorted to the maturing PVE by these cargo 
receptors. These receptors are then recycled away from the PVE by means of a novel 
coat complex, known as Retromer, whilst the soluble proteins remain in the lumen of 
the PVE. The PVE then matures into an MVB by lipid partitioning that creates micro 
domains within the late endosome/PVE. These micro domains are rich in specific 
lipids including PtdIns3P (Vicinanza et al., 2008a, Odorizzi et al., 2000, Jeffries et al., 
2004). Inward budding occurs to form intralumenal vesicles and is controlled by the 
Yeast class E VPS proteins. Specific trans-membrane domains can also direct sorting 
into the MVB (Urbanowski and Piper, 2001). Membrane proteins such as Cps1p 
(Carboxypeptidase S) or Phm5p (vacuolar polyphosphate phosphatase) that are 
transported into the vacuole lumen utilise this pathway; Cps1p is transported to the 
MVB as a membrane protein. It is then integrated into internal vesicles for delivery to 
the vacuole. Once at the vacuole it is processed to remove the membrane domain 
(Bowers and Stevens, 2005). Ubiquitinated proteins are also sorted into MVB lumenal 
vesicles; indeed this is how many unfolded membrane proteins are degraded in yeast. 
In order to deliver proteins for degradation, the MVB undergoes homotypic and 
heterotypic fusion with vacuoles/lysosomes (Piper and Luzio, 2001) after maturation.  
Members of the V-ATPase also transit the biosynthetic pathway but do not enter the 
interlumenal vesicles of the MVB (Piper et al., 1995, Bowers and Stevens, 2005) and 
so end up on the vacuole outer membrane when the MVB fuses with the vacuole.  
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1.4.1 Endocytosis. 
The major route to internalise receptors is the clathrin coated vesicle pathway (CCV). 
Here, receptors are linked to the clathrin lattice by a variety of adapter proteins 
(Kirchhausen, 1999). In mammalian cells PtdIns(4,5)P2 binds to Epsin through the 
ENTH domain (Vicinanza et al., 2008a, Odorizzi et al., 2000), and this allows 
recruitment of endocytic machinery to internalise the cargo.  
Endocytosed receptors are delivered to the PVE/endosome, where sorting occurs, and 
proteins can be committed into a pathway to the vacuole for degradation (Vicinanza et 
al., 2008a). Carrier vesicles are also received from the Golgi in a clathrin dependent 
process. Outward recycling pathways are also present (Clague et al., 2009). The 
FYVE domain is recognised to act as an early endosomal localisation signal (Clague 
et al., 2009, Gaullier et al., 1998), implicating PtdIns3P in the homotypic fusion of 
endosomes. This role is further supported by inhibition of PDGF receptor trafficking 
in wortmannin treated animal cells (Li et al., 1995, Joly et al., 1995).  
 
1.4.2 The AP-3 Pathway. 
The ‘AP-3’ or ‘ALP pathway’ controls direct trafficking from the TGN to the 
vacuole, in a clathrin independent process that bypasses the MVB completely (Cowles 
et al., 1997, Piper et al., 1997). Vps41p first associates with the AP-3 complex (an 
adapter complex, consisting of four class C VPS proteins) and later the HOPS 
complex (required for fusion), providing a link from cargo selection to eventual 
docking and fusion with the target membrane (Darsow et al., 2001).  
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1.4.3 The Cytoplasm to vacuole (Cvt) pathway and Autophagy. 
In the Cvt pathway (see Figure 1.1), membrane of unknown origin creates an 
envelopment of API complexes (vacuolar amino-peptidase I) which delivers vesicles 
to the vacuole so that this hydrolyase is correctly targeted (Dove et al., 2009). 
Autophagy is induced upon starvation, and delivers cytoplasm and organelles to the 
vacuole for amino acid recycling using a machinery that largely overlaps with that of 
the Cvt pathway but with additional components. In both the Cvt and autophagy 
pathways, double membrane vesicles are formed de novo in the cytoplasm (Teter and 
Klionsky, 2000). 
 
As mentioned abovelipids and particularly phosphoinositides are crucial for the 
function of membrane trafficking at various compartments within the cell. In order to 
understand membrane trafficking we must also understand phosphoinositides.  
 
1.5 Phosphoinositide-based regulatory systems.  
PPIn are a class of lipid signalling molecules that decorate different organelle 
membranes of all eukaryotic cells and seem to act as ‘compartment markers’ (Clague 
et al., 2009). PPIn also help regulate general homeostasis and stress responses of 
many types of cell (Michell et al., 2006). PPIn play diverse roles throughout the 
cellular system, and are essential mediators of a wide variety of cellular processes, 
including cytoskeletal rearrangements, membrane trafficking and stimulus-response 
coupling from cell surface receptors. This multitude of functions are instigated 
through interaction with specific effector proteins, which can either gain or lose a 
function as a result of the lipid-protein interaction (Michell et al., 2006).  
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1.6 Phosphoinositide binding domains. 
Localisation of effector proteins to membrane surfaces occurs through association of 
specific protein domains on the effector that recognise and bind PPIn. Several 
domains have been identified and are known to recognise specific PPIn including, 
FYVE, PX (phox homology), PH (Pleckstrin homology), ENTH, ANTH, PROPPIN, 
Tubby and FERM domains (Cullen et al., 2001). Some domains can also have an 
effect on the properties of membranes with which they interact, such as the ENTH 
domain that causes curvature of its target membranes (Ford et al., 2002). Although a 
domain that binds PtdIns(3,5)P2 remained elusive for many years, several proteins 
which will be discussed later, have now been shown to bind PtdIns(3,5)P2. These 
include binding through a PROPPIN motif (Han and Emr, 2011, Dove et al., 2004), 
an ENTH domain or directly, as in the case of the N terminus of TRPML1 (Dong et 
al., 2010). 
 
1.6.1. PX domains  
Phox homology or PX domains are mainly required for the binding of PtdIns3P 
(Kanai et al., 2001), although it is possible that they may bind both PtdIns(3,5)P2 and 
PtdIns(4,5)P2 in some cases (Song et al., 2001, Kanai et al., 2001). Most proteins 
containing PX domains normally have roles in vesicular trafficking, protein sorting or 
lipid modification, e.g. the family of sorting nexins have roles in cargo receptor 
recycling in the endocytic system. PX domains are comprised of around 120 amino 
acids, with an N terminal 3-stranded β-sheet and a helical sub domain (Lemmon, 
2008). Hydrogen bonds are made with the phosphoinositide head group PX domains, 
creating nine in total. Van der Waals contact with the glycerol backbone of the 
phosphoinositide increases membrane affinity of the protein (Lemmon, 2008).  
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 1.6.2. PH domains 
PH or Pleckstrin homology domains are present in large number of proteins, including 
both Protein kinase B and GRP1 (general receptor for phosphoinositides-1) (Lemmon 
and Ferguson, 2000, Isakoff et al., 1998). PH domains are structurally well 
characterised, and contain approximately 120 amino acids (Lemmon, 2008). They 
share a core fold consisting of a 7-stranded β-sandwich formed from two near-
orthogonal β-sheets, this causes two corners to be ‘open’ and the two opposite corners 
to be ‘closed’ (Lemmon, 2008). A common C-terminus is shared and comprises an α-
helix, this covers one of the open corners, whilst the other is covered by three 
interstrand loops that form much of the positively charged phosphoinositide-binding 
site (Lemmon, 2008, Lemmon and Ferguson, 2000). There is some understanding of 
PH domains and it is thought that specific sequence motifs exist to identify, and allow 
the domain to recognise and bind with a particular phosphoinositide. A sequence 
motif of basic residues exists at the loop between the first two strands of the domain, 
perhaps allowing recognition of PtdIns(3,4,5)P3 (Isakoff et al., 1998). It also allows a 
spatial disposition of basic side-chains that complements the arrangement of 
phosphate groups in the head group to maximise hydrogen bonding.  
 
1.6.3. FYVE domains 
FYVE domains were named, by the Stenmark lab, after the proteins in which the 
domain was first identified; Fab1p, YOTB, Vac1p and EEA1 (Stenmark et al., 1996). 
Like PX domains, FYVE domains allow binding of PtdIns3P (Sbrissa et al., 2002, 
Stenmark et al., 2002). FYVE domains contain approximately 60-70 amino acids and 
contain two β-hairpins and a C-terminal α-helix held together by two Zn2+ binding 
clusters creating a zinc finger like structure (Misra and Hurley, 1999). A basic 
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sequence motif is present in the first β-strand, creating a shallow positively charged 
pocket, that is responsible for PtdIns3P binding (Lemmon, 2008). Side-chains 
stemming from the basic motif are responsible for almost all hydrogen bonding with 
the head group (Lemmon, 2008, Dumas et al., 2001). Targeting of FYVE domains to 
membranes requires additional elements due to relatively weak hydrogen binding, and 
the low abundance of its target phosphoinositide, PtdIns3P making most FYVE 
domain proteins into ‘coincidence detectors’ that require binding to both lipid and 
protein binding partners before they can stably associate with membranes (Lemmon, 
2008). FYVE domains are able to penetrate the membrane through insertion of non-
polar side-chains from the membrane interaction loop into the membrane interior 
(Sankaran et al., 2001). Hydrogen bonding of the head group combines with these 
non-specific hydrophobic interactions in order to promote membrane targeting, 
however targeting of most FYVE proteins requires dimerisation of the FYVE domain 
(Lemmon, 2008, Gillooly et al., 2000). 
 
1.7 Metabolism of phosphoinositides 
Alterations in PPIn signalling are common properties of many human diseases, 
particularly when the cellular levels of these lipids are inappropriately elevated, 
highlighting their importance throughout the cellular system (Vicinanza et al., 2008b). 
Turnover and levels of PPIn are therefore tightly controlled. PPIn appear very 
transiently during a cellular process and then rapidly disappear, with a lifetime that is 
often only a few seconds or minutes.  
All PPIn are generated through sequential phosphorylation of hydroxyls located on 
the inositol ring of the ubiquitous membrane lipid phosphatidylinositol (PtdIns) see 
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Figure 1.2. PtdIns is generated at the endoplasmic reticulum by phosphatidylinositol 
synthase, all other steps of phosphorylation take place in specific cell compartments.  
 
Figure 1.2 Diagram of PtdIns (monophosphate). 
 
Schematic diagram showing the inositol ring with labelled hydroxyls.  
 
Phosphorylations are mediated by four distinct families of highly regulated, ATP-
dependent lipid kinases, which attack the D3, D4 and D5 hydroxyls (Michell et al., 
2006). To date no PPIn with phosphorylation at the D2 residue has been identified. 
Turnover is maintained by specific phosphatases that act to remove phosphates from 
the PPIn (Michell et al., 2006) see Figure 1.3.   
The specific kinases that produce phosphoinositides were separated into three groups: 
the Type I/III “PI-kinases”, the type II “PI-kinases” that share no sequence homology 
with the Type I/III enzymes and the PtdInsP kinases. However most of the inositol 
lipid kinases are specific, and phosphorylate only one lipid at one ring position (Balla, 
2006). Therefore they are now classified according to the reactions they catalyse: 
phosphoinositide 3-kinases (PI3Ks), PtdIns 4-kinases (PI4Ks) and three types of 
PtdInsP kinases (PIPKs) (Strahl and Thorner, 2007). 
 
 18 
The mechanism by which phosphoinositides function in trafficking is not always 
clear, however it is thought that they carry out their roles in a similar manner to the 
way in which Rab-GTPases function (Dove et al., 2009). PPIn seem to allow the 
formation of specific complexes at the membrane. When PPIn are absent, the protein-
protein affinities of membrane proteins are too low for them to interact and form a 
complex. Specific PPIn effector proteins, when able to interact with the membrane are 
then able to act as a ‘bridge’ binding both PPIn and transmembrane proteins, allowing 
formation of a stable complex (Dove et al., 2009). Phosphatases that hydrolyse PPIn 
act once the complex has served its purpose, causing disassembly. 
 
This model can explain why PPIn are able to regulate many different functions at the 
same time. An individual effector can only be recruited to a protein complex if both 
its preferred PPIn and its preferred protein are present (Efe et al., 2007, Dove et al., 
2009). Therefore PPIn can regulate many different protein complexes by regulating 
several effectors that bind the same ligand but have different protein partners (Efe et 
al., 2007, Dove et al., 2009). This along with compartmentalisation allows PPIn to 
have many varied roles.  
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1.8. Seven Species of phosphoinositides and their function 
Figure 1.4 Metabolism of the 7 species of PPIn. 
 
Kinases and phosphatases act to convert specific PPIn.  Blue backgrounds indicate phosphoinositides 
present in both mammalian and yeast cells. Green backgrounds indicate those found only in higher 
eukaryotes, although PtdIns(3,4,5)P3 and PtdIns5P have recently been detected  in S. pombe mutants 
(Mitra et al., 2004)).  
 
Seven PPIn are currently known, four of which are found in yeast (depicted in Figure 
1.4). As mentioned previously, they are present in transient but distinct pools 
throughout cellular membranes, and each phosphoinositide is associated with one 
compartment; e.g. PtdIns(4,5)P2 with the plasma membrane, PtdIns3P with early 
endosomes and PtdIns4P with the Golgi (Odorizzi et al., 2000). 
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1.8.1 PtdIns3P. 
PtdIns3P is constitutively present in eukaryotic cells (Auger et al., 1989) and is 
produced by the PI-3 kinase (PI3K) Vps34p in yeast. Vps34p is the sole class III 
enzyme in yeast, and was first found to function in the regulation of vesicular 
trafficking in the endosomal/lysosomal system, where it is responsible for the 
recruitment of proteins containing FYVE domains to intracellular membranes 
(Odorizzi et al., 2000, Lindmo and Stenmark, 2006). PtdIns3P is localised primarily 
to membranes of early endosomes and internal vesicles of  multivesicular bodies 
(MVBs) in mammalian cells (Gillooly et al., 2000). In yeast it is also found on 
vacuolar membranes. It has important roles in the regulation of the early endocytic 
pathway (Corvera, 2001) and in Golgi to lysosome vacuolar sorting (Odorizzi et al., 
2000). It is also required for autophagy, the Cvt pathway and glucose repression 
pathway (Backer, 2008, Odorizzi et al., 2000). PtdIns3P is also the precursor 
phosphoinositide to PtdIns(3,5)P2. 
 
1.8.2 PtdIns(3,4)P2. 
PtdIns(3,4)P2 levels are increased after animal cells are stimulated with growth factors 
or agonists (Stephens et al., 1993) and is not found in Yeast. The main source of 
production for PtdIns(3,4)P2 is from dephosphorylation of PtdIns(3,4,5)P3 (Andrews 
et al., 2007). PtdIns(3,4)P2 is a lipid second messenger and functions by recruitment 
of a large number of effector proteins to the membrane through PH domains. 
PtdIns(3,4)P2 is known to activate the serine/theronine kinase Akt (Franke et al., 
1997), which is involved in cell survival mechanisms and can inhibit apoptosis 
through phosphorylation leading to inactivation of Bad; a factor that promotes cell 
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death (Franke and Cantley, 1997). PtdIns(3,4)P2 is also known to have roles in  
gluconeogenesis and glycolysis, again through interaction with the Akt pathway.  
 
1.8.3 PtdIns(3,4,5)P3. 
PtdIns(3,4,5)P3 is only found in animals and slime molds, and is the major product of 
agonist-stimulated PI-3-kinases (Stephens et al., 1993). Stimulation increases levels 
by 40-fold within seconds; basal levels of the phosphoinositide are normally very low. 
PtdIns(3,4,5)P3 also acts as a second messenger to control many cellular functions and 
is downstream of the Akt pathway which has an important role in stimulating cell 
proliferation and suppression of apoptosis (Franke et al., 1997). Following activation, 
PDK (Phosphoinositide dependent kinase) and Akt are recruited to the plasma 
membrane by PtdIns(3,4,5)P3.  Akt is then phosphorlated and activated by PDK to 
interact with other important signalling pathways. Akt can also phosphorylate 
forkhead transcription factors, such as FKHR seen in breast cancers (Jackson et al., 
2000). These pathways are often mutated in various cancers and are negatively 
regulated by PTEN, a phosphatase that removes the D3 phosphate group, and SHIP-1 
and 2. These phosphatases are therefore tumour suppressors and the targets for cancer 
drug development (Cantley, 2002, Czech, 2003). PtdIns(3,4,5)P3, Akt, PTEN and the 
PI3Ks have all been identified within the nucleus and research has identified that they 
may regulate cell survival by pathways from within the nuclear membrane (Martelli et 
al., 2007). PtdIns(3,4,5)P3 has also been shown to stimulate actin polymerisation and 
controls the cytoskeleton (Funamoto et al., 2001). 
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1.8.4 PtdIns4P. 
PtdIns4P is the most abundant monophosphorylated derivative of PtdIns present in 
both yeast and mammalian cells (Lemmon, 2008). For many years PtdIns4P was 
considered to just be a precursor for PtdIns(4,5)P2 with no specific cellular role. 
However recent work using yeast has suggested that it controls many cellular 
processes (D'Angelo et al., 2008). A large concentration of PtdIns4P is observed at 
the Golgi and this is where many of its functions are based, new work however 
suggests it may play a wider role throughout the cell (D'Angelo et al., 2008, 
Vicinanza et al., 2008a). PtdIns4P is generated from PtdIns by members of the family 
of PI-4 kinases (PI4Ks) (Vicinanza et al., 2008a). Yeast have three PI4Ks; Pik1p, 
Stt4p and Lsb6p. Effectors of PtdIns4P have been identified and they fall into two 
main groups, with a role in adapter and coat complexes e.g. AP-1, GGA and EpsinR 
or a role in non-vesicular lipid transfer e.g. OBSP, CERT and FAPP proteins 
(D'Angelo et al., 2008). In both cases PtdIns4P is used as part of a complex Golgi-
membrane localisation code (D'Angelo et al., 2008). 
 
 
1.8.5  PtdIns(4,5)P2. 
 
PtdIns(4,5)P2  is present in both yeast and mammalian cells. It is the most abundant 
phosphoinositide at the plasma membrane, where it is responsible for the recruitment 
of the AP-2 complex, which promotes clathrin coated vesicle formation and 
internalisation of cell surface receptors (Vicinanza et al., 2008a). PtdIns(4,5)P2 can 
also bind to ENTH domains and therefore, can indirectly recruit components of the 
endocytic machinery. It is generated from PtdIns4P e.g. by Mss4p in yeast (Odorizzi 
et al., 2000). PtdIns(4,5)P2 has a role in regulating many important cellular pathways 
including exocytosis, endocytosis and recycling. It is also known to regulate cadherin 
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trafficking in epithelial morphogenesis (Schill and Anderson, 2009). PtdIns(4,5)P2 is 
also the precursor of both IP3; an inositol phosphate that can function as a second 
messenger in Ca
2+
 release; and of PtdIns(3,4,5)P3. 
 
1.8.6 PtdIns5P. 
PtdIns5P was first discovered in mammalian fibroblasts as a source for PtdIns(4,5)P2 
(Rameh et al., 1997), and is probably the least characterised phosphoinositide. It has 
yet to be reported in yeast. Synthesis of PtdIns5P has not been demonstrated directly 
in cells, and it could be produced from three different precursors, PtdIns, 
PtdIns(3,5)P2 or PtdIns(4,5)P2, with a mechanism of production from PtdIns(3,5)P2 
being favoured (Lecompte et al., 2008). This would be catalysed through the removal 
of the D3 phosphate group by myotubularins. A role in signal transduction is 
beginning to emerge, with its regulatory genes are often disrupted in a variety of 
human diseases (Lecompte et al., 2008). Nuclear levels of PtdIns5P are known to 
increase under cellular stress, and it can then bind to the plant homeodomain (PHD) 
domain of ING2 a tumour suppressor which promotes p53- dependent apoptosis 
(Lecompte et al., 2008, Jones et al., 2006). PtdIns5P may also help to regulate 
PtdIns(3,4,5)P3 levels (Carricaburu et al., 2003), and a role in membrane trafficking 
from the late endosome to plasma membrane has also been proposed (Lecompte et al., 
2008).  
 
1.8.7 PtdIns(3,5)P2 
PtdIns(3,5)P2 is the focus of this thesis,it will be discussed in detail below.   
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1.9. Discovery of PtdIns(3,5)P2. 
Phosphatidylinositol 3,5-bisphosphate is the most recently discovered PPIn, first 
identified in S.cerevisiae in 1997 through HPLC analysis of [
3
H]inositol radiolabelled 
lipids (Dove et al., 1997). PtdIns(3,5)P2, along with the components controlling its 
production, are conserved amongst all major eukaryotes from fungi to animals, 
indicating a function for PtdIns(3,5)P2 required throughout evolution (Michell et al., 
2006) . Perhaps one reason why PtdIns(3,5)P2 remained elusive is because of its 
steady state levels; in normal unstressed S. cerevisiae cells, PtdIns(3,5)P2 levels are 
around 20-fold lower than that of the other identified yeast phosphoinositides. 
However, this basal level of PtdIns(3,5)P2 is vital for many cellular functions in yeast 
(Dove and Johnson, 2007). Even a small decrease in the levels of PtdIns(3,5)P2 in 
unstressed cells can create defects. Different processes require different amounts of 
the lipid; only a small amount is required for acidification of the vacuole, but more is 
necessary for vacuole fragmentation. Hyper-osmotic stress with 1.4M sorbitol or 
0.9M NaCl  triggers a rapid (5-15 minutes) but transient increase (up to 20-fold), in 
the levels of PtdIns(3,5)P2 that is not observed for other phospholipids or PPIns (Dove 
et al., 1997), so levels of PtdIns(3,5)P2 are of a similar concentration to that of 
PtdIns(4,5)P2. Both the magnitude and the duration of the increase in PtdIns(3,5)P2 
are proportional to the molarity of the hyperosmotic stress given, indicating that this is 
likely to represent an adaptive response (Dove et al., 1997).  
 
Where the extra stress-induced PtdIns(3,5)P2 is synthesized, and how it is degraded 
are both unclear. Neither an increase in PtdIns3P or PtdIns5P levels after treatment 
with a stress is observed. The increase in PtdIns(3,5)P2 does however, coincide with 
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fragmentation of the yeast lysosome-like vacuole into many smaller vesicles, although 
the adaptive advantage this confers is not clear (Dove et al., 1999) (discussed below).  
 
1.10 Regulation of PtdIns(3,5)P2 metabolism 
 
PtdIns(3,5)P2 is synthesised through two tightly controlled sequential phosphorylation 
events, as shown in Figure 1.5. The PtdIns-specific PI 3-kinase, Vps34p, first 
produces PtdIns3P which is then further phosphorylated by a PtdIns3P 5-kinase, to 
generate PtdIns(3,5)P2 (Cooke et al., 1998) 
 
Figure 1.5 Pathway of PtdIns(3,5)P2 synthesis and degradation. 
 
 
Vps34p produces PtdIns3P, which is further phosphorylated by Fab1p to PtdIns(3,5)P2 (Cooke et al 
1998). The indicated proteins; Vac7p and Vac14p are required for Fab1p activity. Fig4p and Ymr1p 
dephosphorylate PtdIns(3,5)P2 and PtdIns3P respectively and Vac14p is required for correct Fig4p 
localisation (Gary et al 1998). The proteins indicated at the right of the diagram are effectors that 
mediate the effects of PtdIns(3,5)P2  in cells (Michell et al 2007). 
 
Although hyper-osmotic stress can generate PtdIns(3,5)P2, the pathway doesn’t 
interact with the well characterised Hyper-osmolarity glycerol (HOG) 
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pathway,mutants of HOG components show normal PtdIns(3,5)P2 accumulation. To 
date there is no specific probe for PtdIns(3,5)P2 so its localisation remains uncertain. 
Generation of PtdIns(3,5)P2 in response to hyperosmotic stress and the resulting 
vacuole fragmentation is rapid, and all components of the Fab1p pathway reside on 
the vacuole membrane, so PtdIns(3,5)P2 generation is probably at least partially 
vacuolar (Dove et al., 2009). However, there is evidence for discrete extra-vacuolar 
pools of PtdIns(3,5)P2 (Shaw et al., 2003).  
 
1.11. Fab1p; the PtdIns3P 5- kinase 
In yeast, the PtdIns3P 5-kinase has been demonstrated to be Fab1p; through in vitro 
kinase assays and because cells with a deletion of the FAB1 gene are unable to 
synthesise PtdIns(3,5)P2 (Dove et al., 1997).  
 
Figure 1.6 Schematic diagrams of Fab1p mRNA  structure and its putative 
homologs in other species. 
 
 
 
Adapted from (Cabezas et al., 2006). Not drawn to scale 
As shown in Figure 1.6, the genes for Fab1p-type PtdIns3P 5-kinases encode large 
150-250 kD proteins, which all contain a kinase domain at the C terminus and a 
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cysteine rich FYVE zinc finger domain at their NH2 terminus. The central domain of 
Fab1p encodes a regulatory CCT-like chaperone domain of unknown function as well 
as a “Fab1p unique” histidine and cysteine rich PtdIns3P 5-kinase specific domain 
(Michell et al., 2006). Constitutively activated mutants of Fab1p all have mutations 
within this regulatory region suggesting that this might represent some kind of 
autoinhibitory centre, though this remains speculation at the present time 
(Bonangelino et al., 2002, Gary et al., 2002).  
 
FAB1 was first discovered during a screen for mutants that possess a nuclear 
segregation defect and so was designated FAB1 for formation of aploid and binuleate 
cells (Yamamoto et al., 1995). However, it was subsequently discovered that the 
reason the nucleus was not correctly segregating in fab1 cells was because of the 
enormously enlarged vacuole and not because of a specific karyokinesis defect. It was 
the sequence of Fab1p kinase domain that originally lead to the belief that it was a 
PtdIns4P 5-kinase before the subsequent discovery of PtdIns(3,5)P2 in 1997 
(Yamamoto et al., 1995). Additional sequence analysis of the kinase domain later 
revealed that Fab1p defines a subfamily of putative PtdInsP kinases that are distinct 
from those that synthesise PtdIns(4,5)P2 and so have been designated as ‘type III 
PtdInsP kinases’  (PIPkIII) (Gary et al., 1998).  In vivo analysis of phosphoinositides 
revealed that strains bearing point mutations in the Fab1p kinase domain lack 
detectable levels of PtdIns(3,5)P2 but levels of PtdIns(4,5)P2 are unaffected (Gary et 
al., 1998, Dove et al., 1997, Cooke et al., 1998). This indicates that Fab1p provides 
the only route to PtdIns(3,5)P2 in yeast. The FYVE domain as mentioned above is not 
required for Fab1p function as expression of a fab1 mutant with no FYVE domain can 
recover the phenotypes associated with FAB1 deletion (Efe et al., 2007). It is however 
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required for Fab1p localisation to the vacuole, and so may play a part in the 
hyperosmotic stress response (Dove et al., 2009).  
 
1.12 Phenotypes of ∆fab1 in S. cerevisiae. 
 
Figure 1.7 Phenotypes associated with a deletion Fab1p. 
 
Cells possessing a deletion of FAB1 are unable to synthesise PtdIns(3,5)P2 and therefore phenotypes 
associated with this mutant are likely to be processes controlled by PtdIns(3,5)P2.  
 
Fab1p inactivated cells display many characteristic phenotypes; including no 
PtdIns(3,5)P2  synthesis, temperature sensitive growth, and a very large, unlobed 
unacidified vacuole (Bryant et al., 1998, Dove et al., 2004) which does not decrease in 
size when treated with a hyper-osmotic stress (Dove and Johnson, 2007, Shaw et al., 
2003). These characteristic phenotypes suggest that PtdIns(3,5)P2 is a regulator of 
vacuole volume, morphology, acidity and membrane potential (Cooke et al., 1998). 
Defects are also observed in retrograde trafficking from the vacuole to the late 
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endosome, suggesting a role for PtdIns(3,5)P2 in the recycling of membranes and 
cargo receptors. Vps34p and PtdIns3P have already been shown to be essential for 
anterograde trafficking of membrane and protein cargos to the vacuole, possibly 
suggesting a mechanism by which a balance of membrane flow into and out of the 
vacuole is achieved (Lindmo and Stenmark, 2006).  Ubiquitin-dependent protein 
sorting to the vacuole lumen via the multivesicular body is also affected in strains 
possessing a FAB1 deletion (Shaw et al., 2003), with certain cargoes failing to enter 
intralumenal vesicles in the absence of this lipid, though the vesicles themselves form 
normally.  The various homologs of FAB1 also display similar defects when 
inactivated in the appropriate organism, suggesting close conservation of the pathway 
between species, such as vacuolation observed in mammalian cells without PIKfyve 
(Dove and Johnson, 2007, Ikonomov et al., 2001). 
 
1.13. Evidence for the role of Fab1p/PIKfyve in other systems 
The mammalian homolog of Fab1p is PIKfyve, which has been shown to rescue the 
defects associated with fab1 mutants when it is expressed in yeast, demonstrating that 
this pathway is conserved between yeast and mammals (Michell et al., 2006, 
Shisheva, 2001, Mitchell et al., 2008). Over-expression of Fab1p or PIKfyve in 
yeastdoes not result in increased PtdIns(3,5)P2 synthesis, which has led to the 
suggestion that its kinase activity is somehow tightly controlled, possibly via auto-
inhibition, although this has yet to be formally shown (Gary et al., 1998).  
 
The DEP domain, present in PIKfyve, is only observed in higher eukaryotic Fab1s 
(see Figure 1.6). The purpose of the domain is unclear as it was first identified via 
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bioinformatics screening, hence its name (Disheveled, Egl-10, Pleckstrin) and is 
found in over 50 proteins involved in G-coupled receptor pathways.  It has also been 
shown to be implicated in membrane binding, both through direct interaction or by 
contacts with other membrane associated proteins. The domain is not essential for 
activity in PIKfyve, as it is not evolutionary conserved (Cabezas et al., 2006), 
however it may be responsible for some of the more recently evolved functions of 
PIKfyve. Human PIKfyve has been shown to co localise with early endosomal 
markers such as EEA1 and Hrs but a small amount is also found in late endosomal 
compartments (Cabezas et al., 2006). This may indicate a role for the protein in 
multiple steps of the endocytic pathway. 
 
Table 1.2 Mammalian homologs of yeast proteins. 
Yeast gene product Mammalian gene product Function 
Fab1p PIKfyve/PIP5K3 Kinase that produces 
PtdIns(3,5)P2 from PtdIns3P 
Vac14p ArPIKfyve Activator of Fab1p, 
composed of HEAT repeats 
and acts as a scaffold for the 
formation of a complex 
essential for PtdIns(3,5)P2 
formation.  
Fig4p Sac3 PtdIns(3,5)P2 phosphatase 
that regulates cellular levels. 
Svp1p/Atg18p WIPI-1 / β- Propeller protein that is a 
known effector of 
PtdIns(3,5)P2. Known roles in 
autophagy, and as an 
inhibitor of Fab1p. 
Hsv1p/Atg21p WIPI-3 / WIPI-49 β- Propeller protein that is a 
known effector of 
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Hsv2p PtdIns(3,5)P2.  
Tup1p Human- TLE 
Drosophila- Groucho  
β- Propeller protein that is 
known to bind PtdIns(3,5)P2. 
Roles in transcriptional 
regulation.  
Ent3p /Ent5p EpsinR ENTH like protein, potential 
effectors of PtdIns(3,5)P2. 
Associates with Clathrin 
adapter Gga2p 
Vps10p Homolog of mannose-6-
phosphate receptors 
Receptor for trafficking of 
CPY. 
 
Mutation of PIKfyve leads to similar phenotypes as those associated with loss of 
Fab1p (see above). A dominant negative or kinase dead form of the PIKfyve results in 
extensive vacuolation of animal cells, as does treatment with a cell permeant kinase 
inhibitor, YM201636 (Ikonomov et al., 2001, Dove and Johnson, 2007). PIKfyve can 
also recover hyper-osmotically- stress-stimulated PtdIns(3,5)P2 synthesis (McEwen et 
al., 1999), suggesting the two enzymes are conserved (Michell et al., 2006). Both 
kinases can produce PtdIns(3,5)P2 in vitro and in vivo (Cooke et al., 1998, Gary et al., 
1998). 
 
A difference between yeast and mammalian systems is that PIKfyve may not be the 
sole PIPkIII in mammals. A recent study using the newly identified PIKfyve inhibitor 
YM201636 on NIH 3T3 cells only reduced PtdIns(3,5)P2 levels by 85% (Jefferies et 
al., 2008) leaving an unexplained pool. No other kinase that phosphorylates PtdIns3P 
to PtdIns(3,5)P2 has been identified in mammalian cells but it is likely that it would 
only contribute to a small amount of overall levels (Dove et al., 2009). Another 
possibility is that the result could just be because of an insensitive pool of 
PtdIns(3,5)P2 that fails to be inhibited by YM201636; perhaps because its cellular 
 32 
location might be inaccessible to lipid phosphatases (Dove et al., 2009). Further 
research is required in this area to clarify the result (Jefferies et al., 2008).  
 
PIKfyve also appears to have additional ability compared to the yeast homolog; Fab1p 
exerts lipid kinase activity, however PIKfyve can also act as a protein kinase. It does 
this both via autophosphorylation, and in phosphorylating the Rab9 effector p40 
(Ikonomov et al., 2003). Fab1p autophosphorylation has not been shown to date.  
PIKfyve is also able to generate PtdIns5P directly; through phosphorylation of PtdIns 
(Shisheva, 2001). Although Fab1p can also do this, it is a minor activity in yeast and 
may just be a biological artefact of in vitro assays.  
 
1.14. Regulation of Fab1p 
Although we do not formally know how Fab1p is regulated, i.e. by activation or by 
relief of constitutive inhibition, additional proteins have now been identified that are 
required for normal production of PtdIns(3,5)P2 (Dove et al., 2002, Gary et al., 2002, 
Bonangelino et al., 2002, Bonangelino et al., 1997). Two are putative activators of 
Fab1p known as Vac7p and Vac14p, that appear to act independently to regulate the 
kinase activity of Fab1p and tightly control production of PtdIns(3,5)P2 (Dove et al., 
2002) whilst the third; Fig4p, appears to be an inositol lipid phosphatase.  
Vac7p seems to only be present in ascomycete fungi and no known mammalian 
homolog has been found (Bonangelino et al., 1997). Vac7p is a single pass trans-
membrane protein, with a large C-terminal lumenal domain, whose sequence varies 
amongst closely related fungal species, possibly indicating that the protein folds in a 
way that is tolerant of mutation (Gary et al., 2002). This may mean that functional 
VAC7 homologs do exist in higher eukaryotes but that they will be difficult to identify 
 33 
by conventional sequence analysis because a putative ‘Vac7p protein fold’ is being 
conserved rather than a primary amino-acid sequence (Gary et al., 2002). 
Vac14p is a hydrophilic peripheral membrane protein that directly interacts with 
Fab1p and is conserved from yeast, through plants to mammals (Efe et al., 2007). It is 
predicted to be composed entirely of between 9 and 21 HEAT repeats (Jin et al., 
2008). HEAT repeats consist of two antiparallel helices connected by a short loop and 
often appear in tandem or as multimers to generate surfaces for protein-protein 
interactions (Groves et al., 1999). Vac14p has been shown to interact with PIKfyve; 
the mammalian homolog of Fab1p. Over-expression of human Vac14p also leads to a 
slight increase in PtdIns(3,5)P2 levels (Sbrissa et al., 2004). Indirect 
immunofluorescence experiments have shown that Fab1p, Vac7p and Vac14p all 
reside on the vacuolar membrane in yeast and that inactivation of any one of these 
three leads to cells that produce little or no PtdIns(3,5)P2, resulting in similar 
phenotypes. Recent research by the Weismann lab, on an inglis mouse mutant, 
containing a missense mutation of mVac14, elucidated how this multi-protein ternary 
complex regulates the levels of PtdIns(3,5)P2 in mice (Jin et al., 2008). Other work in 
yeast also supports this model (Botelho et al., 2008). Co-immunoprecipitation 
experiments were used to determine that Vac14p acts as a scaffold onto which the 
regulatory units bind to form a complex.Vac14p interacts with itself, Fab1p, Fig4p, 
Atg18p and Vac7p, see Figure 1.8 (Jin et al., 2008). Fab1p-TAP also co-precipitates 
with Fig4p in the presence of Vac14p (Jin et al., 2008). Fab1p and Fig4p appear to 
bind to non-overlapping sites of Vac14p, which brings them into close proximity so 
they can share access to the same pool of PtdIns3P and PtdIns(3,5)P2 (Jin et al., 
2008). Vac14p is not only a general activator of Fab1p under normal conditions but 
also plays a critical role in the hyper-osmotic response of PtdIns(3,5)P2 (Bonangelino 
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et al., 2002). When ∆vac14 mutants are exposed to hyper-osmotic shock only a small 
amount of PtdIns(3,5)P2 is observed, much lower than that of wild-type cells. Over 
expression of FAB1 restores some synthesis of PtdIns(3,5)P2 under basal conditions 
but fails to allow any elevation of PtdIns(3,5)P2 induced in response to osmotic stress 
(Bonangelino et al., 2002).  
 
Figure 1.8 Diagram of the multi protein PtdIns(3,5)P2 regulatory complex. 
 
Vac14p
Vac14p
Vac7p
Fab1p
Fig4p
Atg18p
 
Vac14p is present at the centre of the two complexes and act as a scaffold for the other components to 
interact on (Modified from Jin et al 2008) 
 
In addition to the known phenotypes associated with FAB1 knockout, mouse vac14 
and fig4 knockouts have also been shown to suffer neurodegeneration; indeed the fig4 
locus is associated with a human neurodegenerative disease that resembles Charcot-
Marie Tooth disease (CMT) (Chow et al., 2007, Zhang et al., 2007). Another recent 
report suggests that mutations that effect the generation of PtdIns(3,5)P2 can result in 
both CMT and also amylotrophic lateral sclerosis (ALS) (Ferguson et al., 2009). Mice 
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with FIG4 and VAC14 mutations were shown to accumulate three proteins; LC3-11, 
p62 and LAMP-2 in both neurons and astrocytes. Cytoplasmic inclusion bodies 
containing ubiquitinated proteins and p62 were also found in areas of the brain that 
undergo degeneration, with formation and recycling of the autolysosome impaired 
(Ferguson et al., 2009). This work indicates a role for PtdIns(3,5)P2 in autophagy in 
the mammalian central nervous system. It also suggests that disruption of the 
regulation of  PtdIns(3,5)P2  can lead to inclusion body disease (Ferguson et al., 
2009). 
1.15. Degradation of PtdIns(3,5)P2 
Fig4p is the PtdIns(3,5)P2 specific 5-phosphatase (Rudge et al., 2004). Unexpectedly, 
Fig4p also appears to be required for basal PtdIns(3,5)P2 synthesis, possibly because 
it is needed for proper localisation and function of Vac14p; ∆fig4 mutants display 
very reduced PtdIns(3,5)P2 synthesis in yeast, and mice after osmotic stress (Duex et 
al., 2006b, Duex et al., 2006a). This is likely to be because Fig4p is required for 
stability of Vac14p, at least in S. cerevisiae. It has also been suggested that Fig4p may 
activate Fab1p through dephosphorylation of Fab1p or Vac14p (Duex et al., 2006b), 
as PPIn phosphatases can, in certain cases, also act as protein phosphatases. An 
example is PTEN which resembles tyrosine phosphatases at the primary amino-acid 
sequence level, and can indeed attack artificial phosphotyrosine substrates such as 
para-nitrophenol phosphate in vitro, but in fact is likely to dephosphorylate 
PtdIns(3,4,5)P3 in vivo (Cui et al., 1998). A protein phosphatase activity for Fig4p has 
not been directly demonstrated and remains speculation at the present time. 
Dephosphorylation of the PIKfyve autophosphorylation site has been shown to 
increase its kinase activity (Sbrissa et al., 2000) although point mutations of Fab1p, 
that would be predicted to prevent autophosphorylation, failed to have any effect on 
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activity of the yeast enzyme, suggesting that this mode of regulation may not be 
conserved. How PIKfyve might be dephosphorylated at the kinase domain is not 
clear. 
The mammalian homolog of Fig4p is Sac3, which acts in the same way as its yeast 
counterpart. Again Sac3 forms a complex with mVac14p and associates with PIKfyve 
to increase levels of PtdIns(3,5)P2. Work from the Shisheva group suggests that 
mVac14 might control and prevent degradation of Sac3 (Ikonomov et al., 2010). A 
mutation in Sac3 can lead to a neuropathy known as CMT4J because mVac14 can no 
longer prevent Sac3 being degraded and this results in a loss of basal synthesis of 
PtdIns(3,5)P2 (Ikonomov et al., 2010). Indeed the mutated Sac3 protein is found to be 
unstable and affected individuals are heterozygotes for the mutated missense allele 
and null allele. Levels of the protein found in tissues are only at 2% of wild-type 
levels, due to impaired interaction with mVac14 causing instability. It has been 
suggested that treatment which would increase levels to 10% would allow long term 
survival (Lenk et al., 2011). This implication in disease also provides further evidence 
of the importance of the Fig4p interaction with Vac14p. 
Myotubularins (MTMs), in higher eukaryotes, can also degrade PtdIns(3,5)P2; these 
enzymes belong to a family of ‘dual-specifically protein phosphatase-like’ PPIn 
phosphatases (Taylor et al., 2000). They can act to remove the D3 phosphate group 
from both PtdIns(3,5)P2 and PtdIns3P. Naturally inactive versions of MTMs are able 
to heterodimerize with active phosphatases acting on PtdIns3P, they are then directed 
to PtdIns(3,5)P2 and convert it to PtdIns5P (Dove et al., 2009, Lecompte et al., 2008). 
Inactivation of MTMs leads to increases in both PtdIns3P and PtdIns(3,5)P2 with a 
decrease in levels of PtdIns5P (Nicot and Laporte, 2008, Lecompte et al., 2008). 
Catalytic sites of MTMs include the same CX5R motif observed in both Fig4p and 
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PTEN (Robinson and Dixon, 2006). Again mutations in MTMs are inactivated in 
similar diseases as those associated with mutated FIG4, i.e. X-linked Myotublar 
Myopathy (XLMTM) and CMT disease (Nicot and Laporte, 2008, Zhang et al., 
2007), Robinson et al 2008). A novel phosphoinositide phosphatase hJUMPY 
conserved through evolution, is similar to MTMs and also dephosphorylates PtdIns3P 
and PtdIns(3,5)P2. Disruptions of hJUMPYs function are also found in patients with 
centronuclear myopathy, a form of a severe congenital myopathy similar to XLMTM 
(Tosch et al., 2006). Understanding the regulation of PtdIns(3,5)P2 is therefore crucial 
to unravelling many neurodegenerative diseases.  
 
1.15.1 Negative Feedback regulation. 
Atg18p, an effector that binds PtdIns(3,5)P2, has now been found to have a role in the 
regulation of PtdIns(3,5)P2 levels. Efe et al (2007) hypothesised that Atg18p can act 
as a sensor of PtdIns(3,5)P2 and continually cycles between the cytosol and limiting 
membrane of the vacuole in response to changes in phosphoinositide levels (Efe et al., 
2007). Atg18p appears to act as an inhibitor of Fab1p, via a negative feedback loop, 
probably to regulate vacuolar morphology. When Atg18p is recruited by 
PtdIns(3,5)P2 to the membrane, it associates with Vac7p, and a myosin-specific 
adapter; Vac17p (Efe et al., 2007). Atg18p may regulate activity of Fab1p through 
sequestration of the activator Vac7p. It is also known that Atg18p and Vac7p bind to 
overlapping sites on Vac14p, close to the site of  Fab1p binding, presumably 
facilitating rapid activation or inactivation of Fab1p (Jin et al., 2008). The role of 
Vac17p is most probably in the retrograde membrane transport, from the vacuole to 
mediate cytoskeletal rearrangements for the process (Efe et al., 2007) and is likely 
downstream of Atg18p and Fab1p.  
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1.15.2 Svp3p/Art1p. 
Svp3p was first identified in a screen along with Atg18p for mutants possessing a 
large unlobed vacuole and is a proposed component of the Fab1p pathway because of 
aberrant synthesis of PtdIns(3,5)P2; levels of this lipid are 10 fold higher in svp3 
cells than in wild-type cells (Dove, SK unpub).(Dove et al., 2004). Svp3p is encoded 
by the YOR322c locus in the S. cerevisiae genome and is also known as ART1, which 
is thought to function in endocytosis of plasma membrane proteins by recruiting the 
ubiquitin ligase Rsp5p, to its target (Lin et al., 2008). This is interesting as the ability 
of Rsp5p to ubiquitinate certain proteins is apparently dependent on PPIn, including 
PtdIns(3,5)P2. The exact role of Svp3p/Art1p has not been widely investigated to date 
and could be part of the Fab1p pathway; this is investigated in greater detail in 
Chapter 6. 
 
1.16. Functional interactions of PtdIns(3,5)P2.  
All phosphoinositides mediate cellular processes through binding to specific effector 
proteins. This allows an array of many different functions for each phosphoinositide. 
Separate pools of phosphoinositides carrying out specific functions with separate 
effector proteins have also been discovered such as in the case of PtdIns3P (Obara et 
al., 2008). Interaction of  potential effectors with PtdIns(3,5)P2 is not fully understood 
although it seems to be either through the PROPPIN domain e.g. the group of seven-
bladed β-propellers such as Atg18p and Tup1p (Han and Emr, 2011) or an ENTH- 
domain such as in the EpsinR like proteins, Ent3p and Ent5p (Dove et al., 2009). 
 
Although several effectors of PtdIns(3,5)P2 have been identified, deletion of the genes 
encoding these effectors do not fully recapitulate the fab1 mutant phenotype (Dove 
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and Johnson, 2007, Dove et al., 2004, Efe et al., 2007, Eugster et al., 2004, Krick et 
al., 2008). For example; there is no effector known to play a role in vacuole 
acidification or heat tolerance. This suggests that there are effectors left to find and 
novel roles for PtdIns(3,5)P2.  
 
It is likely that, as for PtdIns3P, there is more than one distinct pool of PtdIns(3,5)P2; 
each with a different function (Michell et al., 2006, Obara et al., 2006, Kihara et al., 
2001).  
 
1.16.1. Atg18p/Svp1p 
Atg18p (also known as Svp1p) was first identified as an effector of PtdIns(3,5)P2 in a 
screen for S. cerevisiae mutants with large ∆fab1 like vacuoles (Dove et al., 2004). 
WIPI-3/ WIPI-1 are the identified human homologs (Proikas-Cezanne et al., 2004, 
Barth et al., 2001). Homologs have also been identified in Drosophila, Arabidopsis, 
and C. elegans. The ATG18 gene encodes a 500 amino acid protein on chromosome 
VI immediately adjacent to the FAB1 gene; which produces a protein with a 
molecular weight of 55,102 Da. The sequence of ATG18 contains seven WD-40 
motifs near the centre of the gene, which are predicted to fold as a seven bladed- β 
propeller (Dove et al., 2004). This prediction is further supported by alignment to 
Tup1p a known β propeller (Dove et al., 2004) which has now also been shown to 
bind to PtdIns(3,5)P2 (Han and Emr, 2011). Binding of Atg18p to PtdIns(3,5)P2 was 
first shown through phosphoinositide ‘dot blots’, and quantitative approaches using 
GST-Atg18p found that specific binding to PtdIns(3,5)P2 involved at least two 
interactions, that occur between the ionic head group and a basic amino acid cluster, 
and between hydrophobic parts of the lipid and a hydrophobic patch of Atg18p (Dove 
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et al., 2004). Mutation of part of the β-propeller sequence from 284-287 was shown to 
decrease affinity more than 40-fold. This mutant also loses the ability to correct the 
enlarged vacuole of a ∆atg18 strain, indicating PtdIns(3,5)P2 is crucial for Atg18p to 
function normally in vacuole membrane trafficking (Dove et al., 2004). Over 
expression of the mutated atg18 in wild-type yeast resulted in a large unlobed 
vacuole, suggesting a dominant negative effect; possibly via sequestration of some 
component required for normal vacuole morphology (Dove et al., 2004). ∆atg18 cells 
also possess a defect in membrane recycling from the vacuole, observed through an 
assay detecting trafficking of a modified alkaline phosphatase enzyme (Dove et al., 
2004). When levels of PtdIns(3,5)P2 were analysed from ∆atg18 cells, they were 
found  almost 10 times higher than wild-type, whereas levels of the other yeast 
phosphoinositides were normal (Dove et al., 2004). Atg18p has been shown to be 
localised in three different compartments, the PAS, vacuolar membrane and the 
endosomes (Krick et al., 2008). In all three locations a role in the biogenesis of 
transport vesicles is observed (Krick et al., 2008). Atg18p is now known to function 
in PtdIns(3,5)P2 synthesis, probably as a sensor of phosphoinositide levels (Jin et al., 
2008, Efe et al., 2007) and acts as an inhibitor of Fab1p (Efe et al., 2007). The main 
role for Atg18p as an effector of PtdIns(3,5)P2 is in retrograde transport, probably 
from the vacuole membrane, and it is likely that it is required for membrane scission 
during this process as it does in autophagy and the Cvt pathways (Barth et al., 2001, 
Weisman, 2003). Atg18p is also strongly implicated in the control of autophagy, 
although this role may not require Fab1p or PtdIns(3,5)P2, at least in S. cerevisiae. 
Atg18p is also known to bind weakly to PtdIns3P in vitro (Stromhaug et al., 2004) 
and a recent paper shows that this phosphoinositide is essential for its full activity in 
both selective and non-selective autophagy (Obara et al., 2008). Atg18p also functions 
 41 
in the selective Cvt-pathway to form vesicles as it does during autophagy (Barth et al., 
2001).  
 
1.16.2. Hsv1p/Atg21p and Hsv2p. 
Hsv1p/Atg21p and Hsv2p (Homologous with Svp1) share many of the same structural 
characteristics as Atg18p (Barth et al., 2002); both Atg21p and Hsv2p are predicted to  
fold into seven bladed- β propellers (Krick et al., 2006, Krick et al., 2008) Both are 
shown to weakly bind PtdIns3P as well as strongly binding to PtdIns(3,5)P2. However 
unlike ∆atg18 deletion of either gene does not result in large unlobed vacuoles. 
Atg21p is only required for the Cvt –pathway and is not required for autophagy  
(Barth et al., 2002,Proikas-Cezanne et al., 2004). Hsv2p is largely uncharacterised and 
has no known function. A recent paper highlights the localisation of a pool of Atg18p, 
Atg21p and Hsv2p at the pre-vacuolar endosome, where they function in a PtdIns3P 
dependent manner (Krick et al., 2008).  Over expression of Atg21p can cause CPY 
secretion, which is not observed with either Hsv2p or Atg18p, as this may disturb 
retromer function through competing to bind to PtdIns3P or Vps21p (Krick et al., 
2008). 
 
1.16.3 Tup1p and Cti6p.  
The most recently identified effectors of PtdIns(3,5)P2. Tup1p was identified through 
a BLAST search for proteins that share sequence similarity with Atg18p, as it 
contains a C-terminal β- propeller, which is crucial for its binding to PtdIns(3,5)P2 
(Han and Emr, 2011). Evidence suggests that PtdIns(3,5)P2 can recruit Cti6p and the 
Cy8p-Tup1p complex to the late endosomal/ vacuole membrane and mediates the 
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formation of a Cti6-Cyc8-Tup1 complex which then can recruit the SAGA complex to 
the GAL1 promoter (Han and Emr, 2011). 
 
1.16.4. Ent3p and Ent5p. 
Both Ent3p and Ent5p contain epsin N-terminal homology (ENTH) domains (Friant et 
al., 2003). The ENTH domain is also known to bind phosphoinositides (Kay et al., 
1999) and it is suggested that both Ent3p and Ent5p bind PtdIns(3,5)P2 through this 
domain. PtdIns(3,5)P2 and ubiquitin are necessary for proper sorting of cargos 
destined for the interior of the vacuole and are sorted into vesicles of the MVB. Ent3p 
and Ent5p are both required for protein sorting into the MVB. The ENTH domain is a 
membrane-interacting module found in proteins that have a role in the early stages of 
the endocytic pathway (De Camilli et al., 2002). Intracellular localisation of Ent3p 
and Ent5p to endosomes is dependent upon PtdIns(3,5)P2, discovered through 
fractionation assays and GFP tagging though some of this work is controversial as a 
number of labs have been unable to repeat it (Friant et al., 2003, Eugster et al., 2004). 
A temperature sensitive Ent3p, ent3-1 was used to define a role for protein sorting at 
the MVB. Intracellular localisation of GFP-CPS and GFP-Phm5p was tested in ent3-1 
cells. At both 24
o
C and 37
o
C the constructs localised to the vacuolar membrane 
instead of being correctly localised the vacuole lumen. Previously ∆fab1 cells were 
shown to be defective in the sorting of these two constructs (Odorizzi et al., 1998). 
Ent3p and Ent5p also have roles in the trafficking of Chs3p, and deletions in both of 
the genes can suppress a ∆chs6 phenotype (Copic et al., 2007). This could be a key 
link to the Fab1p pathway, as similar effects are seen with a FAB1 deletion.  
Unlike ∆fab1 neither ∆ent3 nor ∆ent5 show enlarged unlobed vacuoles; in fact ent 
or ent5 cells have small and fragmented vacuoles (Friant et al., 2003, Eugster et al., 
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2004). These mutants also have normal levels of PtdIns(3,5)P2 and do not have 
defects in the synthesis of this phosphoinositide.  
 
1.16.5. Vps24p.  
Vps24p was first identified as a PtdIns(3,5)P2 effector in 2003 (Whitley et al., 2003) 
through the use of mammalian cDNA phage libraries with synthetic biotinylated 
derivative of PtdIns(3,5)P2 immobilised on beads. Vps24p is a class E member of the 
vacuolar protein-sorting mutants (Raymond et al., 1992, Babst et al., 1998). S. 
cerevisiae mutants with a deletion of Vps24p have the large swollen vacuole 
phenotype observed with ∆fab1 cells. It has been suggested that many of the class E 
Vps proteins may interact with PtdIns(3,5)P2 maybe in the form of a complex 
(Odorizzi et al., 1998). Vps24p unlike the other identified effectors does not contain a 
characteristic phosphoinositide binding domain, and it is unclear exactly how it binds 
PtdIns(3,5)P2. Through truncation experiments it was discovered that the N-terminus 
of mVps24 associates with class E compartments in a phosphoinositide dependent 
manner (Whitley et al., 2003). Vps24p is one of four subunits of the endosomal 
sorting complex required for transport III (ESCRT-III). It forms an ESCRT-III sub 
complex along with Did4p (Isakoff et al., 1998, Song et al., 2001). Both ESCRT-III 
and PtdIns(3,5)P2 are involved in the sorting of transmembrane proteins into the MVB 
pathway (Raiborg et al., 2003, Shaw et al., 2003) and this is where a link between the 
two pathways may lie. The proposed model suggests PtdIns(3,5)P2 production 
influences events co-ordinated by an assembled ESCRT-III complex (Whitley et al., 
2003). 
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1.17. Roles of PtdIns(3,5)P2 that lack effector proteins. 
The above discussion on effectors highlights those processes for which an effector has 
been isolated. However, there remain a number of phenotypes/defects displayed by 
cells that lack PtdIns(3,5)P2 that lack such molecular definition. These are discussed 
below. 
1.17.1. PtdIns(3,5)P2 in stress responses. 
As previously mentioned, the levels of PtdIns(3,5)P2 cellular levels increase 
dramatically in response to stress, in a transient manner. Therefore it is proposed that 
PtdIns(3,5)P2 plays a major role in the response of cells to stress. The most obvious 
event to take place when cells are given a hyper-osmotic stress is the fragmentation of 
the yeast vacuole into smaller compartments; fragmentation is maintained for the 
length of time PtdIns(3,5)P2 levels are raised. The reasons for this event and the 
machinery that control it are unclear; this is one of the focuses of this thesis and is 
discussed in greater detail in chapter 5.  
Deletion of Fab1p or Vac14p leads to a large unlobed vacuole that can no-longer 
undergo fragmentation when a stress is applied. These mutants lack PtdIns(3,5)P2 and 
it is likely that an effector protein(s) control this process but these remain to be 
identified. It has been shown that members of the Vacuolar V-ATPase are also 
components of the vacuolar fission machinery (Baars et al., 2007). Previous work has 
shown that both acidification of the vacuole and the presence of the V-ATPase are 
necessary for fragmentation during hyper-osmotic stress.  
Hyper-osmotic stress induced vacuole fragmentation may also require the recently 
identified CORVET complex which is required for macro-fragmentation. This 
complex shares many of the same subunits as the HOPS complex which is responsible 
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for homotypic vacuole-vacuole fusion (Seals et al., 2000). Vps21p, which regulates 
CORVET, is also responsible for the controlling entry of proteins into the PVE (Baars 
et al., 2007). PtdIns(3,5)P2 may therefore influence vacuolar fission and/or retrograde 
trafficking from the vacuole to the PVE, promoting HOPS-CORVET subunit 
exchange (Dove et al., 2009). Fab1p has also been linked with the CORVET 
machinery, as deletion of some CORVET subunits causes a mislocalisation of 
Atg18p, Atg21p and Hsv2p (Kane, 2005). Accumulation of PtdIns(3,5)P2 also occurs 
in response to other stresses. The pathway can also be activated by heat and changes 
in pH; similar responses are observed but are less profound and occur at a slower rate 
(Dove and Johnson, 2007, Mollapour et al., 2006).  
It also remains unclear how the PtdIns(3,5)P2 signalling pathway interacts with the 
external environment to sense disruption of the milieu and acts to bring back internal 
homeostasis. This connection with the external environment may involve interaction 
with a specific effector protein that is yet to be identified (Dove et al., 2009). It has 
also been suggested that Fab1p itself may sense conformational changes in its partner 
proteins through its CCT domain during stress (Dove and Johnson, 2007, Michell et 
al., 2006). 
 
1.17.2. Vacuolar acidification 
Acidification is a defining feature of yeast vacuoles and mammalian lysosomes, and 
many of the functions of the vacuole require a low pH (Li and Kane, 2009). The 
Vacuolar ATPase controls acidification of the vacuole/lysosome, and is conserved 
amongst yeast and mammals (Li and Kane, 2009). ATP hydrolysis is coupled to 
proton transport from the cytosol to lumen. The yeast V-ATPase is regulated at the 
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level of assembly, through its two sectors.A similar mechanism is seen in lysosomes. 
A further level of regulation implicates the lipid composition of organelles (Li and 
Kane, 2009, Paroutis et al., 2004). The contents of the vacuole may also act as buffers 
to determine pH. For example polyphosphate, present in a very high concentration in 
the vacuole acts as such a buffer (Brett et al., 2006, Li and Kane, 2009). 
Yeast cells lacking PtdIns(3,5)P2 have a neutral vacuole (Nicot et al., 2006, Rusten et 
al., 2006). This defect is also observed in both C. elegans and D. melanogaster cells 
(Gary et al., 1998), but remains unreported in mice (Bonangelino et al., 2002, Dove et 
al., 2002). This may be due to an incomplete knockout of FAB1 in some systems; 
even a small amount of PtdIns(3,5)P2 can suppress this phenotype. Although the V-
ATPase is linked to vacuole fragmentation as above, defects in vacuole acidification 
occur independently of vacuole enlargement (Dove et al., 2009). The unacidified 
vacuole in cells lacking PtdIns(3,5)P2 is not due to the mis-localisation of the V-
ATPase (Weisman et al., 1990, Starai et al., 2005). It is currently unknown how 
PtdIns(3,5)P2 regulates vacuolar acidification and no effector proteins have been 
identified that are involved in this process. It is likely that a novel effector of 
PtdIns(3,5)P2 could somehow directly or indirectly activate the V-ATPase (Dove et 
al., 2009).  
 
1.17.3. Roles in autophagy 
Recently Fab1p and ESCRT complexes have been shown to play roles in autophagy 
in higher eukaryotes (Rusten et al., 2007b, Rusten et al., 2007a). Autophagy is a 
process used by cells to recycle organelles, protein aggregates, and cytoplasmic 
constituents during nutrient limitation. Autophagy is a critical process in multicellular 
organisms and if inhibited can cause defects in development, starvation sensitivity, 
 47 
the accumulation of protein aggregates, neuronal degradation, and eventually cell 
death. Atg18p has also been shown to be required for formation of autophagosomes 
during nutrient stress in most higher eukaryotes though this is likely in a PtdIns(3,5)P2 
independent but PtdIns3P dependent fashion. Autophagosomes are double membrane 
organelles that sequester cytoplasm containing items to be degraded and then fuse 
with endosomes or lysosomes where they are broken down and removed from the cell 
(Noda et al., 2002). The importance of the endosomal system in the regulation of 
autophagy and associated disease is not well known. But it has been shown in a recent 
report using Drosophila melanogaster that regulators of endosomal biogenesis play an 
important role in autophagy. Genetic and ultrastructural experiments were used to 
show that subunits of the endosomal sorting complex required for transport (ESCRT)-
I, -II and -III, their regulatory ATPase Vps4p and also Fab1p, are all required for 
autophagy in D. melanogastor. Loss of ESCRT or Vps4p function leads to an 
accumulation of autophagosomes, which is probably due to inhibition of fusion with 
the endo-lysosomal system. Fab1p activity is necessary for the maturation of 
autolysosomes (Rusten et al., 2007b, Rusten et al., 2007a).  
Another recent report implicates PtdIns(3,5)P2 in the process of autophagy in mice 
(Ferguson et al., 2009). Results indicate that mutations in either VAC14 or FIG4, lead 
to accumulation of several proteins in neurons and astrocytes, shown to be due to 
defective autophagy. Co-localisation studies indicate that this is due to the failure of 
recycling or formation of the autolysosome and they have proposed two models 
(Ferguson et al., 2009). It may be that PIKfyve is involved in autophagosome 
consumption rather than formation. Disruption of PIKfyve with siRNA means the late 
endosome/lysosome can no longer fuse with autophagosomes or MVBs (de Lartigue 
et al., 2009). It is likely that Atg18p, Atg21p and/or Hsv2p are the effectors 
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responsible for PtdIns(3,5)P2 dependent autophagy, though this has yet to be formally 
investigated. 
It may be that PtdIns(3,5)P2 is not involved in the autophagic process in yeast cells 
because there is no actual lysosome, so maturation stops at the vacuole which is likely 
to be a modified late endosome and hence autolysosome formation is not observed or 
required because that compartment has been lost during evolution or exists only as a 
hybrid organelle fused with the late endosome.  Hence autophagy in yeast is probably 
truncated and therefore PtdIns(3,5)P2 independent. 
 
1.17.4 PIKfyve regulation of ion channels.  
A recent paper has suggested that during hyperosmotic stress in yeast, Ca
2+
 is released 
from the vacuole in a process requiring both PtdIns(3,5)P2 and the mucolipin transient 
receptor potential (TRPML) channel  (Dong et al., 2010). Like cells unable to 
synthesise PtdIns(3,5)P2, cells that lack TRPMl have also been found to have many 
similar phenotypes, e.g. enlarged vacuoles and trafficking defects in the late endocytic 
pathway, although these are not as severe as in ∆fab1 cells (Dong et al., 2010). The 
authors propose that TRPMLS are the connection between Ca
2+
 and PtdIns(3,5)P2, 
and changes of the lipid are used to regulate Ca
2+
, which trigger membrane fusion and 
fission events. Indeed it has been shown that PtdIns(3,5)P2 can bind TRPML1 (Dong 
et al., 2010).  
 
PIKfyve has also been shown to regulate a Ca
2+
 channel; this time voltage gated. This 
however, is through sustained activation of glutamate receptors, which recruit 
PIKfyve to increase levels of PtdIns(3,5)P2 around the calcium channel which seems 
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to target them for degradation at the lysosome (Tsuruta et al., 2009). This may explain 
some of the apparent links between PtdIns(3,5)P2 and neuronal diseases.  
 
The glutamate transporter EAAT4 can be regulated by PIKfyve (Alesutan et al., 2010, 
Klaus et al., 2009b, Gehring et al., 2009b, Klaus et al., 2009a). Activity of the 
transporter is stimulated by a signalling cascade involving SGK1, a kinase which can 
regulate channels and carriers by phosphorylation, and interference with 
ubiquitination (Alesutan et al., 2010). Previously SGK1 has been shown to 
phosphorylate PIKfyve, resulting in increased cell surface expression of EAAT4 
(Seebohm et al., 2007). PIKfyve, has also been observed in regulation of trafficking 
of the sodium glucose cotransporter SGLT1 and in the SGK1 mediated regulation of 
the creatine transporter SLC6A8 (Shojaiefard et al., 2007, Strutz-Seebohm et al., 
2007). SGK1 stimulation of PIKfyve is also required for the increased cell surface 
expression of the Ca
2+
 channel TRPV6 (Sopjani et al., 2009), and the chloride channel 
CLC-2 where PIKfyve both stimulates the channel and contributes to SGK1 
dependent regulation of localisation (Klaus et al., 2009b). PIKfyve can also up-
regulate CFTR the cystic fibrosis transmembrane conductive regulator, in a similar 
way (Gehring et al., 2009a). PtdIns(3,5)P2 also regulates cardiac contractibility 
through directly activating Ca
2+
 release and activation of the ryanodine receptor 
(Touchberry et al., 2010). 
 
A role for PIKfyve in regulation of the insulin stimulated GLUT4 glucose transporter 
and phosphorylation of PIKfyve by protein kinase B (PKB) has also been recently 
identified (Berwick et al., 2004). Through use of YM201636, an inhibitor of PIKfyve 
catalysed PtdIns(3,5)P2 synthesis, it has been shown that PIKfyve is involved in 
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glucose entry in adipocytes (Ikonomov et al., 2009b).  In response to both insulin and 
osmotic stresses, PIKfyve becomes phosphorylated by PKB (Berwick et al., 2004). 
Data presented by the Tavarè group strongly suggests that PIKfyve is regulated by 
external phosphorylation, which increases activity of PIKfyve rather than decreases it 
(Berwick et al., 2004) . This indicates that PIKfyve is able to control both the 
trafficking and activity of many mammalian channels in the early endocytic system. 
Such a function for Fab1p in S. cerevisae so far remains un-investigated. 
 
Other recent research has also defined a role for PIKfyve in the endosome to TGN 
trafficking of furin (de Lartigue et al., 2009), which has protease activity and may be 
responsible for the cleavage of the HIV envelope. Using yeast two hybrid and co-
immunoprecipitation assays it was found that a novel splice variant of the Jip4 gene 
product JLP, is a kinesin adapter that links PIKfyve to microtubules in this trafficking 
pathway (Ikonomov et al., 2009a). Knockdown of PIKfyve also results in marked 
inhibition of HIV replication due to its roles in retroviral budding (Murray et al., 
2005). Only low levels of PtdIns(3,5)P2 may be required for many of these trafficking 
pathways, hence only pharmacological intervention may disrupt them (de Lartigue et 
al., 2009).  
 
1.17.5. Exocytosis 
PIKfyve has also been shown to have roles in exocytosis (Osborne et al., 2008). 
Regulated secretion of neurotransmitters and hormones depends on both protein-
protein and protein-lipid interactions. Both PtdIns3P and PtdIns(4,5)P2 have 
previously been shown to be required to prime the secretary apparatus in an ATP 
dependent manner before Ca
2+
 dependent secretion (Kong et al., 2006). Through the 
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use of YM201636, a selective inhibitor of PIKfyve activity and PIKfyve knock-down 
by siRNA, it was discovered that PIKfyve localises to a sub-population of secretory 
granules in chromaffin and PC12 cells (Osborne et al., 2008). When PtdIns(3,5)P2 
was down regulated, secretion of granule exocytosis was potentiated. When PIKfyve 
or Fab1p was over expressed, regulated secretion in PC12 cells was inhibited. A 
catalytically inactive PIKfyve mutant had no effect. The investigation demonstrates a 
new role for PIKfyve and Fab1p in regulated secretion (Osborne et al., 2008). A role 
for Fab1p will be investigated in the secretion of Chs3p, this will be discussed in more 
detail in Chapter 4.  
 
1.18 Aims. 
The above introduction highlights an emerging role for PIKfyve in the regulation of 
trafficking in the early endocytic system. The mechanism for this mode of regulation 
is unknown, as no effectors have been isolated that might be responsible. The aims of 
this thesis were as follows: 
 To dissect novel PtdIns(3,5)P2 dependent trafficking events in the early 
endocytic system.  
 To examine the role of PtdIns(3,5)P2 in the trafficking of retromer. 
 To see if PIKfyve’s control of recycling in mammalian cells was conserved in 
yeast, using thetrafficking of Chs3p as a model. 
 As part of this work, we also wanted to examine if Svp3p/Art1p interacted 
with this pathway, since this arrestin-like protein also both affects synthesis of 
PtdIns(3,5)P2 and also regulates endocytosis. 
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 To examine possible proteins involved in the fragementation of the yeast 
vacuole under hyperosmotic stress. 
The study was carried out in S. cerevisiae, as the mammalian system is largely 
homologous, and much of the work on PtdIns(3,5)P2  was originally conducted in 
yeast. S. cerevisiae also provides a convenient model system that can be genetically 
manipulated easily, making it a good choice in which to study trafficking events if the 
caveats about compartment identity, noted above, are accepted.  
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Chapter 2 
Materials and Methods 
2.1. MATERIALS 
2.1.1. Plasmid and S. cerevisiae strains 
Plasmids pUG23-YIF1 and pUG34-YIF1 were kind gifts from Dr D. Pearce 
(University of Rochester, NY, USA). Plasmid pGem-T-Easy was obtained from 
Invitrogen. The mCherry PHO8 marker, was made by Dr E.Khaznajdi, by creating an 
N terminal fusion in pRS416 (Sikorski and Hieter, 1989). The pRS315-APL2, 
pYCplac111-APL4 and pRS316-STE3 plasmids, were kind gifts of Dr F. Cooke 
(UCL, London, UK). pRS313-SOI1 was a gift from Prof R. Fuller (University of 
Michigan, USA). pCHS3-GFP was a kind gift from Prof R. Schekman (University of 
California, Berkley, USA). 
 pUG34  is a low copy centromeric yeast expression vector and was modified by Dr. 
Hegemann (Heinrich-Heine-Universität, Düsseldorf, Germany) so that GFP is 
expressed as an N-terminal fusion to any gene cloned into the multiple cloning site 
(Niedenthal et al., 1996).  
Plasmid pUG36 (YCp, URA3, PMET25-yEGFP3-MCS-TCYC1) (Niedenthal et al., 1996) 
was used as a vector to express green fluorescent protein, (GFP) fusion proteins. This 
version of yEGFP does not contain the anti-dimerisation mutation. Proper cloning of 
an insert into the multiple cloning sites (MCS) of pUG36 allows the expression of 
yEGFP N-terminal fusion proteins under the control of methionine-regulated MET25 
promoter (Mumberg et al., 1994). 
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Plasmid pGEX-6P-K1 was obtained from Dr Dove who modified the commercially 
available vector pGEX-6P-1 (G.E Biotech) by inserting sequences that encode a 
protein kinase A phosphorylation consensus motif between the GST and the protein of 
interest. 
All cloning and sub-cloning was carried out in E. coli TOP10 competent cells, which 
were prepared in the lab, as described below. E. coli strains were grown in LB broth 
containing the appropriate antibiotics. Plasmids used, and those created in this study, 
are summarised in Table 2.1. BL21-star (DE3)-RIL cells were obtained from the 
Dove lab E. coli strain collection and were used to express GST (glutathione-S-
transferase)-fusion proteins. 
The fab1::LEU2 allele was a kind gift from Dr D. Koshland (Carnegie Institution of 
Washington, Maryland, USA.) (Yamamoto et al., 1995). The vps26::LEU2 allele was 
a kind gift of Dr M. Seaman (University of Cambridge, Cambridge Institute for 
Medical Research/Clinical Biochemistry, U.K). The yeast RFP marker strains 
BY4741 CHC1::CHC1-RFP, BY4741 ANP1::ANP1-RFP, BY4741 COP1::COP1-
RFP and BY4741 SNF7::SNF7-RFP were kind gifts from Dr E. O’Shea (Harvard 
University, Massachusetts, USA)(Huh et al., 2003). The BJ3505 strain (pep4::HIS3 
allele) was a kind gift from Dr A. Mayer (Université de Lausanne, Switzerland). Dr 
G. Payne (UCLA Los Angeles, USA) kindly provided apl2::TRP and apl4::TRP 
alleles. The sec22::HIS3 allele was kindly provided by Dr D.Schmitt (Max Planck 
Institute, Germany).  
Wild-type and some yeast deletion strains, bearing the kanMX4 deletion cassette in 
BY4741,BY4742 and BY4739 background (Brachmann et al., 1998) were obtained 
from EUROSCARF (Institute for Microbiology, Frankfurt, Germany). Other deletion 
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strains were either from the Dove Lab yeast strain collection, or were made in this 
study. The S. cerevisiae strains used in this study are summarised in Table 2.2.  
All budding yeast strains were grown in standard Yeast extract- Peptone-Dextrose 
(YPD) or Synthetic Complete (SC) minimal media supplemented with the appropriate 
essential amino acids, prepared as described below.
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Table 2.1: Plasmids used in this study 
Plasmid name E.coli resistance: S.cerevisiae Marker Source 
pUG23 
 
amp
R
 HIS3 J. Hegemann 
pUG34 
 
amp
R
 HIS3 J. Hegemann 
pUG36 
 
amp
R
 URA3 J. Hegemann 
p-Gem-T-Easy amp
R
 - Invitrogen 
p-Gem-T-Easy-CHS6 amp
R
 - This study 
p-Gem-T-Easy-CHS6::LYS2 amp
R
 - This study 
m.CherryPHO8 amp
R
 URA3 Dove Lab 
pUG23-YIF1 
  
amp
R
 HIS3 D. Pearce 
pUG34-YIF1 
 
amp
R
 HIS3 D. Pearce 
pUG36-YIF1 amp
R
 URA3 This study 
pUG23-MRL1 
  
amp
R
 HIS3 This study 
pUG34-MRL1 
 
amp
R
 HIS3 This study 
pRS416-PHM5-GFP amp
R
 URA3 Dove Lab 
pRS416-UbPHM5-GFP amp
R
 URA3 Dove Lab 
pRS316-STE3-GFP amp
R
 URA3 F.Cooke 
pAEM42 amp
R
 URA3 Dove Lab 
pAEM44 amp
R
 URA3 Dove Lab 
pUG36-ATG18 amp
R
 URA3 Dove Lab 
pYEp13 based yeast plasmid library amp
R
 LEU2 Dove Lab 
pYCplacIII-APL4 amp
R
 LEU2 F.Cooke 
pRS315-APL2 amp
R
 LEU2 F.Cooke 
pRS313-SOL1 amp
R
 HIS3 R. Fuller 
pEGKT-FAB1 amp
R
 URA3 Dove Lab 
pEGKT-FAB1
Kinase dead
 amp
R
 URA3 Dove Lab 
pEGKT-FAB1
FYVE
 amp
R
 URA3 Dove Lab 
pEGKT-FAB1
CTT-like
 amp
R
 URA3 Dove Lab 
pEGKT-FAB1
PIPKIII unique
 amp
R
 URA3 Dove Lab 
pEGKT-SpFAB1 amp
R
 URA3 Dove Lab 
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pEGKT –PIKfyve ampR URA3 Dove Lab 
pGEX6T11 amp
R
 chp
R
 - Dove Lab 
pGEX6T1-VMA1 amp
R
 chp
R
 - This study 
pGEX6T1-VMA2 amp
R
 chp
R
 - This study 
pGEX6T1-VMA4 amp
R
 chp
R
 - This study 
pGEX6T1-VMA5 amp
R
 chp
R
 - This study 
pUG36-SVP3 amp
R
 URA3 Dove Lab 
pUG36-SVP3
CT1
 amp
R
 URA3 Dove Lab 
pUG36-SVP3
NT1
 amp
R
 URA3 Dove Lab 
pUG36-SVP3
PAIA/PACA
 amp
R
 URA3 This study 
pUG36-SVP3
K486R
 amp
R
 URA3 This study 
pRS313-VPS13
E003K
 amp
R
 URA3 This study 
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Table 2.2: S. cerevisiae strains used in this study 
Strain Genotype Source 
BY4742 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 Euroscarf 
BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0  Euroscarf 
BY4742 ∆fab1 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fab1::kanMX4 Euroscarf 
BY4741 ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 fab1::kanMX4 Euroscarf 
BY4742 ∆vps29 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vps29::kanMX4 Euroscarf 
BY4742 ∆btn2 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 btn2::kanMX4 Euroscarf 
BY4742 ∆apl2 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 apl2::kanMX4 Euroscarf 
BY4742 ∆apl4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 apl4::kanMX4 Euroscarf 
BY4742 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 chs6::kanMX4 Euroscarf 
BY4742 ∆fig4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fig4::kanMX4 Euroscarf 
BY4742 ∆svp1 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 svp1::kanMX4 Euroscarf 
BY4742 ∆svp3 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 svp1::kanMX4 Euroscarf 
BY4742 ∆vac7 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vac7::kanMX4 Euroscarf 
BY4742 ∆vac14 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vac14::kanMX4 Euroscarf 
BY4742 ∆hsv1 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 hsv1::kanMX4 Euroscarf 
BY4742 ∆hsv2 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 hsv2::kanMX4 Euroscarf 
BY4742 ∆doa4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 doa4::kanMX4 Euroscarf 
BY4742 ∆pep12 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 pep12::kanMX4 Euroscarf 
BY4742 ∆vps4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vps4::kanMX4 Euroscarf 
BY4742 ∆vps13 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vps13::kanMX4 Euroscarf 
BY4742 ∆lcl3 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 lcl3::kanMX4 Euroscarf 
BY4742 ∆gup1 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 gup1::kanMX4 Euroscarf 
BY4742 ∆scy1 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 scy1::kanMX4 Euroscarf 
BY4742 ∆ygl082w MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 ygl082w::kanMX4 Euroscarf 
BY4742 ∆fsk2 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fsk2::kanMX4 Euroscarf 
BY4742 ∆gas1 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 gas1::kanMX4 Euroscarf 
BY4739 ∆vps8 MATα leu2Δ0 lys2Δ0 ura3Δ0 vps8::kanMX4 Euroscarf 
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BY4742 ∆vma1  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma1::kanMX4 Euroscarf 
BY4742 ∆vma2  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma2::kanMX4 Euroscarf 
BY4742 ∆vma3  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma3::kanMX4 Euroscarf 
BY4742 ∆vma4  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma4::kanMX4 Euroscarf 
BY4742 ∆vma7  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma7::kanMX4 Euroscarf 
BY4742 ∆vma8  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma8::kanMX4 Euroscarf 
BY4742 ∆vma9  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma9::kanMX4 Euroscarf 
BY4742 ∆vma10  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma10::kanMX4 Euroscarf 
BY4742 ∆vma11  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma11::kanMX4 Euroscarf 
BY4742 ∆stv1  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 stv1::kanMX4 Euroscarf 
BY4742 ∆vph1  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vph1::kanMX4 Euroscarf 
BY4742 ∆vps3  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vps3::kanMX4 Euroscarf 
BY4742 ∆vps8  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vps8::kanMX4 This study 
BY4742 ∆pho81  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 pho81::kanMX4 Euroscarf 
BY4742 ∆pho85  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 pho85::kanMX4 Euroscarf 
MSY2629 MATα leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 suc2-Δ9 lys2-801 vps26::LEU2 vps29::HIS3 M. Seamen 
BY4741 CHC1-RFP  MATa his3∆1 leu2∆0 met15∆0 ura3∆0 CHC1::CHC1-RFP::kanMX4 E. O'Shea 
BY4741 COP1-RFP  MATa his3∆1 leu2∆0 met15∆0 ura3∆0 COP1::COP1-RFP::kanMX4 E. O'Shea 
BY4741 ANP1-RFP  MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ANP1::ANP1-RFP::kanMX4 E. O'Shea 
BY4741 SNF7-RFP  MATa his3∆1 leu2∆0 met15∆0 ura3∆0 SNF7::SNF7-RFP::kanMX4 E. O'Shea 
BY4741 CHC1-RFP ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 CHC1::CHC1-RFP::kanMX4 fab1::LEU2 This study 
BY4741 COP1-RFP ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 COP1::COP1-RFP::kanMX4 fab1::LEU2 This study 
BY4741 ANP1-RFP ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ANP1::ANP1-RFP::kanMX4 fab1::LEU2 This study 
BY4741 SNF7-RFP ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 SNF7::SNF7-RFP::kanMX4 fab1::LEU2 This study 
BY4741 CHC1-RFP ∆vps26 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 CHC1::CHC1-RFP::kanMX4 vps26::LEU2 This study 
BY4741 COP1-RFP ∆vps26 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 COP1::COP1-RFP::kanMX4 vps26::LEU2 This study 
BY4741 ANP1-RFP ∆vps26 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ANP1::ANP1-RFP::kanMX4vps26::LEU2 This study 
BY4741 SNF7-RFP ∆vps26 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 SNF7::SNF7-RFP::kanMX4 vps26::LEU2 This study 
BY4741 CHC1-RFP VPS10-GFP MATa his3∆1 leu2∆0 met15∆0 ura3∆0 CHC1::CHC1-RFP::kanMX4VPS10-GFP::HIS3MX6 This study 
BY4741 COP1-RFP VPS10-GFP MATa his3∆1 leu2∆0 met15∆0 ura3∆0 COP1::COP1-RFP::kanMX4 VPS10-GFP::HIS3MX6 This study 
BY4741 ANP1-RFP VPS10-GFP MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ANP1::ANP1-RFP::kanMX4 VPS10-GFP::HIS3MX6 This study 
BY4741 SNF7-RFP VPS10-GFP MATa his3∆1 leu2∆0 met15∆0 ura3∆0 SNF7::SNF7-RFP::kanMX4 VPS10-GFP::HIS3MX6 This study 
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BY4741 CHC1-RFP VPS10-GFP ∆fab1  MATa his3∆1 leu2∆0 met15∆0 ura3∆0 CHC1::CHC1-RFP::kanMX4 fab1::LEU2 VPS10-GFP::HIS3MX6 This study 
BY4741 COP1-RFP VPS10-GFP ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 COP1::COP1-RFP::kanMX4 fab1::LEU2 VPS10-GFP::HIS3MX6 This study 
BY4741 ANP1-RFP VPS10-GFP ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ANP1::ANP1-RFP::kanMX4 fab1::LEU2 VPS10-GFP::HIS3MX6 This study 
BY4741 SNF7-RFP VPS10-GFP ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 SNF7::SNF7-RFP::kanMX4 fab1::LEU2 VPS10-GFP::HIS3MX6 This study 
BY4741 CHC1-RFP VPS10-GFP ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 CHC1::CHC1-RFP::kanMX4 vps26::LEU2 VPS10-GFP::HIS3MX6 This study 
BY4741 COP1-RFP VPS10-GFP ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 COP1::COP1-RFP::kanMX4vps26::LEU2 VPS10-GFP::HIS3MX6 This study 
BY4741 ANP1-RFP VPS10-GFP ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 ANP1::ANP1-RFP::kanMX4 vps26::LEU2 VPS10-GFP::HIS3MX6 This study 
BY4741 SNF7-RFP VPS10-GFP ∆fab1 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 SNF7::SNF7-RFP::kanMX4 vps26::LEU2 VPS10-GFP::HIS3MX6 This study 
BY4742 VPS10-GFP MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 VPS10-GFP::HIS3MX6 This study 
BY4742 VPS10-GFP ∆vps29 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vps29::kanMX4 VPS10-GFP::HIS3MX6 This study 
BY4742 VPS10-GFP ∆svp1 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 svp1::kanMX4 VPS10-GFP::HIS3MX6 This study 
BY4742 VPS10-GFP ∆hsv1 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 hsv1::kanMX4 VPS10-GFP::HIS3MX6 This study 
BY4742 VPS10-GFP ∆hsv2 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 hsv2::kanMX4 VPS10-GFP::HIS3MX6 This study 
BY4742 VPS10-GFP ∆vac7 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vac7::kanMX4 VPS10-GFP::HIS3MX6 This study 
BY4742 VPS10-GFP ∆vac14 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vac14::kanMX4 VPS10-GFP::HIS3MX6 This study 
BY4742 ∆atg18 ∆ atg21 ∆hsv2 MATα ; his3∆1; leu2∆0; lys2∆0; ura3∆0 atg18:: kanMX4 atg21::LEU2 hsv2::HIS3 Dove Lab 
BY4742 ∆ atg18 ∆ atg21 MATα ; his3∆1; leu2∆0; lys2∆0; ura3∆0 atg18:: kanMX4 atg21::LEU2 This study 
BY4742 ∆ atg21∆hsv2 MATα ; his3∆1; leu2∆0; lys2∆0; ura3∆0 atg21::HIS3 hsv2::LEU2 This study 
BY4742 ∆ atg18 ∆ atg21VPS10-GFP MATα ; his3∆1; leu2∆0; lys2∆0; ura3∆0 atg18:: kanMX4 atg21::LEU2VPS10-GFP::HIS3MX6 This study 
BY4742 ∆ atg21 ∆hsv2 VPS10-GFP MATα ; his3∆1; leu2∆0; lys2∆0; ura3∆0 hsv2:: kanMX4 atg21::LEU2 VPS10-GFP::HIS3MX6 This study 
BY4742 ∆vps29 ∆ fab1 VPS10-GFP MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vps29::kanMX4 fab1::LEU2 VPS10-GFP::HIS3MX6 This study 
SEY6210.1 VPS5-GFP MATa leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 suc2-Δ9 lys2-801VPS5::VPS5-GFP S.Emr 
SEY6210.1 VPS5-GFP ∆fab1 MATa leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 suc2-Δ9 lys2-801VPS5::VPS5-GFP fab1::LEU2 This study 
SEY6210.1 VPS5-GFP ∆vac14 MATa leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 suc2-Δ9 lys2-801VPS5::VPS5-GFP vac14::kanMX4 This study 
SEY6210.1 VPS5-GFP ∆vps26 MATa leu2-3,112 ura3-52 his3-Δ200 trp1-Δ901 suc2-Δ9 lys2-801VPS5::VPS5-GFP vps26::LEU2 This study 
BY4742 MRL1-GFP MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 MRL1-GFP::HIS3MX6 This study 
BY4742 ∆fab1 MRL1-GFP MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fab1::kanMX4 MRL1-GFP::HIS3MX6 This study 
BY4742 ∆vps29 MRL1-GFP MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vps29::kanMX4 MRL1-GFP::HIS3MX6 This study 
BJ3505 MATa pep4::HIS3 prb1-∆1.6R his3 lys2-208 trp1-∆101 ura3-52 gal2 can A. Mayer 
BY4741 ∆chs6 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 chs6::kanMX4 This study 
YPH499 ∆chs6 MATa ura3-52 lys2-801 ade2-101 trp1-Δ63 his3-Δ200 leu2-Δ1 chs6::LYS2 This study 
fab1-1ts MATa fab1-1ade3 trp1 can1 cyh1 gal1 D. Koshland 
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GPY1783-20D MATα ura3-52 leu2-3, 112 his3-Δ200 trp1-Δ901 lys2-801suc2-Δ9 GAL mel apl2∆6::TRP1 G. Payne 
GPY2424.1 MATα ura3-52 leu2-3, 112 his3-Δ200 trp1-Δ901 lys2-801suc2-Δ9 GAL mel apl4∆::TRP1 G. Payne 
BY4742 CHS3-GFP MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 CHS3-GFP::HIS3MX6 This study 
BY4742 ∆fab1 CHS3-GFP MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fab1::kanMX4 CHS3-GFP::HIS3MX6 This study 
BY4742 ∆apl4 CHS3-GFP MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 apl4::kanMX4 CHS3-GFP::HIS3MX6 This study 
BY4742 ∆chs6 CHS3-GFP MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 chs6::kanMX4 CHS3-GFP::HIS3MX6 This study 
BY4742 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 chs6::LYS2 This study 
BY4742 ∆fab1 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fab1::kanMX4 chs6::LYS2  This study 
BY4742 ∆fab1 ∆chs6 CHS3-GFP MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fab1::kanMX4 chs6::LYS2 CHS3-GFP::HIS3MX6 This study 
BY4742 ∆apl4 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 apl4::kanMX4 chs6::LYS2 This study 
BY4742 ∆apl4 ∆chs6CHS3-GFP MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 apl4::kanMX4 chs6::LYS2 CHS3-GFP::HIS3MX6 This study 
BY4742 ∆fab1 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fab1::kanMX4 chs6::LYS2  This study 
BY4742 ∆fab1 ∆chs6  MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fab1::LEU2 chs6::LYS2  This study 
BY4742 ∆apl4 ∆chs6 ∆fab1 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 apl4::kanMX4 chs6::LYS2 fab1::LEU2 This study 
BY4742 ∆atg21∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 atg21::kanMX4 chs6::LYS2 This study 
BY4742 ∆hsv2 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 hsv2::kanMX4 chs6::LYS2 This study 
BY4742 ∆vac7 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vac7::kanMX4 chs6::LYS2 This study 
BY4742 ∆vac14 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vac14::kanMX4 chs6::LYS2 This study 
BY4742 ∆svp3 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 svp3::kanMX4 chs6::LYS2 This study 
BY4742 ∆doa4 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 doa4::kanMX4 chs6::LYS2 This study 
BY4741 ∆vps13 ∆chs6 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 vps13::kanMX4 chs6::LYS2 This study 
BY4742 ∆vps13 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vps13::kanMX4 chs6::LYS2 This study 
BY4742 ∆lcl3 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 lcl3::kanMX4 chs6::LYS2 This study 
BY4742 ∆gup1 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 gup1::kanMX4 chs6::LYS2 This study 
BY4742 ∆scy1 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 scy1::kanMX4 chs6::LYS2 This study 
BY4742 ∆ygl082w ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 ygl082w::kanMX4 chs6::LYS2 This study 
BY4742 ∆fsk2 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fsk2::kanMX4 chs6::LYS2 This study 
BY4742 ∆gas1 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 gas1::kanMX4 chs6::LYS2 This study 
BY4742 ∆apl2 ∆chs6 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 apl2::kanMX4 chs6::LYS2 This study 
BY4742 ∆fab1 ∆chs6 ∆pep12 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fab1::LEU2 chs6::LYS2 pep12::kanMX4 This study 
BY4742 ∆fab1 ∆chs6 ∆vps4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 fab1::LEU2 chs6::LYS2 vps4::kanMX4 This study 
GPY2424.1∆chs6 MATα ura3-52 leu2-3, 112 his3-Δ200 trp1-Δ901 lys2-801suc2-Δ9 GAL apl4∆::TRP1 chs6::LYS2 This study 
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GPY2424.1∆chs6 ∆pep12 MATα ura3-52 leu2-3, 112 his3-Δ200 trp1-Δ901 lys2-801suc2-Δ9 GAL pep12::kanMX4 apl4∆::TRP1 
chs6::LYS2 
This study 
GPY2424.1∆chs6 ∆vps4 MATα ura3-52 leu2-3, 112 his3-Δ200 trp1-Δ901 lys2-801suc2-Δ9 GAL vps4::kanMX4 apl4∆::TRP1 chs6::LYS2  This study 
SUA1-3D MATα ade2∆ ade8his3∆1 leu2∆0 lys2∆0 ura3∆ trp1-Δ0 sec22::HIS3 H.D.Schmitt 
BY4742 ∆vma1 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma1::kanMX4 pep4::HIS3 This study 
BY4742 ∆vma2 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma2::kanMX4 pep4::HIS3 This study 
BY4742 ∆vma3 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma3::kanMX4 pep4::HIS3 This study 
BY4742 ∆vma4 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma4::kanMX4 pep4::HIS3 This study 
BY4742 ∆vma7 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma7::kanMX4 pep4::HIS3 This study 
BY4742 ∆vma8 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma8::kanMX4 pep4::HIS3 This study 
BY4742 ∆vma9 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma9::kanMX4 pep4::HIS3 This study 
BY4742 ∆vma10 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma10::kanMX4 pep4::HIS3 This study 
BY4742 ∆vma11 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vma11::kanMX4 pep4::HIS3 This study 
BY4742 ∆ stv1 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 stv1::kanMX4 pep4::HIS3 This study 
BY4742 ∆vph1 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vph1::kanMX4 pep4::HIS3 This study 
BY4742 ∆ pho81 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 pho81::kanMX4 pep4::HIS3 This study 
BY4742 ∆pho85 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 pho85::kanMX4 pep4::HIS3 This study 
BY4742 ∆vps3 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vps3::kanMX4 pep4::HIS3 This study 
BY4742 ∆vps8 ∆pep4 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 vps8::kanMX4 pep4::HIS3 This study 
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2.1.2. Reagents for culture of S. cerevisiae and E. coli. 
Bactopeptone, Bactoagar, yeast extract and yeast nitrogen base without amino acids 
were obtained from Difco Laboratories (Detroit, MI, USA).  
 
2.1.3. Reagents for molecular biology. 
Restriction enzymes (BamHI, EcoRI, XhoI EcoRV, ClaI, XbaI, NruI and AdeI), 
dNTPs, T4 DNA ligase, 1KB DNA ladder and Biotaq polymerase were obtained from 
New England Biolabs (Beverly, MA, USA). Expand proof-reading DNA polymerase; 
long template DNA polymerase and ×10 reaction buffer were obtained from Roche 
(Nutley, NJ, USA). Oligonucleotides were synthesised by Alta Bioscience 
(Birmingham, UK) or MWG Biotech (Ebersberg, Germany). Qiagen II resin gel 
extraction kits, genomic DNA kit, mini and midi prep plasmid kits were obtained 
from Qiagen Ltd (Valencia, CA, USA). All other reagents were obtained from Sigma-
Aldrich (St. Louis, MI, USA), and were of biotechnological grade or better. 
 
2.1.4. Materials for Microscopy. 
22 x 22 mm coverslips and prewashed slides were purchased from Fischer Scientific 
(Loughborough, UK). Non fluorescent emersion oil was purchased from Nikon Ltd 
(Melville, NY, USA). FM4-64 lipid dye, Fluorescent brightener 28, WGA-FITC and 
Poly L-lysine were obtained from Sigma-Aldrich (St.Louis, MI, USA).  
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2.1.5. Materials for high efficiency transformation of Yeast and E. coli 
Polyethylene glycol (PEG), lithium acetate, single-stranded salmon testis DNA, 
Ampicillin, 10 x TXN salts, glucose and MgCl2 were obtained from Sigma-Aldrich 
(St.Louis, MI, USA). Isopropyl β-D-1-thiogalactopyranoside (IPTG) and X-gal were 
obtained from Bio-Line (London, UK).  
 
2.1.6. Media composition and solutions 
All yeast media were autoclaved for 15 minutes at 121°C and cooled. Glucose was 
added to a final concentration of 2% (from a 40% w/v stock) prior to use. 
 
Yeast extract Peptone Dextrose (YPD) (1L): 
Glucose (2.0% w/v), Bactopeptone (2.0% w/v), Yeast extract (1.0% w/v), Adenine 
(100 mg), Uracil (100 mg) 
Yeast extract Tryptone Dextrose (YTD) (1L): 
Glucose (2.0% w/v), Bacto-tryptone (2.0% w/v), Yeast extract (1.0% w/v), Adenine 
(100 mg), Uracil (100 mg). 
Rich media (pre sporulation) 
Glucose (4.0%w/v), Bactopeptone (2.0% w;v), Bacto-tryptoe (2.0% w/v) Yeast 
extract (2% w/v) Amino acid stock mix (0.2%)  
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Rich YEPA  
Potassium acetate (2.0%w/v), Bactopeptone (2.0% w/v), Bacto-tryptoe (2.0% w/v) 
Yeast extract (2% w/v) Amino acid stock mix (0.2%)  
SPM sporulation media 
Potassium acetate (0.3% w/v), Raffinose (0.1% w/v), Essential amino acids (20mg 
each) 
Luria Broth (LB) (1L): 
Tryptone (1.0% w/v), Yeast Extract (0.5% w/v), NaCl (1.0% w/v)  
LB + 100 µg/ml
 
Ampicillin (1L): 
LB, Ampicillin (100 µg/ml) 
To prepare agar plates for YPD, YTD or LB media, Bacto agar (2.0% w/v) was added 
prior to autoclaving. Media was cooled to 50ºC and then glucose and/or antibiotics 
were added.  
Amino acid (AA) mix stock: 
Adenine (2 g), Arginine (2 g), Tyrosine (30 mg), Isoleucine (2g), Phenylalanine (2.06 
g), Glutamic acid (2 g), Aspartic acid (2 g), Valine (2 g), Threonine (2 g), Serine (2 
g), Glycine (2 g), Proline (2 g), Alanine (2 g). Powder was milled in powder mill for 1 
minute and then stored at 4°C in sealed bottles. 
Synthetic Complete (SC) (1L): 
Glucose (2.0% w/v), Yeast Nitrogen Base without Amino Acids & Ammonium  
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Sulphate (1.7 g), Ammonium Sulphate (5 g), AA stock mix (2g), 100 mg leucine, 
lysine, tryptophan, histidine, methionine, uracil; pH 5.7 
For selective SC medium, the corresponding amino acid was omitted. For example, to 
make SC-His, 100mg Histidine was left out.    
In order to make SC plates, the pH was adjusted to 5.7 prior to the addition of Bacto 
agar (2.0% w/v). Media was then autoclaved, cooled and glucose (2% w/v final) 
added. 
SOC medium (1L): 
Tryptone (2.0% w/v), Yeast Extract (0.5% w/v), NaCl (0.05% w/v), KCl (2.5 mM), 
adjust pH to 7 with NaOH. After autoclaving and immediately prior to use, sterile 
solutions of MgCl2 (10 µM) and Glucose (20 µM) were added. 
 
2.2. METHODS 
2.3. High efficiency transformation of yeast. 
The following method was adapted from Methods in Yeast Genetics (Adam, A., 
Goccschling, D. E., Kaiser, C. A., and Sterns, T., eds), Cold Springs Harbour 
Laboratory Manual [1997]. 
Cells were subcultured at 5 x 10
6
 cells/ml in YPD+2.0% glucose medium (50ml), and 
were grown at 25°C to 2 x 107 cells/ml. Cells were collected, resuspended in H2O 
(25ml), and centrifuged at 1000g for 5 minutes at 25°C. Cell were again collected, 
resuspended in 1ml of 100mM lithium acetate (LiAc) and transferred to a 1.5ml 
Eppendorf tube. The cell suspension was centrifuged at 2000g for 1 minute and the 
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supernatant removed. Single-stranded salmon testis DNA 2mg/ml (carrier DNA) was 
boiled for 7 minutes and chilled on ice. The cell pellet was resuspended with a 
mixture of; 240µl PEG (50% w/v), 36µl LiAc (1.0 M), 50µl boiled carrier DNA and 
25µl ddH2O containing plasmid or construct DNA (0.1-10µg). The resulting mixture 
was vortexed for 1 minute, incubated for 20 minutes at 30
o
C, and then heat-shocked 
for 20 minutes at 42°C. Cells were collected by centrifugation at 3000g for 1 minute. 
The supernatant was discarded and the cells gently washed with 1ml of ddH2O, 
centrifuging as above. The resulting pellet was resuspended in ddH2O (150µl), plated 
on selective agar plates and incubated at 25°C
 
for three days. 
 
2.4. Extraction of Genomic DNA from S. cerevisiae. 
Genomic DNA was extracted from Yeast strains using the Gentra Puregene 
Yeast/Bact. Kit from Qiagen. The following method is from Gentra Puregene 
Handbook, second edition, Qiagen, p47- 48, 09/2007. 
Cells were subcultured at 5 x 10
6
 cells/ml in YPD+2.0% glucose medium (50 ml), and 
were grown at 25°C to 1 x 108 cells/ml. 1ml of the cell suspension was transferred to a 
1.5ml Eppendorf  tube on ice, and centrifuged for 5 seconds at 16000g to collect cells. 
Cells were resuspended in 300µl of cell suspension solution (part of kit), 1.5µl of 
Lytic enzyme solution was added, then incubated at 37°C for 30 minutes. Cells were 
collected by centrifugation at 16000g for 1 minute and the supernatant discarded. 
Cells were resuspended in 300µl of cell lysis solution, and then 100µl of protein 
precipitation solution was added. The sample was vortexed, then centrifuged at 
16000g to form a pellet of precipitated proteins. The supernatant was transferred to a 
fresh tube containing 300µl of isopropanol, was mixed by inversion and centrifuged 
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for 1 minute to pellet DNA. The supernatant was discarded and the pellet washed with 
300 µl of 70% ethanol. The supernatant was removed, and pellet air dried for 10 
minutes, before being resuspended in 50µl of DNA hydration solution. 1.5µl of 
RNase A solution was added, and the sample mixed. To dissolve the DNA, sample 
was incubated at 37°C for 30 minutes, then at 65°C for 1 hour. 
 
2.5 Changing the mating type of S. cerevisiae cells. 
In order to change the mating type of S. cerevisiae strains, two haploid strains were 
mated to create a diploid. This was then sporulated (to divide and form spores) and 
the tetrad (the four spores that separate after mating) dissected to create haploid cells 
of interest. 
2.5.1 Mating of haploid cells to form a diploid. 
Two haploid strains of opposite mating type, were grown to 1 x 10
7
 cells/ml. Equal 
amounts of each strain were mixed, and  incubated at 30°C for 3 hours. Diploid cells 
were selected by plating onto selective SC plates that would only permit growth of a 
diploid cell because of amino-acid deficiencies.   
2.5.2 Sporulation. 
A diploid colony was sub-cultured to 1 x 10
7
 cells/ml in rich pre sporulation media at 
30°C overnight, and was then used to inoculate rich YEPA (20ml). Cells were 
incubated at 30°C for 4 hours, then collected by centrifugation at 2000g for 5 minutes, 
and washed twice with ddH20. The cells were resuspended in SPM (20ml) in a 250ml 
conical flask, and incubated at 30°C 220rpm for 3-5 days until asci (wall bound 
structure containing four spores) developed.  
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2.5.3 Tetrad dissection. 
50µl of the sporulation mixture (containing asci) was incubated with 5µl of 
zymolyase (dissolved in sorbitol) for 5 minutes. A loop full was used to inoculate the 
start position on a YTD plate.  A singer MSM MKIII micromanipulator, (Singer 
Instrument Co Ltd. Watchet, Somerset, UK) was used to dissect the tetrad. A four 
spore tetrad was picked up from the inoculation strip then deposited at position A1. 
The needle was used to separate the ascospores; the remaining three spores were 
moved to position B1, where another spore was deposited. The next spore was 
deposited at C1 and the final spore deposited at D1. This process was repeated to fill 
the plate. The plate was incubated at 25°C for 3 days and then replica plated onto 
various SC and drug containing plates to genotype each spore. 
Mating type was discovered by performing test matings with known haploids, to look 
for the formation of a diploid. 
 
2.6. Preparation of competent E. coli cells.  
LB medium (10ml) was inoculated with an appropriate E. coli strain, and incubated 
overnight at 37°C. 1ml of culture was used to inoculate super comp media (BIO101 
Carlsbad, CA, USA Formulation is proprietary, and therefore not defined further) 
(100ml) and was grown at 37°C in a 2 litre flask to an OD of A660 ~0.8. Cells were 
collected through centrifugation at 4000g for 15 minutes at 4°C. Cells were then 
resuspended in ice-cold 1 x TXN salts (30ml) and incubated on ice overnight. Cell 
suspensions were centrifuged at 3000g 4°C for 15 minutes and were then resuspended 
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in 1x TXN salts + glycerol (20%v:w final) (5ml). Cells were incubated at 4°C for 1 
hour, before being aliquoted and stored at -80°C.  
 
2.7. Transformation of competent E. coli cells.   
Plasmid DNA (0.1-10µg) was added to an aliquot of competent E. coli cells (100µl), 
incubated on ice for 15 minutes and heat shocked at 42°C for 45 seconds. Ice cold 
SOC medium (1.0 ml) was added to the cell suspension, mixed gently and incubated 
at 37°C for 30 minutes. Cells were collected through centrifugation at 8000g for 1 
minute, and were then resuspended in LB medium (100µl). Sample was plated onto a 
LB + 100µg/ml amp plate and incubated at 37°C overnight.  
For blue white selection of pGem-T-Easy, E. coli transformations were carried out as 
above and plated onto LB + 100µg/ml amp agar plate + IPTG + X-Gal. 
 
2.8. Purification of plasmids from E. coli. 
2.8.1 Mini-prep. 
Single colonies were picked from agar plates, resuspended in LB+100µg/ml amp 
(5ml) and were grown at 37°C, 220rpm for 12-16 hours. E. coli was harvested by 
centrifugation at 8000g for 3 minutes at 25°C. The Qia-prep spin mini-prep kit and 
protocol was then followed.  
2.8.2 Midi preps  
A starter culture was inoculated using a single colony off a fresh plate into 
LB+100µg/ml amp (5ml). This was then used to inoculate LB+100µg/ml amp (50ml), 
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and was grown at 37°C 220 rpm for 12-16 hours. E. coli cells were harvested by 
centrifugation at 6000g 4°C for 15 minutes. The Qiagen anion exchange midi-prep 
protocol and Qiagen tip-100 were then used to complete the plasmid extraction. 
2.8.3 Boiling preps 
Single colonies were picked from agar plates, resuspended in LB+100µg/ml amp 
(5ml) and were grown at 37°C, 220rpm for 12-16 hours. E. coli cells were harvested 
by centrifuging at 16000g, 25°C for 2 minutes. Each pellet was resuspended in 110µl 
of STETL (8% Sucrose, 5% Triton X100, 50mM EDTA, pH 8.0, 50mM Tris, pH 8.0, 
1 mg/ml lysozyme) and was incubated at room temperature for 15 minutes. Samples 
were boiled for 40 seconds and centrifuged at 16000g for 20 minutes. The pellet was 
removed and 110µl of 100% isopropanal added to the supernatant. The samples were 
centrifuged at 16000g for 20 minutes and supernatant discarded. Pellet was washed 
with 70% ethanol and centrifuged at 16000g for 1 minute, supernatant was removed 
and pellet air dried for 15 minutes. The pellet was resuspended in 40µl of 10mM Tris-
HCl with 20µg/ml RNAseA and incubated at 55
 
°C for 10 minutes. 
 
2.9 Extraction of plasmids from S. cerevisiae. 
Plasmids were extracted by a method adapted from a protocol by Julia Sidorova and 
Linda Breeden from Hoffman and Winston, Gene, 1987, Vol. 57: 267-272.  
Fresh colonies of yeast were resuspended in yeast lysis buffer (100mM NaCl, 10mM 
Tris-HCl pH8.0, 1mM EDTA, 0.1% SDS) (20µl). Acid washed glass beads (200µl) 
and 1:1 (v/v) Phenol:chloroform (20µl) were added to each sample in a 1.5ml 
Eppendorf tube. Samples were vortexed for 5 minutes and then centrifuged at 16000g 
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for 5 minutes. The aqueous layer was moved to a fresh tube and centrifuged at 16000g 
for 5 minutes.  The aqueous layer (10µl) was used for TOP10 E. coli transformation 
as above. 
 
2.10 Polymerase chain reaction (PCR) 
All PCRs were prepared on ice, and performed with Expand High Fidelity PCR 
system unless indicated. Reactions were carried out in a TECHNE TC-3000 
(Staffordshire, UK) thermal block cycler. ‘Master mix 1’ (50μl) contained 
Deoxyribonucleotide mix (25mM stock), upstream primer (300nM), downstream 
primer (300nM), and target DNA. ’Master mix 2’ (50μl) contained, 10x buffer with 
MgCl2 (10μl), and Expand enzyme (1μl). Each master mix was mixed, then ‘master 
mix 2’ was added to ‘master mix 1’ mixed well, and aliquoted (50μl), the volume the 
thermal cycler profile was calibrated for. The general cycling profile was as follows: 
94°C 94°C TMI-5°C 68°C 94°C TM-5°C 68°C 68°C 4°C 
3 minute 1 minute 1 minute 1 
minute/kb 
+1 
minute 
1 minute 1 minute 1 
minute/kb 
+1 
minute 
20 
minutes 
To store 
1cycle 5 cycles 20 cycles 1cycle 1cycle 
  
TMI indicates TM of the initial matching region only. 
 
2.11. Purification and concentration of DNA after PCR. 
DNA was purified by gel extraction for use in cloning. The Qiagen gel extraction spin 
kit and protocol was followed. 
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Ethanol precipitation was carried out to concentrate construct DNA after PCR 
amplification. DNA was precipitated by adding two volumes of ice cold 100% ethanol 
and one tenth volume of 0.3M sodium acetate. Samples were mixed well and 
incubated at -20°C for 1 hour. Samples were centrifuged at 16000g, 4°C for 40 
minutes, supernatant was removed and pellet washed with 70% ethanol. DNA was 
pelleted by centrifugation at 16000g, 4°C for 20 minutes, supernatant was discarded 
and pellet air dried for 10-15 minutes. The pellet was resuspended in 10mM Tris-HCl, 
pH 8.5.  
 
2.12. Plasmid construction and GFP tagging of proteins. 
2.12.1. VPS10-GFP, CHS3-GFP and MRL1-GFP 
Constructs were generated via the short-flanking homology approach (Longtine et al., 
1998). One step-PCR was used to modify the chromosomal genes and introduce a 
green fluorescent protein tag that was expressed under the target genes own promoter. 
Plasmid pFa6A-GFP(S65T)-HIS3MX6 was used as a template for each of the PCR 
reactions. Oligonucleotides were designed that had 5’ ends that corresponded to the 
desired target gene sequences and 3’ ends that annealed to and allowed amplification 
of the selectable marker gene and the GFP tag. The gene specific sequences of the 
sense oligonucleotide were chosen to end just upstream of the stop codon to preserve 
the reading frame of the tag, those of the anti-sense oligonucleotide were chosen to 
end just downstream of the stop codon. The specific oligonucleotides and conditions 
are as follows: 
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Vps10p 5’-CTCTGCCTTATTTCCTTGTAGTTC -3’ 5’- 
CCCATCACAACTGGCCAT TTAT - 3’. Vps10p-GFP genomic DNA was used as a 
template. The reactions were conducted by denaturing at 94°C for 3 minutes, followed 
by 5 cycles with denaturing at 94°C for 1 minute, annealing at 49oC for 1 minute and 
extension at 68°C for 10 minutes. This was followed by 20 cycles with denaturing at 
94°C for 1 minute, annealing at 58°C for 1 minute, and extension at 68°C for 10 
minutes, and a final extension step at 68°C for 20 minutes. A PCR product of around 
8.0 Kb was produced.  
 
Mrl1p 5’-
AACAGAAAGCGACCACCCAACTTTGGCTGATAATAGCGTACGGATCCC 
CGGGTTAATTAA -3’ 5’-
GCATAAATATATCTACTGCATTGTATTTTGAACGTACAA AGTATGCAT 
TGTGAATTCGA GCTCGTTTAAAC -3’ The reactions were conducted by 
denaturing at 94°C for 4 minutes, followed by 10 cycles with denaturing at 94°C for 1 
minute, annealing at 55°C for 1 minute and extension at 72oC for 3 minutes. This was 
followed by 20 cycles with denaturing at 94°C for 1 minute, annealing at 65oC for 1 
minute, and extension at 72
o
C for 3 minutes, followed by a final extension step at 
72
o
C for 10 minutes. A PCR product of around 2.6Kb was produced.  
 
Chs3p 5’-
ATATTCTCAATCGGAAGGAGGAAAGTGACTCCTTCGTTGCAGCGATC 
CCCGGGTTAATTAA -3’ 5’- CACACAACCATATATCAACTTGTAAGTATCAC 
AGTAAAAATATTTTCATACTGTGAATTCGAGCTCGTTTAAAC -3’ The 
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reactions were conducted by denaturing at 94
o
C for 4 minutes, followed by 10 cycles 
with denaturing at 94
o
C for 1 minute, annealing at 55
o
C
 
for 1 minute and extension at 
72
o
C for 5 minutes. This was followed by 20 cycles with denaturing at 94
o
C for 1 
minute, annealing at 65
o
C for 1 minute, and extension at 72
o
C for 5 minutes, followed 
by an additional extension step at 72
o
C for 10 minutes. A PCR product of around 
2.8Kb was produced.  
After PCR tagging with GFP, the fragments were gel purified using the Qiagen kit 
and transformed into S. cerevisiae as above.  
2.12.2. pUG36-YIF1 
pUG36–YIF1 was constructed by PCR amplification of the YIF1 ORF from yeast 
genomic DNA, using sense and antisense oligonucleotides integrating EcoRI and XhoI 
restriction sites respectively, 5’-TTTGGGAATTCATGTCTTATAATCCGT 
ACGCATATGC-3’ and 5’-TTTTTCTCGAGTCAACCCATTAACCACATTAGA 
ACA-3’. The reactions were conducted by denaturing at 94oC for 2 minutes, followed 
by 5 cycles with denaturing at 94
o
C for 1 minute, annealing at 50
o
C for 1 minute and 
extension at 68
o
C for 4 minutes. This was followed by 20 additional cycles denaturing 
at 94
o
C for 1 minute, annealing at 58
o
C for 1 minute and extension at 68
o
C for 4 
minutes and a final extension step at 68
o
C for 20 minutes. The resulting products of 
around 1Kb were purified using Qiagen gel purification kit. 
Plasmid pUG36–YIF1 was created by ligation of a ~1.0 kb PCR fragment encoding 
the entire YIF1 ORF, digested with EcoRI and XhoI into the EcoRI and XhoI sites of 
pUG36. The ligated plasmid was transformed into E .coli. Correct clones were 
identified by performing mini-preps and diagnostic restriction enzyme digests. A 
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midi-prep of the correct clone was performed and sent for sequencing to confirm 
integration.  
 
Fig 2.1: pUG36 map 
 
 
 
2.12.3. pUG23-MRL1 and pUG34-MRL1. 
pUG23-MRL1 contained MRL1 tagged at the C terminus with GFP. pUG34-MRL1 
contained MRL1 N terminally tagged with GFP. Both plasmids were created in similar 
ways. The entire MRL1 ORF was amplified by PCR using the following sense 
oligonucleotide to introduce a BamH1 restriction site: Oligo A 5’-TGTTGTGGATCC 
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ATGTTGAAACGATCATCTCTAA-3, and an anti sense oligonucleotide to introduce 
a SalI restriction site, either incorporating the stop codon: oligo B 5’-GTGTTT 
GTCGACTTATACGCTATTATCAGCCAAA -3’or without stop codon, Oligo C 5’-
TGTTTGTCGACTACGCTATTATCAGCCAAAGTT-3’. Oligo A and C were used 
for integration into pUG23 and oligos A and B for integration into pUG34. The 
reactions were conducted by denaturing at 94
o
C for 2 minutes, followed by 5 cycles 
with denaturing at 94
o
C for 1 minute, annealing at 45.7
o
C for 1 minute and extension 
at 68
o
C for 3 minutes. This was followed by 20 additional cycles, denaturing at 94
o
C 
for 1 minute, annealing at 58
o
C for 1 minute and extension at 68
o
C for 3 minutes and 
a final extension step at 68
o
C for 20 minutes. The resulting products were purified 
using Qiaex II resin.  
Plasmids pUG34–MRL1 and pUG23-MRL1 were created by ligation of the 
appropriate ~1.2 kb PCR fragment, encoding the entire MRL1 ORF with or without 
stop codon, digested with BamHI and SalI into the BamHI and SalI sites of pUG34 or 
pUG23. Plasmids were transformed into E. coli, mini-preps and restriction enzyme 
digests were performed to confirm correct integration. The plasmid was then 
sequenced to confirm.  
2.12.4. Construction of pGEX6PK-1 VMA1, pGEX6Pk-1 VMA2, pGEX6Pk-1 
VMA4 and pGEX6Pk-1 VMA5.  
Plasmid pGEX6T1-VMA1 was constructed by amplification of the whole VMA1 ORF 
from BY4742 genomic DNA, using sense and antisense oligonucleotides integrating 
BamHI and XhoI restriction sites respectively, 5’- TTATTGGATCCATGGCTGG 
TGCAATTGAAAAC -3’ and 5’- CCTCGAGTTAATCGGTAGATTCAGCAAA 
TCTT -3’ The reactions were conducted by denaturing at 94oC for 2 minutes, 
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followed by 5 cycles with denaturing at 94
o
C for 1 minute, annealing at 48.9
o
C for 1 
min and extension at 68
o
C for 4 min. This was followed by 20 additional cycles 
denaturing at 94
o
C for 1 minute, annealing at 57
o
C for 1 minute and extension at 68
o
C 
for 4 minutes and a final extension step at 68
o
C for 20 minutes. The resulting product 
of ~ 3.25 Kb was purified using Qiagen gel purification kit. The purified gene 
fragment was digested with BamHI and XhoI and inserted into the BamHI and XhoI 
sites of digested pGEX6pK1 digested. The ligated plasmid was transformed into E. 
coli. Midi-preps and restriction enzyme digests were performed to identify a correct 
clone. This was then further verified by sequencing.  
 
Plasmid pGEX6T1-VMA2 was constructed by amplification of the whole VMA2 ORF 
from BY4742 genomic DNA, using sense and antisense oligonucleotides integrating 
BamHI and XhoI restriction sites respectively, 5’- TGGATCCATGGTTTTGTCT 
GATAAGGAGTTGT -3’ and 5’- TCTCGAGTTAGATTAGAGATTCTTCT 
TGGCTG -3’. The PCR was conducted by denaturing at 94oC for 2 minutes, followed 
by 5 cycles with denaturing at 94
o
C for 1 minute, annealing at 50
o
C for 1 minute and 
extension at 68
o
C for 2 minutes. This was followed by 20 additional cycles denaturing 
at 94
o
C for 1 minute, annealing at 57
o
C for 1 minute and extension at 68
o
C for 2 
minutes and a final extension step at 68
o
C for 20 minutes. The resulting product of 
~1.55 Kb was purified using Qiagen gel purification kit. The purified gene fragment 
was digested with BamHI and XhoI and inserted into the BamHI and XhoI sites of 
digested pGEX6T1. The ligated plasmid was transformed into E. coli. Midi-preps and 
a restriction enzyme digest were performed to identify a correct clone. This was then 
further verified by sequencing.  
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Plasmid pGEX6T1-VMA4 was constructed by amplification of the wholeVMA4 ORF 
from BY4742 genomic DNA  using sense and antisense oligonucleotides integrating 
BamHI and XhoI restriction sites respectively, 5’- TTTTTGGATCCATGTCC 
TCCGCTATTACTGCT -3’ and 5’- TTTTCTCGAGTCAATCAAAGAACT 
TTCTTGTCTTGG -3’. The reactions were conducted by denaturing at 94oC for 2 
minutes, followed by 5 cycles with denaturing at 94
o
C for 1 minute, annealing at 50
o
C 
for 1 minute and extension at 68
o
C for 1.5 minutes. This was followed by 20 
additional cycles denaturing at 94
o
C for 1 minute, annealing at 58
o
C for 1 minute and 
extension at 68
o
C for 1.5 minutes and a final extension step at 68
o
C for 20 minutes. 
The resulting product of ~0.7 Kb was purified using Qiagen gel purification kit. The 
purified gene fragment was digested with BamHI and XhoI and inserted into the 
BamHI and XhoI sites of digested pGEX6T1. The ligated plasmid was transformed 
into E. coli. Midi-preps and a restriction enzyme digest were performed to identify a 
correct clone. This was then further verified by sequencing. Plasmid pGEX6T1-VMA5 
was constructed by amplification of the whole of the VMA5 ORF from BY4742 
genomic DNA, using sense and antisense oligonucleotides integrating BamHI and 
XhoI restriction sites respectively, 5’- TTTTTGGATCCATGGCTACTGCGTTATAT 
ACTG -3’ and 5’- CTCGAGTTATAAATTGATTATATACATCACAAATGG -3’. 
The reactions were conducted by denaturing at 94
o
C for 2 minutes, followed by 5 
cycles with denaturing at 94
o
C for 1 minute, annealing at 48
o
C for 1 minute and 
extension at 68
o
C for 2 minutes. This was followed by 20 additional cycles denaturing 
at 94
o
C for 1 minute, annealing at 54.5
o
C for 1 minute and extension at 68
o
C for 2 
minutes and a final extension step at 68
o
C for 20 minutes. The resulting product of 
~1.2 Kb was purified using Qiagen gel purification kit. The purified gene fragment 
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was digested with BamHI and XhoI and inserted into the BamHI and XhoI sites of 
digested pGEX6T1. The ligated plasmid was transformed into E. coli. Midi-preps and 
restriction enzyme digests were performed to identify a correct clone. This was then 
further verified by sequencing.  
2.12.5 Creation of pUG36-SVP3, pUG36-SVP3
CT1
, pUG36-SVP3
NT1
  pUG36-
SVP3
K486R
 and pUG36-SVP3
PPIY/PPCY to PAIA/PACA
. 
pUG36-SVP3, pUG36-SVP3
CT1
and pUG36-SVP3
NT1
 were previsously made by Dr 
Stephen Dove and Gavin McNee (Birmingham Uk.) They created the plasmids as 
follows: 
pUG36-SVP3 was made by PCR amplifying the full length SVP3 ORF (YOR322c) 
from wild-type genomic DNA using the Expand polymerase and the following 
oligonucleotides 5’-TTTCCAAGCTTATGGCATTT TCACGTCTTACA-3’ and 5’-
TTTTTCTCGAGCTACTGGGTTATTCTATTGGA-3’ which incorporated HindIII 
and XhoI restriction sites 5' and 3' of the ORF respectively. The resulting 2.4kB 
fragment was gel purified and digested with Hind III and Xho I. It was thenligated 
with pUG36 plasmid that had been similarly digested. The resulting ligation mixture 
was transformed into competent TOP10 E.coli and recombinant plasmids identified 
by digesting 5mg amounts of plasmid DNA with the same two enzymes. This yielded 
the plasmid pUG36-SVP3, that was analysed by DNA sequencing, to ensure that the 
PCR amplification had introduced no errors into the YOR322c ORF. 
pUG36-SVP3
CT1
 was made by digesting the pUG36-SVP3 plasmid with the enzyme 
EcoRI and gel purifying the resulting fragments. The large 7.4 kB fragment, 
comprising the entire sequence of plasmid pUG36 ligated to a 1.1kB fragment of the 
SVP3 ORF, constituting the most 3' third of the gene, was then self ligated to produce 
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a construct that would express the C-terminal most third of Svp3p expressed as a N-
terminal GFP tagged protein in S. cerevisiae. This ligation was transformed, analysed 
and sequenced according to standard procedures and designated pUG36-SVP3CT1.  
pUG36-SVP3
NT1
 was made by digesting the pUG36-SVP3 plasmid with the enzyme 
BamHI. the resulting 1.6 kB fragment, comprising the 5' two-thirds of the SVP3 ORF, 
was gel purified, and ligated with BamHI digested pUG36 to yield a construct that 
would express the N-terminal two thirds of the SVP3/YOR322c ORF as an N-
terminal GFP fusion when transformed into E.coli. This construct was recovered, 
identified and sequenced according to standard practise and designated pUG36-
SVP3NT1.  
 
pUG36-SVP3
K486R
 and pUG36-SVP3
PPIY/PPCY to PAIA/PACA 
were created by serial overlap 
extension (SOE), a method adapted from Molecular Cloning: A laboratory manual, 
third edition. (Sambrook J & Russell DW., eds), Cold Spring Harbour Laboratory 
Press, Cold Spring Harbour, New York, USA, 2001, Volume 2: 13.36.  
 
Four oligonucleotides were used to introduce a site-specific mutation by overlap 
extension (See Figure 2.2). The primers B and C were used to amplify the DNA and 
introduce the specific mutation site. Primers A and D bound to the pUG36 plasmid at 
either side of the SVP3 ORF, allowing amplification of the whole gene.  
 
Two sets of primers were used in two separate amplification reactions using pUG36-
SVP3, to amplify over-lapping DNA fragments (Fragments AB and CD) containing 
the mutations required. The fragments were purified using the Qiagen gel extraction 
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kit, and were used as a template for a third PCR. The overlapping fragments were 
mixed, denatured and annealed to generate heteroduplexes, which were extended and 
amplified into full-length DNA using primers A and D, which bound to the extremes 
of the two initial fragments. The full length fragment was purified and digested 
through the qiagen gel extraction kit and was then digested with XhoI and HindIII and 
cloned back into pUG36. 
 
Fig 2.2 Strategy for creation of pUG36-SVP3
K486R
 by SOE method 
 
Strategy for the creation of the pUG36-SVP3
K486R
 mutant by site overlap extension method. Process 
involves two rounds of PCR, as above using the PCR products from the first round, as DNA templates 
for the final round of PCR to amplify the whole gene containing the mutation (not drawn to scale). 
 
The following oligonucleotides were used for the pUG36-SVP3 
PAIA/PACA
 and pUG36-
SVP3 
K486R
 mutations: 
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pUG36-SOEA1- 5’-GTGTGTGTGTCTTGTTACCAGACAACCATTACTTAT -3’ 
pUG36-SOED1- 5’-GTTTGTTTTTGTTTGATTAAGTTGGGTAACGCCAGG -3’ 
PAIA/PACA_B1-5’-TATAGAGAGCTCGGCACATGCTGGCGAGAGCAACT 
CGACATCTTGGGCAATGGCAGGAACTTCTTC-3 
PAIA/PACA_C1-5’ -GAAGAAGTTCCTGCCATTGCCCAAGATGTCGAGTTGC 
TCTCGCCAGCATGTGCCGAGCTCTCTATA -3’ 
K486R_B1- 5’ - GTCAAAATCGGTTCTCCATCCACTCTT -3’ 
K486R_C1- 5’ -AAGAGTGGATGGAGAACCGATTTTGAC -3’ 
*Red indicates nucleotide base change. 
The PCR reaction conditions were as follows: 
SVP3
PACA/PAIA 
AB and CD PCRs - Both reactions were conducted by denaturing at 
94
o
C for 2 minutes, followed by 5 cycles with denaturing at 94
o
C for 1 minute, 
annealing at 50.85
o
C for 1 minute and extension at 68
o
C for 3 minutes. This was 
followed by 20 additional cycles denaturing at 94
o
C for 1 minute, annealing at 59.0
o
C 
for 1 minute and extension at 68
o
C for 3 minutes, and a final extension step at 68
o
C 
for 20 minutes. The resulting AB product was ~1.9 Kb and the CD product ~0.9Kb.  
SVP3 
PACA/PAIA
 AD PCR - The reaction was conducted by denaturing at 94
o
C for 2 
minutes, followed by 25 cycles with denaturing at 94
o
C for 1 minute, annealing at 
54
o
C for 1 minutes and extension at 68
o
C for 5 minutes with a final extension step at 
68
o
C for 20 minutes. The resulting product was ~2.9 Kb.  
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SVP3
K486R
 AB PCR - The reaction was conducted by denaturing at 94
o
C for 2 
minutes, followed by 5 cycles with denaturing at 94
o
C for 1 minute, annealing at 51
o
C 
for 1 minute and extension at 68
o
C for 3 minutes. This was followed by 20 additional 
cycles, denaturing at 94
o
C for 1 minute, annealing at 55
o
C for 1 minute and extension 
at 68
o
C for 3 minutes, with a final extension step at 68
o
C for 20 minutes. The 
resulting product was ~1.6kb.  
SVP3
K486R
 CD PCR - The reaction was conducted by denaturing at 94
o
C for 2 
minutes, followed by 5 cycles with denaturing at 94
o
C for 1 minute, annealing at 50
o
C 
for 1 minute and extension at 68
o
C for 3 minutes. This was followed by 20 additional 
cycles denaturing at 94
o
C for 1 minute, annealing at 55
o
C for 1 minute and extension 
at 68
o
C for 3 minutes and a final extension step of 68
o
C for 20 minutes. The resulting 
product was around 1.3kb.  
SVP3 K486R AD PCR - The reaction was conducted by denaturing at 94
o
C for 2 
minutes, followed by 25 cycles with denaturing at 94
o
C for 1 minute, annealing at 
54.0
o
C for 1 minute and extension at 68
o
C for 5 minutes, and a final extension step at 
68
o
C for 20 minutes. The resulting product was ~2.8kb.  
 
2.12.6 Creation of VPS13
E003K
 
The pRS313-VPS13
E003K
 plasmid was created by SOE as above. A 1.02kb fragment of 
DNA was excised from pRS313-VPS13 by digesting the plasmid with restriction 
enzymes NruI and AgeI. Two rounds of PCR reaction were carried out. AB and CD 
fragments were amplified by PCR reactions using pRS313-VPS13 as a template and 
the following oligonucleotides: 
 85 
VPS13 E003K A1 5’-GATGGTAGAACCTTGTCTGACTACAACATCC -3’ 
VPS13 E003K B1   5’-GCCTAGCAATCGGTTTAGCAAATTAGCAGC 
TAAAGACTTTAACATTTAACTGT TCTTAATTTTCCT -3’ 
VPS13 E003K C1  5’-AGGAAAATTAAGAACAGTTAAATGTTAAAGTCTTTAG 
CTGCTAATTTGCTAAACCGA TTGCTAGGC -3’ 
VPS13 E003K D1 5’- GAGCTAGCTGTTGGTGTGGGTGAGTCTT -3’  
 
AB and CD PCRs - The reaction was conducted by denaturing at 94
o
C for 2 minutes, 
followed by 25 cycles with denaturing at 94
o
C for 1 minute, annealing at 59
o
C for 1 
minute and extension at 68
o
C for 2 minutes, and a final extension step at 68
o
C for 20 
minutes. The resulting AB product was ~750bp and CD product was ~1.3Kb.  
 The gel purified products from the above PCRs were used as templates to amplify the 
whole AD fragment, which incorporated sequence upstream and downstream of the 
AgeI and NruI restriction enzyme sites. 
 AD PCR - The reaction was conducted by denaturing at 94
o
C for 2 minutes, followed 
by 25 cycles with denaturing at 94
o
C for 1 minute, annealing at 59
o
C for 1 minute and 
extension at 68
o
C for 3 minutes, and a final extension step at 68
o
C for 20 minutes. 
The resulting product was ~2.0kb.  
The AD PCR product was gel purified and digested with AgeI and NruI restriction 
enzymes overnight. This produced a 1.02kb fragment which was gel purified and 
ligated into the digested pRS313-VPS13 plasmid. A correct plasmid was confirmed by 
transformation into E. coli, mini preps, diagnostic restriction enzyme digests and 
sequencing. 
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2.13. Transfer of deletions 
2.13.1 BY4742 ∆vps8::kanMX4 
 
Fig 2.3 Strategy for Δvps8 deletion. 
 
VPS8 was deleted through a process involving homologous recombination. Genomic replacement of 
the VPS8 ORF and part of the EFB1 and TFC3 ORFs (not drawn to scale), with a PCR fragment where 
the VPS8 ORF has been replaced with a dominant kan
r
 marker was used to create BY4742 Δvps8.  
 
 
Genomic DNA was prepared from BY4739 vps8::kanMX4 cells as above. This was 
used as a template to amplify the complete VPS8 ORF and N- and C-terminal regions 
of the ORFs from flanking genes. PCR amplification using the sense and antisense 
oligonucleotides 5’-CTACCGATATTGCTGCTATGC-3’and 5’- TGATGGCTATTG 
GGTCAATCATA -3’, resulted in the generation of a PCR fragment ( ~2.8 kb). The 
reactions were conducted by denaturing at 94
o
C for 3 minutes, followed by 25 cycles 
 87 
with denaturing at 94
o
C for 1 minute, annealing at 49.8
o
C for 1 minute and extension 
at 68
o
C for 4 minutes. This was followed by an additional extension step at 68
o
C for 
20 minutes. The resulting products were purified using Qiagen spin gel extraction kit.  
The ~2.8 kb PCR fragment containing the putative VPS8 ORF replaced by the 
dominant kan
r
 marker was transformed into BY4742 wild-type cells. Kanamycin-
resistant colonies were selected by growth on G418-containing agar plates and these 
colonies were re-streaked on G418-containing agar plates to further select the kan
r
 
marker. Replacement of the VPS8 ORF with the kan
r
 marker was confirmed through 
colony PCR using the kanamycin-resistant colonies and resulted in the generation of a 
fragment ~3.0 kb in size if correct. 
 
2.13.2 ∆atg21::LEU2 
Deletion was transferred using the method above. Genomic DNA was prepared from a 
BY4742 ∆atg18::KAN ∆atg21::LEU2 ∆hsv2::HIS3 strain and the following sense 
and anti-sense oligonucleotides used. 5’-TCGGAACAGTCACAT TCACAC-3’ and 
5’-GAAGCCT TGGTATAGGAGATG -3’  
 
2.13.3 ∆fab1::LEU2 
Mutation was deleted as above using fab1::LEU2 genomic DNA and the following 
sense and anti-sense oligonucleotides, 5’-ATGCACCTGAAATAGCACCAACAGG 
TACGC-3’ 5’-GGGTCGATTATTGAGTTGCTGATTACCTCC-3’ 
 
 88 
2.13.4 ∆vps26::LEU2 
Mutation was deleted as above using genomic DNA from MSY2629, and the 
following sense and anti-sense oligonucleotides, 5’-AGGAAGAGCCAGAATCA 
GATA-3’, 5’-ATCTACCGATTCTACCGAAC-3’ 
 
2.13.5 ∆vac14::kanMX4   
Deletion was transferred using the method above. Genomic DNA was prepared from 
BY4742 ∆vac14::kanMX4 and the following sense and anti-sense oligonucleotides 
used, 5’-ACCGACTTATCTCGATGAGCT-3’ 5’-GCCATTAATACGCAGATCC 
GT-3’ 
 
2.13.6 ∆vps13::kanMX4   
Mutation was deleted as above using genomic DNA from BY4742 ∆vps13::kanMX4 
and the following sense and anti-sense oligonucleotides, 5’-GCCATACCCTTCTTC 
GTCACC-3’ 5’-CACCTTGTCTTGAGGTTGAGGG-3’  
 
2.13.7 ∆pep4::HIS3 
Mutation was deleted as above using BJ3505 genomic DNA and the following sense 
and anti-sense oligonucleotides, 5’-CGGTAAGTTTATCGCAATCAC-3’ 5’-ACGA 
TGAAGTTGATCGTACAG -3’ 
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2.13.8 ∆pep12::kanMX4   
Mutation was deleted as above using genomic DNA from BY4742 ∆pep12::kanMX4 
and the following sense and anti-sense oligonucleotides, 5’-TTCCCTTTCTCACAC 
AGTGGC-3’ 5’-GCCTACGTGTTATTCGGGAAC-3’   
 
2.13.9 ∆vps4::kanMX4   
Mutation was deleted as above using genomic DNA from BY4742 ∆vps4::kanMX4 
and the following sense and anti-sense oligonucleotides, 5’-AATCTCCGACTGA 
GGATTCGG -3’ 5’- GGTGGCGAAACCGAAATTGTC -3’  
 
2.13.10 ∆sec22::HIS3 
Mutation was deleted as above using genomic DNA from SUA1-3D and the 
following sense and anti-sense oligonucleotides, 5’-GCTCAATTAGAGGACGA 
CTCTAAC -3’ 5’- GGTTGGAATCGAGGACACTAAC -3’.  
 
2.14. Creation of BY4742 ∆chs6::LYS2 
Genomic DNA was prepared from BY4742 cells as above and used as a template to 
amplify the complete CHS6 ORF, and N- and C-terminal regions of the flanking 
ORFs. The following sense and antisense oligonucleotides were used, 5’- GCGGCTA 
CAAATAGTCAATTCC -3’ and 5’- AGCTAATGGAGACTGTGAACC -3’, and 
resulted in the generation of a PCR fragment ~3.2Kb. The reactions were conducted 
by denaturing at 94
o
C for 3 minutes, followed by 25 cycles with denaturing at 94
o
C 
 90 
for 1 minute, annealing at 50
o
C for 1 minute and extension at 68
o
C for 4 minutes. This 
was followed by an additional extension step at 68
o
C for 20 minutes. The resulting 
products were purified using Qiagen spin gel extraction kit. LYS2 was PCR amplified 
using fab1-1(ts) genomic DNA as a template and the following oligonucleotides 5’-
TTTTTTCTAGAACGCCAGCTGATTTACAGTTC-3’ and 5’- TTTTTATCGATAG 
CAGTTGCTTTCTCCTATGG-3’. This resulted in the generation of a PCR fragment 
(~6.0kb) which introduced the restriction sites XbaI and ClaI. The PCR reactions was 
conducted by denaturing at 94
o
C for 3 minutes, followed by 5 cycles with denaturing 
at 94
o
C for 1 minute, annealing at 50
o
C for 1 minute and extension at 68
o
C for 7 
minutes, followed by 20 cycles with denaturing at 94
o
C for 1 minute, annealing at 
55
o
C for 1 minute and extension at 68
o
C for 7 minutes. This was followed by an 
additional extension step at 68
o
C for 20 minutes. TA cloning was used to ligate the 
CHS6 and LYS2 fragments into p-Gem-T-Easy plasmid using T4 DNA ligase, and 
incubation overnight at 4
o
C. The plasmids were transformed into Top10 E. coli and 
blue/white colonies used to select correct clones. Minipreps were digested with XbaI 
and ClaI in a double digest reaction overnight to release the LYS2 fragment.  
The middle section of CHS6 (~1.3kb) was excised and the resulting p-Gem-T-Easy 
plasmid with CHS6 flanking genes either side, purified through gel extraction. The 
sticky ended LYS2 was also purified, through gel extraction. The resulting purified 
fragments were then ligated with T4 DNA ligase at 15
o
C for 5 hours, and transformed 
into E.coli. Mini preps were used to identify correct plasmids through size, and PCR. 
Sequencing was used to confirm integration.  
The resulting plasmid was then used as a template for PCR to amplify the chs6::LYS2 
construct using the original CHS6 oligonucleotides. This was then transformed into a 
range of BY4742 strains to create Δchs6::LYS through homologous recombination. 
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Colonies exhibiting lysine prototrophy were selected by growth on SC-LYS agar 
plates, and were re-streaked on SC-LYS agar plates to further select the LYS2 marker. 
Replacement of the CHS6 ORF with the LYS2 marker was confirmed through PCR 
amplification of CHS6 using genomic DNA prepared from the Lysine producing 
colonies and the generation of a fragment ~6.0 kb in size compared to the wild-type of 
~3.0 kb. 
 
2.15. DNA Sequencing 
DNA sequencing was performed by a service run at the functional Genomics and 
Proteomics unit at the University of Birmingham (Birmingham, UK). A reaction mix 
(10μl) was prepared for each template to be sequenced, as follows: template (100 ~ 
500ng), primer (3.2pmol), and ddH2O added to total volume. The Genomics facility 
then added a Terminator Reaction Mix to each primer/DNA mix supplied, to give a 
final volume of 20μl. The reaction mixes were amplified via PCR and the resulting 
chain-termination reaction resolved using an ABI sequencing device that separated 
the dye labelled fragments by capillary electrophoresis. The sequencing data was then 
analyzed in Chromas (version 1.45). Sequences were compared to wild-type S. 
cerevisiae sequences available by performing a BLAST search on the Sachromyces 
genome database website. 
 
2.16. Visualisation of GFP and RFP tagged proteins. 
Yeast strains were grown to a density of 2 x 10
6
- 1 x 10
7
 cells/ml in SC-Ura-Met + 
2.0% glu medium (the promoter in pUG36 is methionine-regulated) at 25
o
C with 
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shaking. Cells were centrifuged at 200g and resuspended in non-fluorescent media 
(5mg/ml (NH4)2SO4, 2% glucose, pH 5.7) and visualised on a Nikon Eclipse E600 
Microscope as live wet mounts, sometimes attached to poly-L-lysine coated cover 
slips. The projector used was a Nikon Plan Apo (100/1.40 oil DIC H). A XF100-3 
filter cube (Omega Optical) was used to visualise GFP. Strains expressing 
DsRed,mCherry-tagged proteins or FM4-64 were visualised with an XF1074-
XF2016-XF309-NQ960 filter cube (Omega Optical). Strains stained with Fluorescent 
Brightener 28 (Calcofluor) were visualised with a DAPI filter cube (Omega Optical). 
Images were acquired with an ORCA digital camera (Hamamatsu, Japan) and 
coloured in Simple PCI (C
•
Imaging Systems). All images were cropped and 
contrast/brightness adjusted as a whole unit in Photoshop 6.0. 
 
2.17. Co-localisation of RFP and GFP tagged proteins. 
Images of cells expressing both GFP and RFP tagged proteins were captured, false 
coloured and viewed as both separate and merged images. The total numbers of dots 
for GFP were counted, and then the number of RFP dots that co-localised to the same 
position also counted. The total numbers of RFP dots were also counted and then the 
total number of GFP dots the co-localised to the same position counted. This resulted 
in the generation of two percentages for GFP and RFP co-localisations. A number of 
random co-localisations were also conducted, this was performed by marking the 
same number of random dots on a DIC picture and then seeing if these co localised 
with the RFP or GFP dots, in order to calculate random co-localisation. Cells without 
obvious expression of both GFP and RFP were not included in the analysis. Some 
attempt was also made to remove from the analysis any dots that co-localised when 
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the shape of the RFP and GFP labelled compartments were obviously very different. 
At least one hundred cells were counted for each compartment.  
 
2.18. FM4-64 staining of vacuoles. 
Adapted from a method developed by Vida and Emr (Vida and Emr, 1995).  100µg 
FM4-64 was made up in DMSO (10.3µl) to a concentration of 16mM and stored at -
80
 o
C. 
Yeast strains were subcultured to 1 x 10
5
 cells/ml in YPD + 2.0% glu medium and 
were grown at 25
o
C to around 1 x 10
7
 cells/ml. 10 ml of the cell culture was collected 
by centrifugation at 200g at 25
o
C for 5 minutes, resuspended in ddH20 (200µl) and 
transferred to a 1.5ml Eppendorf tube, and centrifuged as above. Cells were 
resuspended in YPD + 2.0% glucose (200µl), and FM4-64 (0.5µl) added to a final 
concentration of 40µM. Cells were then incubated at 25
o
C, 200 rpm for 15 minutes. 
Cells were collected as described previously and washed twice with YPD + 2.0% glu 
(400 µl). Cells were resuspended in 400µl of YPD + 2.0% glucose and chased for 1 
hour at 25
o
C 200 rpm, before being visualised. 
 
2.19 Hyper osmotic stress. 
After treatment with FM4-64, cells were subjected to a hyperosmotic stress. 
Microscope buffer containing 0.4M NaCl was used to resuspend cells prior to 
microscopy. Cells were incubated for 10 minutes in the solution prior to taking 
pictures. 
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2.20 WGA-FITC staining of bud scars 
Staining of bud scars was performed by a method adapted from (Chen et al., 2003). 
Yeast strains were subcultured at 1 x 10
5
 cells/ml in YPD + 2.0% glu and were grown 
at 25
o
C to around 1 x 10
7
 cells/ml. Cell number was counted using a haemocytometer, 
and density adjusted to give 1 x 10
7
 cells/ml in a Eppendorf tube. Cells were 
centrifuged for 3 minutes at 200g and media removed. The pellet was resuspended in 
PBS (Phosphate buffered saline) (1ml), and 6µl of 2mg/ml WGA-FITC added to give 
a final concentration of 12µg/ml. Cells were stained in the dark for 1.5 hours at room 
temperature. Cells were washed twice with PBS, with centrifugation at 200g for 3 
minutes.   
 
2.21 Calcofluor staining of bud scars 
Adapted from Methods in Yeast Genetics (Adam, A., Goccschling, D. E., Kaiser, C. 
A., and Sterns, T., eds), Cold Springs Harbour Laboratory Manual [1997].  
1mg/ml stock of Fluorescent Brightener 28 (Calcofluor) was prepared with ddH2O 
and stored in the dark at -20
o
C. Yeast strains were subcultured to 1 x 10
5
 cells/ml in 
YPD+2.0% glu and were grown at 25
o
C to around 1 x 10
7
 cells/ml. 1ml of the cell 
culture was centrifuged at 200g for 2 minutes, media removed and pellet resuspended 
in YPD without glucose, and incubated for three hours at 25
o
C. To stain, caclofluor 
stock solution was added, to a final concentration of 100µg/ml. Cultures were 
incubated at room temperature for 10 minutes, and washed twice with ddH2O, with 
centrifugation at 200g.  
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2.22 Calcofluor resistance spot dilutions 
Yeast strains were subcultured to 1 x 10
5
 cells/ml in appropriate SC+2.0% glu 
medium, and were grown at 25
o
C to around 1 x 10
7
 cells/ml. Cell densities were 
counted using an improved Neubauer haemocytometer and adjusted to 1 x 10
7
 
cells/ml, 5µl samples of 5 fold or 10 fold spot dilutions were pipetted onto YTD+ 
200ng/ml Fluorescent Brightener 28 + 2.0% glu and a control of YTD +2.0% glucose 
(unless indicated otherwise). Plates were grown at 25
o
C for at least two days.  
 
2.23 Calcofluor resistance replica plating. 
EMS mutagenised cells were diluted to give 200 colonies per plate and were spread 
onto YTD + 2% glu plates. Colonies were allowed to grow at 25
o
C for three days and 
then replica plated using velvet onto another YTD + 2% glu plate and a YTD + 2% 
glu + 600 µg/ml Fluorescent Brightener 28 + 20µg/ml Phloxine B plate. The two 
plates were allowed to grow at 25
o
C for 2 days. Colonies that appeared to not be 
growing on the YTD + 2% glucose + 600 µg/ml Fluorescent Brightener 28 + 20µg/ml 
Phloxine B plate but were growing on the YTD + 2% glucose plate were picked out 
and restreaked onto an additional YTD + 2% glucose plate. This plate was 
immediately replica plated onto a YTD + 2% glucose + 500 µg/ml calcofluor white + 
20µg/ml Phloxine B plate to confirm the original result. 
 
2.24 EMS mutagenesis. 
BY4742 Δchs6 was subcultured to 1 x 105 cells/ml in YEPD +200µg/ml G418 +2.0% 
glu medium and was grown at 25
o
C to around 1 x 10
8
 cells/ml. The cell density was 
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determined using an improved Neubauer haemocytometer and adjusted to 1 x 10
8
 
cells/ml. The cells were collected by centrifugation for 5 minutes at 3000g, the pellet 
was then washed twice with 0.1M sodium phosphate buffer NaH2PO4 pH 7.0 (5ml). 
Cells were centrifuged as above and resuspended in 0.1M sodium phosphate buffer 
(1.7ml). In a fume hood EMS (ethyl methanesulfonate) (50µl) was added, cells were 
incubated with shaking at 30
o
C for 40 minutes. After this time around 40% of cells 
were killed. An excess of sterile 5% sodium thiosulfate was added to stop the 
mutagenesis reaction. The cells were spun down at 1000g for 5 minutes and 
resuspended in ddH20 (9ml). The cell suspension was then diluted to give around 200 
colonies, and plated onto YTD with incubation at 25
o
C for three days. To find out kill 
rate, a control reaction without EMS addition was carried out, cells from both samples 
were plated and colony production compared. 
 
2.25 Flow cytometry data collection and FACS sorts. 
This work was carried out in collaboration with Dr Tim Overton (Chemical 
engineering, University of Birmingham, Birmingham UK). Data was collected on a 
BD FACS Aria Cell-sorter. For each data set at least 10000 events were sampled. For 
calcofluor staining the UV laser (351 to 364 nm) was used. For WGA-FITC the 
Hoescht laser (248 nm) was used. Sort boundary gates were defined by comparing 
single mutant and double mutant data, as indicated in the relevant results chapter. 
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2.26 Expression of GST-Vma1p, GST-Vma2p, GST-Vma4p and GST-Vma5p 
pGEX6T1–VMA1, pGEX6T1–VMA2, pGEX6T1–VMA4 and pGEX6T1-VMA5 were 
transformed into BL21 competent E. coli cells. To purify GST-Vma1p, GST-Vma2p, 
GST-Vma4p and GST-Vma5p, the BL21 strains were diluted to an A600 of 0.1-0.2 in 
LB+100 µgml
-1
 ampicillin+ 50µgml
-1 
chloramphenicol (1.0L), grown to an A600 of 
0.6-0.8 (~2.5 hours) and induced with IPTG at a final concentration of 1mM (4-5 
hours). After incubation at 30
o
C for 5 hours the cells were collected (centrifugation at 
10000g for 15 min at 4
oC) and ‘washed’ in 40 ml ice-cold breakage buffer (40ml) 
(100 mM HEPES KOH pH7.5, 150mM NaCl, 1mM PMSF). Cells were resuspended 
in ice cold breakage buffer containing bacterial protease inhibitor cocktail and 4 
mgml
-1
 lysozyme (40ml). All subsequent procedures were carried out at 4
o
C. The E. 
coli cells were lysed by incubation on ice for 1 hour.  This was followed by the 
addition of 10% (v:v) Triton X-100 (4.5ml), and incubation with gentle swirling for 
30 minutes.  Protease inhibitors were then added and incubated as above. The 
Glutathione-Sepharose 4B resin was prepared by resuspending 1ml of a 75% slurry in 
breakage buffer + protease inhibitors+ 1%Triton X-100 (10ml). This was end-to-end 
mixed for 30 min and the resin was washed twice in the same buffer with 
centrifuagation at 500g for 5minutes. The cell debris was pelleted at 10000g for 20 
minutes and then further centrifuged  to pellet the triton insoluble debris at 25000rpm 
for 20 minutes. The supernatant was filtered through a 0.45µM filter. The filtrate was 
added to the 1ml of pre-swollen and washed Glutathione-Sepharose beads in a 50ml 
tube and were end-to-end mixed for 1 hour at 4
o
C. Beads were pelleted at 500g for 5 
minutes at 4
o
C . The beads were washed twice with ice-cold breakage buffer +O.1% 
Triton X-100+ protease inhibitors (50ml). The beads were then washed twice with ice 
cold breakage buffer + protease inhibitors (50ml) and centrifuging to collect the 
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beads. The beads were resuspended in ice cold washing buffer (5ml)(100mM Hepes 
KOH pH7.5, 300 mM NaCl, bacterial protease inhibitors) and transferred to a 10 ml 
Econo-Pac column and the beads allowed to settle. The column was washed with 
again with washing buffer. GST-tagged proteins were eluted in ice cold elution buffer 
(3ml)(50mM Tris pH8.5, 150mM Nacl, 1mM PMSF) containing 20mM Glutathione 
(flow rate 0.5 ml/min). 0.5 ml fractions were collected and protein concentration was 
quantified using Bradford’s reagent and the manufacture’s protocol (modified from 
Bradford [1976]). Fractions containing protein were stored at -20
o
C. 
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Chapter 3 
Fab1p and Retromer 
 
3.1 Introduction. 
The 1980s saw the isolation of the generic machinery that eukaryotic cells use to sort 
cargo in the endocytic system (Banta et al., 1988).  Genetic screens using chemical 
mutagenesis of S. cerevisiae, identified mutant cells that aberrantly secreted the 
vacuolar hydrolase carboxypeptidase Y (CPY) (Robinson et al., 1988). The 
subsequent identification and characterisation of these vacuolar (VPS) genes is one of 
the cornerstones upon which our current understanding of endosomal trafficking is 
built (Robinson et al., 1988, Banta et al., 1988).   
These studies showed that soluble protein cargoes such as CPY are normally directed 
to the correct compartment via interaction with membrane bound “cargo receptors”. 
The receptor for CPY was identified as Vps10p, a 177 kD type I protein that has 
homologs in animal cells known as Sortillins (Cooper and Stevens, 1996, Rutherford 
et al., 2006) or analogs known as mannose-6-phosphate receptors. CPY was the first 
identified cargo of this pathway, and has been the focus of research in the area. 
However, it is now known that receptors for other vacuolar hydralases including 
proteinase A (PrA) Pep4p and amino-peptidase Y (Marcusson et al., 1994, Cooper 
and Stevens, 1996) also cycle in the same fashion. 
Correct trafficking of Vps10p is essential for sorting of CPY to the vacuole. Cells that 
lack Vps10p secrete around 90% of newly synthesised CPY (Cooper and Stevens, 
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1996, Marcusson et al., 1994, Jorgensen et al., 1999). Vps10p has been identified as a 
receptor for CPY (Marcusson et al., 1994). VPS10 encodes a large 177kDa type1 
trans-membrane protein. Research has shown that during anteograde (forward) 
trafficking, CPY bound Vps10p exits the Trans Golgi network (TGN) in clathrin 
coated vesicles and fuses with the pre-vacuolar endosome (PVE) (Cooper and 
Stevens, 1996, Rutherford et al., 2006). Once at the PVE, Vps10p and CPY 
dissociate, probably due to the low pH of the endocytic compartment. This leaves 
Vps10p free to be recycled back to the TGN, a process which involves a novel protein 
coat (comprising a complex of proteins) known as retromer (Seaman et al., 1998). The 
recycling or retrograde step in this process is very important because failure to 
retrieve Vps10p from the PVE leads to degradation of the cargo receptor, when the 
PVE matures and fuses with the lysosome like vacuole (Cooper and Stevens, 1996). 
This results in the secretion of CPY to the cell surface, because nascent Vps10p 
cannot be generated quickly enough. CPY is secreted because this is the default 
pathway for the trafficking of soluble proteins in yeast (Cooper and Stevens, 1996). 
The cytosolic domain of Vps10p is known to be required for trafficking (Cooper and 
Stevens, 1996, Cereghino et al., 1995), it contains two aromatic based signals YSSL 
and FYVF (Bowers and Stevens, 2005). Ligand and cargo binding takes place in the 
lumenal portion of Vps10p in a specific region named domain 2 (Jorgensen et al., 
1999). Over expression of Vth2p, a glycoprotein with similarity toVps10p, can 
partially suppress secretion of CPY in a ∆vps10 mutant (Cooper and Stevens, 1996). 
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Figure 3.1; PtdIns(3,5)P2 dependent membrane trafficking. 
 
 
PtdIns(3,5)P2  is required for at least 3 different trafficking steps; in yeast, it regulates vacuole to late 
endosome/MVB trafficking (Bryant et al 1997; pathway 1) and also the sorting of some proteins into 
the internal vesicles of the MVB (Odorizzi et al 1998). In mammalian cells, PtdIns(3,5)P2 may also 
mediate the retromer pathway (pathway 2); i.e. late and/or early endosome to Golgi trafficking 
(Rutherford et al 2007). 
 
The retromer complex is conserved between S. cerevisiae and mammalian cells. The 
yeast complex is composed of five proteins, Vps35p, Vps29p, Vps26p, Vps17p and 
Vps5p. The proteins are able to form a protein coat, which tubulates PtdIns3P 
containing membranes when added to them in vitro (Seaman, 2005).  Vps17p and 
Vps5p are sorting nexins, which the cargo selective complex comprising Vps26p, 
Vps29p and Vps35p associate onto (Seaman, 2005). Mammalian versions of this 
complex have been identified and their structures characterised (Hierro et al., 2007, 
Bonifacino and Hurley, 2008). SNX1 and SNX2 seem to be the mammalian 
equivalents of Vps5p and Vps17p respectively, although some doubt surrounds 
Vps17p, and SNX5 and SNX6 may in fact be its functional equivalents (Wassmer et 
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al., 2007). A model where retromer couples membrane deformation with cargo sorting 
has been suggested (Cullen, 2008).   
 
 
Figure 3.2 Diagram of the yeast retromer coat  complex 
 
Individual proteins form a complex on the phospholipid bi-layer to act as a coat to recycle the 
transmembrane protein Vps10p (Adapted from an image on the Cullen lab website) 
 
Recycling of cargo receptors like Vps10p in yeast and the mannose-6-phosphate 
receptor (M6R) in mammalian cells is dependent on at least one lipid. PtdIns3P is a 
phosphoinositide required for the function of the retromer complex (Cozier et al., 
2002). PtdIns3P is known to be required for recycling because two essential 
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components of the retromer complex are members of the sorting nexin family of 
proteins (Seaman, 2005, Horazdovsky et al., 1997). It has also recently been shown 
that these sorting nexins can bind to PtdIns(3,5)P2 (Catimel et al., 2008). Sorting 
nexins appear to be involved in both retromer dependent and independent retrieval of 
cargo receptors from endosomes to the TGN (Hettema et al., 2003). All sorting nexins 
contain a PtdIns3P binding motif known as a PX domain that is required for their 
association with the endosomal membrane (Cozier et al., 2002, Carlton et al., 2004). 
Hence PtdIns3P is required for the correct localisation of sorting nexins and formation 
and function of the retromer coat complex. PtdIns3P has also previously been shown 
to be required for Vps10p recycling due to Vps15p; a protein kinase that recruits 
Vps34p to a membrane complex to sort proteins in both the Golgi to endosome and 
endosome to Golgi transport pathways (Burda et al., 2002, Stack et al., 1995). 
 PtdIns(3,5)P2 has recently been implicated in the retrieval of cargo receptors from 
endosomes in some systems. It was demonstrated that PIKfyve (the mammalian 
homolog of Fab1p; the PtdIns3P5-kinase) has a role in regulation of endosome to 
trans-Golgi network retrograde transport,  since the M6R is mislocalised when 
PIKfyve is silenced via siRNA (Rutherford et al., 2006). The disruption of 
PtdIns(3,5)P2 synthesis by use of a kinase dead PIKfyve also resulted in mis-sorting 
of the M6R in  mice (Ikonomov et al., 2003, Murray et al., 2005, Zhang et al., 2007). 
This has led to speculation that one of the primary defects in cells unable to synthesise 
PtdIns(3,5)P2 is a failure of retrograde endosome to TGN trafficking (Rutherford et 
al., 2006). The evidence is somewhat conflicting as studies in other systems including 
C.elegans and D. melanogaster have not reported this effect (Nicot et al., 2006, 
Rusten et al., 2006). Also the use of YM201636, the recently discovered small 
molecule inhibitor of PIKfyve that inhibits PtdIns(3,5)P2 synthesis, also failed to 
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show mis-sorting of M6R raising the possibly that this defect is an indirect phenotype 
of cells that lack PtdIns(3,5)P2 (Jefferies et al., 2008).  
Due to conflicting data this chapter seeks to examine the role Fab1p and PtdIns(3,5)P2 
in the endosome to TGN recycling of several cargos in S. cerevisiae, as this is the 
system in which Fab1p, PtdIns(3,5)P2 and retromer are best characterised and offers a 
convenient model system. 
 
3.2 Generation of an assay to assess retromer function. 
Vps10p has previously been used as a marker for the integrity of the endosome to 
TGN retrieval pathway known as retromer (Seaman et al., 1997). However in 
previous studies aberrant Vps10p trafficking was assayed using antibodies and SDS-
PAGE analysis to detect vacuole protease mediated cleavage of Vps10p.  
It was decided that a Vps10-GFP probe may offer a more convenient marker, 
allowing a fluorescence microscopy assay to be performed. A strain was constructed 
bearing a VPS10 gene fused to GFP at its C terminus so expression was from the 
VPS10 native promoter at the normal chromosomal locus. In wild-type cells where 
retromer is functioning, the Vps10-GFP should appear as small dot like punctuate 
structures throughout the cell, which represent the pre-vacuolar endosomes.  In 
retromer inactivated cells e.g. ∆vps29, the Vps10-GFP localisation would change 
dramatically and become directed to the vacuole membrane, as Vps10p can no-longer 
be recycled back to the Golgi complex via the retromer coat.  
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Figure 3.3 Cartoon of Vps10-GFP assay. 
 
In Wild-type cells the Vps10-GFP tagged construct appears as punctae throughout the cell. Whereas in 
a cell where retromer trafficking is no longer functioning, Vps10-GFP cannot recycle back to repeat 
the process and is visualised on the vacuole membrane, where it builds up and is eventually degraded. 
 
3.3 Sub-cellular localisation of Vps10-GFP 
To confirm that Vps10p recycling is truly retromer dependent, a ∆vps29 mutant 
expressing both a vacuole marker (mCherry-Pho8p) and Vps10-GFP was constructed. 
Cells that posses a retromer defect cannot recycle Vps10p back to the Golgi and hence 
the GFP signal should appear on the vacuole.  Indeed, Vps10-GFP co-localises with 
the RFP marker for the vacuole as shown in Figure 3.4 when VPS29, a component of 
retromer is deleted. As expected in wild-type cells Vps10-GFP can be visualised as 
punctae throughout the cell. 
Since re-distribution to the vacuole is not the only potential defect that could be 
induced in Vps10p trafficking, it was decided to closely define the nature of the 
punctate compartment that is the wild-type steady-state localisation of Vps10p.  To 
identify the compartments Vps10p localised to in Wild-type cells, Vps10-GFP was 
co-expressed with a series of RFP tagged proteins that are known residents of various 
compartments in yeast and act as good markers for those organelles (Huh et al., 2003). 
Figure 3.5 shows the results of these co-localisations. 
Wild Type 
Defective retromer 
trafficking (e.g. Δvps29) 
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Figure 3.4 Localisation of Vps10-GFP in a wild-type and retromer deficient strain. 
 
      Wild-type                                         ∆vps29 
  
Vps10-GFP is a reliable marker for retromer function. mCherry-Pho8p is used as a marker for the 
vacuole. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 
cells/ml) of wild-type (left -hand columns) and ∆vps29(right hand columns) cells transformed with 
VPS10-GFP (top panels) and mCherry-Pho8p (middle panels). The bottom panel shows a merge of 
both red and green images for co-localisation study. Both strains were cultured in SC-His-Ura+2% glu 
medium and grown at 25ºC. These images are representative of three replicate cultures. Scale bar 
represents 5µM. 
 
 
Vps10-GFP 
m-Cherry Pho8p 
(Vacuole membrane) 
Merge 
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Figure 3.5 Co-localisations of Vps10-GFP with RFP-markers in wild-type cells. 
              Snf7p (PVE)          Anp1p (ER)            Chc1p (TGN)       Cop1p (GOLGI) 
      
[Significantly different from random co-localiation: ***P<0.001, N/S not indicated] 
 
In wild-type cells Vps10-GFP co-localises with Snf7p, a marker for the endocytic compartment Shown 
above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of BY4741 
wild-type cells containing various RFP tagged proteins acting as markers (middle panels) transformed 
with VPS10-GFP (top panels). The bottom panel shows a merge of both red and green images for co-
localisation.  Strains were cultured in SC-His+2% glu medium and grown at 25ºC. Images are 
representative of three replicate cultures and scale bar represents 5µM. 
 
The data shows that Vps10-GFP significantly co-localises with the Snf7-RFP positive 
compartment which is the pre-vacuolar endosome (PVE), but not with Anp1-RFP, 
Chc1-RFP or Cop1-RFP that mark the ER, TGN and Golgi respectively. Careful 
63.5% ±3.1*** 8.5% ±4.8 8.3% ±1.4 12.5% ±3.2 GFP co-localisation 
6.7% ±2.9 8.3% ±3.2 4.5% ±1.7 8.1% ±2.3 Random GFP co-
localisation 
56.8% ±5.6        0.2% ±6.8 3.8% ±3.2 4.4% ±2.1 Adjusted GFP co-
localisation 
72.7% ±7.2*** 11.7% ±3.9 11.5% ±.0.8 13.6% ±2.9 RFP co-localisation 
4.5% ±1.6 6.1% ±3.0 4.0% ±2.0 11.0% ±.0.7 Random RFP co-
localisation 
68.2% ±12.9 5.6% ±4.4 7.5% ±3.2 2.6% ±3.3 Adjusted RFP co-
localisation 
Vps10-GFP 
RFP Marker 
Merge 
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quantification of merged images shows that most Vps10-GFP co-localises with the 
Snf7p-RFP marker in around 60% of spots, suggesting a late endosomal steady-state 
localisation for Vps10p. The other compartments showed co-localisation of less than 
5% when adjusted for random co-localisation events. Note that this result suggests 
that Vps10-GFP spends much (40%) of its lifetime in a compartment that is not 
defined or labelled by any of the RFP-markers that we have available. 
The experiments were replicated for a retromer deficient strain bearing a deletion of 
VPS26, another component of retromer.  In contrast almost all of the Vps10-GFP is 
vacuolar not punctate, with only a minor pool still present in the Snf7-RFP positive 
compartment, although this is probably due to the compartment size as the random co-
localisation result suggests. A small amount of co-localisation, similar to that of wild-
type is seen with the other RFP markers (Figure 3.6). The only significant 
colocalisation seen is with the Anp1 positive compartment which marks the ER. This 
data demonstrates that Vps10-GFP is a reliable marker for endosome to TGN 
recycling and is not substantially mis-localised as a result of the GFP-tag. It also 
demonstrates that Vps10p is unable to recycle when a different component of 
retromer is deleted. 
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Figure 3.6 Co-localisation of Vps10-GFP with RFP markers in a retromer mutant 
strain. 
      Snf7p (PVE)          Anp1p (ER)            Chc1p (TGN)       Cop1p (GOLGI) 
  
[Significantly different from random co-localiation: 0.01<*P<0.05, N/S not indicated] 
 
In retromer deficient cells Vps10-GFP is seen as a ring on the vacuole membrane. Shown above are 
fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of ∆vps26 cells 
containing various RFP tagged proteins acting as markers (middle panels) transformed with VPS10-
GFP (top panels). The bottom panel shows a merge of both red and green images for co-localisation.  
Strains were cultured in SC-His+2% glu medium and grown at 25ºC. These images are representative 
of three replicate cultures. Scale bar represents 5µM. 
 
 
 
12.6 % ±7.4 13.6% ±9.2 10.3% ±1.9 12.8% ±7.8 GFP co-localisation 
20.1% ±11.8 4.9% ±1.6 6.8% ±6.0 6.0% ±6.2 Random GFP co-
localisation 
-7.5% ±5.6 8.7% ±10.8* 3.5% ±2.2 6.8% ±3.4 Adjusted GFP co-
localisation 
14.1% ±8.3 6.4% ±3.0 3.8% ±0.5 5.0% ±3.4 RFP co-localisation 
16.8% ±9.7 12.5% ±4.6 10.3% ±5.4 9.8% ±4.7 Random RFP co-
localisation 
-2.7% ±1.6 -6.1% ±5.3* -6.5% ±5.5 -4.8% ±2.6 Adjusted RFP co-
localisation 
Vps10-GFP 
RFP Marker 
Merge 
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3.4 PtdIns (3,5)P2 is not involved in retromer mediated recycling 
This work set the basis to investigate whether PtdIns(3,5)P2 is required for endosome 
to TGN recycling. The FAB1 gene encodes the sole known PtdIns3P 5-kinase in yeast 
and once deleted results in complete loss of PtdIns(3,5)P2 synthesis (Gary et al., 1998, 
Cooke et al., 1998). This makes ∆fab1cells a good background in which to study 
PtdIns(3,5)P2 function. Cells with a deleted FAB1 gene were examined for Vps10-
GFP mis-localisation. Figure 3.7 shows that despite the characteristic huge swelling of 
the vacuole seen in ∆fab1 cells, Vps10-GFP recycling appears to be unaffected as 
significant co-localisation is observed between Snf7-RFP and Vps10-GFP, in dot like 
structures. There is no observation of vacuolar Vps10-GFP in the ∆fab1 strain, 
indicating that endosome to TGN recycling is indistinguishable from wild-type in the 
absence of Fab1p and PtdIns(3,5)P2 and therefore Vps10p recycling via retromer is 
unaffected in a ∆fab1strain (see Figure 3.7) 
In order to ensure that Vps10-GFP trafficking was not aberrant in some fashion in 
∆fab1 cells, the distribution of Vps10-GFP against the other membrane markers was 
also determined. The data show that, whilst there is a slightly greater co-localisation 
of Vps10p with Cop1-RFP and Chc1-RFP than wild-type cells this is not 
significant.The percentage of Vps10-GFP that displays this co-localisation is 
relatively minor especially when it is considered that the cytoplasm makes up a much 
smaller percentage of a ∆fab1 cell due to its enlarged vacuole. This result again 
further suggests that localisation of Vps10p is not different in the absence of Fab1p 
and implies that retromer function is completely independent of PtdIns(3,5)P2 in 
yeast.  
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To confirm that Snf7-RFP is a functional marker a strain which contained Fur4-GFP 
and Snf7-RFP was constructed. Localisation was not affected and this confirmed that 
Snf7 was functional (data not shown). 
Figure 3.7 Co-localisation of Vps10-GFP and RFP markers in a ∆fab1 strain. 
      Snf7p (PVE)          Anp1p (ER)            Chc1p (TGN)       Cop1p (GOLGI) 
 
[Significantly different from random co-localiation: ***P<0.001, N/S not indicated] 
  
Vps10-GFP appears to co localise with Snf7p-RFP; a marker for the endosome. Shown above are 
fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of ∆fab1 cells containing 
various RFP tagged proteins acting as markers (middle panels) transformed with VPS10-GFP (top 
panels) The bottom panel shows a merge of both red and green images for co-localisation.  Strains 
were cultured in SC-His+2% glu medium and grown at 25ºC. These images are representative of three 
replicate cultures. Scale bar represents 5µM. 
72.6% ±2.8  7.7% ±1.4 14.1% ±5.4 18.3% ±3.7 GFP co-localisation 
5.9% ±1.7 7.8% ±2.5 7.4% ±2.5 9.5% ±2.1 Random GFP co-
localisation 
66.7% ±11.0*** -0.1% ±1.8 6.7% ±4.0 8.8% ±5.3 Adjusted GFP co-
localisation 
81.2% ±7.4 9.0% ±3.0 13.2% ±4.5 22.7% ±3.3 RFP co-localisation 
5.3% ±0.4 7.8% ±2.1 16.3% ±3.4 12.4% ±6.5 Random RFP co-
localisation 
75.9% ±16.0*** -1.2% ±0.9 -3.1% ±2.0 10.3% ±2.4 Adjusted RFP co-
localisation 
Vps10-GFP 
RFP Marker 
Merge 
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To check whether the recycling Vps10p is dependent on downstream effectors of 
PtdIns(3,5)P2 or whether an indirect role may exist, Vps10-GFP localisation was 
investigated in strains bearing a deletion of  proteins that are proposed effectors of 
PtdIns(3,5)P2; ∆atg18, ∆atg21 and ∆hsv2 
 
Figure 3.8 VPS10-GFP localisation in effectors of PtdIns(3,5)P2. 
 
                    DIC                                   Vps10-GFP 
  
 
In all deletion strains of potential PtdIns(3,5)P2 effectors, VPS10-GFP appears as punctae throughout 
the cell. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) 
of ∆atg21(top panel), ∆hsv2(middle panel) and  ∆atg18 (bottom panel) transformed with Vps10-GFP. 
All strains were cultured in SC-His+2% glu medium and grown at 25ºC.The left-hand columns show 
low light DIC images. The right-hand columns show the GFP localisation of Vps10-GFP visualised as 
punctae. These images are representative of three replicate cultures. Scale bar represents 5µM. 
∆atg21 
∆atg18 
∆hsv2 
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The results obtained in Figure 3.8 suggest that trafficking of Vps10-GFP is still 
correct and unaffected, when any of the genes that encode potential PtdIns(3,5)P2 
effectors are deleted. The Vps10-GFP is not seen on the vacuole membrane, as in a 
strain with a true retromer defect. A subtle observation is that there are fewer Vps10-
GFP punctae present in the ∆atg21 and ∆hsv2 strains. This may be due to the close 
homology between the proteins, allowing compensation for loss of function when one 
is deleted. Vps10-GFP trafficking may be dependent upon both genes. Deletion of just 
one protein may allow enough recycling of Vps10-GFP to take place, to still visualise 
it as punctae. It may be that to interrupt Vps10p recycling both components need to be 
deleted. To investigate whether this was the case double mutants containing either 
∆atg21∆hsv2 or ∆atg18∆atg21 were made, results are shown in Figure 3.9. 
Figure 3.9 VPS10-GFP localisation in double mutants of PtdIns(3,5)P2 effectors. 
                    DIC                                   Vps10-GFP 
  
VPS10-GFP is visualised as punctae throughout the cell in double mutants of PtdIns(3,5)P2 effectors. 
Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of 
∆atg18::KAN ∆atg21::LEU2 (top panel) and ∆hsv2::KAN ∆atg21::LEU2 (bottom panel) transformed 
with VPS10-GFP. Both strains were cultured in SC-His-Leu+2% glu medium and grown at 25ºC.The 
left-hand columns shows low light DIC images. The right-hand columns show the GFP localisation of 
VPS10-GFP. These images are representative of three replicate cultures. Scale bar represents 5µM. 
∆atg18::KAN 
∆atg21::LEU2 
∆hsv2::KAN 
∆atg21::LEU2 
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From the data in Figure 3.9 it seems that retromer is still able to recycle Vps10-GFP, 
even in strains lacking two potential effectors of PtdIns(3,5)P2. Vps10-GFP can still 
be seen as punctae inside the cell and not visualised as a ring on the vacuole. Neither 
Atg18p, Atg21p nor Hsv2p seem to play a role in Vps10p recycling. 
There is a possibility that it is not Fab1p that plays a role in Vps10p recycling but one 
of its activators,therefore what happens in strains bearing a deletion of two proteins 
which are necessary to make PtdIns(3,5)P2, was investigated. During production of 
PtdIns(3,5)P2  Vac14p acts as a scaffold on which Fab1p and other accessory proteins 
form a complex in order to activate Fab1p. Vac7p is also involved in production of 
yeast PtdIns(3,5)P2 but no mammalian homolog has been found to date. ∆vac14 and 
∆vac7 strains both have reduced levels of PtdIns(3,5)P2  however unlike ∆fab1, they 
do possess some of the lipid. 
The results obtained for activators of Fab1p (Figure 3.10) seem to suggest that Vac7p 
plays no role in Vps10-GFP recycling. There is still  punctae present throughout the 
cell as observed in the wild-type strain, indicating that Vps10-GFP is correctly being 
recycled via retromer. The large vacuole of ∆vac7, similar to that visualised in ∆fab1 
strain makes the punctae closer together and appear slightly on the vacuole, but the 
dots are present in the neck and daughter cell indicating that retromer is still 
functioning. The ∆vac14 strain provides more interest; in the majority of the cells 
Vps10-GFP punctae is seen throughout. However, in approximately 40% of cells 
Vps10-GFP is aberrantly localised to form a clear circle on the vacuolar membrane. In 
these cells it can clearly be seen that Vps10-GFP is not being trafficked correctly, the 
ring is continuous and not composed of punctae fused together. In a population of 
cells there is always some diversity visualised from cell to cell but this phenotype was 
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not observed in any of the other strains examined. This indicates that mis-trafficking 
of Vps10-GFP in ∆vac14 is likely to be a true phenotype and not an artefact.  
Figure 3.10 Localisation of VPS10-GFP in activators of Fab1p; Vac7p and 
Vac14p. 
 
                             DIC                                   Vps10-GFP 
 
 
 Percentage of cells with 
punctae VPS10-GFP 
Percentage of cells with 
vacuole VPS10-GFP  
∆vac14 61.5% ± 3.3*** 38.5% ± 3.2*** 
∆vps29 0% ± 0*** 100% ± 0*** 
Wild-type 100% ± 0 0% ± 0 
[Significantly different from  wild type values: ***P<0.001,]Vps10-GFP is visualised as punctae in 
both activators of Fab1p. In the ∆vac14 mutant, VPS10-GFP can additionally be seen on the vacuole 
membrane. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 
cells/ml) of ∆vac7 (top panel) and ∆vac14 (bottom panel) transformed with Vps10-GFP. Both strains 
were cultured in SC-His +2% glu medium and grown at 25ºC. The left-hand columns show low light 
DIC images. The right-hand columns show the GFP localisation of Vps10-GFP visualised as punctae. 
These images are representative of three replicate cultures. Scale bar represents 5µM. 
 
By calculating the percentage of cells that show Vps10-GFP as a ring on the vacuole 
it emerges that 38% of ∆vac14 cells are unable to recycle Vps10-GFP in a retromer 
∆vac7 
∆vac14 
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dependent manner. The phenotype is not as striking as that seen in a cell possessing a 
deletion of VPS29, where 100% of cells have defective recycling of Vps10-GFP. 
Therefore Vac14p is not absolutely essential for retromer dependent recycling. 
To further study the role of Vac14p in retromer dependent Vps10p recycling, rescue 
of ∆vac14 with two plasmids was carried out. pAEM42 is a URA based plasmid with 
C terminal expressed Vac14p. pAEM44 possess N terminal expressed Vac14p. 
As seen in Figure 3.11 addition of either pAEM42 or pAEM44 plasmids expressing 
Vac14p should rescue the ∆vac14 Vps10-GFP strain, and allow correct recycling of 
Vps10p via the retromer complex. In both strains some Vps10-GFP does still appear 
on the vacuole, and values are not significantly different when compared to 
∆vac14VPS10-GFP cells. Upon further investigation it appears that both VAC14 
constructs do not offer a full rescue of the ∆vac14 strain in many other situations. This 
is potentially because the VAC14 gene on these plasmids may lack essential 
regulatory elements upstream or downstream of this gene. 
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Figure 3.11 Localisation of VPS10-GFP in ∆vac14 strains with a plasmid rescue of 
VAC14. 
 
                             DIC                                   Vps10-GFP 
 
 Punctae Vacuole 
∆vac14+pAEM42 72.2% ± 3.5 27.7% ± 2.1 
∆vac14+pAEM44 63.7% ±6.1 36.2% ± 4.27 
[There was no significant difference between the above and ∆vac14 VPS10-GFP values] 
Vps10-GFP is visualised as both punctae and on the vacuole membrane in both strains. Shown above 
are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of ∆vac14 
transformed with VPS10-GFP and either pAEM42 (top panel) and ∆vac14+ pAEM44 (bottom panel). 
Both strains were cultured in SC-His-Ura +2% glu medium and grown at 25ºC.The left-hand columns 
show low light DIC images. The right-hand columns show the GFP localisation of Vps10-GFP. These 
images are representative of three replicate cultures. Scale bar represents 5µM. 
 
To further investigate the phenotype observed in the ∆vac14 strain the localisation of 
other components of retromer was investigated. A Vps5-GFP construct, a kind gift 
from Prof Emr, was used to see whether any other retromer components were 
∆vac14 + 
pAEM42 
∆vac14 + 
pAEM44 
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mislocalised in a ∆vac14 strain. Vps5-GFP was constructed by endogenously tagging 
VPS5 with GFP and expression was under the native promoter 
 
Figure 3.12 Vps5-GFP localisation. 
 
         DIC                                   Vps5-GFP 
 
Vps5-GFP can be visualised as punctae throughout all strains. Additionally it can be observed on the 
vacuole membrane in cells deficient in PtdIns(3,5)P2. Shown above are fluorescence images of 
logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type (top panel), ∆vps26 (second panel) 
∆fab1 (third panel) and ∆vac14 (bottom panel) cells with integrated chromosomally tagged Vps5-GFP. 
The left-hand column shows low light DIC images. The right-hand column shows the GFP localisation 
of Vps5-GFP. These images are representative of three replicate cultures. All strains were cultured in 
SC-His+2% glu medium and grown at 25ºC. Scale bar represents 5µM. 
 
∆vps26 
Wild type 
∆fab1 
∆vac14 
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As shown in Figure 3.12, in a retromer deficient strain Vps5-GFP can be seen on the 
vacuole membrane and as punctae. In wild-type cells, Vps5-GFP is visualised as 
punctae throughout the cytoplasm. However in both ∆fab1 and ∆vac14 strains, Vps5-
GFP can be seen as a ring on the vacuole. A reason for this may be due to an 
increased amount of PtdIns3P on the vacuole membrane in the absence of 
PtdIns(3,5)P2, forcing Vps5p to bind inappropriately. 
 
As a further control to the Vps10-GFP work, a double retromer mutant was 
constructed that contained a deletion of a retromer component VPS29 and also FAB1. 
Therefore the strain produced no PtdIns(3,5)P2 and retromer should be unable to 
recycle. Figure 3.13 shows that no changes in the localisation of Vps10-GFP are seen, 
therefore it seems that Fab1p on its own does not play a role in the retrograde 
trafficking of Vps10p in S.cerevisiae. 
Figure 3.13 Vps10-GFP double mutant localisation 
                       DIC                                   Vps10-GFP 
  
Vps10-GFP can be visualised on the vacuole membrane in a retromer and PtdIns(3,5)P2 deficient 
strain.Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) 
of ∆vps29::KAN ∆fab1::LEU2 transformed with Vps10-GFP. The left-hand column shows low light 
DIC images. The right column shows the GFP localisation of Vps10-GFP on the vacuole membrane. 
These images are representative of three replicate cultures. Scale bar represents 5µM. 
 
∆vps29::KAN 
∆fab1::LEU2 
 120 
In order to confirm the Vps10p results, the localisation of two other cargos of the 
endosome to TGN machinery were examined.  
 
3.5 Yif1p another mode of retrograde trafficking. 
Yif1p is a Golgi localised multispan membrane protein that is reported to cycle via the 
endosome, back to the Golgi in a retromer and Btn2p dependent fashion. Deletion of  
YIF1 causes a block in ER to Golgi transport (Matern et al., 2000). Localisation of 
Yif1-GFP is reported to be disrupted in both ∆btn2 cells and in mutants of members 
of the retromer complex including ∆vps26 and ∆snx4. Instead of being seen as GFP 
punctae throughout the cell, it becomes trapped inside the vacuole (Kama et al., 2007) 
where it is degraded. 
3.6 Localisation of YIF1-GFP 
 In retromer or ∆btn2 cells Yif1p was reported to enter the MVB pathway and end up 
inside the vacuole (Kama et al., 2007). To examine if ∆fab1 mutants caused 
mislocalisation of Yif1p, a pUG36-Yif1 plasmid was created and transformed into 
wild-type, ∆fab1, ∆ vps29 and ∆btn2 strains to see the localisation of N-terminally 
GFP tagged Yif1p. However, contrary to the published report, the construct was 
already mislocalised in wild-type cells; it is already inside the vacuole, whereas the 
reported true steady-state localisation of this protein is known to be the mid-Golgi. 
Oddly, when the exact construct described in the original paper on Yif1p recycling, 
was obtained, in our hands, this construct was also vacuolar and not localised to the 
Golgi.  This suggested that the original description of Yif1p trafficking was incorrect 
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or not consistent between different strains. The observed mislocalisation of Yif1p 
could be induced by the GFP tag as has been seen in yeast before. (Tsien, 1998) 
 Discussions with another researcher, Dr Pearce (University of Rochester, NY; USA) 
who has worked on Yif1p extensively, revealed that the localisation of Yif1p may be 
dependent upon pH. To investigate this, media was buffered to a pH of 4.0 and 7.0 
and cells were grown overnight before microscopy. As shown in Figure 3.14, buffered 
media does not seem to make a difference to the localisation of Yif1p so both 
constructs were deemed unusable. 
 
Figure 3.14 pUG36 GFP -YIF1 localisation at pH 4.0 and 7.0 in Wild-type and 
∆fab1 cells. 
                              pH4.0                                                         pH7.0 
              DIC                   pUG36-YIF1              DIC                        pUG36-YIF1 
 
Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-
type (top panels) and ∆fab1 (bottom panels) transformed with pUG36-YIF1. The left-hand panel shows 
images of cells grown at pH4.0. The right-hand panel shows images of cells grown at pH7.0 The two 
left hand columns show low light DIC images. The two right-hand columns show GFP localisation of 
pUG36-YIF1. These images are representative of three replicate cultures. All strains were cultured in 
SC-Ura+2% glu medium buffered to either pH 4.0 or 7.0 and grown at 25ºC. Scale bar represents 
5µM. 
 
 ∆fab1 
 Wild-type 
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A gift of pUG23-Yif1p from Dr Pearce allowed the Yif1p work to be continued. The 
plasmid  recieved bears a C-terminally tagged Yif1p, that earlier work had shown was 
stable. Again the same strains were transformed with the construct, and a marker for 
the vacuole (mCherry-Pho8p), so it could be established more easily whether Yif1p-
GFP is mislocalised.  
 
Figure 3.15 pUG23 Yif1-GFP and mCherry-Pho8p visualised in various strains. 
      Wild-type              ∆fab1                        ∆vps29                 ∆btn2 
 
YIF1 was tagged at the C terminal with GFP in a pUG23 plasmid and could be observed as punctae in 
all strains although somewhat faintly. mCherry-Pho8p is a marker for the vacuole, if trafficking of yif1 
is not correctly working the Yif1-GFP should be seen in the vacuole. Shown are Shown above are 
fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of Wild-type (first 
column), ∆fab1 (second column), ∆vps29 (third column) and ∆btn2(fourth column) transformed with 
VPS10-GFP(top panels) and mCherry-Pho8p (middle panels) the bottom panel shows a merge of both 
red and green images for co-localisation. Both strains were cultured in SC-His-Ura+2% glu medium 
and grown at 25ºC. These images are representative of three replicate cultures. Scale bar represents 
5µM. 
 
As shown in Figure 3.15 the pUG23-YIF1 construct was expressed weakly, and 
images show faint punctate compartments, as expected in wild-type cells. Oddly, 
deletion of BTN2 did not affect Yif1p-GFP trafficking, suggesting that the original 
pUG23 YIF1 
GFP 
m-Cherry Pho8p 
(Vacuole 
membrane) 
 Merge 
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description of this protein’s recycling could be artefactual (Kama et al., 2007). To 
observe whether a small difference in localisation of the punctae could be observed, 
the set of RFP markers used previously for the Vps10p work were utilised to define 
the exact compartment to which Yif1p localises.  
 
Figure 3.16 pUG23-Yif1 localisation in Wild-type cells containing the RFP markers 
Snf7p, Anp1p,Chc1p and Cop1p. 
 
       Snf7p (PVE)          Anp1p (ER)            Chc1p (TGN)       Cop1p (GOLGI) 
 
8.7% ±6.6  15.0% ±8.8 7.0% ±0.4 28.1% ±4.4 GFP co-localisation 
22.4% ±9.4 14.5% ±1.3 10.6% ±8.8 9.4% ±13.3 Random GFP co-
localisation 
-13.7% ±8.0 0.5% ±10.1 -3.6% ±9.2 18.7% ±8.8 Adjusted GFP co-
localisation 
8.7% ±6.6 18.8% ±3.7 9.2% ±5.4 25.0% ±3.6 RFP co-localisation 
14.5% ±10.3 12.4% ±3.6 8.4% ±6.2 34.4% ±4.4 Random RFP co-
localisation 
-5.8% ±13.6 6.4% ±0.1 0.8% ±11.6 -9.4% ±7.9 Adjusted RFP co-
localisation 
RFP Marker 
 Merge 
pUG23 Yif1 
GFP 
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[There was no significant difference between co-localistion  and random co-localisation  values] 
Yif1-GFP can be visualised as punctae. Shown are Shown above are fluorescence images of 
logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type cells containing various RFP tagged 
proteins acting as markers (middle panels) transformed with pUG23YIF1-GFP(top panels. The bottom 
panel shows a merge of both red and green images for co-localisation.  Strains were cultured in SC-
His+2% glu medium and grown at 25ºC. These images are representative of three replicate cultures. 
Scale bar represents 5µM. 
 
As seen in Figure 3.16 it is hard to clearly define the compartment YIF1–GFP is 
localised to in the Wild-type strain and there is no significant co-localisation with any 
markerVps26p was used as a retromer control because a vps26::LEU2 allele was 
available. In this strain there appears to be significant co-localisation with the Cop1p 
positive compartment which marks the Golgi. There do seem to be additional punctae 
that do not co localise with any of the examined compartments, so this may mean that 
Yif1p is localised to another compartment as well (as seen in Figure 3.17). It also 
looks like Yif1-GFP is localised on the vacuole membrane. 
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Figure 3.17 pUG23-YIF1 localisation in ∆vps26 cells containing the RFP markers 
Snf7p, Anp1p Chc1p and Cop1p. 
       Snf7p (PVE)          Anp1p (ER)            Chc1p (TGN)       Cop1p (GOLGI) 
 
[Significantly different from random co-localiation: ***P<0.001, N/S not indicated] 
Yif1-GFP is visualised as punctae. Shown are Shown above are fluorescence images of logarithmic 
phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of ∆vps26 cells containing various RFP tagged proteins 
acting as markers (middle panels) transformed with pUG23YIF1-GFP(top panels) and various RFP 
markers (middle panels). The bottom panel shows a merge of both red and green images for co-
localisation.  Strains were cultured in SC-His+2% glu medium and grown at 25ºC. These images are 
representative of three replicate cultures. Scale bar represents 5µM 
 
 
0.0% ±0.0 3.3% ±3.9 2.9% ±1.0 28.1% ±1.2 GFP co-localisation 
6.9% ±1.8 8.9% ±1.5 3.3% ±4.7 12.1% ±3.4 Random GFP co-
localisation 
-6.9% ±1.76 -5.6% ±2.3 -0.4% ±1.5 16.% ±8.0 Adjusted GFP co-
localisation 
0.0% ±0.0 2.2% ±2.6 6.7% ±2.4% 32.2% ±7.0*** RFP co-localisation 
0.0% ±0.0 10.6% ±5.0 3.2% ±4.6 5.9% ±2.4 Random RFP co-
localisation 
0.0% ±0.0 -8.4% ±1.5 3.5% ±3.8 26.3% ±2.9 Adjusted RFP co-
localisation 
pUG23 Yif1 
GFP 
RFP Marker 
 Merge 
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Figure 3.18 pUG23-YIF1 localisation in ∆fab1 cells containing the RFP markers 
Snf7p, Anp1p Chc1p and Cop1p. 
 
       Snf7p (PVE)          Anp1p (ER)            Chc1p (TGN)       Cop1p (GOLGI) 
 
[Significantly different from random co-localiation: 0.01<*P<0.05, N/S not indicated] 
Yif1-GFP is visualised as punctae. Shown above are fluorescence images of logarithmic phase cultures 
(5 x 10
6
 – 1 x 107 cells/ml) of ∆fab1 cells containing various RFP tagged proteins acting as markers 
(middle panels) transformed with pUG23YIF1-GFP(top panels). The bottom panel shows a merge of 
both red and green images for co-localisation.  Strains were cultured in SC-His+2% glu medium and 
grown at 25ºC. These images are representative of three replicate cultures. Scale bar represents 5µM. 
 
6.4% ±2.5 7.6% ±4.3% 49.4% ±9.4* 40.0% ±11.8* GFP co-localisation 
7.9% ±12.1 10.2% ±10.3% 14.4% ±6.5 13.3% ±9.4 Random GFP co-
localisation 
-1.5% ±6.3 -2.6% ±12.2 35.0% ±9.4 26.7% ±6.8 Adjusted GFP co-
localisation 
9.0% ±6.5 6.9% ±5.3 38.3% ±12.4 46.5% ±8.5* RFP co-localisation 
2.9% ±1.1 15.1% ±9.1% 8.3% ±8.8 14.8% ±5.0 Random RFP co-
localisation 
6.1% ±10.4 -8.2% ±6.0 30.0% ±8.4% 31.7% ±9.4 Adjusted RFP co-
localisation 
pUG23 Yif1 
GFP 
RFP Marker 
 Merge 
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The ∆fab1 strain appears to have some significant co-localisation with the Cop1p and 
Chc1p positive compartments(Figure 3.18). This difference in Yif1p trafficking in the 
∆fab1 strain is not observed in the retromer deficient strain, suggesting that this 
phenotype is not due to a deficiency in retromer trafficking. The random co-
localisations suggest that the difference in co-localisation is not due to the 
compartment sizes as when random co-localisation is taken into account, a difference 
is still observed. This effect may be due to the Cop1p and Chc1p compartments 
overlapping in a ∆fab1cell because they mark the Golgi and TGN respectively.The 
colocalisation with the Cop1p positive compartment is not as significant as in the 
retromer deficient strain. This data suggests that Yif1p trafficking, if it even does 
recycle, is not retromer or Fab1p-dependent and hence neither Yif1p nor Vps10p 
require PtdIns(3,5)P2  to recycle. This strongly suggests that retromer function does 
not require PtdIns(3,5)P2  and that the results from animals either represent a 
difference between fungi and animals or else that the data from animals are 
misleading. 
 
3.7 Mrl1p a homolog of the mammalian mannose-6-phosphate receptors. 
Mrl1p is a yeast protein identified in 2001 which shares homology to cation 
dependent mammalian mannose-6-phosphate receptors (Whyte and Munro, 2001). 
This raises the possibility that Mrl1p may also be a cargo receptor and recycle in a 
retromer dependent manner. In mammalian cells soluble hydrolases of the lysosomes 
are marked for delivery to the organelle by addition of mannose-6-phosphate to their 
N-glycans. This is recognised by two mannose 6-phosphate receptors in the TGN and 
who then deliver the hydrolases to the late endosome (Whyte and Munro, 2001). 
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S.cerevisiae vacuolar hydrolases do not have this feature and VPS10 encodes the 
sorting receptor that cycles between the Golgi and late endosome. However Vps10p is 
unrelated to the mammalian mannose 6-phosphate receptors. Mrl1p is not a widely 
researched protein but it cycles as Vps10p does from the Golgi to the PVE. Although 
there is currently no evidence for direct binding of vacuolar hydrolases to Mrl1p, it is 
possible it does play a role in their sorting (Bowers and Stevens, 2005). Mrl1p is a 
candidate for the transport of PrA and PrB which are transported along the same 
pathway as CPY. Mrl1p is encoded by the ORF YPR079w and is predicted to encode 
a protein of 381 amino acids with a single transmembrane domain and a cleaved 
signal peptide. Closely related proteins are found in both S. pombe and the fungus 
Botrytis cinerea (Bowers and Stevens, 2005). A role for PtdIns(3,5)P2 in the cycling 
of Mrl1p was investigated, by making several constructs that allow expression of this 
protein as a GFP-fusion. 
 
3.8 Localisation of Mrl1p 
 Mrl1p has been previously shown to co-localise with Vps10p, but to date has not 
been shown to recycle via the retromer pathway. A pUG34 MRL1-GFP plasmid was 
made with the GFP located at the N-terminal and expressed under a Met25 promoter. 
As shown in Figure 3.19 it appears that the N terminal construct was not correctly 
trafficked and the GFP signal appeared throughout the cell in the cytoplasm. This is 
probably due to the transmembrane domain of Mrl1p and the N terminus of the 
protein being situated inside the lumen, therefore the signal could not be observed 
correctly. A C-terminal GFP tagged plasmid was also made, so Mrl1p would not be 
over expressed. 
 129 
Figure 3.19 Localisation of pUG34 Mrl1  
 
                       DIC                                         pUG34-Mrl1 
 
pUG34-Mrl1GFP can be visualised throughout the cellular cytoplasm in all strains. Shown above are 
fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type (top panel), 
∆fab1 (middle panel) and ∆vps29 (bottom panel) transformed with pUG34 Mrl1-GFP. The left-hand 
column shows low light DIC images. The right-hand column shows the GFP localisation of N terminal 
GFP tagged Mrl1p. These images are representative of three replicate cultures. All strains were 
cultured in SC-His+2% glu medium and grown at 25ºC. Scale bar represents 5µM. 
 
 
 
Wild type 
∆fab1 
∆vps29 
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Figure 3.20 pUG23 MRL1 (C-terminal plasmid GFP tagged) localisation 
                       DIC                                         pUG23-MRL1 
    
 pUG23-Mrl1GFP can be visualised on the vacuole membrane in all strains. Shown above are 
fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type (top panel), 
∆fab1 (middle panel) and ∆vps29 (bottom panel) transformed with pUG23 Mrl1-GFP. The left-hand 
column shows low light DIC images. The right-hand column shows the GFP localisation of C terminal 
GFP tagged Mrl1p. These images are representative of three replicate cultures. All strains were 
cultured in SC-His+2% glu medium and grown at 25ºC. Scale bar represents 5µM. 
 
In the C terminal plasmid construct, Mrl1-GFP appeared to be on the vacuole 
membrane in all strains examined (See Figure 3.20). No clear difference could easily 
∆fab1 
∆vps29 
Wild type 
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be observed between any of the strains. If more time was available GFP could have 
been inserted elsewhere in the gene but due to restriction site locations this couldn’t 
quickly be done so due to time constraints this work was abandoned. 
At the same time a construct with GFP fusion of MRL1 at the C-terminus was created, 
using the Longtine homology approach. In this case Mrl1-GFP was expressed 
constitutively under the control of the endogenous promoter. The results in Figure 
3.21 indicate that Fab1p and PtdIns(3,5)P2 may play a role in the trafficking of Mrl1p. 
As seen in Figure 3.21, in the ∆vps29 strain in around 85% of cells, the Mrl1-GFP 
construct appears on the vacuole membrane with a few bright punctae coming off of 
the vacuole and in some cases in the cytoplasm. It is likely that this is because Mrl1p 
is not being trafficked correctly, maybe due to retromer dysfunction. The wild-type 
strain appears to have both punctate (~60%) and vacuolar (~40%) Mrl1-GFP 
localisation. The ∆fab1 strain has signal on the vacuole membrane in virtually every 
cell; sometimes small dot like structures can be seen on the vacuole but this occurs 
less than in wild-type cells. Levels of vacuolar Mrl1-GFP are almost at the levels seen 
in the retromer deficient strain.  This suggests that deletion of FAB1 creates a defect 
in Mrl1p trafficking and leads to its mis-localisation on the vacuole membrane.  
The Mrl1p work suggests that there may be a role for Fab1p or PtdIns(3,5)P2 in the 
trafficking of some cargoes who recycle via retromer.  
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Figure 3.21 Mrl1-GFPendogenesly tagged fusion protein localisation 
                       DIC                                         pUG23-MRL1 
 
 Punctate Vacuole 
Wild-type  59.1% ± 6.1 40.1% ± 3.1 
∆fab1 15.2% ± 0.7*** 84.9% ± 4.9*** 
∆vps29 14.7% ± 2.4*** 85.3% ± 1.7*** 
[Significantly different from  wild type values: ***P<0.001,] 
Mrl1-GFP can be visualised on the vacuole membrane in all strains, however can also be observed as 
punctae in wild-type. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 
10
7
 cells/ml) of wild-type (top panel), ∆fab1 (middle panel) and ∆vps29 (bottom panel) transformed 
with MRL1-GFP. The left-hand column shows low light DIC images. The right-hand column shows the 
GFP localisation of C terminal GFP tagged Mrl1. These images are representative of three replicate 
cultures. All strains were cultured in SC-His+2% glu medium and grown at 25ºC. Scale bar represents 
5µM. 
Wild type 
∆fab1 
∆vps29 
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3.9 Discussion 
The results obtained from this chapter of experiments indicate that retromer mediated 
trafficking of Vps10p and Yif1p does not appear to be affected by Fab1p. Vac14p 
does however appear to play a role in the trafficking of Vps10p, but without further 
work it is hard to envisage a mechanism. The results show that deletion of VAC14 
does not lead to a total defect in Vps10p localisation and so it may be that some 
Vps10p can still be recycled and that this enough for us to observe some normal 
localisation. The results rule out the possibility that retromer trafficking is absolutely 
dependent on PtdIns(3,5)P2, at least in yeast, because a single knockout of FAB1, 
creating a cell with no PtdIns(3,5)P2 has no effect on localisation of Vps10p nor 
Yif1p. It may be that PtdIns(3,5)P2 is playing an accessory role and it is not the 
phosphoinositide itself that is required for retromer mediated trafficking but part of 
the activation complex. Vac14p is composed of HEAT motifs and acts as a scaffold 
for a complex essential for PtdIns(3,5)P2  production, so maybe it plays a similar 
scaffolding role during retromer trafficking. A yeast two hybrid analysis to see if there 
is interaction between Vac14p and the retromer complex may be a way to further 
dissect this process.  
The findings also suggest that Yif1p may not recycle in the way that has been 
postulated; in our hands such recycling is neither PtdIns(3,5)P2 nor retromer 
dependent. It would be interesting to see if Vac14p plays a role in trafficking of this 
construct. 
Intriguing results have been obtained for one of the Mrl1p constructs and suggests that 
PtdIns(3,5)P2 does play a role in the trafficking of this cargo receptor. Localisation of 
Mrl1p in a Δfab1 strain is clearly aberrant and similar to that observed in a retromer 
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deficient strain; this suggests that Mrl1p is recycled in a retromer dependent fashion, 
as deletion of a retromer component results in mislocalisaion of Mrl1p to the vacuole 
membrane. To establish a role for PtdIns(3,5)P2 in the trafficking of Mrl1p, further 
experiments need to be performed. A rescue of the Δfab1 strain with different FAB1 
constructs would indicate whether or not the process is dependent upon the lipid. 
Expression of Mrl1p and dot blots could be performed to see if direct interaction with 
PtdIns(3,5)P2 takes place. A role for Vac14p could also be investigated.  
 Several studies where PIKfyve function was inhibited via siRNA mediated knock-
down or via over expression of a dominant negative PIKfyve strongly suggested that 
one function of PtdIns(3,5)P2 might be to regulate endosome to TGN sorting of 
membrane proteins such as the Vps10p-like sortillins and M6R (Ikonomov et al., 
2003, Rutherford et al., 2006). The differences observed between the mammalian and 
S. cerevisiae systems may also be due to the fact that Fab1p is a lipid kinase whereas 
PIKfyve also has protein kinase activity (Sbrissa et al., 2000, Ikonomov et al., 2003). 
Indeed it has been suggested that PIKfyve can phosphorylate p40, a Rab9 effector that 
is implicated in retromer function (Sbrissa et al., 2005, Ikonomov et al., 2003). Since 
p40 and Rab9 are essential for endosome to TGN recycling in animal cells (Murray et 
al., 2005) but are absent from yeast, this may explain why there is a difference 
between these two groups of organisms; we have been unable to demonstrate Fab1p 
auto-phosphorylation indicating that the yeast enzyme may not express protein-kinase 
activity. Indeed, mutation of the site in Fab1p that would be predicted to 
autophosphorylate if Fab1p is also a protein kinase resulted in no substantial 
difference in Fab1p-activity, suggesting that Fab1p and PIKfyve are not identical in 
this respect (Duex et al., 2006b). Perhaps this is the reason for the divergent functions 
of these enzymes. The differences between yeast and animals may also reflect the fact 
 135 
that sorting nexins in yeast do not bind PtdIns(3,5)P2 as they are reported to in animal 
cells. This work shows a key difference between mammalian and yeast systems that 
has previously been unreported 
There is no exact M6R homologue in yeast, so it may be that the result observed in 
mammalian cells may be a different trafficking event not observed in yeast. Vps10p is 
not a homologue for M6R, but Mrl1p does share a region of homology to cation 
dependent M6R (Whyte and Munro, 2001). The results do indicate that Mrl1p 
trafficking is disrupted in cells lacking PtdIns(3,5)P2. This suggests that Vps10p 
trafficking of CPY is a different event in yeast to that in mammalian cells and utilises 
different machinery.   
The exact nature of the apparent endosome to TGN sorting defect observed in some 
PtdIns(3,5)P2 deficient cells has not been defined and therefore it is difficult to know 
if the effect is direct, which may explain the Vac14p result. Currently no 
PtdIns(3,5)P2 effector has been identified that might explain the requirement for 
PtdIns(3,5)P2 in the retrograde trafficking step although both sorting nexin1 and an 
Atg18p like protein, known as WIPI, have been proposed (Jeffries et al., 2004, 
Carlton et al., 2004). Sorting nexin1 can bind PtdIns(3,5)P2 through a FYVE domain 
although it has a much higher affinity for PtdIns3P even in in vitro binding assay 
whilst the lipid binding specificity of WIPI is in doubt because it resembles Atg18p; a 
protein that is known to be a true effector of PtdIns(3,5)P2 in yeast, yet WIPI is 
reported to bind PtdIns3P in vitro. It would be interesting to see if atg18 has an 
effect on the trafficking of Mrl1p. 
Alternatively the apparent endosome to TGN recycling defect that is variably 
observed when PIKfyve is ablated may be a secondary consequence of perturbation of 
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a genuine PtdIns(3,5)P2 dependent process further upstream and hence an artefact of 
chronic loss of PtdIns(3,5)P2. Studies conducted in lower organisms such as C. 
Elegans and also a new study of mammalian cells using a specific PIKfyve inhibitor 
have failed to show any such role for PtdIns(3,5)P2 in this process (Jefferies et al., 
2008, Rusten et al., 2006, Nicot et al., 2006).  
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Chapter 4 
PtdIns(3,5)P2 in the early endosomal system? 
4.1 Introduction  
Evidence has recently emerged pointing to a role for PtdIns(3,5)P2 in the regulation of 
the early endocytic system in mammalian cells. The mammalian homolog of Fab1p; 
PIKfyve has been shown to control a multitude of ion channels ranging from the 
chloride CLC-2 (Klaus et al 2009a), the calcium TRPV6 channel (Sopjani et al 2010), 
Sodium coupled glutamate EAAT3 transporter (Klaus et al 2009b) and ryanodine 
receptor trafficking. This makes a role for Fab1p in the early endocytic system likely; 
even through these functions of PIKfyve could be lipid kinase independent.  
 Also, since the retromer phenotype observed in animal cells may be an indirect effect 
of losing PtdIns(3,5)P2, one of the compartments linked to the mammalian early 
endosome might have trafficking regulated by Fab1p.  
It was therefore decided to see if Fab1p or PtdIns(3,5)P2 has any role in the retrograde 
trafficking between the recycling endosome and the TGN in the yeast S. cerevisiae. 
Due to the problem of compartment identity between mammalian and yeast systems, 
it is hard to identify equivalent organelles. The compartment most likely to be the 
recycling endosome in yeast, is the Snc1p (t-SNARE) positive compartment. This 
compartment underlies the yeast plasma membrane, and appears to have no direct 
trafficking route to the cell surface. Cargo must first pass through the Golgi, so the 
compartment is sometimes named the Post Golgi endosome (PGE) (See Figure 4.1). 
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FM4-64 is endocytosed and appears in this compartment at early time points, 
providing evidence it is either an early or recycling endosome (Dove et al., 2009).  
 
Figure 4.1 Diagram of Chs3p trafficking 
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Chs3p is normally trafficked from the PGE to the plasma membrane in a Chs6p dependent manner. If 
this pathway is blocked then Chs3p can no longer reach the mother- daughter bridge. However if 
retrograde trafficking is compromised Chs3p accumulates at either the TGN or PGE and somehow 
finds its way to the cell surface. 
 
When S. cerevisiae cells grow and divide, they do so by budding from the mother cell. 
A daughter cell is initiated as a bud from the mother cell, when the latter attains a 
critical size and DNA replication has occurred. Genetic information and organelles 
are shared between the two cells in a process that requires the mother cell wall to 
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weaken, so cytoplasm can be allowed into the new daughter cell that is bound by a 
new cell wall, in a process requiring specific proteins and membrane receptors 
(Feldmann, 2005). The daughter cell grows and eventually ‘buds off’ and separates 
from the mother cell.  During this process the polysaccharide chitin is deposited at the 
mother daughter cell junction, forming a ring. This ring is retained at the surface of 
the mother cell after separation and is known as a bud scar. The number of bud scars 
present can give an indication of cellular ‘age’ and how many budding events have 
occurred (Feldmann, 2005).   
 
The process of chitin disposition requires an integral membrane enzyme; chitin 
synthase 3 (Chs3p) (Bulawa, 1993). Chs3p is responsible for around 90% of the total 
cellular chitin. Chitin is not only deposited at the mother-daughter neck junction but is 
also present in the walls of S. cerevisiae (Bulawa, 1993). During the G1 phase of the 
cell cycle Chs3p builds a ring of chitin at the junction between mother and daughter 
cell, in a process requiring septins.  
When visualised, Chs3p is localised to both the plasma membrane and internal 
‘punctate’ structures. These internal punctae co-localise with the TGN and early 
endosome markers (Chaung et al., 1996, Ziman et al., 1996, Valdivia et al., 2002) and 
have been termed ‘chitosomes’. Chitosomes are suggested to represent an internal 
pool of Chs3p, ready for trafficking to the plasma membrane during times of cellular 
stress such as heat shock, and in a cell cycle dependent manner. Chs3p is only found 
in the daughter cell during G1, at all other phases it can been seen in the chitosomes 
(Chuang and Schekman, 1996). 
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To gain access to the mother-daughter cell bridge Chs3p transits from the internal 
chitosomes via the TGN and endosomal system. Two proteins have been identified as 
being required to sort selected cargo proteins into secretary vesicles; Chs5p and 
Chs6p, (Trautwein et al., 2006, Ortiz and Novick, 2006). Deletion of either Chs5p or 
Chs6p causes disruption of localisation of Chs3p to the incipient bud site at the onset 
of bud emergence. Redistribution of Chs3p upon heat stress is also hindered (Ziman et 
al., 1998, Valdivia and Schekman, 2003, Ruiz-Herrera et al., 2006). 
 
Research in 2006 discovered a large novel coat complex of around 1 MD, known as 
exomer (Wang et al., 2006). The complex transiently interacts with Chs3p and is 
necessary for its correct trafficking. Exomer is comprised of Chs5p, Chs6p and three 
Chs6 paralogues: Bch1p, Bud7 and Bch2p. Every component is critical for the 
association of Chs3p with exomer (Sanchatjate and Schekman, 2006). Chs5p and 
Chs6p have non-redundant roles in the complex, deletion of either gene causes a large 
reduction in the amount of Chs3p bound to the remaining coat. Whereas the roles of 
Bch1p and Bud7p seem to be somewhat overlapping, as deletion of both genes is 
required in order to impede Chs3p binding to exomer (Sanchatjate and Schekman, 
2006). Chs5p is required for structural integrity of the complex and may act as a 
scaffold on which the other subunits assemble. It  is also essential for the transport of 
other cargos to the cell surface; such as Fus1p (Santos and Snyder, 2003). Chs5p is 
recruited to the TGN surface in vivo in a GTP dependent process by Arf1p (Wang et 
al., 2006). 
 
Regulatory proteins control the formation of transport carriers at the TGN by 
modulating lipid composition, and other proteins such as FAPPs (four phosphate 
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adapter proteins), which are able to bind PPIns and associate with the TGN through 
interaction with Arf1p (Godi et al., 2004).  Arf1p-GTP may act to tether Chs5p to the 
membrane as it does for coatmer in Cop1p vesicle formation and adapter proteins 
(AP-1 and AP-2) do for clathrin coated vesicles (Wang et al., 2006). Acidic 
phospholipids have been shown to stimulate coat recruitment and assembly on 
artificial membranes; recombinant Chs5p interacts with Chs6p and with a variety of 
acidic phospholipids (Wang et al., 2006) 
 
Several other proteins are essential for the regulation of Chs3p transport to the cell 
surface. Chs7p is a chaperone that controls export of Chs3p from the endoplasmic 
reticulum (Trilla et al., 1999). Chs4p is needed to activate and link Chs3p to the 
septins at the mother-daughter bridge (Bulawa, 1993).  
  
Figure 4.2 Cartoon of how an Exomer complex might form. 
 
The exact way the Exomer complex forms is not known. It is likely that Chs5p acts as a scaffold for the 
other components to form onto. Arf1-GTP is required for interaction with the TGN. Chs6p, Bch1p and 
Bud7p are required for Chs3p interaction. 
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Interrupted transport of Chs3p when either CHS6 or CHS5 are deleted has been 
reported to be restored when any subunit of the clathrin AP-1 complex is also 
inactivated (Valdivia et al., 2002). It has also been suggested that clathrin and AP-1 
mediate the cycling of Chs3p between the TGN and the early endosome, and that the 
pathway serves to retain an underlying Chs5p and Chs6p independent route of Chs3p 
traffic to the cell surface (Sanchatjate and Schekman, 2006). The normal purpose of 
this division of Chs3p between the TGN and the early endosome may be to maintain 
Chs3p in the internal chitosomes that are required when cells are stressed or in G1 
(Sanchatjate and Schekman, 2006).  
Research by the Cooke group in 2006 presented evidence that Fab1p and AP-1 are 
required for the trafficking of ubiquitiylated cargos from the TGN to the vacuole 
lumen (Phelan et al., 2006). Biochemical analysis shows all components of the AP-1 
complex, when deleted, have compromised PtdIns(3,5)P2 synthesis and any 
trafficking defects of ∆apl2 and ∆apl4 can be recovered by Fab1p over-expression 
(Phelan et al., 2006).  
Calcofluor white, can be use to visualise chitin rings, deposited at the neck of the 
mother-daughter cell during replication (Manheit et al., 1984). In a ∆chs6 strain, 
calcofluor white staining is diffuse. This is because chitin can no longer reach the 
mother-daughter junction correctly, and chitin rings are absent (Valdivia et al., 2002). 
Wild-type cells lacking a component of the AP-1 complex, and ∆fab1 strains all 
appear to have normal calcofluor white staining. Here, bud scars from previous 
daughter cells are observed. Intriguingly, when an additional deletion of an AP-1 
subunit, is added to a ∆chs6 strain, the bud scars are reported to be restored.  The 
same phenotype is also reported to be observed when an additional Fab1p deletion is 
added to the ∆chs6 strain (Phelan et al., 2006, Valdivia et al., 2002).  This suggests 
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that Fab1p, as well as AP-1, may mediate the internal recycling of Chs3p that occurs 
in wild-type cells but becomes much more exaggerated when Chs6p is inactivated. 
Research has also implicated Ent3p and Ent5p, two putative effectors of PtdIns(3,5)P2 
in this process. Deletion of both Ent3p and Ent5p together, can reverse the calcofluor 
resistance observed in a ∆chs6 strain (Copic et al., 2007). Several studies have linked 
Ent3p, Ent5p and PtdIns(3,5)P2 in the regulation of Chs3p trafficking, to and from the 
cell surface (Phelan et al., 2006) Ent3p and Ent5p have also been implicated in 
intracellular retention of Chs3p, they have previously been shown to bind clathrin, 
AP-1 and Gga2p (Dove et al., 2009, Seaman, 2005, Costaguta et al., 2006).  
 
4.2 Aim 
The aim of this work was to use the endocytic trafficking of Chs3p in yeast, in order 
to identify additional components of the pathway influenced by Fab1p and  
PtdIns(3,5)P2. Another aim was to establish what this pathway actually is. In order to 
find additional components of the pathway, a screen was devised. A secondary screen 
to identify potential mutants with Fab1p like ‘co-phenotypes’ was also developed. 
This was calculated to allow discovery of the machinery involved in this pathway and 
shed light on the role of PIKfyve and PtdIns(3,5)P2 in the early endosomal system. 
4.3 Chs3-GFP localisation  
To verify localisation of Chs3p a Chs3-GFP construct was made using the Longtine 
short flanking homology approach as detailed in Chapter 2. The construct also 
allowed investigation into whether Fab1p or any AP-1 subunit plays a role in the 
localisation of Chs3p in a ∆chs6 strain. Chs3p-GFP was expressed under the 
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endogenous promoter, so trafficking defects would not be due to over expression; 
though mislocalisation due to GFP was still possible. 
As shown in Figure 4.3. Chs3-GFP localisation is disrupted in a ∆chs6 strain. In wild-
type, ∆apl4 and ∆fab1 strains, Chs3-GFP can be localised on the mother-daughter 
bridge of budding cells. This is observed in around 60% of wild-type cells. In a ∆chs6 
strain Chs3-GFP is no longer seen on the bridge as often (around 7%), and is present 
mostly as internal punctate vesicles. It appears that without Chs6p, Chs3p can no 
longer reach the bridge of the mother/daughter bud. This is likely due to exomer no 
longer functioning to transport Chs3p to the cell surface, without Chs6p. 
To investigate whether Fab1p or Apl4p (a subunit of the AP-1 complex) have a role in 
trafficking Chs3p, double mutants with an additional mutation of CHS6 were 
constructed and examined (Figure 4.4). 
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Figure 4.3 Localisation of Chs3-GFP in single deletion mutant strains. 
                       DIC                                         Chs3-GFP 
            
Strain Percentage of cells with Chs3-GFP on 
bridge 
Wild-type 60.6% ±5.2 
∆chs6 7.2% ±2.4*** 
[Significantly different from  wild type values: ***P<0.001,] 
Chs3-GFP is seen in punctae in all single mutant stains. Shown above are fluorescence images of 
logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type (top panel), ∆fab1 (second panel), 
∆apl4 (third panel) and ∆chs6 (bottom panel) transformed with Chs3-GFP. The left-hand column 
shows low light DIC images. The right-hand column shows the GFP localisation of C terminal GFP 
tagged Chs3p. These images are representative of three replicate cultures. All strains were cultured in 
SC-His+2% glu medium and grown at 25ºC. Scale bar represents 5µM. 
∆fab1 
∆apl4 
∆chs6 
Wild type 
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Figure 4.4 Chs3-GFP localisation in double mutants 
                       DIC                                         Chs3-GFP 
   
Strain Percentage of cells with 
Chs3-GFP on bridge 
Average number of 
punctae per cell 
∆chs6 7.2% ±2.4 2.7 ±0.9 
∆fab1∆chs6 12.5% ±4.2 4.7 ±1.1 
∆apl4∆chs6 8.9% ±1.7 3.7 ±0.7 
[No significant difference with ∆chs6 values was observed] 
Chs3-GFP is seen in punctae in both double mutant stains, and is not observed on the bridge between 
mother and daughter cell. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 
– 1 x 107 cells/ml) of  ∆fab∆chs6 (top panel) and ∆apl4∆chs6 (bottom panel) transformed with Chs3-
GFP. The left-hand column shows low light DIC images. The right-hand column shows the GFP 
localisation of C terminal GFP tagged Chs3p. These images are representative of three replicate 
cultures. All strains were cultured in SC-His+2% glu medium and grown at 25ºC. Scale bar represents 
5µM. 
 
∆fab1::KAN 
∆chs6::LYS2 
 
∆apl4::KAN 
∆chs6::LYS2 
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The results demonstrate that the additional deletion of FAB1 in a ∆chs6 strain does 
not significantly alter the localisation of Chs3-GFP.  
4.4 Calcofluor staining. 
Calcofluor white is a non-specific flurochrome, that can be used to stain 
polysaccharides and has long been used as a fluorescence signal to visualise chitin and 
cellulose (Harrington and Raper, 1968). Calcofluor white can be used to visualise the 
bud scars which are rich in chitin, and remain on mother cells following budding. 
Haploid cells only bud from one position so the bud scars should stem from the same 
region of the cell. Calcofluor was therefore used to observe bud scars in a variety of 
strains. The literature reports that bud scars can no longer be observed in a ∆chs6 
strain, because chitin cannot reach the mother-daughter bridge, due to disruption of 
Chs3p transport.  
As shown in Figure 4.5, bud scars of previous daughter cells can be observed in a 
wild-type strain. These are visualised as clear rings at one end of the cell. A ∆chs6 
mutant no-longer shares this phenotype. Staining can still be seen on the wall of the 
cell, as this contains other polysaccharides that calcofluor will also bind. A small 
amount of chitin will also still be present, as its synthesis is due to other chitin 
synthases. A small gap in calcofluor staining of the cell wall can be seen in the ∆chs6 
strain where bud scars would normally be present. This represents the lack of chitin 
that would normally build up at the mother-daughter bridge. Bud scars can also be  
seen in single deletion mutants of FAB1 and APL4. The bud scars in these strains are 
not significantly different to those in wild-type. This means that correct trafficking of 
chitin to the mother daughter bridge is occurring during budding in these strains, this 
is not surprising since no studies implicate Fab1p function in control of exomer. 
 148 
Figure 4.5 Calcofluor staining of bud scars in Wild-type and single deletion 
mutants. 
 
                                                  Calcofluor staining  
 
Strain Percentage of cells with bud scars 
Wild type 94.6% ±2.1 
∆chs6 16.1% ±1.4 *** 
∆fab1 92.7% ±4.5 
∆apl4 89.8% ±5.4 
[Significantly different from wild type values: ***P<0.001, N/S not indicate] 
Bud scars can be visualised by staining cells with calcofluor. Bud scars are seen in all strains except 
∆chs6. Shown above are fluorescence images of logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) 
of wild-type (top left), ∆chs6( top right), ∆fab1 (bottom left) and ∆apl4 (bottom right) stained with 
calcofluor white for 10 minutes. The images show calcofluor staining visualised using a DAP1 filter. 
These images are representative of three replicate cultures. All strains were cultured in SC-YETD+2% 
glu medium and grown at 25ºC. Scale bar represents 5µM. 
 
To investigate whether an additional deletion of FAB1 or APL4 in a ∆chs6 strain can 
also bring back bud scars, staining of double mutants with calcofluor was also 
conducted.  
 
∆chs6 
∆apl4 
Wild type 
∆fab1 
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Figure 4.6 Calcofluor staining of bud scars in ∆chs6 double mutants 
 
                                                  Calcofluor staining  
 
Strain Percentage of cells with bud scars. 
∆chs6 16.1% ±1.4 
∆fab1∆chs6 
49.4% ±5.2*** 
∆apl4∆chs6 
48.8% ±6.0*** 
[Significantly different from ∆chs6 values: ***P<0.001,] 
Deletion of either FAB1 or APL4 can bring back the presence of bud scars in a ∆chs6 strain. Shown 
above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of  ∆fab::KAN 
∆chs6::LYS2(left hand panel) and ∆apl4::KAN ∆chs6::LYS2 (right hand panel) stained with calcofluor 
white for 10 minutes. The images show calcofluor staining visualised using a DAP1 filter. These 
images are representative of three replicate cultures. All strains were cultured in SC-Lys+2% glu 
medium and grown at 25ºC. Scale bar represents 5µM. 
 
As seen in Figure 4.6 when both APL4 (a subunit of the AP-1 complex) and CHS6 are 
deleted, then bud scars are observed in just under 50% of cells. The same result is 
observed if a FAB1 deletion is added to the ∆chs6 strain. Therefore, when APL4 and 
FAB1 are deleted chitin is again able to traffic to the cell surface in some manner. 
This is possibly due to build up of Chs3p at the TGN or PGE, because Fab1p and AP-
1 appear to act in an ill-defined trafficking step between the PGE and the Golgi. This 
build up of Chs3p may allow this protein to find a new route to the cell surface via 
bulk secretion or via a novel route from the PGE. Once Chs3p is able to access the 
cell surface chitin is again present at the bridge between mother and daughter cells, 
overriding the ∆chs6 phenotype. However, the occurrence of bud scars is still less 
∆apl4::KAN 
∆chs6::LYS2 
∆fab1::KAN 
∆chs6::LYS2 
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than  seen in wild-type cells (Figure 4.5), suggesting that this pathway does not allow 
as much Chs3p to reach the cell surface as is normally the case. 
To further investigate this result, several other double mutants were made, combining 
∆chs6 with deletions of other known genes in the Fab1p pathway. The double mutants 
were stained with calcofluor to see if they could reverse the ∆chs6 phenotype and 
allow the visualisation of bud scars from previous divisions. 
Figure 4.7 shows the results of calcofluor staining in a variety of double mutants, all 
possessing deletion of CHS6. The ∆chs6 ∆vac7 strain does not have any visible bud 
scars, although a greater amount of calcofluor staining may be observed at the bridge 
between mother and daughter cell. An additional deletion of VAC14 seems to have a 
bigger effect on calcofluor staining and a small number of bud scars can be observed. 
These however are not as obvious or as prominent as in the ∆fab1∆chs6 or 
∆apl4∆chs6 strains, suggesting only a partial restoration in this process; consistent 
with the fact that inactivation of VAC14 leaves some PtdIns(3,5)P2 present in the cell 
(Bonangelino et al., 2002). The ∆hsv2 ∆chs6 strain seems to have staining similar to 
that of the ∆vac7 ∆chs6 strain with a greater intensity of calcofluor being observed at 
the bridge, however no bud scars are seen. The ∆atg21 ∆chs6 strain serves as a nice 
control; here calcofluor staining appears as it did in a single CHS6 knockout strain 
with no increased staining or bud scars.  This suggests that it is likely that neither 
Vac7p, Atg21p nor Hsv2p play a role in the cycling of Chs3p between the PGE and 
TGN.  
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Figure 4.7 Calcofluor staining of bud scars in ∆chs6 double mutants 
 
                                                  Calcofluor staining  
 
Strain Percentage of cells with bud scars. 
∆chs6 
16.1% ±1.4 
Wild type 
94.6% ±2.1 
∆atg21∆chs6 15.4% ±2.6 
∆hsv2∆chs6 19.1% ±3.5 
∆vac7∆chs6 18.3% ±3.2 
∆vac14∆chs6 29.7% ±4.2* 
∆svp3∆chs6 17.2% ±2.3 
 
∆hsv2::KAN 
∆chs6::LYS2 
∆atg21::KAN 
∆chs6::LYS2 
∆vac14::KAN 
∆chs6::LYS2 
∆vac7::KAN 
∆chs6::LYS2 
∆svp3::KAN 
∆chs6::LYS2 
Wild-type 
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[Significantly different from ∆chs6 values: 0.01<*P<0.05, N/S not indicated] 
Shown above are fluorescence images of logarithmic phase cultures (5 x 106 – 1 x 107 cells/ml) of 
various ∆chs6::LYS2 double mutants (left hand panel) and wild-type (bottom right panel) for 
comparison stained with calcofluor white for 10 minutes. The images show calcofluor staining 
visualised using a DAP1 filter. These images are representative of three replicate cultures. All strains 
were cultured in SC-Lys+2% glu medium and grown at 25ºC. Scale bar represents 5µM. 
 
4.5 Calcofluor resistance. 
It has previously been shown that when calcofluor is added to S. cerevisiae growth 
media either in liquid culture or plates, it is toxic and shows antifungal activity 
(Roncero et al., 1988). Calcofluor works by binding to microfibrils of cellulose and 
chitin and as a result of this interaction β-glucan chains cannot co-crystallise and form 
microfibrils. Chitin is one of the main structural polysaccharides in the fungal cell 
wall and abnormal deposition may cause lysis and weakening of the wall (Roncero et 
al., 1988). Because of this activity S. cerevisiae cells are sensitive to calcofluor and 
cannot grow in/on media which contains the compound. The ∆chs6 strain has a defect 
in chitin disposition; because of this, the levels of chitin present in the cell wall are 
much lower than are present in wild-type (Sanchatjate and Schekman, 2006). This can 
be measured because chs6 strains are resistant to calcofluor and can still grow on/in 
media with it present. This calcofluor resistant phenotype is also observed for other 
strains with deletion of proteins involved in the chitin synthase III pathway as cellular 
chitin levels are reduced, therefore decreasing the target for the fluorophore 
(Harrington and Raper, 1968). 
An assay was developed to assess whether any of the double mutant strains made, and 
stained above also showed sensitivity to calcofluor. A variety of concentrations of 
calcofluor in YETD pates were tested to verify the best concentration. It was found 
that 200 µg/ml of calcofluor was sufficient to allow growth of a ∆chs6 strain and stop 
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growth of a wild-type strain. This allowed the other mutants to be assayed. It should 
be noted that calcofluor was found to produce unreliable results in YEPD medium. 
This may be due to the composition of peptone. Peptone is produced by digestion of 
animal milk or meat by proteolytic enzymes, which produces small peptides but also 
many other compounds such as fat, metals, salts and vitamins, which may inhibit 
calcofluor action. YETD containing tryptone was found to be a much better medium 
to use. The peptides present in tryptone are longer and produced only from milk. 
Calcofluor also appears to be quite unstable in plates and has a short lifetime, 
resulting in experiments that are only reproducible when media containing calcofluor 
is freshly made. 
 
 
Figure 4.8 10X spot dilution of ∆chs6 mutants 
         YTD                              YTD + 200 µg/ml calcofluor white 
                       25
o
C 2 days                                                    25
o
C 2 days 
      
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu for wild-
type cells or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in 
methodology section. Cells were serially diluted ten-fold then grown on YTD+2% glu agar plates or on 
the same plate but with 200µg/ml calcofluor white at 25
 o
C for 2 days. Data represents three 
independent experiments. 
 
Wild type 
∆apl4 ∆chs6::LYS2 
∆chs6 
∆chs6::LYS2 
∆fab1 ∆chs6::LYS2 
∆apl4 ∆chs6::LYS2 
∆fab1::LEU2 
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A ten-fold serial spot dilution from a starting culture of 1x 10
7
cells/ml was prepared 
for each of the above strains. A BY4742 chs6::LYS2 strain was made as a control to 
verify that any reduction in calcofluor resistance wasn’t construct specific and was in 
fact a true phenotype associated with CHS6 deletion. The wild-type strain shows high 
calcofluor sensitivity when grown at 25
o
C for two days, and hardly any growth is 
observed compared to the control plate. The two strains possessing a deletion of the 
CHS6 gene showed resistance to calcofluor, although growth was slightly reduced 
from the control YEPD plate. Both the ∆fab1∆chs6 and ∆apl4∆chs6 strains showed 
reduced growth on the calcofluor plate, demonstrating that they are reversing the 
∆chs6 resistance and have raised levels of chitin in their cell walls. The additional 
deletion of either FAB1 or APL4 is therefore somehow allowing some transport of 
Chs3p back to the cell surface and allowing chitin to form during budding. Levels of 
sensitivity however are not brought back to that of wild-type, suggesting this route is 
not as efficient. To investigate if Apl4p and Fab1p are indeed on the same pathway, a 
triple mutant was made, with simultaneous inactivations of Fab1p, Apl4p and Chs6p. 
It is hard to tell whether ∆fab1 and ∆apl4 are having an additive effect and whether 
the triple mutant is reducing calcofluor resistance further using the standard protocol. 
To see if a lower dilution factor would yield clearer results, a 5-fold serial spot 
dilution plate was completed.  
It appears from these results that the calcofluor resistance is decreased in both the 
double and triple mutants to almost wild-type levels. Hardly any growth is seen on the 
calcofluor plate apart from that of the two ∆chs6 mutants. Some variability is seen 
between calcofluor plates made at different times, and once stored the properties of 
calcofluor appear reduced. The above result comes from a freshly made plate and it 
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appears that an additional deletion of FAB1 or APL4 in a ∆chs6 strain can induce 
calcofluor sensitivity.  
In order to confirm that neither the ∆fab1 or ∆apl4 strains have defects in this 
pathway spot dilutions of the single mutants were also carried out. 
 
Figure 4.9 5X spot dilution of ∆chs6 mutants 
         YTD                               YTD +  200 µg/ml Calcofluor white 
                       25
o
C 2 days                                                    25
o
C 2 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu for wild-
type cells or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in 
methodology section. Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or 
on the same plate but with 200µg/ml calcofluor white at 25
 o
C for 2 days. Data represents three 
independent experiments. 
 
 
 
 
 
 
∆apl4 ∆chs6::LYS2 
∆chs6 
∆chs6::LYS2 
Wild type 
∆fab1 ∆chs6::LYS2 
∆apl4 ∆chs6::LYS2 
∆fab1::LEU2 
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Figure 4.10 5X spot dilution mutants 
                                                       YTD                               YTD +  200 µg/ml Calcofluor white 
                       25
o
C 3 days                                                    25
o
C 3 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu with 
added G418 for mutants. Dilution assay was carried out as described in methodology section. Cells 
were serially diluted five-fold then grown on YTD+2% glu agar plates or on the same plate but with 
200µg/ml calcofluor white at 25
 o
C for 2 days. Data represents three independent experiments. 
 
As shown in Figure 4.10 ∆chs6 cells are calcofluor resistant as previously shown. 
Wild-type strains and mutants with a single ∆fab1 or ∆apl4 deletion appear to be 
calcofluor sensitive. This is because in these strains the exomer complex is 
functioning and chitin is being deposited as it should be, during the cell cycle. 
The calcofluor resistance of the other ∆chs6 double mutants examined for bud scars 
above, was also investigated in order to fully see any role, if any they had in the 
trafficking of Chs3p. 
 
 
 
 
Wild type 
∆chs6 
∆fab1 
∆apl4 
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Figure 4.11 10X spot dilution of ∆chs6 double mutants.  
                                                       YTD                               YTD +  200 µg/ml Calcofluor white 
                       25
o
C 2 days                                                    25
o
C 2 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu for wild-
type cells or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in 
methodology section. Cells were serially diluted ten-fold then grown on YTD+2% glu agar plates or on 
the same plate but with 200µg/ml calcofluor white at 25
 o
C for 2 days. Data represents three 
independent experiments. 
 
The 10-fold spot dilution plate as shown in Figure 4.11with wild-type used as a 
control shows the ∆chs6 strain is still resistant to calcofluor. The ∆vac7∆chs6, 
∆hsv2∆chs6 and ∆atg21∆chs6 strains do not appear to have reduced calcofluor 
resistance, which agrees with the bud scars observed microscopically. However a 
small increase in calcofluor sensitivity is seen in the ∆vac14∆chs6 and ∆svp3∆chs6 
strains. The growth of these strains on the calcofluor plate is however increases when 
compared to the wild-type control.  Only a reduction in calcofluor resistance is seen 
and sensitivity has not been brought back to the levels seen in ∆fab1∆chs6 or 
∆apl4∆chs6 double mutants. A 5 fold spot dilution plate was carried out to get clearer 
results. 
 
Wild type 
∆chs6 
∆vac7 ∆chs6::LYS2 
∆vac14∆chs6::LYS2 
∆atg21 ∆chs6::LYS2 
∆hsv2∆chs6::LYS2 
∆svp3 ∆chs6::LYS2 
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Figure 4.12 5X spot dilution of ∆chs6 double mutants.  
                                                       YTD                               YTD +  200 µg/ml Calcofluor white 
                       25
o
C 2 days                                                    25
o
C 2 days 
 
Various strains were grown  to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu for 
wild-type cells or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in 
methodology section. Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or 
on the same plate but with 200µg/ml calcofluor white at 25
 o
C for 2 days. Data represents three 
independent experiments. 
 
The wild-type control is calcofluor sensitive and no growth is observed on the test 
plate. In agreement with the previous results of the 10-fold spot dilution plate, no 
decrease in calcofluor resistance is observed for the ∆vac7∆chs6, ∆hsv2∆chs6 and 
∆atg21∆chs6 strains. Interestingly growth of the ∆vac14∆chs6 and ∆svp3∆chs6 
strains does seem to be calcofluor sensitive, growth is not reduced to the level seen in 
the wild-type or in the apl4 or fab1 mutant strains but the deletions appear to be 
having a clear effect and may partially contribute to the Fab1p/AP-1 trafficking 
pathway. 
The role of Doa4p a ubiquitin ligase was also examined by making a double mutant, 
as this might be what connects this phenotype of ∆fab1 cells to other Fab1p associated 
phenotypes such as defects in MVB sorting. 
Wild type 
∆chs6 
∆vac7∆chs6::LYS2 
∆vac14 ∆chs6::LYS2 
∆atg21∆chs6::LYS2 
∆hsv2 ∆chs6::LYS2 
∆svp3∆chs6::LYS2 
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Figure 4.13 5X spot dilution of ∆doa4∆chs6 mutant 
         YTD                               YTD +  200 µg/ml Calcofluor white 
                       25
o
C 2 days                                                    25
o
C 2 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu for wild-
type cells or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in 
methodology section. Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or 
on the same plate but with 200µg/ml calcofluor white at 25
 o
C for 2 days. Data represents three 
independent experiments. 
 
As shown above the additional deletion of DOA4 does not appear to reverse the 
calcofluor resistance of a ∆chs6 mutant. This result makes a role for ubiquitin in the 
trafficking of Chs3p unlikely. 
To investigate the role of Vac14p in the Chs3p pathway further, the ∆vac14∆chs6 was 
rescued by adding back VAC14 expressed in a plasmid. Two constructs were available 
pAEM42 and pAEM44, both were used.  
As shown in Figure 4.14 the ∆vac14 ∆chs6 double mutant appears to show reduced 
calcofluor sensitivity even when grown for a number of days at 25
 o
C. As a control the 
wild-type strain shows no growth. The pAEM42 plasmid does not appear to rescue 
the ∆vac14 ∆chs6 double mutant and exhibits the same amount of growth as the 
double mutant, on the calcofluor plate. The pAEM44 plasmid appears to increase 
growth on the test plate slightly. These results are consistent with Vac14p being part 
∆apl4 ∆chs6::LYS2 
∆chs6 
Wild type 
∆fab1 ∆chs6::LYS2 
∆doa4 ∆chs6::LYS2  
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of the same pathway that influences Chs3p trafficking as Fab1p. It also provides 
evidence that the plasmids may not fully rescue a VAC14 deletion as previously 
observed in Chapter 3.  
 
Figure 4.14 5X spot dilution of ∆vac14 ∆chs6 double mutant rescue. 
 
YTD                               YTD +  200 µg/ml Calcofluor white  
                       25
o
C 4 days                                                    25
o
C 4 days 
  
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu for wild-
type cells or SC-Lys+2% glu  for ∆vac14∆chs6 and additionally –Ura for strains with additional 
plasmid’s. ∆vac14∆chs6 was transformed with the pAEM42 or pAEM44 plasmid. Dilution assay was 
carried out as described in methodology section. Cells were serially diluted five-fold then grown on 
YTD+2% glu agar plates or on the same plate but with 200µg/ml calcofluor white at 25
 o
C for 4 days. 
Data represents three independent experiments. 
 
In order to further investigate the role of Svp3p in this pathway, new constructs were 
made. It was discovered that heat shock can cause a ∆svp3 mutant to revert, because 
of its temperature sensitivity. The original strain as observed in Figures 4.10 and 4.11 
had been made using heat shock, so the mutant was re-made adding the SVP3 deletion 
in last. The strain was also rescued with various SVP3 plasmid constructs.   
 
Wild type 
∆chs6 
∆vac14 ∆chs6::LYS2 
∆vac14∆chs6 + 
pAEM42 
∆vac14∆chs6 + 
pAEM44 
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Figure 4.15 5X spot dilution of ∆svp3 ∆chs6 double mutant rescue. 
 
                                                         YTD                              YTD +  200 µg/ml Calcofluor white    
                       25
o
C 4 days                                                    25
o
C 4 days 
  
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu for wild-
type cells or SC-Lys+2% glu  for ∆svp3∆chs6 and additionally –Ura for strains with additional 
plasmid’s. ∆svp3∆chs6 was transformed with various Svp3 plasmids. Dilution assay was carried out as 
described in methodology section. Cells were serially diluted five-fold then grown on YTD+2% glu 
agar plates or on the same plate but with 200µg/ml calcofluor white at 25
 o
C for 4 days. Data 
represents three independent experiments. 
 
As shown in Figure 4.15  it appears that Svp3p does not in fact play a major role in 
Chs3p trafficking. It appears the previous results were probably due to a revertant 
strain. Although the of ∆svp3 ∆chs6 double mutant does show slightly reduced 
growth on the calcofluor plate this is no where near as reduced as seen in the fab1, 
apl4 or vac14 ∆chs6 double mutants, and in fact on the control plate reduced growth 
is also seen. Consistent with this, the pUG36 SVP3 plasmid can rescue the double 
mutant. The other mutant plasmids containing various portions of SVP3 (detailed in 
chapter 6) do not appear to rescue.  
 
 
Wild type 
∆chs6 
∆svp3 ∆chs6::LYS2 
+ pUG36 Svp3 
+ pUG36 Svp3
CT1
 
+ pUG36 Svp3
NT1
 
+ pUG36 Svp3
K486R
 
+ pUG36 Svp3
PACA/PAIA
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4.6 Calcofluor sensitivity of ∆chs6∆fab1 is PtdIns(3,5)P2 dependent  
To test whether the rescue of calcofluor sensitivity in a ∆chs6∆fab1strain is dependent 
upon the Fab1p protein, part of the protein, or whether it is in fact lipid dependent a 
series of Fab1p expression plasmids were transformed into the ∆chs6∆fab1 strain to 
see if they could rescue the calcofluor sensitivity phenotype. All the constructs were 
expressed under a galactose inducible promoter in the pEGKT vector.  
 
Figure 4.16 diagram of fab1p domains. 
 
2278
S.Cerevisiae 
Fab1p
FYVE domain
Chaperonin-
like domain 
(CCT)
Cysteine-rich 
domain
PIKc domain
(Catalytic) 
 
Fab1p contains various domains that were mutated. Fab1p mutated in its FYVE domain in conserved 
Cys residues, loses its ability to bind PtdIns3P. Mutation in the PIPKinase domain yields a 
catalytically inactive protein, unable to make PtdIns(3,5)P2. The CCT-like domain was mutated in a 
conserved central Gly residue. The PIPKIII-unique mutant contains mutations in conserved Cys 
residues in the region of the protein. 
 
As a control the plasmid pEGKT–Fab1 was used as this contains the whole ORF. A 
kinase dead version of FAB1 was used to see if the process was lipid dependent as this 
plasmid lacks the ability to make PtdIns(3,5)P2. Other controls with deletions of the 
following domains were also used: FYVE deleted so it can no longer bind PtdIns3P; 
CCT-like domain ablated; and PIPkIII unique Cysteine rich domain ablated.  
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Figure 4.17 5X spot dilution of ∆fab1 ∆chs6double mutant  rescue. 
 
                                             YTD                               YTD +  200 µg/ml Calcofluor white 
                       25
o
C 4 days                                                    25
o
C 4 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in SC-Lys+2% glu  for 
∆fab1∆chs6 and additionally –Ura for strains with additional plasmids. ∆fab1 ∆chs6 was transformed 
with various Fab1p  plasmids. Dilution assay was carried out as described in methodology section. 
Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or on the same plate but 
with 200µg/ calcofluor white at 25
 o
C for 4 days. Data represents three independent experiments. 
 
From the results shown in Figure 4.17 it appears that the process Fab1p is involved in 
is dependent upon PtdIns(3,5)P2. The FAB1 construct lacking the kinase domain is 
unable to rescue the calcofluor sensitivity defect of ∆fab1 ∆chs6. Full length FAB1 is 
able to rescue the double mutant strain as expected. Deletion of the PIPkIII domain 
makes a difference which again we would expect if the process relies on the lipid 
rather than the protein. Deletion of the CCT like and FYVE domains do not seem to 
make a difference, therefore it is likely these are not crucial for the process. 
To see if the process could be complemented by other homologs of FAB1, plasmids 
containing an S. pombe FAB1 and the mammalian homolog PIKfyve were also used. 
Bud scars were also examined for the same rescues carried out in this section and the 
results agreed with what is observed in the spot dilutions (Data not shown) 
∆chs6 
∆fab1∆chs6 
+ pEGKT Fab1
Kinase -ve
 
+ pEGKT Fab1 
+ pEGKT Fab1
FYVE
 
+ pEGKT                  
Fab1
CCT Like-vee
 
+ pEGKT Fab1
PIPKIIIe
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Figure 4.18 5X spot dilution of ∆fab1 ∆chs6 double mutant  rescue. 
 
                                                 YTD                               YTD +  200 µg/ml Calcofluor white 
                       25
o
C 4 days                                                    25
o
C 4 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in SC-Lys+2% glu  for 
∆fab1∆chs6 and additionally –Ura for strains with additional plasmids. ∆fab1 ∆chs6 was transformed 
with various Fab1p  plasmids. Dilution assay was carried out as described in methodology section. 
Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or on the same plate but 
with 200µg/ml calcofluor white at 25
 o
C for 4 days. Data represents three independent experiments. 
 
The results shown in Figure 4.18 indicate that both the S. pombe and PIKfyve 
versions of FAB1 are not able to rescue the calcofluor sensitivity observed in the 
∆fab1 ∆chs6 strain. The constructs, although expressed do not rescue the strains like 
wild-type S. cerevisiae FAB1, suggesting that the constructs are not properly regulated 
due to an inability to interact with S. cerevisiae proteins. 
 
4.7 Fab1p and Apl4p are in the same pathway and perform the same role?  
A question arose as to whether Fab1p and Apl4p were in fact carrying out the same 
role, in the same pathway or whether they were in the same pathway but were 
responsible for different jobs. To test this, FAB1 plasmids as used above were 
transformed into a ∆apl4∆chs6 strain. If the proteins were in the same pathway, but 
∆chs6 
∆fab1∆chs6 
+ pEGKT Fab1 
+ pEGKT Fab1
S.pombe
 
+ pEGKT Fab1
PIKfyvee
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with different roles, over expression of FAB1 should rescue the calcofluor sensitive 
phenotype and bring back calcofluor resistance. 
 
Figure 4.19 5X spot dilution of ∆apl4 ∆chs6 double mutant  rescue. 
 
                                 YTD                               YTD +  200 µg/ml Calcofluor white  
                       25
o
C 4 days                                                    25
o
C 4 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in SC-Lys+2% glu for 
∆apl4∆chs6 and additionally –Ura for strains with additional plasmids. ∆apl4 ∆chs6 was transformed 
with various Fab1p plasmids. Dilution assay was carried out as described in methodology section. 
Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or on the same plate but 
with 200µg/ml calcofluor white at 25
 o
C for 4 days. Data represents three independent experiments. 
 
From Figure 4.19 it appears that the pEGKT-Fab1 plasmid can rescue the ∆apl4∆chs6 
double mutant. One explanation for this is that Fab1p and Apl4p are in the same 
pathway. Over-expression of FAB1 is able to rescue a ∆apl4 strain, which may mean 
that the role of Apl4p can be compensated for, by Fab1p when it is over expressed. 
Another explanation is that Fab1p is downstream of Apl4p, an insight supported by 
earlier work (Phelan et al., 2006). 
4.8 An alternative route for Chs3p to the cell surface. 
The results above and the literature suggest that when APL4 or FAB1 are deleted in a 
∆chs6 background some Chs3p is still able to reach the cell surface. Schekman and 
collegues have suggested that when exomer is inactivated, such as in a chs6 strain, 
∆chs6 
∆apl4∆chs6 
+ pEGKT Fab1 
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Chs3p just cycles continually from the TGN to the recycling endosome and this 
cycling is sufficient to prevent Chs3p from gaining access to the cell surface. It is only 
when an additional pathway, from the recycling endosome to the TGN is disrupted, 
that build up of Chs3p may occur in one of these compartments. This build up 
apparently allows some of the Chs3p to escape and leak back to the cell surface non-
specifically (Valdivia et al., 2002).  This hypothesis further suggests that Fab1p and 
AP-1 control just such an internal cycling pathway, between the PGE and the TGN 
but do not tell us in which direction this pathway acts. On one hand, it seems more 
likely that Fab1p controls the TGN to PGE step, because there is no known route from 
the PGE to the cell surface. Inactivation of the TGN to PGE step would lead to build-
up of Chs3p in the TGN; a compartment which is constantly sending material to the 
cell surface, whereas inactivation of the PGE to TGN step would lead to build-up of 
Chs3p in the PGE; a compartment from which there appears to be no route to the 
plasma membrane. Having said this, the above argument is based the limited 
information we possess at present, as the PGE has been the subject of very few 
studies. 
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Figure 4.20 Diagram of disruption of exomer. 
 
 
When exomer is not working such as in ∆chs6 cells, Chs3p can no longer reach the cell surface and is 
instead cycled between the recycling endosome and TGN via a pathway that is controlled by Fab1p and 
the AP-1 complex. 
 
What we wanted to know is does Chs3p then reach the cell surface by default or non-
specific secretion from the TGN or does it reach the cell surface via another route? In 
order to discover if Fab1p was taking a known route a series of triple mutants were 
made to see if calcofluor resistance could be brought back in either a ∆fab1∆chs6 or 
∆apl4∆chs6 strain.  
If VPS4 is deleted then Chs3p cannot take an alternative route to the TGN from the 
early/late endosome as shown in Figure 4.21. From the TGN Chs3p may be 
transported to the cell surface via mass secretion. Therefore a VPS4 mutation was 
combined with the double mutants to see if Chs3p is transported from the early/late 
endosome to the TGN. 
Vacuole 
Trans Golgi  
network 
Secretion 
MVB 
Snc1p + 
Pep12 + 
Fur4p Fab1p/Apl4p? 
Chs3p 
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Figure 4.21 Diagram of disruption of exomer and retrograde pathway. 
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When exomer and the retrograde pathway from the recycling endosome and TGN controlled by Fab1p 
and the AP-1 complex is not working, such as in ∆fab1∆chs6 cells, Chs3p builds up at the recycling 
endosome and finds an alternative route to the plasma membrane. 
 
An additional deletion of PEP12 was also made in the double mutants, as when this 
gene is disrupted proteins are unable to be transported into the early endosome. This 
would indicate whether Chs3p finds a new route to the cell surface via the early/late 
endosome. To see if Chs3p reaches the cell surface by default or non specific 
secretion an additional triple mutant would need to be made. Unfortunately the only 
alleles of classical secretion mutants that are viable are the temperature sensitive 
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versions. Because fab1 mutants also exhibit temperature sensitive growth, such alleles 
cannot be used to answer this question.  
 
Figure 4.22 5X ∆ fab1 triple mutant spot dilution. 
         YTD                               YTD +  200 µg/ml calcofluor white  
                       25
o
C 2 days                                                    25
o
C 2 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu for wild-
type cells or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in 
methodology section. Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or 
on the same plate but with 200µg/ml calcofluor white at 25
 o
C for 2 days. Data represents three 
independent experiments. 
 
As shown in Figures 4.22 and 4.23, additional deletion of either VPS4 or PEP12 does 
not bring back calcofluor resistance in either double mutant. This raises the possibility 
that Chs3p is not using either of these pathways to reach the cell surface. It is likely a 
novel route from the recycling endosome is used by Chs3p to leak back to the cell 
surface. Alternatively it may be that the triple mutants are so sick, they are 
increasingly drug sensitive. A further experiment to discover this would be to measure 
the amount of chitin in the cell walls of the triple mutants. 
 
∆fab1 ∆chs6::LYS2 
∆chs6 
Wild type 
∆pep12 ∆fab1 ::LEU2 
∆chs6::LYS2 
∆vps4  ∆fab1 ::LEU2 
∆chs6::LYS2 
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Figure 4.23 5X ∆apl4 triple mutant spot dilution. 
         YTD                               YTD +  200 µg/ml calcofluor white 
                       25
o
C 2 days                                                    25
o
C 2 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu for wild-
type cells or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in 
methodology section. Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or 
on the same plate but with  200µg/ml calcofluor white at 25
 o
C for 2 days. Data represents three 
independent experiments. 
 
4.9 Mutagenesis 
Having established a role for Fab1p in the trafficking of Chs3p, a screen was devised 
to identify potential effectors of Fab1p, or more of the machinery that Fab1p acts with 
in this system.  The logic for this is simple; if inactivation of Fab1p and AP-1 causes 
chs6 cells to become calcofluor sensitive again, then inactivation of other 
components of the same pathway should also result in restoration of calcofluor 
sensitivity. A classical mutagenesis approach was adopted in order to create mutations 
in a BY4742 ∆chs6 strain.  EMS was used to create random point mutations. For the 
mutagenesis reaction to work best, around 60% cell survival was required. The 
incubation period with EMS required to achieve this was found, by experiment, to be 
~40 minutes. In order to select mutants that contained a mutation which brought back 
calcofluor sensitivity, mutants were plated both onto standard YEPD and replica 
plating using velvet onto the following media; YETD + 500µg calcofluor + 20µg/ml 
∆apl4 ∆chs6::LYS2 
∆chs6 
Wild type 
∆pep12  ∆apl4 ::LEU2 
∆chs6::LYS2 
∆vps4 ∆apl41 ::LEU2 
∆chs6::LYS2 
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Phloxine B. The concentration of calcofluor had previously been arrived at by using a 
range of calcofluor concentrations to discover one that allowed ∆chs6 cells to grow, 
but not the double mutants. Essentially, the screen was looking for mutants that grew 
normally on the YEPD plate but died on the calcofluor plate. Phloxine B was added to 
the calcofluor plates because it is a vital stain which allows colonies that are mainly 
composed of dead cells to be identified. Dead colonies accumulate the dye and appear 
dark pink, whereas, live colonies appear white/light pink. As a secondary screen, all 
mutants identified as calcofluor sensitive were spot diluted onto calcofluor plates as 
above, to confirm their sensitivity, as this seems to be the most reliable test for 
mutants with defects in the Chs3p pathway. 
 
4.9.2 Spot dilutions   
Mutants were isolated and spot dilutions were carried out, using the same method as 
in section 4.5 and detailed in Chapter 2. For each of the mutants identified above, spot 
dilutions were carried out, to see whether in fact they were calcofluor sensitive. From 
spot diluting 72 mutants initially identified, it appeared that 26 did in fact show 
calcofluor sensitivity on re-test. These mutants were then used as the basis for further 
screens to characterise the mutations and see if they possessed any other Fab1p-like 
co-phenotypes.  
The process of identifying these mutants was very lengthy, as the majority of initial 
plates examined contained no colonies which appeared to lose calcofluor resistance. A 
novel method using flow cytometry was therefore developed to make the initial 
screening process more efficient. 
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 4.10 FACS sorting of strains 
Flow cytometry can be used as a powerful method to sort groups of cells exhibiting a 
particular phenotype. It has previously been used to sort yeast cells into different 
groups on the basis of age, by calculating the number of bud scars present. It has also 
been used to isolate yeast mutants defective in localisation of vacuolar dyes (Zheng et 
al 1998).  During FACS, a stream of cells is passed through a beam of light. Detectors 
are present and calculate the forward, side scatter and fluorescence. This data is then 
used to form a graph with a point for each ‘event’ or cell. Thousands of events can be 
captured in seconds. The aim of this work was to develop a FACS based assay that 
allowed sorting of the EMS mutagenised ∆chs6 cells to identify mutants that had 
brought back bud scars and sensitivity to calcofluor white, or to enrich for calcofluor 
sensitive mutants. It also served as another way to characterise potential mutants that 
may be part of the Fab1p pathway because the FACs profile of any strain, after 
staining with calcofluor, is very distinctive. The FACS work was carried out in 
conjunction with Dr Tim Overton, Chemical Engineering, University of Birmingham 
UK. 
 
In order to see if FACS could be used for this work, wild-type strain and ∆chs6 strains 
needed to be examined to see if any difference could be observed in bud scar staining. 
The double mutants ∆fab1∆chs6 and ∆apl4∆chs6 could then be examined to see if 
their FACS profile became more like wild-type. Two different stains were used for 
this work; calcofluor white as previously used for microscopy and WGA-FITC that 
had previously been used for previous FACS work on yeast bud scars, because of its 
much narrower excitation and emission spectra. 
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4.10.1 Characterisation of the strains 
Yeast cells were stained with calcofluor as previously described for microscopy and 
WGA-FITC as described in Chapter 2. Yeast strains were grown to late exponential 
phase, stained both ways and 10,000 events captured each time for single budded cells 
of each of the following strains; ∆fab1, ∆chs6, ∆fab1∆chs6, ∆apl4∆chs6. A ∆fab1 
strain was used as a control because a FAB1 mutation makes the vacuoles of yeast 
cells larger and this could affect the scatter results. The sort graphs indicated that 
calcofluor appears to be better for distinguishing between the strains. 
Table 4.1. Mean fluorescence data for the four different strains. 
     
Strain 
Hoechst blue mean for 
calcofluor stained cells 
(Population P2 single 
cells)  
 
FITC-A mean for WGA-FITC  
stained cells (Population P2 single 
cells) 
∆fab1 (bud 
scars) 
 
414 ±62*** 
 
4589 ±172 
∆chs6 (no 
bud scars) 
 
165 ±28 
 
2305 ±157 
∆fab1∆chs6  
378 ±44*** 
 
3854 ±168 
∆apl4∆chs6  
318 ±47*** 
 
2179 ±162 
[Significantly different from  ∆chs6 values: ***P<0.001, NS not shown] 
 
The ∆fab1 single mutant strain seemed to have the greatest calcofluor fluorescence 
which is as expected because it contains wild-type levels of bud scars and does not 
contain a defect in Chs3p transport. The lowest calcofluor fluorescence is seen in the 
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∆chs6 strain, which again agrees with previous results, as although there are no bud 
scars, fluorescence of the cell wall is still seen. The double mutants appear to lie in the 
middle of the two controls, which suggests they are bringing back some bud scars but 
do not completely return the levels to normal amounts. This is consistent with what is 
observed microscopically and the proposal that Chs3p ‘leaks’ back to the cell surface 
in the double mutants. Looking at just single cells (population P2), the levels seen in 
the double mutants seem to be close to the ∆fab1 control suggesting that the double 
mutants do bring back bud scars, and that they can be identified through flow 
cytometry. It is better to look at just single cell population as having budding cells 
will naturally increase the variable fluorescence because there is almost double the 
amount of cell wall present.   
To find out why the WGA-FITC staining didn’t appear to work as well as calcofluor 
WGA stained cells were examined microscopically. 
 
As shown in Figure 4.24 WGA-FITC stains bud scars in wild-type, and double mutant 
strains, although these are not as easy to see as staining with calcofluor. In ∆chs6 
cells, diffuse staining is observed and in some cases small punctate like structures. 
The population, as with calcofluor staining, is not homogenous and some bud scars 
are still seen.  
Figure 4.25 shown below shows ∆chs6 cells double stained with both calcofluor white 
and WGA-FITC. 
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Figure 4.24 WGA-FITC  staining of bud scars in wild-type and double deletion 
mutants. 
                                                  Calcofluor staining  
 
Bud scars can be visualised by staining cells with WGA-FITC. Shown above are fluorescence images of 
logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type (top left), ∆chs6( top right), ∆fab1 
(bottom left) and ∆apl4 (bottom right) stained with WGA-FITC. The images show staining visualised 
using a GFP filter. These images are representative of three replicate cultures. All strains were 
cultured in SC-YETD+2% glu medium and grown at 25ºC. Scale bar represents 5µM. 
 
Figure 4.25 WGA-FITC and calcofluor white stained∆chs6 cells 
     DIC   WGA-FITC  Calcofluor 
 
 
Staining of ∆chs6 cells with both WGA-FITC and calcofluor. Shown above are fluorescence images of 
logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) Images are representative of three replicate 
cultures. All strains were cultured in SC-YETD+2% glu medium and grown at 25ºC. Scale bar 
represents 5µM 
 
∆chs6 
∆apl4∆chs6 
Wild type 
∆fab1∆chs6 
∆chs6 
 176 
Some cells in the population stained with WGA-FITC seem to contain small 
structures which may distort the FACS results. The WGA stain co-localises with 
calcofluor white on the bud scars of the few cells which contain them. On other cells 
where WGA is observed in smaller punctate structures, localisation with calcofluor is 
not seen, suggesting this is a difference between the stains (Data not shown). 
Incubating cells with WGA-FITC for an extra 15 minutes and washing three times 
seems to improve the staining of cells and reduce the amount of background observed, 
but it appears that calcofluor is a better stain for FACS analysis. It may be that 
differences are observed because of the specificities of each dye; calcofluor can also 
bind to other polysaccharides.  
4.10.2 Sort 1 of low and high fluorescence population of the ∆fab1∆chs6 strain. 
The ∆fab1∆chs6 strain produced an interesting fluorescence graph for the calcofluor 
staining, where there seem to be two separate peaks; this was also apparently the case 
for the other double mutant, although not quite as distinctly. 
To investigate the result as seen in Figure 4.26 a sort was taken of the low 
fluorescence population and the high fluorescence population to be examined 
microscopically (Figure 4.27).  
As shown in Figure 4.27, it appears that the low fluorescence population does not 
contain cells with bud scars. All of the cells examined from the high fluorescence 
population clearly had one or more bud scars present; this is intriguing as previous 
microscope experiments had indicated that the bud scars were present in only a subset 
of cells in any population and this result confirms it. 
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Figure 4.26. Fluorescence profiles of  ∆fab1∆chs6 and ∆apl4∆chs6 . 
  
Samples were stained with calcofluor, graph represents 10000 events. 
 
 
 
Figure 4.27. Microscopy of  sorted ∆fab1∆chs6  cells. 
 
            Low fluorescence sort                  High fluorescence sort 
 
 
Calcofluor staining of ∆fab1 ∆chs6 cells sorted for both high and low fluorescence. with both WGA-
FITC and calcofluor. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 
x 10
7
 cells/ml) Images are representative of three replicate cultures. All strains were cultured in SC-
YETD+2% glu medium and grown at 25ºC. Scale bar represents 5µM 
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To see if either of the populations showed differences in sensitivity to calcofluor, a 
growth test was also performed. Cell suspensions used for microscopy were diluted to 
get around 200 colonies per plate. After growth on a YETD plate for two days at 25
o
C 
the plates were replica plated using velvet onto new plates containing 500µg/ml 
calcofluor white and 20µg/ml Phloxine B. Plates were again grown for 2 days at 25
o
C 
(See Figure 4.19). Contamination seemed to be present; probably due to the buffer 
used for FACS.  
For the high fluorescence sort, around 30% could grow on the calcoflour media which 
means, 70% showed the calcofluor sensitivity expected of a ∆fab1∆chs6 strain. In the 
low fluorescence sort around 60% of the colonies could grow on calcoflour media 
meaning 40% of colonies showed calcoflour sensitivity. So there is a significant 
difference between the two sorts, but the data suggests that the calcofluor is killing 
even resistant cells when they are plated as single cells. If more time was available 
experiments could have been performed tooptimise the calcofluor concentration, 
especially for this assay. 
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Figure 4.28. Replica plating of both low and high fluorescence sorts of ∆fab1∆chs6 
cells 
 
Low fluorescence 
∆fab1∆chs6 cell sort
High fluorescence 
∆fab1∆chs6 cell sort
YETD
YETD+ calcofluor 
+phloxine b
YETD dead colonies 
indicated
 
Medium Low fluorescence sort High fluorescence sort 
 Percentage of colonies that are alive 
16.1% ±1.4 YETD               100% ±0               100% ±0 
YETD+Calcofluor+Phloxine b 59.7% ±5.3*** 27.2% ±4.6*** 
[Significant difference between high and low fluorescence sort at ***P<0.001,] 
Replica plating of both low (left hand columns) and high fluorescence sort (right hand column) of 
∆fab1∆chs6 cells. The first panels show original colonies on YETD plates. The middle panel shows 
growth on calcofluor plates. The bottom panels are of the original YETD plates that have been 
adjusted in Photoshop to remove contamination red dots to indicate colonies that are calcofluor 
sensitive. 
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Sort 2 Sorting double mutants from a mixture. 
Sort 2 was designed to see if FACS could be used to sort potential double mutants 
which bring back bud scars from the EMS mutagenised cell culture. To see if this 
would work ∆chs6:KAN  and ∆apl4 ∆chs6::LYS2 calcofluor stained strains were 
mixed to give a 1% population of double mutants. The sample was run on the FACS 
machine and a gate was drawn around the resulting graph, to select cells with high 
fluorescence; this was, as expected, approximately 0.1% of the population. The graphs 
for the double mutant and ∆chs6 samples were used to help define the gate for cells to 
be sorted.Approximately 51% of the sorted cells survived the process of being plated 
onto YETD and were alive after being grown at 25
 o
C for three days. The plate was 
then replica plated onto YETD+ 500µg/ml calcofluor white + 20µg/ml Phloxine B, to 
see how many of the colonies were actually double mutants and resistant to 
calcofluor. Replica plating was also carried out onto SC-Lys media to select the ∆apl4 
∆chs6::LYS2 double mutants.  
From Figure 4.29 it can be seen that approximately 22.3% of colonies  failed to grow 
on SC-LYS and are therefore ∆chs6::KAN colonies. This means that around 77% of 
sortedcolonies are in fact ∆apl4::KAN ∆chs6::LYS cells. If the mixture had been 
plated without any form of sorting, out of 100 cells only 1 colony would be expected 
to grow. It appears that the sorting worked very well to enrich the number of double 
mutants present. This represents a good method in order to sort mutagenised ∆chs6 
cells that have bud scars. This meant the screen could be performed more efficiently.  
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Figure 4.29. Replica plating sorts from mixture. of ∆apl4::KAN∆chs6::LYS and 
∆chs6::KAN cell sorted to get just ∆apl4::KAN∆chs6::LYS 
cells
YETD
YETD+ calcofluor 
+phloxine b
SC-LYS
YETD dead colonies 
indicated
 
 
 
 
Replica plating sort from mixture of ∆apl4::KAN∆chs6::LYS and ∆chs6 cell sorted to get just 
∆apl4::KAN∆chs6::LYS cells Red dots indicate colonies that do not contain the LYS marker and 
therefore cannot grow on SC-LYS so are ∆chs6 colonies. 
 
4.11 Characterisation of the EMS mutants. 
From the initial plate based screen (numbered with the prefix 1) twenty six mutant 
colonies were identified that revert the ∆chs6 strain calcofluor resistance back to 
sensitivity.  A further thirty five colonies were identified by FACS (numbered with 
the prefix 2). 
Medium Percentage of alive colonies 
YETD                    100% ±0 
YETD+Calcofluor+Phloxine b 80.2% ±9.7 
SC-LYS                    77.7% ±6.1 
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To characterise the mutants, and see if it was likely any of them were involved in the 
Fab1p pathway, a number of secondary screens were initiated. The DIC light phase 
image was examined to determine the morphology of the cells, with particular 
attention paid to mutants with abnormal vacuoles, as aberrations in this compartment 
are characteristic of mutants in components of the Fab1p pathway. Calcofluor staining 
was also conducted to see if bud scars had been restored, localisation of Chs3-GFP 
(clones in group one) was also examined. For results of these experiments please see 
appendix 1 and 2. 
The mutants were also spot diluted onto YETD plates containing 0.9M NaCl and 
incubated at 25’C to see if the clones were salt resistant. A characteristic of FAB1 
mutant cells is temperature sensitivity, so the mutants were also tested to see if they 
exhibited this ‘co-phenotype’. To test temperature sensitivity a YETD spot dilution 
was also incubated at 37’C.  
As a further test for Fab1p phenotypes, the mutants were also screened for defects in 
MVB sorting. This was performed by visualising two constructs, Phm5-GFP and 
ubiquitinated Phm5-GFP. Cells in which Fab1p or AP-1 have been inactivated, 
display a defect in MVB sorting, and do not correctly target Phm5p to the vacuole 
lumen. In these cells Phm5-GFP is visualised as a ring on the vacuole membrane. 
However UbPhm5-GFP can be correctly targeted to the vacuole lumen in ∆fab1 cells, 
as the construct expresses Phm5-GFP as an in frame, N-terminal fusion with a single 
ubiquitin. We reasoned that because Phm5p and Chs3p mislocalisation both occur in 
fab1 and apl4 cells, they might also in novel mutants as well. 
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4.12 Rescue of large vacuole bearing EMS mutants by Fab1p overexpression. 
From the microscope data gathered in section 4.11 it could be seen that some of the 
clones had a large vacuoled phenotype similar to that of a ∆fab1 strain; some also 
possessed a temperature sensitive growth defect. To test whether these clones 
contained a mutation in the FAB1 gene, a plasmid that expressed FAB1: pEGKT –
FAB1 was placed into each of the strains. This plasmid is under the control of a 
galactose inducible promoter. Spot dilutions were carried out onto media containing 
200µg calcofluor and galactose as a carbon source. This tested whether the 
introduction of the FAB1 plasmid had reversed the phenotype of the EMS mutants and 
brought back calcofluor resistance.  
From the results it could be seen that none of the group 1 mutants tested (1-2, 1-4, 1-
5, 1-13, 1-16, 1-20, 1-21, 1-22, 1-23 and 1-24) could be rescued and made calcofluor 
resistant again by the addition of the full length FAB1 gene.  
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Figure 4.30 5X spot dilution of pEGKT Fab1 rescues 
         YTD                              YTD + 200 µg/ml Calcofluor white  
                       25
o
C 2 days                                                    25
o
C 2 days 
      
 Various strains were grown to exponential phase till about ~1 x 107 cells/ml in YPD + G418.Each 
mutant had been transformed with pEGKT Fab1. Dilution assay was carried out as described in 
methodology section. Cells were serially diluted ten-fold then grown on YTD+2% glu agar plates or on 
the same plate but with  200µg/ml calcofluor white at 25
 o
C for 2 days. Data represents three 
independent experiments. 
 
As shown in Figure 4.30 it appears that mutants 2-25 and 2-27 can be rescued by 
addition of FAB1. However, the ‘rescue’ of 2-25 is more dubious as the growth of 2-
25 on calcofluor plates is already more than expected. The change in growth observed 
for 2-27 however is large and it appears it is truly being rescued. Mutants 2-13, 2-14, 
2-15, 2-31 and 2-34 were also tested but showed no difference in growth. The screen 
was performed to try and isolate additional components of the pathway influenced by 
Fab1p and PtdIns(3,5)P2. FAB1 over expression is an important experiment, as those 
mutants who FAB1 can rescue are likely to be in the same pathway.  
4.13 Complementation analysis. 
To discover whether the mutants identified represent mutations in different genes or 
just different mutations in the same gene, yeast complementation analysis was used. 
2-17 
2-17+Fab1p 
2-27+Fab1p 
2-27 
2-25 
2-25+Fab1p 
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When two haploid S. cerevisiae strains are mated together they will form a diploid. If 
the two haploid strains contain a deletion in the same gene that is bringing back 
calcofluor sensitivity, the mutations will not be able to complement in the diploid, and 
the diploid will still be calcofluor sensitive. If the two strains contain mutations in 
different genes, complementation can occur because the cell will contain one 
unmutated copy of each gene, so the diploid will be calcofluor resistant. One caveat is 
that the above assumes that gene-dosage has no effect in the system under study; 
however, Chs3p trafficking does not appear subject to gene dosage for those 
components that are known. A diagram of this system is shown in Figure 4.31. 
To be able to mate each of the clones with each other, the mating type of the cells 
needed to be changed. In laboratory strains of S. cerevisiae, two mating types are 
present; a and α, and each strain is ‘locked’ into one of these types because of 
inactivation of the HO locus. The gene product of HO is usually responsible for 
random mating type switching in wild yeast. In order to mate, one haploid strain 
needs to be a and the other α (Sherman, 2002). 
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Figure 4.31 Cartoon of complementation 
 
Haploid cells contain one copy of each gene. If the point mutation is present in the same gene in two 
haploid strains, when they are mated the diploid will not be able to complement and will be calcofluor 
sensitive. If the mutation is present in two different genes in the haploid cells when mated the diploid 
will also contain a wild-type copy of each gene. The mutation will be complemented and the strain will 
become calcofluor resistant.  
 
The EMS mutagenesis was carried out in the BY4742 ∆chs6 background and 
therefore all mutants isolated were α type. To change the mutants to the a mating type, 
the mutant strains were backcrossed with a BY4741 ∆chs6 strain; this also had the 
secondary effect of cleaning up the genetic background since chemical mutagenesis 
often introduces more than one mutation into each cell, and sporulation is an excellent 
way to remove unlinked mutations that are on different chromosomes (or even on the 
same chromosomes because of chiasmata). In order to select a haploid strain which 
contained the desired mutation, and was ∆chs6 and a type, sporulation and tetrad 
dissection were carried out. When a diploid is starved under certain conditions it will 
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sporulate and form a tetrad of four haploids, which can be separated and analysed by 
replica plating, to discover the haploid cell with the desired auxotrophic markers and 
the phenotype of interest. In order to uncover the colony which had the mutation of 
interest, tetrad plates were replica plated onto G418 to select ∆chs6, onto calcofluor 
plates to select the mutation as the colony will still be calcofluor sensitive and then 
onto SC-Lys and SC-Met to select for markers which are required to select for 
diploids. In order to test for mating type, test matings were conducted with known 
mating types, to see if diploids would form; diploids will only form if opposite mating 
types were present.  
Once the mating type of the mutants had been changed, each mutant was crossed with 
the other mutants to form a diploid. The diploid was then tested for complementation, 
by plating onto a calcofluor plate.  
It appears that all of the mutations tested are able to complement each other and 
therefore the screen is likely to represent 61 distinct complementation groups. This 
high number of distinct complementation groups suggests that the screen was not 
saturated and that multiple processes and pathways can lead to loss of calcofluor 
resistance in yeast. Many of the ways to become calcofluor sensitive may have 
nothing to do with Chs3p trafficking and might include inactivation of drug 
transporters or defects in the cell wall; these processes are known to result in non-
specific drug sensitivity from previous screens.  
As a test for dominant negative mutations, all the haploid mutants were mated with 
BY4741 ∆chs6 cells. If any strain possessed a dominant negative mutation this cross 
would remain calcofluor sensitive. None of the strains showed this phenotype so no 
dominant negative mutants were isolated. 
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In order to discover which gene had been mutated in each of the clones identified, a 
plasmid library was used to rescue the mutation. A pYEp13 based library was used 
which contains fragments of the whole yeast genome inserted into a LEU2 based 
plasmid. The library was made by partially digesting yeast genomic DNA with 
BamHI and covers the genome approximately 5 times. 
When the library is transformed into the mutant strains, the plasmid containing the 
gene that is mutated in the strains will be able to complement the mutation. The 
plasmid can be isolated by plating transformants onto Sc-Leu plates to select for yeast 
which have taken up the plasmid, and then onto plates containing 600µg/ml calcofluor 
white and 20µg/ml Phloxine B.  The colonies containing plasmids which have 
complemented should now be able to grow on the calcofluor plates. This method 
proved to be problematic as some of the strains are not as calcofluor resistant as 
others, so when replica plated onto calcofluor plates many of the colonies still grew. 
This is because a colony of cells can grow on calcofluor plates more easily than if you 
spot dilute because larger numbers of cells often ‘shield’ some members of the colony 
from the full effects of any drug or treatment, resulting in many ‘false positives’. If 
more time was available a way to overcome this would have been to keep replica 
plating onto media that does not select for the plasmid but does for calcofluor 
resistance (e.g. plates with calcofluor). Eventually the colonies which are not resistant 
due to complementation from the plasmid will lose this episome as there is no 
selective pressure to keep the gene encoded by the plasmid in the genome. Thus when 
these mutants are replica plated back onto Sc-Leu plates eventually only a small 
number of colonies should remain whose plasmids can be extracted and transformed 
back into the original strain to see if they do in fact rescue. 
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When a plasmid was isolated that did indeed restore calcofluor resistance it was 
sequenced to get the start and end of the insert. The sequencing results were then 
BLAST searched on the Sacchromyces Genome Database and the insert contained 
thereby delineated. This usually resulted in identification of a piece of genomic DNA 
encoding 3 or 4 genes because the average insert size in this library is around 15 kb. 
Potential candidates were then further examined, by creation of double deletions of 
each potential gene with ∆chs6. 
Due to the lengthy process of identifying genes it was only possible to confirm the 
nature of mutations in four of my strains.  
 
4.14 Mutant 2-14 is APL2 
Through the process described above, mutant 2-14, sorted in the FACS screen was 
identified. 
As shown in Figure 4.32, the plasmid that appeared to rescue mutant 2-14, does 
indeed allow the strain to grow on calcofluor containing plates. The plasmid however 
does not rescue another mutant, so the rescue observed is the result of specific 
complementation. To make sure the insert is what is conferring resistance, another 
library plasmid was transformed into mutant 2-14; as shown this does not restore 
calcofluor resistance.  
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Figure 4.32 5X spot dilution of 2-14 rescues. 
                                                       YTD                               YTD +  200 µg/ml Calcofluor white  
                       25
o
C 3 days                                                    25
o
C 3 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu +G418 
or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in methodology 
section. 2-14 was transformed with the plasmid from the library that rescued the strain. This plasmid 
was also transformed into mutant 2-10. Another library plasmid was transformed into 2-14 to sever as 
a control. Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or on the same 
plate but with 200µg/ml calcofluor white at 25
 o
C for 3 days. Data represents three independent 
experiments. 
The plasmid was sequenced and APL2 was contained in the insert. Apl2p is a beta 
adaptin and a large subunit, of the AP-1 complex, like Apl4p. Like the other members 
of the AP-1 complex APL2 has previously been shown to have a role in this pathway. 
A ∆apl2∆chs6 double mutant was made to see if it does in fact have calcofluor 
sensitivity. 
As shown in Figure 4.33 the ∆apl2∆chs6 double mutant, like 2-14 is unable to grow 
on media supplemented with calcofluor. APL2 possess the same phenotype as FAB1, 
in that when deleted in addition to ∆chs6 it is able to bring back calcofluor sensitivity. 
To confirm that 2-14 did contain a mutation in APL2, 2-14 was mated with 
∆apl2∆chs6, and the resulting diploid was calcofluor sensitive, showing that the 
mutation could not be complemented. This suggests 2-14 possesses a mutation in the 
∆chs6 
2-14 + library 
rescue plasmid 
2-14 
2-14 + library 
plasmid 
2-10 + 2-14 
library rescue 
plasmid 
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APL2 gene. Therefore APL2 should be able to rescue 2-14, in order to verify this 
pRS315-APL2 plasmid was transformed into 2-14.  
Figure 4.33 5X spot dilution of 2-14.  
                                                       YTD                               YTD +  200 µg/ml calcofluor white 
                       25
o
C 3 days                                                    25
o
C 3 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu +G418 
or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in methodology 
section. Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or on the same 
plate but with 200µg/ml calcofluor white at 25
 o
C for 3 days. Data represents three independent 
experiments. 
 
Figure 4.34 5X spot dilution of 2-14 Apl2p rescue.  
                                                       YTD                               YTD +  200 µg/ml Calcofluor white  
                       25
o
C 3 days                                                    25
o
C 3 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu +G418 
or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in methodology 
section. 2-14 was transformed with pRS315Apl2, or the empty vector. Cells were serially diluted five-
fold then grown on YTD+2% glu agar plates or on the same plate but with 200µg/ml calcofluor white 
at 25
 o
C for 3 days. Data represents three independent experiments. 
 
∆chs6 
2-14 
∆apl2 ∆chs6::LYS2 
∆chs6 
2-14 + pRS315 Apl2 
2-14 
2-14 + pRS315 empty  
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As shown in Figure 4.34 APL2 expressed in pRS315 can rescue the calcofluor 
sensitivity of 2-14, this is further proof that 2-14 contains a mutated APL2. Any good 
screen should isolate both known and unknown components of the pathway 
examined. Identification of APL2 as one of the mutants helps to validate the screen, 
because a known component has been isolated. This indicates the screen should be 
well placed to identify novel members of the trafficking pathway.  
 
4.15 Mutant 2-2 is GUP1. 
A library plasmid as shown in Figure 4.35 was identified that only rescued mutant 2-
2. 
Figure 4.35 5X spot dilution of 2-2 rescues. 
                                                       YTD                               YTD +  200 µg/ml Calcofluor white 
                       25
o
C 3 days                                                    25
o
C 3 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu +G418 
or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in methodology 
section. 2-2 was transformed with the plasmid from the library that rescued the strain. This plasmid 
was also transformed into mutant 2-10. Another library plasmid was transformed into 2-2 to serve as a 
control. Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or on the same 
plate but with 200µg/ml calcofluor white at 25
 o
C for 3 days. Data represents three independent 
experiments. 
 
∆chs6 
2-2 + library 
rescue plasmid 
2-2 
2-2 + library 
plasmid 
2-10 + 2-2 library 
rescue plasmid 
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The plasmid isolated from the yeast library, is only able to rescue the 2-2 strain. 
Another library plasmid is unable to rescue the mutant. This indicates that the insert is 
specifically complementing the mutation in strain 2-2.  
When sequenced, the insert contained a region of DNA including genes LCL3, GUP1, 
SCY 1 and YGL082W. Known functions of the genes were looked at and double 
mutants with deletions of each gene combined with ∆chs6 were made. These double 
mutants were spot diluted and mated back with 2-2. The results indicated that the gene 
mutated in 2-2 is GUP1, as shown in Figure 4.35. When 2-2 was mated with the other 
double mutants complementation occurred and the diploids were calcofluor resistant. 
When mated with the ∆gup1 ∆chs6 double mutant the diploid remained calcofluor 
sensitive. 
Figure 4.36 5X spot dilution of 2-2.  
                                                       YTD                               YTD +  200 µg/ml Calcofluor white  
                       25
o
C 3 days                                                    25
o
C 3 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu +G418 
or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in methodology 
section. Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or on the same 
plate but with 200µg/ml calcofluor white  at 25
 o
C for 3 days. Data represents three independent 
experiments. 
 
Both the mutant 2-2 and ∆gup1 ∆chs6 appear to have reduced calcofluor resistance. 
The calcofluor resistance of the ∆gup1 ∆chs6 double mutant is less than 2-2 which 
∆chs6 
2-2 
∆gup1∆chs6::LYS2 
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suggests that complete knockout of the gene causes more disruption in the process 
than the point mutation present in 2-2. 
From sequencing the GUP1 gene from 2-2 genomic DNA, it appears that the mutation 
in this gene is E238K. This mutation obviously partially inactivates Gup1p. 
Figure 4.37 Sequence line up of Wild-type and mutated Gup1p 
Query  1    MSLISILSPLITSEGLDSRIKPSPKKDASTTTKPSLWKTTEFKFYYIAFLVVVPLMFYAG  60 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||                     
Gup1p  1     MSLISILSPLITSEGLDSRIKPSPKKDASTTTKPSLWKTTEFKFYYIAFLVVVPLMFYAG  60 
Query  61   LQASSPENPNYARYERLLSQGWLFGRKVDNSDSQYRFFRDNFALLSVLMLVHTSIKRIVL  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Gup1p  61   LQASSPENPNYARYERLLSQGWLFGRKVDNSDSQYRFFRDNFALLSVLMLVHTSIKRIVL  120 
 
Query  121  YSTNITKLRFDLIFGLIFLVAAHGVNSIRILAHMLILYAIAHVLKNFRRIATISIWIYGI  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Gup1p  121  YSTNITKLRFDLIFGLIFLVAAHGVNSIRILAHMLILYAIAHVLKNFRRIATISIWIYGI  180 
 
Query  181  STLFINDNFRAYPFGNICSFLSPLDHWYRGIIPRWDVFFNFTLLRVLSYNLDFLERWKNL  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||+|| 
Gup1p  181  STLFINDNFRAYPFGNICSFLSPLDHWYRGIIPRWDVFFNFTLLRVLSYNLDFLERWENL  240 
 
Query  241  QKKKSPSYESKEAKSAILLNERARLTAAHPIQDYSLMNYIAYVTYTPLFIAGPIITFNDY  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Gup1p  241  QKKKSPSYESKEAKSAILLNERARLTAAHPIQDYSLMNYIAYVTYTPLFIAGPIITFNDY  300 
 
Query  301  VYQSKHTLPSINFKFIFYYAVRFVIALLSMEFILHFLHVVAISKTKAWENDTPFQISMIG  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Gup1p  301  VYQSKHTLPSINFKFIFYYAVRFVIALLSMEFILHFLHVVAISKTKAWENDTPFQISMIG  360 
 
Query  361  LFNLNIIWLKLLIPWRLFRLWALLDGIDTPENMIRCVDNNYSSLAFWRAWHRSYNKWVVR  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Gup1p  361  LFNLNIIWLKLLIPWRLFRLWALLDGIDTPENMIRCVDNNYSSLAFWRAWHRSYNKWVVR  420 
 
Query  421  YIYIPLGGSKNRVLTSLAVFSFVAIWHDIELKLLLWGWLIVLFLLPEIFATQIFSHYTDA  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Gup1p  421  YIYIPLGGSKNRVLTSLAVFSFVAIWHDIELKLLLWGWLIVLFLLPEIFATQIFSHYTDA  480 
 
Query  481  VWYRHVCAVGAVFNIWVMMIANLFGFCLGSDGTKKLLSDMFCTVSGFKFVILASVSLFIA  540 
            ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||                    
Gup1p  481  VWYRHVCAVGAVFNIWVMMIANLFGFCLGSDGTKKLLSDMFCTVSGFKFVILASVSLFIA  540 
 
Query  541  VQIMFEIREEEKRHGIYLKC  560 
            |||||||||||||||||||| 
Gup1p  541  VQIMFEIREEEKRHGIYLKC  560 
 
Gup1p is predicted to have 10 trans-membrane domains and it blasts to the MBOAT 
family of membrane-bound O-acyltransferases. 
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Figure 4.38 Calcofluor staining of 2-2 and ∆gup1∆chs6. 
Calcofluor staining 
 
Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of  2-2 
(left hand panel) and ∆gup1::KAN ∆chs6::LYS2 (right hand panel) stained with calcofluor white for 10 
minutes. The images show calcofluor staining visualised using a DAP1 filter. These images are 
representative of three replicate cultures. All strains were cultured in SC-Lys+2% glu medium and 
grown at 25ºC. Scale bar represents 5µM. 
 
As shown in Figure 4.38 bud scars are hard to visualise in both the 2-2 mutant and the 
∆gup1 ∆chs6 double mutant. This suggests that these mutants are not allowing Chs3p 
to reach the cell surface. This makes it unlikely that Gup1p is on a specific pathway 
that controls trafficking of Chs3p and increases the likelihood that the calcofluor 
sensitivity result is as a consequence of a more general drug hyper-sensitivity of 
∆gup1. 
To see if Gup1p may be involved with the Fab1p pathway or share any phenotypes 
several assays were performed in order to see if MVB sorting was working normally. 
The localisation of Phm5p and Ste3p were examined for defects. 
 
 
2-2 ∆gup1::KAN 
∆chs6::LYS2 
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Figure 4.39 Phm5p trafficking in 2-2 and ∆gup1∆chs6 
                                  DIC             Phm5-GFP                 DIC            UbPhm5-GFP 
 
 
Both Phm5 GFP and UbPhm5 GFP can be visualised in the vacuole.. Shown above are fluorescence 
images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of cells transformed Phm5-GFP 
constructs. The left-hand columns show low light DIC images. The right-hand columns show the GFP 
localisation of the constructs. The panel to the left showsPhm5-GFP localisations. The panel to the 
right shows Ub Phm5 GFP localisation. Images are representative of three replicate cultures. All 
strains were cultured in SC-Ura+25mg/L Met +2% glu medium and grown at 25ºC. Scale bar 
represents 5µM. 
 
In both 2-2 and the ∆gup1 ∆chs6 double mutant targeting of Phm5p appears to be 
correct, and the GFP construct is visualised in the vacuole. This suggests that no 
disruption of MVB sorting is occurring in this mutant. As a confirmation of this 
result, trafficking of UbPhm5-GFP is still seen in the vacuole. In a ∆fab1 or ∆apl4 
2-2 
∆gup1 ∆chs6 
Wild type 
∆fab1 
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strain only the UbPhm5-GFP construct is sorted to the vacuole, Phm5-GFP is mis- 
sorted to the vacuole membrane (Shaw et al., 2003). To confirm this result with a 
different cargo, the localisation of Ste3-GFP was also examined since cargo specific 
trafficking defects are widespread in all eukaryotic systems. 
 
Figure 4.40 Ste3p trafficking in 2-2 and ∆gup1∆chs6 
DIC     Ste3-GFP   DIC     Ste3-GFP 
 
Ste3 GFP can be visualised in the vacuole.. Shown above are fluorescence images of logarithmic phase 
cultures (5 x 10
6
 – 1 x 107 cells/ml) of  cells transformed with Ste3-GFP. The left-hand column shows 
low light DIC images. The right-hand columns shows Ste3-GFP localisation. Images are representative 
of three replicate cultures. All strains were cultured in SC-Ura+25mg/L Met +2% glu medium and 
grown at 25ºC. Scale bar represents 5µM. 
 
It appears in Figure 4.40 that neither the isolated mutant nor the full knockout, possess 
a defect in the localisation of Ste3-GFP as it is correctly targeted to the vacuole. In 
some mutants of the Fab1p pathway, Ste3p is mistrafficked to the vacuole membrane 
or cytoplasm. 
2-2 
∆gup1  
∆chs6 
Wild  
type 
  
∆fab1 
 198 
To see if ∆gup1 may have a defect in PtdIns(3,5)P2 metabolism the localisation of 
GFP-Atg18p, an effector of PtdIns(3,5)P2 ,was also examined. Atg18p is usually 
found on the vacuole membrane when PtdIns(3,5)P2 synthesis is normal.   
Figure 4.41 Localisation of pUG36 GFP-Atg18p. 
                             Control                                     0.4M NaCl after 10 minutes 
            DIC                      GFP-Atg18p                    DIC                         GFP-Atg18p 
 
 
pUG36-GFP-ATG18P can be visualised on the vacuole membrane, and this localisation is increased 
when cells are subjected to a hyperosmotic stress. Shown above are fluorescence images of logarithmic 
phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wildtype (top panel), Δfab1(middle panel), 2-2(middle 
panel), ∆gup1(bottom panel) transformed with pUG36-GFP-Atg18p. The left-hand panel shows 
localisation under control conditions. The right hand panel shows localisation under 0.4M NaCl 
conditions. The left hand columns show low light DIC images. The right-hand columns show GFP 
localisation. These images are representative of three replicate cultures. All strains were cultured in 
SC-Ura-Met+2% glu medium and grown at 25ºC. Scale bar represents 5µM. 
2-2 
∆gup1  
Wild type 
Δfab1 
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It appears that a gross defect in PtdIns(3,5)P2 synthesis is not present in either of the 
strains; though more minor perturbations cannot be ruled out using this assay. Under 
normal conditions GFP-Atg18p can be clearly visualised on the vacuole membrane, 
and when the cell is given hyperosmotic stress the amount of GFP-Atg18p on the 
vacuole membrane increases as it does in wild-type cells. 
It appears likely that Gup1p is not part of the PtdIns(3,5)P2 or Fab1p pathway and 
may be playing an independent role in this process. It is likely that calcoflour 
sensitivity is due to a defect in the cell wall structure and not as a consequence of 
Chs3p trafficking. 
Other mutants 
Another mutant identified was 1-11, a disruption in the GAS1 gene. This gene is 
already known to have a role in cell wall biosynthesis, as 1,3-beta-
glucanosyltransferase which helps make 1,3 β glucan a major polysaccharide of the 
cell wall (Mouyna et al., 2000). GAS1 mutants, in common with most mutants that 
affect cell wall biosynthesis, display a non-specific drug hypersensitivity phenotype 
and hence calcofluor sensitivity is likely to be a facet of this cell integrity defect rather 
than being a specific disregulation of the Fab1p/ AP-1 complex pathway.  
4.16 Mutant 2-27 is VPS13 
As shown in previously 2-27 is an intriguing mutant because the calcofluor sensitivity 
of the strain can be overcome by expression of Fab1p in a plasmid as shown in Figure 
4.30. This suggests the mutant may be of a gene that is part of the Fab1p or 
PtdIns(3,5)P2 pathway. Expression of Apl2p or Apl4p on a plasmid cannot rescue 2-
27. This strain also proved difficult to work with as it possesses a serious sporulation 
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defect; when sporulated, very few spores were produced and all proved inviable when 
dissected. This meant the mating type of the strain could not be changed easily. It has 
previously been noticed that ∆fab1 strains also possess defects in sporulation although 
not to the extent of 2-27, as some viable spores can be produced.  
It was difficult to isolate a plasmid that would rescue the calcofluor defects of the 2-
27 mutant, as the strain appeared to be very sensitive to the drug, so a lower dosage of 
calcofluor (400µg/ml) was used. It was still difficult to get a plasmid to rescue and 
this raised the possibility that the mutation was present in a large gene, since larger 
genes are usually under-represented in genomic libraries. Eventually a plasmid was 
isolated that rescued the strain.  
 
Figure 4.42 5X spot dilution of 2-27 rescues. 
                                                       YTD                               YTD +  200 µg/ml calcofluor white 
                       25
o
C 3 days                                                    25
o
C 3 days 
 
Various strains were grown to  ~1 x 10
7
 cells/ml in YPD + 2% glu +G418 or SC-LYS+2% glu for 
double mutants. Dilution assay was carried out as described in methodology section. 2-27 was 
transformed with the plasmid from the library that rescued the strain. Another library plasmid was 
transformed into 2-27 to serve as a control. Cells were serially diluted five-fold then grown on 
YTD+2% glu agar plates or on the same plate but with 200µg/ml calcofluor white at 25
 o
C for 3 days. 
Data represents three independent experiments. 
∆chs6 
2-27 + library 
rescue plasmid 
2-27 
2-27 + library 
plasmid 
2-27+pRS313 
Vps13 
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As shown above in Figure 4.42, the plasmid isolated can rescue the 2-27 calcofluor 
sensitive phenotype. The plasmid was sequenced and found to contain a stretch of 
DNA encoding the SDH2 and VPS13 genes. From known functions of the genes, the 
mutant seemed likely to be a mutation in VPS13 so a double mutant was made. At the 
same time a VPS13 plasmid was obtained and used to transform into 2-27. As shown 
above, reintroduction of VPS13 can rescue the 2-27 calcofluor sensitivity.  
 
Figure 4.43 5X spot dilution of 2-27.  
                                                       YTD                               YTD + 200 µg/ml Calcofluor white  
                       25
o
C 3 days                                                    25
o
C 3 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu +G418 
or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in methodology 
section. Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or on the same 
plate but with 200µg/ml calcofluor white at 25
 o
C for 3 days. Data represents three independent 
experiments. 
 
Like 2-27, the ∆vps13∆chs6 double mutant is no longer calcofluor resistant and as 
shown below in Figure 4.43, bud scars are clearly visible. The deletion of VPS13 was 
thus able to reverse the calcofluor resistance of ∆chs6 cells in a specific fashion. This 
provides further evidence supporting the assertion that 2-27 does in fact contain a 
mutated version of VPS13. To obtain direct evidence, the VPS13 gene from the 2-27 
strain was isolated from genomic DNA and sequenced. The VPS13 gene is around 
∆chs6 
2-27 
∆vps13::KAN 
∆chs6::LYS2 
Wild type 
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9.5Kb and a single mutation in the sequence was found at E003K. This is a change 
from glutamate acid to Lysine right at the start of the gene which could be quite 
disruptive, particularly if this area contains a localisation signal or if it affects protein 
stability via the N-rule system. This is the same type of mutation observed in GUP1; 
consistent with the fact that a base change from G to an A is the most common type of 
mutation resulting from EMS treatment. As shown below in Figure 4.44 this residue 
in VPS13 is conserved, particularly amongst fungi.  
 
Figure 4.44 Sequence alignment of Vps13 (From (Velayos-Baeza et al., 2004)).  
 
 
Alignment of Vps13p from the following homologs: S. cerevisiae, S. pombe Vps13a and Vps13b, 
Human Vps13A, Vps13B, Vps13C and Vps13D, D. melangastor CG2093, CG15523, CG32113, C. 
elegans T08G11.1, “C25H3.11+8”, A. thaliana Atg48090, “At4g17140-20” and  At5g24740,  
 
Vps13p has known homologs in higher eukaryotes, with several proteins showing 
similarity in C. elegans, D. melangastor and Humans. There are four human 
homologues of VPS13, and disruption of any of these genes causes Cohen syndrome, 
a disorder characterised by psychomotor retardation and retinal dystrophy 
(Kolehmainen et al., 2003). The human Vps13p proteins are associated with the 
Golgi. Most conservation of Vps13p is at the C and N terminal ends, suggesting these 
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are the most necessary for function; and this is where the mutation found is located. 
The sequence of Vps13p has previously been analysed and contains 25% charged 
residues (Glu, Asp, Arg and Lys) with a predicted pI of 5.23. It is also rich in residues 
found in α-helical coiled coils (Brickner and Fuller, 1997). It has been proposed that 
its sequence is suggestive of an extensive structural motif, although no heptad repeats 
longer than two to three turns are predicted (Brickner and Fuller, 1997). The protein 
has three potential transmembrane domains, although this is also doubtful because of 
hydrophilic and charged residues. No other motifs, domains or structural features have 
been predicted (Brickner and Fuller, 1997). 
To see if ∆vps13 strains shared any other phenotypes with ∆fab1 strains, the mutant 
was put through a battery of tests for co-phenotypes. 
Figure 4.45 Calcofluor staining of 2-27 and ∆vps13∆chs6. 
Calcofluor staining 
 
Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of  2-27 
(left hand panel) and ∆vps13::KAN ∆chs6::LYS2 (right hand panel) stained with calcofluor white for 
10 minutes. The images show calcofluor staining visualised using a DAP1 filter. These images are 
representative of three replicate cultures. All strains were cultured in SC-Lys+2% glu medium and 
grown at 25ºC. Scale bar represents 5µM. 
 
 
2-27 ∆vps13::KAN 
∆chs6::LYS2 
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Figure 4.46 5X temperature sensitive spot dilution of 2-27.  
YTD 37
o
C 3 days 
 
Various strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu +G418 
or SC-LYS+2% glu for double mutants. Dilution assay was carried out as described in methodology 
section. Cells were serially diluted five-fold then grown on YTD+2% glu agar plate at 37
 o
C for 3 days. 
Data represents three independent experiments 
 
Figure 4.47 MVB sorting in ∆vps13 
          DIC                GFP 
         Δvps13                                           Wild Type 
 
Wild type 
∆chs6 
2-27 
∆vps13::KAN  
Phm5-GFP 
Ub Phm5-GFP 
Ste3-GFP 
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Phm5 GFP, UbPhm5 GFP and Ste3 GFP can be visualised in the vacuole. Shown above are 
fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of  cells transformed with 
GFP constructs. The left-hand columns show low light DIC images. The right-hand columns show the 
GFP localisation of the constructs. Images are representative of three replicate cultures. All strains 
were cultured in SC-Ura+25mg/L Met +2% glu medium and grown at 25ºC. Scale bar represents 
5µM. 
 
As shown in Figure 4.46 both 2-27 and ∆vps13 are temperature sensitive at 37oC like 
fab1. It appears that ∆vps13 does not possess the same defects in MVB sorting Ste3p 
as ∆fab1; Ste3p is correctly localised in the strain (Figure 4.47). However there 
appears to be mis-localisation of Phm5p, partially to the cell surface in ∆vps13 and 
although this is not the same mislocalisation as in ∆fab1, the defect is corrected by 
ubiquitination of Phm5p. Ubiquitination dependent mislocalisation of Phm5p is so far 
only known to occur because of inactivation of the Fab1p pathway and this is strongly 
suggestive of link between Vps13p upstream of Fab1p and possibly AP-1. 
In order to find out whether ∆vps13 was likely to have a defect in PtdIns(3,5)P2 
metabolism, the localisation of pUG36 GFP-Atg18p, was also examined. Atg18p is 
usually found on the vacuole membrane when PtdIns(3,5)P2 synthesis is normal. As 
shown in Figure 4.45 GFP-Atg18p can be visualised on the vacuole membrane under 
control conditions in vps13 cells but note that far more GFP-Atg18p is present in the 
cytoplasm as compared with wild-type; suggesting a defect in PtdIns(3,5)P2 
metabolism. This may be the consequence of reduced levels of PtdIns(3,5)P2. When 
cells are treated with a hyper osmotic stress, the levels of PtdIns(3,5)P2 should 
increase, if no defects in its metabolism are present. More GFP-Atg18p seems to be 
on the vacuole after 0.9M NaCl stress, which may mean levels of PtdIns(3,5)P2 can 
increase in this mutant. This assay will not rule out small interruptions to levels of 
PtdIns(3,5)P2 so further inositol lipid labelling experiments would need to be 
 206 
performed in order to see if Vps13p is a potential effector but an upstream role seems 
more likely.    
Figure 4.48 GFP-Atg18p localisation in  ∆vps13 
      Control                                     0.4M NaCl after 10 minutes 
        DIC                GFP-Atg18p              DIC                    GFP-Atg18p 
 
 
pUG36-ATG18GFP can be visualised on the vacuole membrane, and this localisation is increased 
when cells are subjected to a hyperosmotic stress. Shown above are fluorescence images of logarithmic 
phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of, ∆vps13 transformed with pUG36-ATG18. The left-hand 
panel shows localisation under control conditions. The right hand panel shows localisation under 0.4M 
NaCl conditions. The left hand columns show low light DIC images. The right-hand columns show 
GFP localisation. These images are representative of three replicate cultures. Strain was cultured in 
SC-Ura-Met+2% glu medium and grown at 25ºC. Scale bar represents 5µM. 
 
The data presented above seem to suggest that Vps13p may indeed be part of the 
Fab1p and PtdIns(3,5)P2 pathway. Several phenotypes of ∆fab1 cells are shared with 
∆vps13 cells. These include temperature sensitivity at 37 oC, a potential defect in 
MVB sorting of Phm5p, a defect in sporulation and a partial mis-localisation of GFP-
Atg18p.  All these phenotypes together, point to a role for Vps13p in the Fab1p 
Δvps13 
Δfab1 
Wild type 
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pathway. Further experiments including a retrograde trafficking assay and interaction 
studies could be performed in order to investigate the exact role of Vps13p. 
 
4.17 Discussion 
This chapter presents new evidence supporting a role for Fab1p and PtdIns(3,5)P2 in 
regulation of the early endocytic system. This data suggests that both Fab1p and the 
AP-1 complex regulate trafficking from the recycling endosome to the TGN or vice -
versa. This confirms and extends previous work (Phelan et al., 2006). A likely model 
is as follows; Chs3p is normally transported to the cell surface by a novel protein coat, 
known as exomer, which is comprised of several proteins including Chs6p. In a ∆chs6 
mutant Chs3p is no longer specifically transported to the cell surface because Chs6p is 
needed to recruit Chs3p to the exomer complex; Chs3p instead endlessly cycles 
between the TGN and recycling endosome (PGE). When the AP-1 complex is 
simultaneously inactivated (via disruption of Fab1p or AP-1 function), then this 
internal sequestration of Chs3p is now disrupted and as Schekman observed, Chs3p is 
likely to build up at the recycling endosome (Valdivia et al., 2002). This concentration 
of Chs3p at the recycling endosome eventually allows some Chs3p to escape to the 
cell surface via mass action or non-specific membrane flow. This allows some chitin 
to be formed and is why, in a double mutant, we see reversion of the ∆chs6 
phenotypes. The route Chs3p takes back to the cell surface in this situation was also 
investigated. Triple mutants were made with a deletion of PEP12 which controls entry 
into the pre vacuolar endosome (early/late endosome) and VPS4 which would disrupt 
the pathway from the pre vacuolar endosome to the TGN. If Chs3p took either of 
these routes a triple vps4 chs6 fab1 mutant should become calcofluor resistant 
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again as the pathway to the cell surface would again be blocked. The results presented 
above indicate this is not the case and these triple mutant strains remain calcofluor 
sensitive. A triple mutant with the deletion of a classical secretion protein such as a 
SEC would be a good experiment to perform to rule out the possibility that Chs3p is 
finding a new route the cell surface through classical secretion from the Golgi via the 
exocyst. It would also allow confirmation of which pathway direction Fab1p is 
involved in, between the recycling endosome and TGN and whether in fact it is the 
retrograde pathway as evidence points to or the anteograde pathway. Unfortunately 
SEC mutants with a total block of secretion are inviable in yeast. Temperature 
sensitive constructs that become inactive at 37
o
C do exist, but these are unable to be 
used in this instance as a ∆fab1 mutant is unable to grow at 37oC. One secretion 
mutant with SEC22 disrupted could be used to perform this experiment as the deletion 
strain is viable, however attempts to perform this experiment were inconclusive.  
The data discussed above point to the existence of a novel pathway that Chs3p is 
taking, in the ∆fab1∆chs6 and ∆apl4∆chs6 double mutants, to the cell surface. There 
is currently no known pathway in yeast from the recycling endosome to the cell 
surface. To further understand the novel route Chs3p is taking in ∆fab1∆chs6 cells a 
screen could be performed to isolate another protein in this pathway.  ∆fab1∆chs6 
cells could be mutagenised and the resultant colonies screened for strains that have 
brought back resistance to calcofluor. This would be relatively easy as plating the 
mutagenised cells onto plates containing calcofluor will only allow these mutants to 
grow. The tricky part of this experiment would be back crossing and complementation 
as it is a triple mutant involved, and all the mutations would have to isolated together 
in each spore; the chances of this are low and so the process of dissection would be 
tedious. It would also be time consuming to identify the mutation, as rescuing the 
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mutant with a yeast genomic library would make the cell calcofluor sensitive again. 
Loss of function is hard to look for as it involves identification of a tiny colony that is 
growing on one plate but not another. However, pictures of replica plates growing 
mutants with and without calcofluor could be taken, false coloured and overlaid using 
photoshop and the colonies growing only on the minus calcofluor plate identified or 
FACS used to isolate mutants, transformed with the library which has low 
fluorescence. FACS would certainly help to cut down the number of colonies that 
needed to be screened.   
The role of Fab1p in the likely retrograde pathway from the recycling endosome to 
the TGN is dependent upon PtdIns(3,5)P2. A Fab1p construct lacking the ability to 
make lipid cannot rescue the associated calcofluor sensitivity defect. This work has 
not identified the effector that mediates this process, but an extension of my screen 
should isolate such a gene in the end. 
The work detailed in this chapter also shows that FACS is a better method for 
performing trafficking screens than plate-based assays. FACS allows thousands of 
cells to be screened and analysed in a matter of seconds. Not only their fluorescence is 
measured, but data about cellular shape and size is also collated, removing many false 
positives. Using FACS in this screen has been much better because it allowed 
concentration of mutants which brought back bud scars and calcofluor sensitivity 
directly. These mutants could easily be sorted by drawing gates around the 
appropriate populations on the graph. This enriched the number of mutants found in 
the resulting culture and cut down the amount of mutant plates that needed to be 
replica plated and colonies spot diluted. It also proved to be a better method because 
of the types of mutants that were isolated. Many of the group one mutants found by 
the traditional method clearly had defects in the cell wall, and this might have been 
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what was making the ∆chs6 strain sensitive again, not disruption of the specific 
internal pathway of Chs3p localisation. Many more of the FACS sorted mutants 
appeared to be ∆fab1 like with a large vacuole or large round cell. FACS allowed 
selection of mutants with a particular shape and size so it specifically sorted more 
correct cells rather than long misshaped cells with likely cell wall defects.  
A successful trafficking screen will identify both known and novel components of the 
target pathway. Isolation of an APL2 mutant helps to validate the screen conducted. 
APL2 encodes a protein known to be involved in the specific localisation of Chs3p. It 
shows that it is possible to isolate components of the Fab1p dependent TGN to PGE 
pathway by the method used. This means it should also be possible to isolate further 
novel components by the same process. 
Identifying the disrupted genes proved to be a difficult task. A library with better 
coverage and overlapping fragments would have helped speed up the process. A big 
problem was that many colonies when plated onto a calcofluor containing plate after 
transformation, still grew even though the plasmid they contained was not in fact 
rescuing the mutation. A way of overcoming this problem was discussed earlier and 
this method although time consuming has been found to work. This method could be 
used to carry on the work and identify some more of the interesting mutants. A 
screening method that would identify those mutants with defects in the cell wall that 
caused hypersensitivity, would also help focus our attentions on identifying the right 
kind of mutants. A way of doing this may be by backcrossing to see if the mutation on 
its own shows increased hypersensitivity to calcofluor.   
The screen has identified two proteins, Gup1p and Gas1p which may be a 
consequence of defects in the cell wall. Gup1p is a membrane bound O-
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acyltransferase but has been implicated in a wide range of functions including cell 
wall composition and integrity and the secretory/endocytic pathway (Bleve et al., 
2011, Bonangelino et al., 2002). However, Gup1p has also been shown to interact 
genetically with several genes involved in chitin and -1,6 glucan synthesis such as 
SKT5, an activator of chitin synthesis (Smits et al., 2001). Absence of Gup1p has been 
shown to create cells defective in cell wall composition that are sensitive to calcofluor 
and other enzymes that affect the cell wall, such as zymolyase. The amount of chitin 
present in the cell wall was measured and a ∆gup1 mutant is found to have an 
increased level of chitin (Ferreira et al., 2006). So like ∆gas1, it is likely that ∆gup1 
also shows calcofluor hypersensitivity. It is probable that the calcofluor sensitivity 
effect observed in 2-2 is independent of the Fab1p /AP-1 dependent pathway. Further 
supporting this are the results that FAB1 over expression cannot rescue the 
∆gup1∆chs6 mutant, and no defect in MVB sorting is observed. Recently Gup1p over 
expression has been shown to increase proliferation of intracellular membranes which 
contain both Golgi and ER proteins (Bleve et al., 2011). Deletion of GUP1 also 
results in and increase of triglycerides and decrease in phospholipids synthesis 
(Oelkers et al., 2000). This raises the possibility that Gup1p may be implicated in the 
control of the ER membrane as this is the major site of lipid synthesis.  
Vps13p is the most interesting mutant identified. VPS13 is encoded by ORF YLL040C 
and is also known as SOL1. The gene is still classified as uncharacterised although it 
has been pulled out in several screens for defects in vacuolar sorting and targeting but 
its molecular function remains elusive (Bankaitis et al., 1986, Robinson et al., 1988, 
Rothman et al., 1989). More recently a role for the protein has emerged in Kex2p 
transport (Brickner and Fuller, 1997, Redding et al., 1996). Deletion of VPS13 impairs 
the localisation of Kex2p at the TGN. Kex2p is a protease required for the production 
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of the mating pheromone α-factor. If Vps13p is not present, Kex2p is partially 
mislocalised to the pre-vacuolar endosome apparently because the retrieval of Kex2p 
from this endosome is much slower than normal. This implies that Vps13p is required 
for correct trafficking of the Kex2p cargo receptor; an as yet unidentified protein, 
back to the TGN (Brickner and Fuller, 1997). Vps13p has also been shown to miss 
sort CPY and lead to the increased vacuolar degradation of Vps10p, linking into the 
work in Chapter 3, suggesting that Vps13p might have a  role in cargo specific 
retrieval of proteins back to the TGN.  Targeting of Kex2p to the TGN is dependent 
on an aromatic TLS1 signal in its C-terminal tail; when this signal is mutated Kex2p 
is routed to the vacuole. Kex2p also possesses a TLS2 signal necessary for cycling 
between the PVC and TGN. Vps13p is thought to function by interaction with these 
signals. It is suggested to that Vps13p antagonises the retention signal (TLS2) and 
promotes the function of the retrieval signal that acts at the PVC (Brickner and Fuller, 
1997). Vps13p functions at both the TGN and PVC. Ste13p is also thought to contain 
similar signals as mentioned above (Brickner and Fuller, 1997) 
It is likely that Vps13p is performing a similar role in the trafficking of Chs3p. It 
could be functioning at the TGN or recycling endosome/PGE or both. Vps13p may 
recognise a signal in Chs3p and promote its recycling or retrieval via recruitment of 
another complex such as AP-1 or Fab1p. The exomer complex is also known to 
transport Fus1p to the plasma membrane. It has now been found that Fus1p contains a 
IXTPK sequence in its cytosolic tail which is necessary for its direction to the plasma 
membrane (Barfield et al., 2009). Although none have been identified to date and 
sequence alignments with Kex2p did not reveal any sequence homology, it may be 
that Chs3p contains similar domains. Chs3p does contain an LITPK sequence in its 
second predicted cytosolic loop but mutation of the sequence does not affect transport 
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to the cell surface (Barfield et al., 2009). Mutation of Chs3p to see if any specific 
regions interact with Vps13p may reveal the process at work.  
The fact that Fab1p can rescue the 2-27 strain and ∆vps13∆chs6 double mutant makes 
it extremely likely that Vps13p can interact with the Fab1p, the AP-1 complex or 
PtdIns(3,5)P2 in some fashion and suggests that all of these components act in the 
same pathway; the control of protein entry into the TGN via some form of retrograde 
trafficking pathway. Hence if either Vps13p, Fab1p or the AP-1 complex are 
inactivated then Chs3p can no longer enter the TGN and instead builds up at the 
recycling endosome (Snc1p positive compartment) where it again finds a new 
pathway to the cell surface. Further experiments are needed to clarify this role. 
Localisation of Vps13p, components of the AP-1 complex, and Fab1p in wild-type 
and ∆chs6 cells, could be performed by tagging each protein with GFP and examining 
microscopically. In order to understand the role of Vps13p, a ∆vps13∆chs6∆sec22 
triple mutant could also be generated to see if this brings back calcofluor resistance or 
not. It may be that in the ∆vps13∆chs6 double mutant Chs3p builds up at the Golgi 
and finds a new route through classical secretion. A two hybrid screen could also be 
performed to see if interaction with Fab1p or the AP-1 complex does occur. A co-
immunoprecipation assay could also be performed to see if interaction occurs in vivo. 
An expression assay could also be used to see if Vps13p can bind PtdIns(3,5)P2. 
Levels of the lipid could also be measured in a ∆vps13 strain to see if it does possess a 
defect in PtdIns(3,5)P2 metabolism or is a potential effector, although the strain only 
appears to have a minor defect in GFP-Atg18p localisation. 
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Chapter 5 
Vacuole Fragmentation. 
5.1 Introduction 
In order to survive a cell needs to be able to grow and adapt to changing conditions. 
When adverse environmental changes occur, the physiology of a cell also changes in 
response. The cell uses internal signals to activate stress response pathways. These 
pathways have been shown to activate in response to pH, osmotic stress and 
hydrostatic pressure changes (Dove and Johnson, 2007, Dove et al., 1999). As 
mentioned in Chapter 1 during hyper-osmotic stress, a transient 20 fold increase in 
PtdIns(3,5)P2 levels is observed that is not seen in any of the other identified 
phosphoinositides (Dove et al., 1997). This increase has only been observed in fungi 
and plants, though at least one mammalian cell responds with a more modest increase 
in PtdIns(3,5)P2 (Ikonomov et al., 2001). A small increase in PtdIns3P is also seen 
due to increased Vps34p activity and is a prerequisite to the dramatic increase in 
PtdIns(3,5)P2 levels that are catalysed by Fab1p activity.  The increase in levels of 
PtdIns(3,5)P2 are seen within seconds of stress and disappear at around 30-60 
minutes; the intensity and duration of this response are proportional to the applied 
osmotic stress (Dove et al., 1997). 
 
5.2. Vacuole fission.  
During normal cellular growth and replication, vacuoles of S. cerevisiae undergo 
fusion and fission events in response to the cell cycle and in response to cellular 
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stress. The end point of many trafficking events in the yeast cell is the vacuole; it 
contains many proteases and is a site of degradation (Bowers and Stevens, 2005). 
Different machinery regulates fusion and fission events and they are antagonistically 
linked (Peters et al., 2004).  Vacuole fission and fragmentation are required to be 
finely balanced in order to maintain cellular homeostasis. 
During cell division the vacuole is required to fragment into smaller vesicles which 
are then transported into the growing daughter cell. Inherited vacuolar vesicles then 
fuse during the later stages of cell division, to maintain a low copy number of the 
organelle (Ostrowicz et al., 2008).  
Yeast vacuole fusion depends on Ypt7p a Rab GTPase, and the HOPS and SNARE 
complexes. Vacuole fusion comprises several different stages, all of which are tightly 
regulated. The first stage is priming, a process that requires ATP. During priming 
vacuoles are prepared for first contact. SNARE complexes present on the vacuole, are 
dissembled by Sec18p an ATPase. Vam7p a soluble SNARE remains partially bound 
to the vacuole, and Vps1p which binds to Vam3p on vacuoles is released, leaving the 
vacuolar SNAREs in an active position (Ostrowicz et al., 2008) . Tethering then 
proceeds, and is dependent on a fully assembled HOPS complex which forms a bridge 
between the vacuoles to be fused. Docking and fusion stages, then allow unpaired 
SNARES, generated during priming to assemble across vacuole membranes. This 
happens through pairing of Q-SNARES on one membrane with R-SNARES on the 
other membrane, forming trans-complexes which bring and fuse opposing membranes 
allowing the vacuole contents to mix (Ostrowicz et al., 2008).  
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5.3. Vacuole fragmentation in response to stress 
Duex and colleagues reported that the vacuoles of wild-type S. cerevisiae undergo 
regulated, PtdIns(3,5)P2  dependent fragmentation into many smaller organelles when 
subjected to hyper-osmotic stress (Duex et al., 2006b). Vacuole fragmentation is not 
seen in cells deficient in PtdIns(3,5)P2, or cells that are unable to increase 
PtdIns(3,5)P2 levels when given a hyper-osmotic stress, so Fab1p Vac7p, Vac14p and 
Fig4p are all necessary for vacuole fragmentation under hyper-osmotic stress (Duex et 
al., 2006b).  This supports the idea that PtdIns(3,5)P2 levels are increased under stress 
in order to carry out processes involving the vacuole. 
 
Figure 5.1 Cartoon of vacuole fragmentation in response to stress. 
 
 
Minutes after hyper-osmotic stress with 0.4M-1.0M NaCl, the vacuoles of wild-type cells fragment into 
a series of smaller vacuoles, however in Fab1p deficient cells the vacuoles are large and unlobed 
before and after application of the stress. Deletion of YCK3 leads to a defect in the matinance of 
vacuole fragmentation and after 60 minutes of hyperosmotic stress vacuoles re-fuse (Peplowska et al., 
2007).  
Δfab1 
Wild Type 
Δyck3 
Unstressed 10 Minutes after 0.4M 
NaCl stress 
60 Minutes after 
0.4M NaCl stress 
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The reasons why the yeast vacuole undergoes fragmentation in response to hyper-
osmotic stress are currently ill-defined. The once widely held belief that the vacuole 
acts as a water reservoir for the cytosol during hyper-osmotic stress is now questioned 
because both the cell and vacuole are now known to shrink with the same kinetics, 
which suggests they are osmotically continuous (Dove and Johnson, 2007). When 
cells are exposed to an osmotic stress, loss of water from
 
the cell is observed. This 
produces a hypertonic cytoplasm, leading to a loss of water from the vacuole due to 
osmosis. It has been suggested that vacuolar water release is regulated by 
PtdIns(3,5)P2 through control
 
of a vacuolar-specific water channel. A vacuolar 
aquaporin
 
has not yet been demonstrated in S. cerevisiae, but at least two
 
aquaporins 
have been identified, AQY1 and AQY2. Either of these may localize, in
 
part, to the 
vacuole membrane (Meyrial et al., 2001). Further, most plant cells contain
 
both 
plasma membrane and vacuolar aquaporins. These prevent the rapid
 
dehydration and 
cell lysis that could occur when the osmolarity
 
of the external environment changes, 
so similar mechanisms may occur in yeast (Soveral et al., 2006). PtdIns(3,5)P2 may 
also regulate a vacuolar ion channel, therefore
 
controlling the internal osmotic 
strength of the vacuole lumen.
 
A decrease in ion flux out of the vacuole would help 
retain
 
water that would otherwise be lost to the cytoplasm. PtdIns(3,5)P2 has been 
shown to control the vacuolar ATPase and more recently it has been shown that 
vacuole acidification and fragmentation may be linked (Baars et al., 2007, Takeda et 
al., 2008). Indeed, a ∆fab1 cell devoid of all PtdIns(3,5)P2  also has a defect in 
vacuole acidification, suggesting a role for PtdIns(3,5)P2 in vacuolar homeostasis. 
There is some evidence that acidification of the vacuole is also increased during 
hyper-osmotic stress although it is unclear if this is an active or passive process.  
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5.4. Process of vacuole Fragmentation. 
The actual mechanism by which the fragmentation occurs is also unknown. One 
possibility is that it could occur through large-scale extrusion of the vacuole followed 
by scission. Another mechanism could be through a process of vesicle budding from 
the vacuole surface followed by fusion of these vesicles into a nascent vacuole. Some 
molecular components required for stress induced fission are known and include 
Fab1p and its upstream regulators, as well as Atg18p and Hsv2p, which are both 
known 7-bladed -propeller type PtdIns(3,5)P2 effectors (PROPPINs) (Cooke et al., 
1998, Dove et al., 2004, Efe et al., 2007). 
5.5 The CORVET-HOPS complex. 
Another potentially important protein complex in fragmentation is the 
HOPS/CORVET complex (Peplowska et al., 2007). The HOPS complex has been 
known for some time as a tethering complex, that “proof-reads” SNARE-SNARE 
interactions to ensure fidelity in vacuole-vacuole fusion in a Rab7 (Ypt7p) dependent 
fashion (Peplowska et al., 2007). Hence HOPS mediates the reverse process to Fab1p 
and PtdIns(3,5)P2.  The HOPS complex has been shown to be able to swap out two of 
its subunits and become a new protein complex, known as CORVET. The CORVET 
complex mediates vacuole fission via Rab5 (Vps21p). Since CORVET interacts with 
Rab5 it could potentially mediate vacuole to PVE trafficking as well, suggesting that 
some link could exist between Fab1p / PtdIns(3,5)P2 and CORVET (Peplowska et al., 
2007).  
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Figure 5.2 HOPS/CORVET complex assembly. 
 
Interconversion from i-CORVET to CORVET is unidirectional (Figure modified from 
Peplowska et al 2007) 
 
Both the HOPS and CORVET complexes share the subunits Vps11p, Vps16p, 
Vps18p and Vps33p. The remaining two subunits of the complex, determine if the 
complex is a Rab7 (Ypt7p) effector (HOPS complex) or a Rab5 (Vps21p) effector 
(CORVET complex). The HOPS complex contains Vps41p/Vam2p and Vam6p and 
CORVET the respective homologs of the HOPS specific proteins: Vps8p and Vps3p 
(Peplowska et al., 2007). Osmolytes generated during osmotic stress, functionally 
destabilise Ypt7p and the HOPS complex. This leads to subunit exchange and 
generation of the CORVET complex on vacuole membranes (Brett and Merz, 2008). 
Intermediate complexes as shown in Figure 5.2 are observed, which suggests that 
modular assembled tethering complexes define organelle biogenesis in the endocytic 
pathway (Peplowska et al., 2007). It will be intriguing to see whether the processes 
and machinery that control vacuole fragmentation are related to that underlying 
vacuole to late endosome (PVE) trafficking.  
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5.6. The V-ATPase 
In addition, the vacuolar V-type H
+
ATPase has been demonstrated to also be required 
for PtdIns(3,5)P2-dependent vacuole fragmentation in response to hyper-osmotic 
stress, as indeed is the proton gradient (Baars et al., 2007). The V-ATPase is found in 
all eukaryotes, and is highly conserved between species. The S. cerevisiae V-ATPase 
has therefore been used as a model system and has many advantageous characteristics 
as mutants who lack V-ATPase subunits are still viable making study of the system 
easier (Sambade and Kane, 2004).  
 
Figure 5.3. Diagram of the V-ATPase subunits. 
 
The V-ATPase is made up from two sub complexes V1 and the membrane bound V0. 
Some of the subunits are tissue specific i.e. C’’.  
V1 (A- Vma1p, B- Vma2p, C- Vma5p, D- Vma8p, E- Vma4p, F- Vma7p, G-Vma10p, 
H-Vma13p).  
V0 (a- Vph1p/Stv1p, c- Vma3p, c’-Vma11p, c’’- Vma16p, d- Vma6p, e- Vma9p. 
 
 221 
V-ATPases are able to acidify multiple organelles, mutants that lack V-ATPase 
activity have a distinctive set of growth defects. Mutants lacking a V-ATPase subunit 
are known as vma mutants and study of these mutants has revealed a much larger role 
for the V-ATPase (Sambade and Kane, 2004). These vma mutants are hypersensitive 
to multiple forms of oxidative stress so an antioxidant role for the V-ATPase has also 
been suggested.  
Recent research by the Mayer lab has now linked the V-ATPase to the regulation of 
the vacuolar fission-fusion equilibrium (Baars et al., 2007). In the course of the 
normal cell cycle, the vacuole undergoes co-ordinated cycles of membrane fission and 
fusion involving both the HOPS and CORVET complexes. The Mayer lab identified a 
novel factor that impinges on the fusion-fission equilibrium which is the vacuolar H
+
-
ATPase of V-ATPase. The V-ATPase performs two distinct roles during fusion and 
fission. Fusion of the vacuole needs the physical presence of the membrane sector of 
the V-ATPase, whilst fragmentation requires proton translocation by the V-ATPase 
(Baars et al., 2007). If the V-ATPase is disrupted by constitutive mutations or 
pharmacology so that it is no longer able to pump protons, then salt induced vacuole 
fragmentation is blocked (Baars et al., 2007). Another report has also noted that V-
ATPase mutants display single vacuoles that do not undergo fragmentation in 
response to hyper-osmotic stress. It is believed that the vacuolar V(1)/V(0)-ATPase is 
involved in the release of the HOPS subunit Vps41p from vacuoles, further linking it 
with vacuole fragmentation and fusion (Bayer et al., 2003). Members of the V1 sector 
are reported to be deficient in fragmentation under hyper-osmotic stress like what is 
observed in a ∆fab1 strain.  
A recent proteomics screen also identified several members of the V1 sector as 
proteins which bind PtdIns(3,5)P2; Vma1p, Vma2p, Vma4p, Vma5p (Catimel et al., 
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2008). This is a very interesting development and strongly suggests that one of 
PtdIns(3,5)P2 functions requires the V-ATPase and this possibly links with vacuolar 
fragmentation under hyper-osmotic stress.  
 
5.7. Maintaining vacuole fragmentation. 
A further clue to the machinery controlling the process of vacuole fragmentation, is 
provided by the ∆yck3 mutant. This mutant initially displays vacuole fragmentation 
during hyper-osmotic stress as is seen in normal functioning wild-type cells. 
However, after 10 minutes the vacuoles re-fuse. This raises the possibility that Yck3p, 
a vacuole membrane localised casein protein kinase, is required to maintain 
fragmentation of the yeast vacuole. Indeed Yck3p is involved in regulation of the 
HOPS/CORVET complex via phosphorylation of Vps41p, however, the role of this 
phosphorylation is not clear (LaGrassa and Ungermann, 2005).  
 
5.8. Aims 
This chapter aims to establish potential proteins which may be involved in the 
mechansim of stress induced vacuole fragmentation. Through the use of the lipid dye 
FM4-64 the requirement for members of the CORVET and V-ATPase complexes in 
vacuole fragmentation was examined.  
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5.9 Results 
Screening of mutants who may play a role in vacuole fragmentation and be potential 
PtdIns(3,5)P2 effectors was carried out to see if numbers of vacuoles inside the cell 
increase after 10 minutes of a 0.4M hyper-osmotic stress.  
In some deletion strains it is harder to observe whether vacuole fragmentation is 
taking place as the vacuoles are too small. To overcome this problem strains with an 
additional deletion of PEP4 a vacuolar protease were made. Deletion of PEP4 
increases the size of the vacuole and therefore makes microscopic visualisation easier.  
To begin, vacuole fragmentation was observed in controls of wild-type cells with a 
PEP4 deletion and a ∆fab1 strain. Strains were stained with FM4-64 as detailed in 
Chapter 2. They were then prepared for microscopy and cells were resuspended in 
either control microscope buffer or microscope buffer with 0.4M NaCl. Cells were 
visualised immediantly or after 10 minutes for hyper-osmotically stressed samples. 
As shown in Figure 5.4, FM4-64 is a reliable marker for the vacuole. In both strains 
the dye is endocytosed and can be visualised on the vacuolar membrane before and 
after treatment with 0.4M NaCl. The results indicate that the vacuoles of the ∆fab1 
strain are usually large and unlobed under control conditions. Cells that lack the 
Fab1p kinase are devoid of PtdIns(3,5)P2 (Dove et al., 1997). This suggests that the 
lipid may be necessary in order to regulate the size and shape of vacuoles. This 
phenotype could be due to imbalance of the fusion-fission equilibrium, with the fusion 
reaction being favoured or could be due to a decrease in fission or fragmentation. 
When ∆fab1 are given hyper-osmotic stress treatment with 0.4M NaCl, the vacuoles 
still remain large and unlobed, no fragmentation of the vacuoles is observed. Again 
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the cells are completely devoid of PtdIns(3,5)P2, the usual increase in this lipid 
induced by hyper-osmotic stress cannot happen.  
 
Figure 5.4 Fragmentation  controls 
                      Control                                     0.4M NaCl after 10 minutes 
         DIC                      FM4-64                      DIC                          FM4-64 
 
FM4-64 staining of vacuoles in wild-type and ∆fab1 strains. Shown above are fluorescence images of 
logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type (top panels) and ∆fab1(bottom 
panels) cells. The left-hand panels show cells under control conditions. The right-hand panels show 
cells after 10 minutes 0.4M NaCl stress. Left hand columns show low light DIC images. The right-hand 
columns show the RFP localisation of FM4-64 on the vacuole membrane. Both strains were cultured in 
YETD+2% glu medium with G418 for and were grown at 25ºC. These images are representative of 
three replicate cultures. Scale bar represents 5µM. 
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The number of vacuolar organelles in wild-type S. cerevisiae under control conditions 
is higher than that observed in the ∆fab1 strain. A spread of the number of vacuoles 
per cell is seen, with some cells possessing up to 9 vacuoles. Vacuoles of wild-type 
cells, as expected, fragment into numerous smaller compartments with the majority of 
cells possessing at least 3-4 vacuoles, compared to 1-2 before stress. The number of 
cells with 1-2 vacuoles is reduced from around 68% to just 20% after treatment with 
0.4M NaCl. The process of stress dependent vacuole fragmentation is functioning 
correctly in wild-type cells, as is the increase in PtdIns(3,5)P2 levels observed under 
stress. 
It has been reported that proteins involved in the activation of Fab1p and metabolism 
of PtdIns(3,5)P2 should also be unable to fragment (Duex et al., 2006b). This is 
probably due to decreased levels of PtdIns(3,5)P2. The roles of Vac14p, Vac7p and 
Fig4p were investigated. If PtdIns(3,5)P2 does indeed play a role in vacuole 
fragmentation, we would expect that cells with decreased levels of the lipid to also 
possess a defect the in hyper-osmotic stress response.   
Vacuole numbers of each strain were examined and data grouped into number of 
vacuoles per cell. Graphs as shown below in Figure 5.6 were drawn to give a clearer 
indication of whether vacuole fragmentation was taking place in response to hyper-
osmotic stress. 
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Figure 5.5 Fragmentation observed in Fab1p regulator mutants. 
                      Control                                     0.4M NaCl after 10 minutes 
         DIC                      FM4-64                      DIC                          FM4-64 
 
FM4-64 staining of vacuoles in ∆vac14, ∆fig4 and ∆vac7 strains. Shown above are fluorescence 
images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml), of ∆vac14 (top panels), ∆fig4 (middle 
panels) and ∆fab1 (bottom panels). The left-hand panels show cells under control conditions. The 
right-hand panels show cells after 10 minutes 0.4M NaCl stress. Left hand columns show low light DIC 
images. The right-hand columns show the localisation of FM4-64 on the vacuole membrane. All strains 
were cultured in YETD+2% glu medium with G418 for and were grown at 25ºC. These images are 
representative of three replicate cultures. Scale bar represents 5µM. 
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Figure 5.6 Graphs of fragmentation observed in Fab1p regulator mutants. 
 
The results shown in Figures 5.5 and 5.6 are somewhat unclear, previously Vac14p 
mutant cells vacuoles have been reported not to fragment under a 0.4M NaCl stress, 
my data however suggests that the defect is partial. The percentage of cells with 1-2 
vacuoles reduces from around 63% of cells to around 38% of cells. ∆vac14 are 
reported have an increase of PtdIns(3,5)P2  levels in response to osmotic stress, 
although this is much lower than that seen in wild-type cells and is similar to basal 
levels (Bonangelino et al 2002). Levels of PtdIns3P are however higher than in wild-
type, probably due to accumulation, as it is not being depleted by production of 
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PtdIns(3,5)P2. The small amounts of PtdIns(3,5)P2 may be sufficient to allow some 
vacuole fragmentation to be carried out. Note however, that vacuoles of cells that 
have received 0.4M NaCl treatment are still large; they just have tiny vacuolar 
structures budding off.  This may be due to a defect in the machinery involved in 
fragmentation, perhaps due to lower levels of PtdIns(3,5)P2 in Δvac14 cells. Results 
may vary from reported results due to strain background or to the method of 
classification/counting. It appears that ∆fig4 cells can carry out vacuole fragmentation 
in response to the hyper-osmotic stress. Under hyper osmotic stress conditions Δfig4 
cells contain around 25% of wild-type levels of PtdIns(3,5)P2 (Duex et al 2006b). 
Fig4p is reported to not only be an activator of Fab1p, but also to be a PtdIns(3,5)P2 
phosphatase, so levels of the lipid are not as low as in a Δvac14 strain. This would 
explain how vacuole fragmentation is still able to take place. Under control conditions 
levels of PtdIns(3,5)P2 are again decreased, and the vacuole structure is enlarged and 
unlobed (Duex et al 2006b). This again suggest a link between PtdIns(3,5)P2  levels 
and vacuole morphology. Interestingly it appears that the vacuoles of the ∆vac7 strain 
fragment in a similar way to that of ∆fig4, this suggests that maybe its role in 
activation of Fab1p may be similar to that of Fig4p. There is currently no known 
mammalian homolog for Vac7p so its role may be redundant, which suggests it may 
carry out a similar process to one of the other components involved in PtdIns(3,5)P2 
synthesis. However Δvac7 cells are reported to have no detectable levels of 
PtdIns(3,5)P2, and unlike in Δvac14 cells this doesn’t change when the strain receives 
a hyper-osmotic stress (Bonangelino et al., 2002). Therefore as previously reported 
the vacuoles of Δvac7 cells would be expected not to fragment. This again may be a 
consequence of a different strain background, or perhaps even a suppression of the 
mutation; such suppressors have been reported to accumulate in fab1 mutants many 
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times. Consistent with little detectable PtdIns(3,5)P2 the vacuoles of Δvac7 cells are 
large and unlobed.  
 
Figure 5.7 Fragmentation observed in PtdIns(3,5)P2 effector mutants. 
                      Control                                     0.4M NaCl after 10 minutes 
         DIC                      FM4-64                      DIC                          FM4-64 
 
FM4-64 staining of vacuoles in ∆atg21, ∆hsv2, ∆atg18  and ∆svp3 strains. Shown above are 
fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of ∆atg21 (top panels), 
∆hsv2 (second row panels), ∆atg18 (third row panels) and ∆svp3(bottom panels). The left-hand panels 
show cells  under control conditions. The right-hand panels show cells after 10 minutes 0.4M NaCl 
stress. Left hand columns show low light DIC images. The right-hand columns show the localisation of 
FM4-64 on the vacuole membrane. All strains were cultured in YETD+ G418 +2% glu medium and 
grown at 25ºC. These images are representative of three replicate cultures. Scale bar represents 5µM. 
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Known PROPPIN domain containing effectors of PtdIns(3,5)P2 were also examined 
for vacuole fragmentation. These strains should have normal levels of PtdIns(3,5)P2, 
if they are located downstream of Fab1p. 
Figure 5.8 Graphs of vacuole fragmentation observed in PtdIns(3,5)P2 effector 
mutants. 
 
If the vacuoles of the mutants do not fragment in response to hyper-osmotic stress, it 
may suggest that the proteins are actually playing a role in this aspect of PtdIns(3,5)P2 
signalling. It would indicate that these effectors are required for vacuole 
fragmentation to occur. As with all phosphoinositides, PtdIns(3,5)P2  requires effector 
 231 
proteins in order to exert its effects so therefore, at least one effector protein should 
have a role in hyper-osmotic induced vacuole fragmentation (Michell et al., 2006) 
Again the number of vacuoles before and after hyper osmotic stress was quantified; 
the results shown in Figures 5.7 and 5.8 suggest that Atg21p and Hsv2p may play a 
role in PtdIns(3,5)P2 fragmentation as when either of the proteins is ablated, vacuoles 
no longer respond to hyper-osmotic shock and fragment properly. Unlike strains with 
decreased PtdIns(3,5)P2, the vacuoles of  ∆atg21and ∆hsv2 are not enlarged and 
unlobed under control conditions; suggesting they do not play a role in maintaining 
vacuole size or number under basal conditions. This suggests that the fusion-fission 
equilibrium is in the same position in these mutants, as in wild-type cells. The defect 
in vacuole fragmentation in response to hyper-osmotic stress must be because the 
proteins deleted are effectors necessary for the fragmentation of vacuoles to take 
place; since the levels of PtdIns(3,5)P2 are normal in these cells and respond to stress 
normally (Dove, SK unpub).  
The vacuoles of the ∆atg18 strain appear large and unlobed both before and after 
hyper-osmotic stress. ∆atg18 cells do not appear to undergo the process of vacuole 
fragmentation, suggesting that Atg18p is critical for the process and is an effector 
involved in this pathway. This is an intriguing result as the levels of PtdIns(3,5)P2 
have been measured in this strain and found to be higher than in wild-type cells. 
Unstressed cells contain 5-10 times more PtdIns(3,5)P2 than wild-type cells and under 
stress four times more PtdIns(3,5)P2 is observed (Dove et al 2004). This again 
suggests that Atg18p may be part of the machinery that controls stress induced 
vacuole fragmentation. The control result also strongly supports the idea that Atg18p 
is required for normal vacuole morphology as the increased levels of PtdIns(3,5)P2 
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would suggest the strain should be highly fragmented if it is not involved in the 
process. 
The results seen for ∆svp3 are intriguing, although the vacuoles appear to fragment 
only slightly, they also do not seem to undergo the process correctly. As shown in 
Figure 5.7 the main vacuole remains large with smaller vacuoles budding off of one 
side. This looks like a partial defect and suggests that Svp3p may play a role in this 
process. In control conditions the vacuoles of ∆svp3 are large but not unlobed; again a 
partial defect. Indeed, when radiolabelled levels of PtdIns(3,5)P2 in ∆svp3 are 
quantified, they are found to be increased (Dove, SK pers comm), which would point 
to the cell having increased vacuole fragmentation. This is therefore an intriguing 
result and likely to point to Svp3p having a role in vacuolar dynamics in response to 
stress. 
As discussed above the CORVET complex plays a crucial role in vacuole 
fragmentation during growth. To investigate whether the same components are 
responsible for micro vacuole fragmentation during hyper-osmotic stress, strains 
possessing a deletion of one of the two CORVET specific units of the 
HOPS/CORVET complex were studied. These cells should no longer be able to form 
complete CORVET complexes, and therefore be unable to undergo macro-
fragmentation during the cell cycle (Peplowska et al., 2007). 
As shown below in Figure 5.9 before stress, both ∆vps3 and ∆vps8 vacuoles are 
enlarged under normal conditions. Some cells possess unlobed vacuoles in both 
strains with ∆vps3 cells possessing vacuoles that are less fragmented than wild-type. 
This suggests that in both of these strains vacuole fusion is favoured; this may be due 
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to shift of the equilibrium towards fusion, as the CORVET subunits required for 
fission are not present.  
It appears that the vacuoles of the ∆vps3 strain do not fragment when given a 0.4M 
NaCl stress. There is little change between control and hyper-osmotic conditions. 
Figure 5.9 Fragmentation observed in CORVET mutants. 
                   Control                                     0.4M NaCl after 10 minutes 
         DIC                      FM4-64                      DIC                          FM4-64 
 
 
 
 
 
 
 
 
 
 
FM4-64 staining of vacuoles in  ∆vps3 and ∆vps8 strains. Shown above are fluorescence images of 
logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of ∆vps3 (top panels), and ∆vps8 (bottom 
panels). The left-hand panels show cells under control conditions. The right-hand panels show cells 
after 10 minutes 0.4M NaCl stress. Left hand columns show low light DIC images. The right-hand 
columns show the localisation of FM4-64 on the vacuole membrane. All strains were cultured in 
YETD+ G418 +2% glu medium and grown at 25ºC. These images are representative of three 
replicate cultures. Scale bar represents 5µM. 
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The ∆vps8 strain undergoes some fragmentation although it does not appear to 
fragment as the wild-type strain does, and a large proportion of cells remain with only 
1-2 vacuoles. When performing this experiment it was noticed that the process of 
fragmentation may be slower and requires a longer period of exposure to hyper-
osmotic stress, suggesting that Vps8p may be involved in the dynamics of vacuole 
fragmentation, and enables the process to happen quickly. It may be that Vsp8p is 
linked to the process of sensing the cellular stress. 
Both of the results above are consistent with the notion of a sharing of machinery 
between macro fragmentation during the cell cycle and the micro fragmentation in 
response to hyper-osmotic stress. 
To investigate the role of the V-ATPase in vacuole fragmentation, mutants of various 
subunits of both the V1 and V0 complexes were examined. 
The V1 domain is required for ATP hydrolysis, and is peripherally associated and 
contains tissue specific units. A central rotor axle is formed by units Vma8p and 
Vma7p, which interacts with the V0 domain (Kane, 2005).  
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Figure 5.10 Fragmentation observed V1 mutants. 
                     Control                                     0.4M NaCl after 10 minutes 
         DIC                      FM4-64                      DIC                          FM4-64 
 
FM4-64 staining of vacuoles in  ∆vma1, ∆vma2, ∆vma4, ∆vma7, ∆vma8 and ∆vma10 strains. Shown 
above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml). The left-hand 
panels show cells  under control conditions. The right-hand panels show cells after 10 minutes 0.4M 
NaCl stress. Left hand columns show low light DIC images. The right-hand columns show the 
localisation of FM4-64 on the vacuole membrane. All strains were cultured in YETD+ G418 +2% glu 
medium and grown at 25ºC. These images are representative of three replicate cultures. Scale bar 
represents 5µM. 
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Figure 5.11 Graphs of vacuole fragmentation observed V1 mutants. 
 
 
 
Figures 5.10 and 5.11 indicate that Vma7p, Vma2p and Vma1p may play a role in 
PtdIns(3,5)P2 dependent fragmentation. Strains possessing a deletion in any of these 
genes either undergo no fragmentation in the case of ∆vma7 or reduced fragmentation 
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in both ∆vma1 and ∆vma2 strains. This is an interesting result as both Vma1p and 
Vma2p have been reported to bind PtdIns(3,5)P2 in the recent proteomics paper 
(Catimel et al., 2008). It would be interesting to see if expressed Vma1p, Vma2p or 
Vma7p bind PtdIns(3,5)P2 selectively on lipid dot blots.  
Vma4p is also reported to bind PtdIns(3,5)P2 in the Catimel paper, however my 
results suggest that strains possessing a deletion of VMA4 are still able to fragment. 
This means that Vma4p is unlikely to be a PtdIns(3,5)P2 effector that is involved in 
vacuole fragmentation. This also agrees with data from the Mayer lab (Baars et al., 
2007).  Alternatively Vma4p may be involved in vacuole fusion. 
Members of the V0 complex were also examined for a role in hyper-osmotic induced 
vacuole fragmentation. The V0 complex is a membrane bound complex which is 
responsible for proton translocation. As shown in Figure 5.12 and the graphs shown in 
Figure 3.13 both Stv1p and Vph1p, which substitute for each other in the V0 complex, 
fragment under hyper-osmotic stress. It also appears from the data that Vma11p does 
not have an effect on vacuole fragmentation. Cells deficient in Vma11p are still able 
to fragment when treated with a 0.4M NaCl stress.  
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Figure 5.12 Fragmentation observed V0 mutants. 
                     Control                                     0.4M NaCl after 10 minutes 
         DIC                      FM4-64                      DIC                          FM4-64 
 
FM4-64 staining of vacuoles in ∆vma9, ∆vma11,  ∆vma3, ∆stv1and ∆vph1 strains. Shown above are 
fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml.) The left-hand panels 
show cells  under control conditions. The right-hand panels show cells after 10minutes 0.4M NaCl 
stress. Left hand columns show low light DIC images. The right-hand columns show the localisation of 
FM4-64 on the vacuole membrane. All strains were cultured in YETD+ G418 +2% glu medium and 
grown at 25ºC. These images are representative of three replicate cultures. Scale bar represents 5µM. 
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Figure 5.13 Graphs of vacuole fragmentation observed V0 mutants. 
 
 
Cells possessing a deletion of VMA3 have previously been reported to not undergo 
hyper-osmotic induced vacuole fragmentation and the results in this study agree with 
this observation (Baars et al., 2007).  
The data also suggests that another V0 member is involved in vacuole fragmentation. 
In a ∆vma9 strain cells do not appear to undergo fragmentation. The number of cells 
with just 1-2 vacuoles actually slightly increases. It is difficult to express membrane 
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proteins and do a dot blot to see if Vma9p binds PtdIns(3,5)P2 but this would be a 
way of seeing if there is in fact any interaction with the lipid. 
 
It is unknown what mechanism or component is used to sense hyper-osmotic stress 
and increase PtdIns(3,5)P2 levels. Members of the PHO family were examined for 
defects in vacuole fragmentation as these proteins are involved in sensing and 
maintaining cellular homeostasis, so may allow the cell to react quickly to hyper-
osmotic stress. Pho85p is a cyclin dependent kinase and associates with the cyclin 
Pho80p. Pho85p is known for its role in the PHO pathway that coordinates the 
response of yeast to phosphate starvation, but it has emerged that this cyclin-CDK 
complex may sense both nutrient and environmental stresses (Carroll and O Shea 
2002). Pho81p is a CDK inhibitor which is bound to the Pho85p-Pho80p complex. It 
has been suggested that Pho85p appears to inform the cell the current environment is 
satisfactory (Carroll and O Shea 2002). It may therefore be performing the same role 
for hyper-osmotic stress.  
The results in Figure 5.14 indicate that deletion of PHO81 OR PHO85 have no effect 
on stress induced vacuole fragmentation and therefore are not involved in the process.  
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Figure 5.14 Fragmentation observed in other mutants. 
                       Control                                     0.4M NaCl after 10 minutes 
         DIC                      FM4-64                      DIC                          FM4-64 
 
 
FM4-64 staining of vacuoles in ∆pho81 and ∆pho85 strains. Shown above are fluorescence images of 
logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of ∆pho81 (top panels), and ∆pho85 (bottom 
panels). The left-hand panels show cells under control conditions. The right-hand panels show cells 
after 10minutes 0.4M NaCl stress. Left hand columns show low light DIC images. The right-hand 
columns show the localisation of FM4-64 on the vacuole membrane. All strains were cultured in 
YETD+ G418 +2% glu medium and grown at 25ºC. These images are representative of three replicate 
cultures. Scale bar represents 5µM. 
 
 
 
∆pho81 
∆pho85 
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Table 5.1 Summary table 
 
 
 
 
 
 
 
 
 
5.10 Discussion. 
This chapter presents results that indicate several novel proteins may be involved in 
PtdIns(3,5)P2 dependent vacuole fragmentation. Mutants deleted for these genes, do 
not possess the machinery to undergo vacuole fragmentation as in wild-type cells.  
 It is likely that the machinery required for vacuole fission during normal cell cycle 
growth is also required for the micro-fragmentation of the vacuole under hyper-
osmotic stress conditions. Evidence for this comes from mutation of the two specific 
CORVET sub units Vps3p and Vps8p. ∆vps3 fails to undergo proper vacuole 
fragmentation, and ∆vps8 shows a decrease and delay in the fragmentation response to 
hyper osmotic stress. It would be interesting to look at point mutations of these two 
genes to see if the same domains are required for the two processes. Labelling of these 
 
Genotype  
 
 Wild Type Δfig4, Δvac7, Δvma4, Δvma8, 
Δvma10, Δvma11, Δpho81, Δpho85 
Δfab1, Δvac14, Δatg18, Δvps3, Δvps8, 
Δvma7, Δvma3 
 
 
Δsvp3 
Δatg21, Δhsv2, Δvma1, Δvma2, 
Δvma9, Δstv1, Δvph1 
Phenotype 
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mutants to observe levels of PtdIns(3,5)P2 has revealed that  the vacuole morphology 
defects are not a consequence of a failure to produce PtdIns(3,5)P2 in the case of 
either mutant.  
As previously reported a number of V-ATPase mutants have also been found to have 
a role in stress induced vacuole fragmentation (Baars et al., 2007). Additionally 
Vma9p, which hasn’t previously been noted as showing defects in this process, has 
been shown to not undergo vacuole fragmentation. In further support for a role in not 
only vacuole acidification but vacuole fragmentation, several of the V-ATPase 
subunits have been suggested to bind PtdIns(3,5)P2 i.e. Vma1p, Vma2p, Vma4p and 
Vma5p (Catimel et al., 2008). Attempts to express these proteins proved unsuccessful; 
not enough protein could be produced in order to see if any of these could bind 
PtdIns(3,5)P2 in a dot blot or vesicle binding assay. Further work is required to see if 
these proteins do in fact bind PtdIns(3,5)P2 and whether binding can regulate the V-
ATPase under hyper-osmotic stress conditions.  
Interestingly three proteins known to contain β propellers and are suggested 
PtdIns(3,5)P2 effectors, have also been shown to have a role in vacuole fragmentation. 
Deletions of ATG21, HSV2 and ATG18 all lead to defects in stress induced vacuole 
fragmentation. This is an intriguing result as both Δatg21 and Δhsv2 are reported to 
not have defects in PtdIns(3,5)P2 synthesis. Vacuole morphology in these mutants 
under control conditions is also normal; this suggests that the proteins may be part of 
the machinery required for stress induced fragmentation only. The Δatg18 strain has 
increased levels of PtdIns(3,5)P2 under both normal and stress conditions, but 
vacuoles are large and unlobed in both control and stressed samples. Cells with 
increased levels of PtdIns(3,5)P2 would be expected to have increased fragmentation 
but this is not seen. This suggests that Atg18p is required to both maintain vacuole 
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fission under control conditions and allow stress induced vacuole fragmentation. 
Atg18p may be part of the vacuolar machinery required before and after stress to 
control vacuole morphology. It would be interesting to see if Atg18p interacts and 
recruits Atg21p or Hsv2p to carry out stress induced vacuole fragmentation. Further 
work is needed in order to understand the role these proteins play. This can be through 
GFP localisation studies and pull down assays to see if any of the proteins interact 
with each other or PtdIns(3,5)P2 through a dot blot assay. Atg18p is already known to 
bind PtdIns(3,5)P2. Again point mutagenesis of the genes could be used to see what 
part of the protein is necessary for vacuole fragmentation.  
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Chapter 6 
PtdIns(3,5)P2 and Svp3p/Art1p. 
6.1 Introduction  
PtdIns(3,5)P2 is known to have roles at the vacuole particularly during times of 
cellular stress, it is also involved in various intracellular protein trafficking pathways. 
It is likely that PtdIns(3,5)P2 is also implicated in processes or trafficking pathways, 
that involve the cell surface (discussed in chapter 4). This chapter explores how 
PtdIns(3,5)P2 may be linked to the cell surface through a potential effector protein; 
Svp3p.  
SVP3/ART1 was first identified as a potential effector of PtdIns(3,5)P2 during a screen 
for yeast mutants which displayed a swollen vacuole phenotype. This characteristic is 
consistent with a defect in PtdIns(3,5)P2  levels. Mutants displaying a large unlobed 
vacuole may be involved in PtdIns(3,5)P2  generation, or be potential effectors (Dove 
et al., 2004). ∆svp3 cells also share another phenotype of ∆fab1 cells, temperature 
sensitivity that can be partially overcome with osmotic support (Dove et al., 2004). 
An increase in PtdIns(3,5)P2 levels is normally observed at increased temperatures, as 
this can induce stress in yeast cells. In a ∆fab1strain, PtdIns(3,5)P2 cannot be 
produced and the strain is unable to grow at 37ºC (Dove et al., 2004).  If a kinase dead 
version of Fab1p is present, the cell is still unable to make PtdIns(3,5)P2, but the 
phenotype can be overcome by adding sorbitol or salt to the growth medium. Adding 
extra osmolytes to the growth medium can also help ∆svp3 cells overcome the 
temperature sensitivity defect. This gives an indication that there may be a defect with 
the cell wall or at the cell surface (Yamamoto et al., 1995). 
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SVP3 is a poorly characterised gene encoded by the S.cerevisiae ORF YOR22C, and 
is also known as ART1. The gene produces an 89 kDa protein, which has been shown 
to contain multiple PY motifs, and have similarity to mammalian arrestins (Lin et al., 
2008). The PY motifs are known to be required for recruitment of a ubiquitin ligase, 
Rsp5p which in turn modifies the cargoes as well as the ARTs. This causes cargoes to 
be internalised and targeted to the vacuole for degradation (Lin et al., 2008). ∆fab1 
cells are known to have a defect in MVB sorting of ubiquitinated cargoes and defects 
in ubiquitination. When FAB1 is deleted, certain MVB cargoes fail to be recognised 
and so are not sorted correctly in the intralumenal vesicles of the MVB (Shaw et al., 
2003, Bryant et al., 1998, Odorizzi et al., 1998, Phelan et al., 2006). Svp3p may be the 
link between PtdIns(3,5)P2 , ubiquitination and the cell surface (Katzmann et al., 2004, 
Phelan et al., 2006, Reggiori and Pelham, 2001). Svp3p is present in both yeast and 
filamentous fungi and has no known mammalian homologs, although sequence 
analysis has revealed nine ART family members in yeast that seem to share a 
conserved fold with mammalian arrestins (Lin et al., 2008).  
 
Basal levels of PtdIns(3,5)P2 in ∆svp3 cells are around 5 to 10- fold higher than 
normal, and an increase of PtdIns(3,5)P2  is observed when cells are treated with an 
osmotic stress (Dove, SK pers comm). This is similar to what is observed in another 
effector of PtdIns(3,5)P2; Atg18p (Dove et al 2004). The increased levels of the lipid 
are however not a consequence of FAB1 up regulation, since an over expression of 
FAB1 does not substantially increase cellular levels of PtdIns(3,5)P2, because levels 
of the other accessory proteins are limiting. This suggests that Svp3p may also have 
some regulatory role in PtdIns(3,5)P2 levels, similar to that of Atg18p and may be 
downstream of Fab1p.  
 247 
 
When grown under standard conditions Svp3-GFP is localised to both the cytoplasm 
and an intense pool in the nucleus. When cells are treated with a hyperosmotic shock 
or heat stress, translocation occurs in less than a minute, to numerous small punctate 
‘granule like’ structures. These structures are maintained for over an hour but reverse 
almost immediately if the stress is removed. This response still occurs in ∆fab1 cells 
indicating that a second pathway, independent of Fab1p and PtdIns(3,5)P2 also 
responds to hyper-osmotic stress and acts on Svp3p.  
 
The aim of this Chapter is to find out the functions and mechanism of Svp3p stress 
induced translocation, as it is probable that this is what links PtdIns(3,5)P2 to the cell 
surface.   
 
6.2 Localisation of Svp3p 
SVP3 was cloned and tagged with GFP at its N terminal under the expression of a Met 
regulated promoter in a pUG36 plasmid. The construct was used to verify the 
localisation of Svp3p under both normal growth and hyper osmotic stress conditions.  
As shown in Figure 6.1, pUG36 Svp3-GFP behaves as described above. Svp3-GFP 
can be observed throughout the cytoplasm and more intensely in the nucleus of wild-
type cells. When the cells receive a hyperosmotic stress Svp3p translocates to a series 
of punctae, which are observed throughout the cytoplasm and in the nucleus. This 
represents two pools of Svp3p that are both able to translocate when given a salt 
stress, suggesting a role for Svp3p in the stress response, and consistent with an 
increase in PtdIns(3,5)P2 in response to stress. Svp3p may translocate into these tiny 
punctate structures because a stress related process, possibly ubiquitination, maybe 
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happening within these ‘granules’, which requires an increased concentration of 
Svp3p. 
The translocation of Svp3-GFP occurs in both wild-type and Δsvp3 cells. The 
construct is however easier to visualise in wild-type cells because they are not as slow 
growing and fragile, therefore all microscopy was carried out in wild-type cells. 
 
Figure 6.1 Localisation of pUG36 Svp3-GFP 
         Unstressed                                                     0.9M NaCl after 10 Minutes 
                  DIC                            Svp3-GFP                            DIC                            Svp3-GFP      
                            
 
pUG36-Svp3 GFP can be visualised in the cytoplasm and nucleus under control conditions. When 
given a hyper osmotic stress Svp3-GFP forms punctae. Shown above are fluorescence images of 
logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type cells transformed with pUG36 
SVP3-GFP. The left-hand columns show low light DIC images. The right-hand columns show the GFP 
localisation of  Svp3p. The panel to the left shows localisation under control conditions. The panel to 
the right shows localisation after treatment with 0.9M NaCl. Images are representative of three 
replicate cultures. All strains were cultured in SC-Ura+25mg/L Met +2% glu medium and grown at 
25ºC. Scale bar represents 5µM.  
 
When SVP3 was aligned, a series of conserved blocks of homology were observed as 
indicated in Figure 6.2. Domain 2 at the N terminus shows some homology to 
mammalian adaptins. 
To discover what part of the SVP3 gene was responsible for this stress driven 
translocation, truncation constructs were made where the SVP3 gene had specific 
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domains removed (Previously made in the Dove lab by Dr Steven Dove and Gavin 
McNee see Chapter 2 for methods). 
Figure 6.2 Domains of SVP3. 
 
Diagram showing the 6 domains of SVP3. 
 
All constructs previously examined lacking domain 3, had cytoplasmic localisation 
only, therefore this domain must contain the NLS. An Svp3
NT1  
GFP construct was 
used which only contains domains 1-4. An Svp3
CT1
GFP construct only contains 
domains 5 and 6. The two constructs were examined under the microscope to see the 
effect of the truncations. 
As shown in Figure 6.3 Svp3
NT1
-GFP, is enriched within the nucleus. The majority of 
Svp3p that was localised to the cytoplasm in the wild-type construct, is no longer 
present. This implies that the domains deleted are crucial for normal localisation of 
Svp3p to the cytoplasm. The overall amount of Svp3-GFP also appears reduced in this 
strain, as the intensity of nuclear Svp3 –GFP doesn’t seem to increase. This construct 
is stable as judged from GFP stability blots (Dove, SK unpub). When subjected to 
0.9M NaCl osmotic stress, Svp3
NT1
-GFP still translocates to punctae, however this is 
restricted to the nucleus. The punctae also appear larger than those of the wild-type 
Svp3-GFP construct. These results suggest domains 5 and 6 may contribute to stress 
induced translocation of Svp3p.  
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Figure 6.3 Localisation of pUG36 Svp3 CT1 and NT1. 
               Unstressed                                      0.9M NaCl after 10 Minutes 
            DIC                        Svp3-GFP                   DIC                       Svp3-GFP     
 
 
pUG36-Svp3 GFP CT1 and NT1 constructs still translocate to punctae when given a salt tress. Shown 
above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type 
cells transformed with pUG36 Svp3
CT1
-GFP( top panel) and  pUG36 Svp3
NT1
-GFP( bottom panel)  The 
left-hand columns show low light DIC images. The right-hand columns show the GFP localisation of  
the Svp3-GFP constructs. The panels to the left show localisation under control conditions. The panels 
to the right show localisation after treatment with 0.9M NaCl. Images are representative of three 
replicate cultures. All strains were cultured in SC-Ura+25mg/L Met +2% glu medium and grown at 
25ºC. Scale bar represents 5µM. 
Previous data from Dr Steven Dove is shown below. The image shows the co-localisation of SVP
NT1
-
GFP with the nucleus marker DsRed-NLS. 
                 Svp3
NT1
-GFP                DsRed-NLS                         Merge     
 
 
The Svp3
CT1-
GFP mutant no longer has the increased nuclear concentration of Svp3-
GFP, as observed in the wild-type construct. This is because the domain necessary for 
nuclear localisation (domain 3) has been deleted. When the cells receive a 0.9M NaCl 
CT1 
construct 
NT1 
construct 
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stress Svp3
CT1-
GFP still translocates to a series of punctae structures. However, it is 
hard to differentiate these from those seen for wild-type Svp3-GFP. Both of the above 
results suggest that the whole protein is not required for stress induced translocation to 
be carried out. It would be interesting to see the amounts of PtdIns(3,5)P2 levels in 
Δsvp3 strains possessing the constructs, to see if they are sufficient to rescue defects 
in the lipid. 
A 2008 paper from the Emr group describing ART1/SVP3, details two mutants. They 
identify K486, a residue that becomes ubiquitinated, by Rsp5p. They also identified 
and mutated the PY motif which is also necessary for Svp3p ubquitination (Lin et al., 
2008). pUG36-Svp3 constructs bearing the above mutations were made using the Site 
overlap extension method (detailed in Chapter 2), to observe the roles of the residue/ 
motif in stress dependent translocation of Svp3p.   
 
Figure 6.4 Localisation of pUG36 Svp3 PAIA and K486R. 
    Unstressed                                                     0.9M NaCl after 10 Minutes 
            DIC                        Svp3-GFP                   DIC                       Svp3-GFP      
   
 
PAIA/PACA 
construct 
K486R 
construct 
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pUG36-Svp3 
PAIA/PACA
 and  pUG36-Svp3
K486R
  constructs still translocate to punctae when given a salt 
stress. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) 
of wild-type cells transformed with pUG36 Svp3
PAIA/PACA
( top panel) and  pUG36 Svp3
K486R
( bottom 
panel)  The left-hand columns show low light DIC images. The right-hand columns show the GFP 
localisation of  the SVP3-GFP construct. The panels to the left show localisation under control 
conditions. The panels to the right show localisation after treatment with 0.9M NaCl. Images are 
representative of three replicate cultures. All strains were cultured in SC-Ura+25mg/L Met +2% glu 
medium and grown at 25ºC. Scale bar represents 5µM. 
 
As shown in Figure 6.4 both Svp3
PAIA/PACA 
GFP and Svp3
K486R
GFP translocate to 
punctae when the cells receive a hyper-osmotic stress. In both constructs this 
translocation is maintained as in wild-type cells. It is unclear whether either of these 
constructs have different localisations to wild-type Svp3-GFP. However under control 
conditions, neither construct seems to localise to the nucleus as fully as the wild-type 
Svp3-GFP construct. 
To discover if there are any small differences with localisations of any of the 
constructs made, a series of co-localisations with known RFP markers were 
performed. This would allow identification of the compartment(s) the Svp3-GFP 
localises to.  
As shown previously Svp3-GFP is observed in both the cytoplasm and intensely in 
the nucleus of wild-type cells. The pools of Svp3-GFP do not form punctae and so do 
not discreetly co-localise with the RFP marked compartments (Figure 6.4). 
To observe what happens to Svp3-GFP when PtdIns(3,5)P2 levels increase, cells were 
treated with a hyperosmotic stress. It could be seen that Svp3-GFP had translocated 
into a numerous small punctate compartments, as observed previously (Figure 6.6).  
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Figure 6.5 Co-localisation of GFP- Svp3p under control conditions. 
           Snf7p (PVE)                Anp1p (ER)                 Chc1p (TGN)           Cop1p (GOLGI) 
 
In unstressed wild-type cells Svp3-GFP localises with both the cytoplasm and intensely in the nucleus. 
Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-
type cells containing various RFP tagged proteins acting as markers (middle panels) transformed with 
pUG36 Svp3-GFP(top panels).The bottom panel shows a merge of both red and green images for co-
localisation.  Strains were cultured in SC-Ura+25mg/L Met +2% glu medium and grown at 25ºC. 
These images are representative of three replicate cultures. Scale bar represents 5µM. 
 
 
 
 
 
 
 
Svp3 
-GFP 
RFP 
marker 
Merge 
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Figure 6.6 Co-localisation of GFP-Svp3p under stressed conditions. 
           Snf7p (PVE)                Anp1p (ER)                 Chc1p (TGN)           Cop1p (GOLGI) 
 
59.6% ±7.9*** 36.7% ±5.1*** 72.1% ±16.4*** 49.7% ±5.5*** Red co-
localisation 
23.2% ±1.7 14.9% ±5.4 24.3%±5.7 15.6% ±4.9 Random co-
localisation 
36.3% ±9.5 21.8% ±0.4 47.8%±15.2 34.2% ±7.9 Adjusted 
coloalisation 
[Significantly different from random co-localiation: ***P<0.001] 
In wild-type cells subjected to a 0.9M NaCl stress Svp3-GFP co localises with a number of RFP 
markers. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 
cells/ml) of  wild-type cells containing various RFP tagged proteins acting as markers (middle panels) 
transformed with pUG36 SVP3-GFP(top panels). The bottom panel shows a merge of both red and 
green images for co-localisation. Strains were cultured in SC-Ura+25mg/L Met +2% glu medium and 
grown at 25ºC. The cells were resuspended in 0.9M NaCl microscope buffer prior to microscopy. 
These images are representative of three replicate cultures. Scale bar represents 5µM. 
 
The stress induced Svp3-GFP punctae compartments, do not fully co localise with one 
compartment alone. Significant co-localisation was observed with all four of the RFP 
markers examined. Note that co-localisations were carried out for RFP markers as the 
Svp3 
-GFP 
RFP 
marker 
Merge 
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GFP punctae were too small and numerous to  quantify in the same manner. Other 
techniques could have been applied but for consistency the method stated in Chapter 2 
was applied.  
To see whether any of the mutants had defects in stress induced translocation, co-
localisations with the RFP markers were looked at for the other Svp3-GFP constructs. 
Figure 6.7 Co-localisation of GFP-Svp3p 
CT1
 under control conditions. 
           Snf7p (PVE)                Anp1p (ER)                 Chc1p (TGN)           Cop1p (GOLGI) 
        
In unstressed wild-type cells Svp3 
CT1
-GFP localises with both the cytoplasm and occasionally in 
punctae. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 
cells/ml) of wild-type cells containing various RFP tagged proteins acting as markers (middle panels) 
transformed with pUG36 Svp3
CT1
-GFP(top panels).The bottom panel shows a merge of both red and 
green images for co-localisation.  Strains were cultured in SC-Ura+25mg/L Met +2% glu medium and 
grown at 25ºC. These images are representative of three replicate cultures. Scale bar represents 5µM. 
 
 Svp3
CT1
-GFP construct localises to the cytoplasm under control conditions like wild-
type Svp3-GFP. 
Svp3 
-GFP 
RFP 
marker 
Merge 
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Figure 6.8 Co-localisation of GFP- Svp3p 
CT1
 under stressed conditions. 
          Snf7p (PVE)                Anp1p (ER)                 Chc1p (TGN)           Cop1p (GOLGI) 
 
68.4% ±8.5*** 33.49% ±.0.5 58.2% ±2.5*** 54.9% ±6.7*** Red co-
localisation 
27.4% ±4.6 
 
19.7% ±6.4 29.0% ±1.5 25.1% ±5.1 Random co-
localisation 
41.0% ±3.9 13.8% ±6.9 29.2% ±3.7 29.7% ±1.6 Adjusted 
coloalisation 
[Significantly different from random co-localiation: ***P<0.001, N/S not indicated] 
 
In wild-type cells subjected to a 0.9M NaCl stress Svp3
CT1
-GFPcolocalises with a number of RFP 
markers. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 
cells/ml) of  wild-type cells containing various RFP tagged proteins acting as markers (middle panels) 
transformed with pUG36 Svp3
CT1
-GFP(top panels). The bottom panel shows a merge of both red and 
green images for co-localisation. Strains were cultured in SC-Ura+25mg/L Met +2% glu medium and 
grown at 25ºC. The cells were resuspended in 0.9M NaCl microscope buffer prior to microscopy. 
These images are representative of three replicate cultures. Scale bar represents 5µM. 
Under hyper osmotic stress, wild-type cells Svp3
CT1
-GFP still translocates to smaller 
punctae compartments that fill the cell, however these appear to be less numerous 
than in wild-type Svp3-GFP. Significant colocalistaion is still seen with three of the 
markers, Snf7p, Chc1p and Cop1p, however no significant  co-localisation is 
observed with the Anp1p RFP marked compartments, which marks the ER. It appears 
Svp3 
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Merge 
 257 
that one of the domains deleted in this construct is responsible for translocation of 
Svp3p to the ER compartment. The Svp3
NT1
 construct was also examined in the same 
way. 
 
Figure 6.9 Co-localisation of GFP-Svp3p
NT1
 under control conditions. 
          Snf7p (PVE)                Anp1p (ER)                 Chc1p (TGN)           Cop1p (GOLGI) 
 
In unstressed wild-type cells Svp3 
NT1
-GFP localises with the nucleus. Shown above are fluorescence 
images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type cells containing various 
RFP tagged proteins acting as markers (middle panels) transformed with pUG36 Svp3
NT1
-GFP(top 
panels).The bottom panel shows a merge of both red and green images for co-localisation.  Strains 
were cultured in SC-Ura+25mg/L Met +2% glu medium and grown at 25ºC. These images are 
representative of three replicate cultures. Scale bar represents 5µM 
 
As shown in Figure 6.9, and as previously observed, in unstressed cells Svp3
NT1
-GFP 
localises to the nucleus compartment only. No co-localisation is observed with any of 
the RFP markers examined. 
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Figure 6.10 Co-localisation of GFP-Svp3p
NT1
 under stressed conditions. 
          Snf7p (PVE)                Anp1p (ER)                 Chc1p (TGN)           Cop1p (GOLGI) 
 
6.9% ±3.3 15.6% ±4.1 14.1% ±3.4 12.4% ±3.2 Red co-
localisation 
9.6% ±6.3 16.5% ±2.2 10.6% ±6.9 17.5% ±5.1 Random co-
localisation 
-2.8% ±3.0 -0.9% ±1.9 -3.5% ±3.5 -5.0% ±1.9 Adjusted 
coloalisation 
[No significant difference was observed beween co-localiations and random colocalisation data] 
 
In wild-type cells subjected to a 0.9M NaCl stress Svp3
NT1
-GFP does not co-localise with any of the 
RFP markers examined. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 
1 x 10
7
 cells/ml) of  wild-type cells containing various RFP tagged proteins acting as markers (middle 
panels) transformed with pUG36 Svp3-GFP(top panels).The bottom panel shows a merge of both red 
and green images for co-localisation.  Strains were cultured in SC-Ura+25mg/L Met +2% glu medium 
and grown at 25ºC. The cells were resuspended in 0.9M NaCl microscope buffer prior to microscopy. 
These images are representative of three replicate cultures. Scale bar represents 5µM. 
 
Svp3
NT1
-GFP still translocates to punctae when cells are subjected to a 0.9M NaCl 
stress. However no significant co-localisation is seen with any of the RFP markers 
Svp3 
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examined anymore as shown in Figure 6.10. The punctae translocation is restricted to 
the nucleus as the construct lacks the domain responsible for cytoplasm localisation 
and translocation. The punctae present after stress induced translocation appear to be 
morphologically different to those observed in wild-type Svp3-GFP. The punctate 
compartments are not as distinct and are somewhat enlarged. This may suggest that 
the domains deleted are also crucial for formation of some punctae and the regulation 
of the granular size. 
The localisation of the Svp3-GFP point mutations was also examined. 
Figure 6.11 Co-localisation of GFP-Svp3p 
K486R
 under control conditions. 
        Snf7p (PVE)                Anp1p (ER)                 Chc1p (TGN)           Cop1p (GOLGI) 
 
In unstressed wild-type cells Svp3
K486R
-GFP co localises with the nucleus. Shown above are 
fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type cells 
containing various RFP tagged proteins acting as markers (middle panels) transformed with Svp3
K486R
-
GFP (top panels).The bottom panel shows a merge of both red and green images for co-localisation.  
Strains were cultured in SC-Ura+25mg/L Met +2% glu medium and grown at 25ºC. These images are 
representative of three replicate cultures. Scale bar represents 5µM. 
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As shown in Figure 6.11 under control conditions Svp3
K486R
 GFP localises to both the 
cytoplasm and the nucleus, although the nuclear signal appears to be weaker than in 
wild-type Svp3-GFP. Co-localisations with the RFP markers under hyper osmotic 
stress, were performed, to see if any difference in the translocation of Svp3
K486R
GFP 
could be observed. 
Figure 6.12 Co-localisation of GFP-Svp3p 
K486R
 under stressed conditions. 
           Snf7p (PVE)                Anp1p (ER)                 Chc1p (TGN)           Cop1p (GOLGI) 
 
65.9% ±9.6*** 42.1% ±0.5 78.9% ±8. 6*** 54.8% ±9.1*** Red co-
localisation 
45.5% ±13.3 43.7% ±4.7 53.1% ±9.7 15.1% ±1.1 Random co-
localisation 
20.3% ±3.7 -1.7% ±4.2 25.8% ±2.6 39.8% ±8.1 Adjusted 
coloalisation 
[Significantly different from random co-localiation: ***P<0.001,  N/S not indicated] 
 
In wild-type cells subjected to a 0.9M NaCl stress Svp3
K486R
-GFP co-localises with a variety of RFP 
markers. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 
cells/ml) of  wild-type cells containing various RFP tagged proteins acting as markers (middle panels) 
transformed with pUG36 Svp3
K486R
-GFP (top panels). The bottom panel shows a merge of both red and 
Svp3 
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green images for co-localisation. Strains were cultured in SC-Ura+25mg/L Met +2% glu medium and 
grown at 25ºC. The cells were resuspended in 0.9M NaCl microscope buffer prior to microscopy. 
These images are representative of three replicate cultures. Scale bar represents 5µM. 
 
As shown in Figure 6.12 Svp3p
K486R
-GFP still translocates to a number of small 
punctae when cells are treated with a 0.9M NaCl stress. Unlike the wild-type 
construct, there no longer appears to be significant co-localisation with the Anp1p 
RFP marker at the ER. Co-localisation decreases from 21.8% to -1.7%. This is a clear 
decrease; it suggests ubiquitination is necessary for translocation to the ER. Co-
localisation with the Snf7p (20.4% vs 36.3%) and Chc1p (25.8% vs 47.8%) RFP 
markers is also decreased but is still significant. This may mean that ubiquitination is 
also necessary for Svp3p to efficiently translocate to the pre-vacuolar, endosome and 
TGN compartments. Translocation to the Golgi appears uninterrupted. 
 
Localisation of the Svp3
PAIA/PACA 
GFP
 
construct was also examined. This construct 
has a mutated PY motif at amino acids 678-681 (PPIY) and 689-692 (PPCY) so it can 
no longer bind to the WW domains of Rsp5, which is required for stress induced 
endocytosis of some cargoes, and is necessary to achieve Svp3p ubiquitination (Lin et 
al., 2008).  
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Figure 6.13 Co-localisation of GFP-Svp3p
PAIA/PACA 
under control conditions. 
           Snf7p (PVE)                Anp1p (ER)                 Chc1p (TGN)           Cop1p (GOLGI) 
 
In unstressed wild-type cells Svp3 
PAIA/PACA
-GFP localises with the nucleus. Shown above are 
fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of  wild-type cells 
containing various RFP tagged proteins acting as markers (middle panels) transformed with pUG36 
Svp3 
PAIA/PACA
 (top panels).The bottom panel shows a merge of both red and green images for co-
localisation. Strains were cultured in SC-Ura+25mg/L Met +2% glu medium and grown at 25ºC. 
These images are representative of three replicate cultures. Scale bar represents 5µM. 
 
As shown in Figure 6.13 the localisation of Svp3 
PAIA/PACA
GFP is in the cytoplasm. 
The construct is no longer observed intensely in the nucleus of wild-type cells, this 
suggest that the C- terminal PY motif along with the NLS signal is required for 
nuclear localisation of Svp3p. 
Co-localisations were also carried out when the cells were subjected to hyper osmotic 
stress to see whether translocation of Svp3p is affected by mutation of the PY motif, 
results are shown in Figure 6.14.  
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Figure 6.14 Co-localisation of GFP-Svp3p
PAIA/PACA
 under stressed conditions. 
           Snf7p (PVE)                Anp1p (ER)                 Chc1p (TGN)           Cop1p (GOLGI) 
 
80.2% ±9.3*** 47.9% ±2.3 84.8% ±3.9*** 64.7% ±3.4*** Red co-
localisation 
49.5% ±4.8 37.1% ±0.9 50.1% ±11.1 31.9% ±9.9 Random co-
localisation 
30.6% ±4.5 10.8% ±3.1 34.7% ±9.9 32.8% ±6.5 Adjusted 
coloalisation 
[Significantly different from random co-localiation: ***P<0.001,  N/S not indicated] 
 
In wild-type cells subjected to a 0.9M NaCl stress Svp3
PAIA/PACA
-GFP co-localises with a variety of RFP 
markers. Shown above are fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 
cells/ml) of  wild-type cells containing various RFP tagged proteins acting as markers (middle panels) 
transformed with pUG36 Svp3
PAIA/PACA
-GFP (top panels). The bottom panel shows a merge of both red 
and green images for co-localisation. Strains were cultured in SC-Ura+25mg/L Met +2% glu medium 
and grown at 25ºC. The cells were resuspended in 0.9M NaCl microscope buffer prior to microscopy. 
These images are representative of three replicate cultures. Scale bar represents 5µM. 
 
Svp3
PAIA/PACA 
GFP translocates to a number of punctate compartments, and significant 
co-localisations can be observed with three of the RFP markers examined (Snf7p, 
Cop1p and Chc1p). The construct however appears to have no significant co-
Svp3 
-GFP 
RFP 
marker 
Merge 
 264 
localisation with the Anp1p positive compartment, the ER. Levels are reduced to 
10.8% compared to 31.8% in wild-type Svp3-GFP. Small decreases in co-localisation 
with the Snf7p (30.6% vs 36.3%) and Chc1p (34.7% vs 47.8%) markers are observed. 
Differences in these compartment co-localisations were also observed for the K486R 
mutant. Suggesting that ubiquitination is necessary for Svp3p to efficiently translocate 
to some compartments. It may also be the result of reduced interaction with Rsp5p 
due to mutation of the PY motifs. 
As an additional note the addition of the Svp3-GFP plasmid seems to protect the 
vacuoles of wild-type cells against hyper osmotic shock. It seems to prevent the 
vacuoles from fragmenting into many smaller compartments that is normally 
observed. All the constructs seem to provide this protection suggesting that over 
expression of Svp3p can help prevent vacuole fragmentation. This may be due to 
decreased levels of PtdIns(3,5)P2 present due to Svp3p over expression, as a Δsvp3 
cell has increased levels of PtdIns(3,5)P2  before and after stress. Another explanation 
could be that over expression of Svp3p allows the cell to regulate osmolytes during 
osmotic shock better. It may also be a secondary consequence of increased Svp3p 
levels. It is intriguing that this effect is observed in all the constructs, which may 
suggest that all the constructs are sufficient to decrease levels of PtdIns(3,5)P2. Again 
labelling to see the effects of the constructs on lipid production would help to shed 
light on this matter.  
To examine whether Δsvp3 cells have a defect in MVB sorting, an assay, using the 
MVB cargo Phm5-GFP, was conducted. As previously explained in Chapter 4, in 
wild-type cells Phm5p can be trafficked normally and is visualised inside the vacuole. 
In cells where trafficking is disrupted, Phm5-GFP is visualised on the vacuolar 
membrane. This is a property of Δfab1 cells and a consequence of a reduction of 
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PtdIns(3,5)P2 levels. In Δfab1 cells, the trafficking defect can be overcome if a 
ubiquinated Phm5-GFP construct is used. This suggests that the failure of Δfab1 cells 
to sort Phm5p correctly is due to the defect in ubiquitination. As discussed in the 
introduction Svp3p is known to interact with Rsp5p a protein involved in 
ubiquitination. Ttherefore it was examined whether Δsvp3 cells shared the same 
defects in MVB sorting as Δfab1 cells. There may already be a role for Svp3p in 
ubiquitination and this might be what links the SVP3 pathway with the FAB1 pathway 
and PtdIns(3,5)P2. 
Figure 6.15 Localisation of pUG36 Phm5-GFP and pUG36 UbPhm5-GFP  
                      pUG36-Phm5                               pUG36-UbPhm5 
               DIC                   GFP                     DIC                          GFP  
 
pUG36-Phm5 can be visualised in the vacuole if trafficked correctly. Shown above are fluorescence 
images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type (top panel), ∆fab1 (middle 
panel) and ∆svp3(bottom panel) transformed with pUG36-Phm5 (left hand panel) or pUG36-UbPhm5 
(right hand panel) . The left-hand column shows low light DIC images. The right-hand column shows 
GFP localisation. These images are representative of three replicate cultures. All strains were cultured 
in SC-Ura+2% glu medium and grown at 25ºC. Scale bar represents 5µM. 
 
Wild type 
Δfab1 
Δsvp3 
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As shown in Figure 6.15 it appears that Δsvp3 cells don’t possess a defect in 
trafficking of Phm5-GFP, as both constructs can be correctly sorted to the vacuole. 
Another cargo that is also missorted in PtdIns(3,5)P2 due to the defect in MVB sorting 
is Ste3-GFP so localisation of this construct was also examined. 
 
 
Figure 6.16 Ste3-GFP localisation . 
 
                                  DIC                             pRS316-Ste3 
               
Ste3-GFP can be visualised in the vacuole if trafficked correctly. Shown above are fluorescence images 
of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type (top panel), ∆fab1 (middle panel) 
and ∆svp3 (bottom panel) transformed with pRS316-STE3-GFP. The left-hand column shows low light 
DIC images. The right-hand column shows GFP localisation. These images are representative of three 
replicate cultures. All strains were cultured in SC-His+2% glu medium and grown at 25ºC. Scale bar 
represents 5µM. 
Δfab1 
Δsvp3 
Wild type 
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As shown in Figure 6.16 Ste3-GFP is trafficked correctly in the wild-type strain and 
therefore can be observed inside the vacuole. In Δfab1 cells, the trafficking of Ste3p is 
disrupted and Ste3-GFP becomes missorted. Ste3p is no longer correctly targeted to 
the vacuole and is instead visualised on the vacuole membrane. In Δsvp3 cells it 
appears that the trafficking of Ste3-GFP is unaffected and it is still correctly targeted 
to the vacuole, where it is clearly visualised.  
These experiments suggest that mutation of SVP3 does not lead a defect in sorting at 
the MVB. It is likely that a defect in trafficking is not observed because levels of 
PtdIns(3,5)P2 are not reduced, in fact they are increased. A defect would have still 
been observed if Svp3p was an effector involved in this process, therefore it is likely 
that Svp3p is not involved in MVB sorting.  
Cells that have a defect in PtdIns(3,5)P2 levels or are involved in the associated 
pathway often have a defect in the localisation of a potential PtdIns(3,5)P2 effector 
protein Atg18p/Svp1p. Atg18p is also known to have a regulatory effect on 
PtdIns(3,5)P2levels. When labelled Δatg18 cells also have increased levels of 
PtdIns(3,5)P2 with and without stress. The localisation of GFP-Atg18p was therefore 
examined in Δsvp3 cells to see whether Svp3p may have a potential connection with 
the PtdIns(3,5)P2 pathway. 
As shown in Figure 6.17, in wild-type cells pUG36 GFP-Atg18p localises on the 
vacuole membrane. Small punctate structures coming off of the vacuole are also 
observed. When the cell is given a hyper-osmotic stress the amount of GFP-Atg18p 
on the vacuole membrane increases and is seen in bigger punctae structures, again 
coming off the vacuole. 
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Figure 6.17 Localisation of GFP-Atg18p. 
                             Control                                     0.4M NaCl after 10 minutes 
            DIC                      GFP-Atg18p                    DIC                         GFP-Atg18p 
 
GFP-Atg18p can be visualised on the vacuole membrane, and this localisation is increased when cells 
are subjected to a hyperosmotic stress. Shown above are fluorescence images of logarithmic phase 
cultures (5 x 10
6
 – 1 x 107 cells/ml) of wild-type (top panel), ∆fab1 (middle panel) and ∆svp3 (bottom 
panel) transformed with pUG36-GFP-Atg18p. The left-hand panel shows localisation under control 
conditions. The right hand panel shows localisation under 0.4M NaCl conditions. The left hand 
columns show low light DIC images. The right-hand columns show GFP localisation. These images are 
representative of three replicate cultures. All strains were cultured in SC-Ura-Met+2% glu medium 
and grown at 25ºC. Scale bar represents 5µM. 
 
In Δfab1 cells GFP-Atg18p can no longer be visualised on the vacuole membrane and 
is instead observed diffusely throughout the cell, probably due to the strain being 
devoid of PtdIns(3,5)P2. This localisation is unchanged when the cell is treated with a 
0.4M NaCl stress. The localisation of GFP-Atg18p in Δsvp3 cells is similar to that 
observed in wild-type. Under control conditions GFP-Atg18p is again observed on the 
Wild type 
Δfab1 
Δsvp3 
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vacuole membrane, with around three small punctae structures where fluorescence is 
increased. When Δsvp3 cells are subjected to the 0.4M NaCl stress GFP-Atg18p again 
increases on the vacuole. The levels of GFP-Atg18p observed on the vacuole 
membrane are not as high as those observed in wild-type cells, but instead GFP is 
seen in much larger disc like punctae structures that protrude from the vacuole 
membrane. It seems that Δsvp3 cells posses a slight defect in Atg18p localisation 
under stressed conditions, this is likely due to increased amounts of PtdIns(3,5)P2 
being present at an aberrant location. This may implicate Svp3p in the PtdIns(3,5)P2 
controlled stress response that may also involve Atg18p. It also helps explain the 
observation above that the Svp3-GFP constructs seem to protect the cell from vacuole 
fragmentation. Atg18p appears to be involved in vacuole fragmentation as observed in 
Chapter 5. Svp3p also seems to regulate localisation of Atg18p. Therefore increased 
levels of Svp3p will affect localisation of Atg18p to the vacuole, which may protect 
the cell from vacuole fragmentation. 
 
6.3 Discussion 
Data has been presented which suggests that the ubiquitination motif present in Svp3p 
is necessary for at least some of it localisation to Anp1p positive vesicles under salt 
stress. This is demonstrated through decreased significant localisation to the ER in all 
constructs examined. Intriguingly in the K486R mutant, which possesses a defect in 
ubiquitination, no significant co-localisation with this compartment is observed. ER 
localisation is also disrupted in the PY motif mutant. This suggests that when cells 
receive a hyper-osmotic stress, ubiquitination of Svp3p is necessary in order to 
translocate it to the ER.  
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In all the constructs examined apart from the NT1 mutant, which had no clear co-
localisation with any of the RFP markers examined, translocation to the Cop1p RFP 
marked compartment;  the Golgi, was uninterrupted.  
Thus no link with the Fab1p pathway was firmly established for this protein, despite 
some intriguing evidence; including the mislocalisation of GFP-Atg18p, presumably 
caused by the hyper-elevated levels of PtdIns(3,5)P2. The problem has been that 
Svp3p is obviously regulated my multiple pathways and is subject to extremely 
complex signalling. My data alone suggests at least 3 modes of localisation and there 
could be more. This protein will be a fascinating subject for future study. 
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CHAPTER 7 
Concluding remarks and future work. 
 
7.1 Fab1p in the early endocytic system 
  
It is now becoming clear, both from previous work in higher eukaryotes and also from 
the data  presented here, that there is at least one role for Fab1p and PtdIns(3,5)P2 in 
the early endocytic system; yet the precise molecular function of this pathway is 
proving hard to define. The major contribution my work makes to this issue is to link 
Fab1p function to Vps13p; because Vps13p is a conserved protein, that is thought to 
be Golgi resident and to affect both trafficking of some cargos in the early endocytic 
system and also the recycling of certain proteins from the forming MVB, back to the 
Golgi. This mirrors my data for Fab1p, because PtdIns(3,5)P2 is influencing recycling 
of Chs3p between the Golgi and the PGE and also appears to influence the recycling 
of the M6R related protein, Mrl1p. The latter result is important because recycling of 
Mrl1p could now be used as a screen to isolate additional components of the Fab1p 
dependent late endosome to Golgi recycling system. 
 
Vps13p appears to act upstream of Fab1p; since overexpression of this lipid kinase 
was able to correct the trafficking defects  observed when Vps13p function was 
compromised. A similar relationship exists between Fab1p and AP-1, suggesting that 
Vps13p and AP-1 may work closely together in time and space. This bears further 
investigation and would have been my next set of experiments, if time had allowed. It 
would also be beneficial to examine levels of lipids in Δvps13 cells; because this was 
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what enabled Phelan et al (2002) to determine that the components of AP-1 were 
indeed upstream of Fab1p in Cps1p trafficking. A search for physical and genetic 
interactions between Vps13p and AP-1 is needed  to define their precise relationship. 
We would also have liked to have spent more time defining where Chs3p is building 
up after double deletion of Chs6p and Fab1p; because this would define what role 
Fab1p plays in the early endocytic system, though it must be  noted that decades of 
research have been insufficient to allow most researchers to agree on an exact role for 
AP-1. In order to study this question, epitope tagged Chs3p would have to be 
localised either by immuno-gold EM approaches, using antibodies labelled with 
different sized gold particles for marker proteins specific for each compartment; or by 
cell fractionation techniques, though a study by Scheckman’s group using this latter 
approach did not take our knowledge much further. 
 
It is also clear from my work that Fab1p may interact with retromer, but it is not an 
integral part of the core machinery and appears to only influence the trafficking of 
certain cargoes; in this case the M6R receptor like protein Mr11p. This might indicate 
an indirect role for Fab1p but what makes this less likely is the fact that Vac14p 
appears also to have a separate and distinct role in retromer function in yeast that 
appears to be independent of PtdIns(3,5)P2. This probably explains the results 
observed in vac14
-/-
 mice where M6R recycling was impaired and highlight the 
importance of checking any result by several methods; in this case mVac14 function 
is likely independent of PIKfyve, as it has proved from my studies in yeast. 
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The localisation of Vps13p would also answer a number of important questions in my 
system; especially if this localisation changes in cells where AP-1 or Fab1p function 
has been compromised. Notably, it would be a potential way of defining where the 
trafficking event mediated by Fab1p and AP-1 is likely to be occurring; in animal 
cells Vps13p seems to localise to the Golgi, though it is uncertain if the same is the 
case in the yeast system. One problem that was encountered working with Vps13p 
was its sheer size; the protein is encoded by an ORF that is over 9 kb in length and is 
one of the largest proteins in the whole genome of S cerevisiae. 
 
Another set of experiments that certainly need to be extended, would be to ‘mine’ my 
mutant collection for more components of the novel Fab1p mediated pathway Chs3p 
recycling pathway. With hindsight, FACs analysis is a far more powerful method for 
pre-enrichment of mutants than classical plating techniques and also seemed to 
eliminate many of the cell wall mutants that seem to be the largest group of ‘false 
positives’ found in any screen relying on drug sensitivity. Transposon mutagenesis 
would also be used to increase the pool of mutants if time allowed; because of the 
ease of isolating the mutated gene versus the problems of determining it via 
complementation analysis using plasmid libraries. 
 
7.2 Role of Svp3p 
It seems clear from my work that Svp3p is likely to lie upstream of Fab1p; because of 
the hyper-elevation of PtdIns(3,5)P2 synthesis observed in the Δsvp3 mutant. Indeed, 
so perturbed is PtdIns(3,5)P2 metabolism in ∆svp3 cells that Atg18p is actually 
mislocalised during osmotic stress; to aberrant looking protrusions of the vacuole 
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membrane or a closely associated organelle. With hindsight, it seems obvious that 
Svp3p acts upstream of Fab1p but the similarity of the synthesis defect to that 
observed in Δatg18 cells initially lead earlier researchers to conclude that this might 
have been an effector of PtdIns(3,5)P2. However, my experiments rule out the 
translocation of Svp3p being dependent upon PtdIns(3,5)P2; indeed they suggest that 
even ubiquitin and Rsp5p binding are only part of the story and imply that Svp3p is 
binding to many different types of proteins or protein domains during hyper-osmotic 
stress. This assertion is borne out by the fact that a screen, looking for mutants that 
fail to translocate Svp3p, in which the entire set of viable S. cerevisiae deletion 
mutants were transformed with GFP-Svp3p and analysed for Svp3p stress induced 
translocation, failed to reveal a single mutant in which translocation was grossly 
impaired. This again suggests many targets and pathways that contribute to Svp3p 
translocation. My analysis of where Svp3p is translocating does indicate that it is 
binding to proteins in every conceivable compartment and suggests that this protein is 
part of some global stress pathway that is activated to bind proteins under conditions 
of cellular stress. Until a molecular role for Svp3p is defined, it will be hard to make 
further progress, and this is hampered by the fact it shows little homology to any other 
proteins. One clue to its function may lie in the prediction that part of Svp3p might 
fold like an arrestin; a series of proteins involved in the ‘down-regulation’ of G-
protein coupled receptors after ligand activation in animal cells. This down-regulation 
results in internalisation of the receptor following phosphorylation, so it would be 
interesting to examine if Svp3p translocation follows on from any kind of 
phosphorylation. Previous work has examined a possible interaction with the Hog1p 
MAP-kinase pathway that is known to be activated by osmotic stress, but found that 
Svp3p translocation is normal in Δhog1 cells (Dove, SK unpub). Therefore, an easier 
 275 
way of determining how Svp3p works would be to TAP tag Svp3p and look at which 
proteins are bound to Svp3p under basal conditions and under those of stress. As this 
analysis would also isolate binding proteins as bands on a gel, these proteins could not 
only be identified but also analysed by FTICR mass spectrometry for covalent 
modifications such as phosphorylation. Such an analysis is fairly simple once protein 
is available, although it is expensive. Indeed it has been used successfully in our lab to 
map phosphorylation sites on Vps41p (K Dong unpub). 
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Appendix 1: Visulisation of the mutants.             EMS mutants 1-1 to 1-6 
 
        DIC     Calcofluor Chs3-GFP        Phm5-GFP   UbPhm5-GFP 
       DIC         GFP DIC    GFP  
 
1-1 
1-2 
1-3 
1-4 
1-5 
1-6 
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EMS mutants 1-7 to 1-12 
 
        DIC     Calcofluor Chs3-GFP        Phm5-GFP   UbPhm5-GFP 
       DIC         GFP      DIC          GFP  
 
1-7 
1-8 
1-9 
1-10 
1-11 
1-12 
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EMS mutants 1-13 to 1-18 
 
        DIC     Calcofluor Chs3-GFP        Phm5-GFP   UbPhm5-GFP 
       DIC         GFP      DIC         GFP  
 
1-13 
1-14 
1-15 
1-16 
1-17 
1-18 
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EMS mutants 1-19 to 1-24 
 
        DIC     Calcofluor Chs3-GFP        Phm5-GFP   UbPhm5-GFP 
       DIC         GFP     DIC    GFP  
         
1-19 
1-20 
1-21 
1-22 
1-23 
1-24 
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EMS mutants 1-25 to 1-26 
 
        DIC     Calcofluor Chs3-GFP        Phm5-GFP   UbPhm5-GFP 
       DIC         GFP     DIC    GFP  
 
 
 
Fluorescence images of logarithmic phase cultures (5 x 10
6
 – 1 x 107 cells/ml) of mutant cells transformed with the indicated GFP constructs.. These images are 
representative of three replicate cultures. All strains were cultured in SC-His, Sc-Ura or YETD G418 media+2% glu medium and grown at 25ºC. All panels represent 11µM. 
 
 
 
 
 
1-25 
1-26 
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Appendix 2: Spot dilutions of the Mutants 
 
     25
o
C                                  200µg Calcofluor                       37
o
C 
 
 
 
Wild type 
Δchs6 
Δfab1Δchs6 
1-1 
1-2 
1-3 
1-4 
1-6 
1-5 
1-7 
1-8 
1-9 
1-10 
1-11 
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Spot dilutions of Mutants 
 
     25
o
C                                  200µg Calcofluor                       37
o
C 
 
 
1-13 
1-12 
1-14 
1-15 
1-16 
1-17 
1-18 
1-20 
1-19 
1-21 
1-22 
1-23 
1-24 
1-25 
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Spot dilutions of Mutants 
     25
o
C                                  200µg Calcofluor                       37
o
C 
 
                  
Wild type 
Δchs6 
Δfab1 
2-1 
2-2 
2-3 
2-4 
2-7 
2-6 
2-8 
2-9 
2-13 
2-10 
2-11 
2-5 
2-12 
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Spot dilutions of Mutants 
     25
o
C                                  200µg Calcofluor                       37
o
C 
 
 
                  
2-15 
2-14 
2-16 
2-17 
2-18 
2-19 
2-20 
2-23 
2-22 
2-24 
2-25 
2-29 
2-26 
2-27 
2-21 
2-28 
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Spot dilutions of Mutants 
     25
o
C                                  200µg Calcofluor                       37
o
C 
 
                  
 
 
 
 
Mutant strains were grown to exponential phase till about ~1 x 10
7
 cells/ml in YPD + 2% glu for wild type cells or added G418 for mutants. Dilution assay was carried out 
as described in methodology section. Cells were serially diluted five-fold then grown on YTD+2% glu agar plates or on the same plate but with 200µg/ml calcofluor white at 
25
 o
C and on YETD plates at37
 o
C for 3 days.  
 
 
2-31 
2-30 
2-32 
2-33 
2-34 
2-35 
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Appendix 3: Complementation analysis of mutants 
Complementation analysis carried was carried out as described in Chapter 2. The mutants in the first column indicate those that have mating type a.  Those 
highlighted in grey could not be successfully backcrossed and therefore  matings have not been carried out. Strains in rows represent the α mating type mutants. 
Mutant 1-1 1-2 1-3 1-4 1-5 1-6 1-7 1-8 1-9 1-10 1-11 1-12 1-13 1-14 1-15 1-16 1-17 1-18 1-19 1-20 1-21 1-22 1-23 1-24 1-25 1-26 
1-1 X - - - - - - - - - - - - - - - - - - - - - - - - - 
1-2 - X - - - - - - - - - - - - - - - - - - - - - - - - 
1-3 - - X - - - - - - - - - - - - - - - - - - - - - - - 
1-4 - - - X - - - - - - - - - - - - - - - - - - - - - - 
1-5 - - - - X - - - - - - - - - - - - - - - - - - - - - 
1-6 - - - - - X - - - - - - - - - - - - - - - - - - - - 
1-7 - - - - - - X - - - - - - - - - - - - - - - - - - - 
1-8 - - - - - - - X - - - - - - - - - - - - - - - - - - 
1-9 - - - - - - - - X - - - - - - - - - - - - - - - - - 
1-10 - - - - - - - - - X - - - - - - - - - - - - - - - - 
1-11                                                     
1-12 - - - - - - - - - - - X - - - - - - - - - - - - - - 
1-13 - - - - - - - - - - - - X - - - - - - - - - - - - - 
1-14 - - - - - - - - - - - - - X - - - - - - - - - - - - 
1-15 - - - - - - - - - - - - - - X - - - - - - - - - - - 
1-16 - - - - - - - - - - - - - - - X - - - - - - - - - - 
1-17 - - - - - - - - - - - - - - - - X - - - - - - - - - 
1-18 - - - - - - - - - - - - - - - - - X - - - - - - - - 
1-19 - - - - - - - - - - - - - - - - - - X - - - - - - - 
1-20 - - - - - - - - - - - - - - - - - - - X - - - - - - 
1-21 - - - - - - - - - - - - - - - - - - - - X - - - - - 
1-22 - - - - - - - - - - - - - - - - - - - - - X - - - - 
1-23 - - - - - - - - - - - - - - - - - - - - - - X - - - 
1-24 - - - - - - - - - - - - - - - - - - - - - - - X - - 
1-25 - - - - - - - - - - - - - - - - - - - - - - - - X - 
1-26 - - - - - - - - - - - - - - - - - - - - - - - - - X 
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Mutant 2-1 2-2 2-3 2-4 2-5 2-6 2-7 2-8 2-9 2-10 2-11 2-12 2-13 
1-1 - - - - - - - - - - - - - 
1-2 - - - - - - - - - - - - - 
1-3 - - - - - - - - - - - - - 
1-4 - - - - - - - - - - - - - 
1-5 - - - - - - - - - - - - - 
1-6 - - - - - - - - - - - - - 
1-7 - - - - - - - - - - - - - 
1-8 - - - - - - - - - - - - - 
1-9 - - - - - - - - - - - - - 
1-10 - - - - - - - - - - - - - 
1-11                           
1-12 - - - - - - - - - - - - - 
1-13 - - - - - - - - - - - - - 
1-14 - - - - - - - - - - - - - 
1-15 - - - - - - - - - - - - - 
1-16 - - - - - - - - - - - - - 
1-17 - - - - - - - - - - - - - 
1-18 - - - - - - - - - - - - - 
1-19 - - - - - - - - - - - - - 
1-20 - - - - - - - - - - - - - 
1-21 - - - - - - - - - - - - - 
1-22 - - - - - - - - - - - - - 
1-23 - - - - - - - - - - - - - 
1-24 - - - - - - - - - - - - - 
1-25 - - - - - - - - - - - - - 
1-26 - - - - - - - - - - - - - 
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Mutant 2-14 2-15 2-16 2-17 2-18 2-19 2-20 2-21 2-22 2-23 2-24 2-25 2-26 2-27 2-28 2-29 2-30 2-31 2-32 2-33 2-34 2-35  
1-1 - - - - - - - - - - - - - - - - - - - - - -  
1-2 - - - - - - - - - - - - - - - - - - - - - -  
1-3 - - - - - - - - - - - - - - - - - - - - - -  
1-4 - - - - - - - - - - - - - - - - - - - - - -  
1-5 - - - - - - - - - - - - - - - - - - - - - -  
1-6 - - - - - - - - - - - - - - - - - - - - - -  
1-7 - - - - - - - - - - - - - - - - - - - - - -  
1-8 - - - - - - - - - - - - - - - - - - - - - -  
1-9 - - - - - - - - - - - - - - - - - - - - - -  
1-10 - - - - - - - - - - - - - - - - - - - - - -  
1-11                                              
1-12 - - - - - - - - - - - - - - - - - - - - - -  
1-13 - - - - - - - - - - - - - - - - - - - - - -  
1-14 - - - - - - - - - - - - - - - - - - - - - -  
1-15 - - - - - - - - - - - - - - - - - - - - - -  
1-16 - - - - - - - - - - - - - - - - - - - - - -  
1-17 - - - - - - - - - - - - - - - - - - - - - -  
1-18 - - - - - - - - - - - - - - - - - - - - - -  
1-19 - - - - - - - - - - - - - - - - - - - - - -  
1-20 - - - - - - - - - - - - - - - - - - - - - -  
1-21 - - - - - - - - - - - - - - - - - - - - - -  
1-22 - - - - - - - - - - - - - - - - - - - - - -  
1-23 - - - - - - - - - - - - - - - - - - - - - -  
1-24 - - - - - - - - - - - - - - - - - - - - - -  
1-25 - - - - - - - - - - - - - - - - - - - - - -  
1-26 - - - - - - - - - - - - - - - - - - - - - -  
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Mutant 1-1 1-2 1-3 1-4 1-5 1-6 1-7 1-8 1-9 1-10 1-11 1-12 1-13 1-14 1-15 1-16 1-17 1-18 1-19 1-20 1-21 1-22 1-23 1-24 1-25 1-26 
2-1 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-2 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-3 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-4 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-5 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-6 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-7 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-8 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-9 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-10 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-11 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-12                                       Y             
2-13 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-14 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-15 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-16 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-17 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-18 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-19 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-20 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-21 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-22 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-23 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-24 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-25 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-26 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-27                                                     
2-28 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-29                                                     
2-30 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-31 - - - - - - - - - - - - - - - - - - - - - - - - - - 
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2-32 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-33 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-34 - - - - - - - - - - - - - - - - - - - - - - - - - - 
2-35                                                     
 
Mutant 2-1 2-2 2-3 2-4 2-5 2-6 2-7 2-8 2-9 2-10 2-11 2-12 2-13 
2-1 X - - - - - - - - - - - - 
2-2 - X - - - - - - - - - - - 
2-3 - - X - - - - - - - - - - 
2-4 - - - X - - - - - - - - - 
2-5 - - - - X - - - - - - - - 
2-6 - - - - - X - - - - - - - 
2-7 - - - - - - X - - - - - - 
2-8 - - - - - - - X - - - - - 
2-9 - - - - - - - - X - - - - 
2-10 - - - - - - - - - X - - - 
2-11 - - - - - - - - - - X - - 
2-12                           
2-13 - - - - - - - - - - - - X 
2-14 - - - - - - - - - - - - - 
2-15 - - - - - - - - - - - - - 
2-16 - - - - - - - - - - - - - 
2-17 - - - - - - - - - - - - - 
2-18 - - - - - - - - - - - - - 
2-19 - - - - - - - - - - - - - 
2-20 - - - - - - - - - - - - - 
2-21 - - - - - - - - - - - - - 
2-22 - - - - - - - - - - - - - 
2-23 - - - - - - - - - - - - - 
2-24 - - - - - - - - - - - - - 
2-25 - - - - - - - - - - - - - 
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2-26 - - - - - - - - - - - - - 
2-27                           
2-28 - - - - - - - - - - - - - 
2-29                           
2-30 - - - - - - - - - - - - - 
2-31 - - - - - - - - - - - - - 
2-32 - - - - - - - - - - - - - 
2-33 - - - - - - - - - - - - - 
2-34 - - - - - - - - - - - - - 
2-35                           
 
Mutant 2-14 2-15 2-16 2-17 2-18 2-19 2-20 2-21 2-22 2-23 2-24 2-25 2-26 2-27 2-28 2-29 2-30 2-31 2-32 2-33 2-34 2-35 
2-1 - - - - - - - - - - - - - - - - - - - - - - 
2-2 - - - - - - - - - - - - - - - - - - - - - - 
2-3 - - - - - - - - - - - - - - - - - - - - - - 
2-4 - - - - - - - - - - - - - - - - - - - - - - 
2-5 - - - - - - - - - - - - - - - - - - - - - - 
2-6 - - - - - - - - - - - - - - - - - - - - - - 
2-7 - - - - - - - - - - - - - - - - - - - - - - 
2-8 - - - - - - - - - - - - - - - - - - - - - - 
2-9 - - - - - - - - - - - - - - - - - - - - - - 
2-10 - - - - - - - - - - - - - - - - - - - - - - 
2-11 - - - - - - - - - - - - - - - - - - - - - - 
2-12                                           
2-13 - - - - - - - - - - - - - - - - - - - - - - 
2-14 X - - - - - - - - - - - - - - - - - - - - - 
2-15 - X - - - - - - - - - - - - - - - - - - - - 
2-16 - - X - - - - - - - - - - - - - - - - - - - 
2-17 - - - X - - - - - - - - - - - - - - - - - - 
2-18 - - - - X - - - - - - - - - - - - - - - - - 
2-19 - - - - - X - - - - - - - - - - - - - - - - 
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2-20 - - - - - - X - - - - - - - - - - - - - - - 
2-21 - - - - - - - X - - - - - - - - - - - - - - 
2-22 - - - - - - - - X - - - - - - - - - - - - - 
2-23 - - - - - - - - - X - - - - - - - - - - - - 
2-24 - - - - - - - - - - X - - - - - - - - - - - 
2-25 - - - - - - - - - - - X - - - - - - - - - - 
2-26 - - - - - - - - - - - - X - - - - - - - - - 
2-27                                             
2-28 - - - - - - - - - - - - - - X - - - - - - - 
2-29                                             
2-30 - - - - - - - - - - - - - - - - X - - - - - 
2-31 - - - - - - - - - - - - - - - - - X - - - - 
2-32 - - - - - - - - - - - - - - - - - - X - - - 
2-33 - - - - - - - - - - - - - - - - - - - X - - 
2-34 - - - - - - - - - - - - - - - - - - - - X - 
2-35                                             
 
 
